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ABSTRACT 
The reported research was an investigation of attitudes and beliefs 
associated with participation in screening programmes and clinical 
trials, carried out by general practitioners. Particular focus was given 
to cardiovascular risk-reduction. 
The work comprised two main studies. The preliminary study was entirely 
exploratory, designed to guage public attitudes towards GP involvement 
with preventive screening programmes and clinical research; and to 
identify the range of variables associated with participation in such 
projects. The subsequent study utilised a more formal approach in which 
the Behavioural Intention Model was utilised to evaluate the power of 
influencing factors. 
Both studies employed self-completion questionnaires, developed from 
preliminary in-depth interview data. For the first study instrument 
distribution was effected by personal approach, for the second study 
postal distribution was employed. 
In all, 1,037 respondents contributed to the surveys - 442 to the 
preliminary exploration and 695 to the follow-on study. These 
represented response rates of approximately 65% and 36% respectively. 
The main findings were that attitudes towards screening were generally 
favourable, though there was less conformity in attitudes expressed 
towards clinical trials. These findings were reflected in reported 
participatory intentions. 
No evidence was found of any factors which might pose widespread 
barr i ers to screen ing part ic i pa t ion, though some potent ia 1 deterren ts 
were identified for older women. It was also noted that other potential 
deterrents may have been masked by the 'middle class' bias of the 
sample. 
Major deterrents to trial entry were identified as worries about: side-
effects, acquired resistance, discontinuation of current effective 
medications and lack of adequate information. These all interacted with 
the 'guinea pig' factor. 
Response rates and responses associated with medical and non-medical 
sampling sources were also discussed; and consideration was made of the 
general utility of the Behavioural Intention Model for research of this 
kind. 
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CHAPTER I 
GENERAL INTRODUCTION 
The work described in the thesis was an investigation of public attitudes 
and beliefs associated with preventive medicine and clinical research. 
Particular focus was given to screening and drug trials for cardio-
vascular risk-reduction, within general practice settings. 
The primary purpose of the reported research was to gain some 
understanding of people's attitudes towards GPs' involvement with 
cl inical research; and to identify factors influencing participation in 
preventive projects. A secondary objective was to test the Behavioural 
Intention Model (Fishbein and Ajzen, 1975) as an effective tool for the 
prediction and understanding of participatory intention. 
The impetus for the thesis research came from an early association with a 
medical research project, the Health Maintenance Study. In this project 
doctors are investigating ways of reducing cardiovascular risk within 
general practice settings. The research entails both screening and 
clinical trials of drugs. 
Cardiovascular events - heart attacks and strokes - are responsible for 
many premature deaths and much chronic disability within our society 
today. A considerable proportion of these events could be avoided by the 
effective application of current medical knowledge, and there is well-
founded hope that new drug treatments may further help to reduce 
cardiovascular risk. Such preventive application has been advocated by 
the World Health Organisation (WHO), and vocally encouraged by our 
Government. Much work has been undertaken to ascertain cost-effectiveness 
of preventive screening programmes and there is a wealth of literature 
representing a biomedical perspective of prevention. However, less work 
has been undertaken into publ ic feel ings about prevent i ve medic ine and 
screening, especially as it related to cardiovascular disease (CVD) , and 
even fewer studies have been devoted to public attitudes to clinical 
trials. 
People's attitudes and beliefs are almost certainly an important factor 
in their decisions as to whether or not they participate in screening or 
clinical trials, and our lack of knowledge in these areas may well be 
contributing to our fai lure to reduce the incidence of cardiovascualr 
events. If preventive medicine is to be put into effective practice it 
will require active participation by both health professionals and the 
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people they seek to serve. Similarly, clinical trial research can only be 
of value if it attracts compliant entrants. 
However, until more is known about the attitudes people hold towards 
prevention, and the beliefs which underly these -attitudes, the 
development of appropriate education and health promotion campaigns will 
remain somewhat 'hit and miss' and the potential benefits of preventive 
medicine may remain unrealised. Equally, until the factors influencing 
participation in clinical trials are more fully understood, problems 
asociated with recruitment and compliance cannot be adequately addressed. 
Therefore, an invest igat ion of the area was undertaken wi th the general 
aims of achieving some understanding of public feelings towards GP 
involvement with preventive medicine and clinical research; and to 
identify factors associated with public participation in these 
activities. In accordance with these aims, two studies were undertaken. 
The first was a purely exploratory investigation of the topic, whilst the 
second was a more formalised approach to understanding, in which Fishbein 
and Ajzen's Behavioural Intention Model was employed. 
Each of these studies will be presented in detail, including their 
specific aims and objectives, after a more global introduction to the 
research area. 
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1. PREVENTIVE MEDICINE, SCREENING AND CLINICAL TRIALS 
1.1 BACKGROUND TO RESEARCH AREA 
Preventive medicine contrasts with curative medicine in that whereas the 
latter seeks to provide a restoration to health when something has 
already gone wrong, the aim of the former is to prevent ill health from 
occuring. Thus the aspiration is towards health maintenance rather than 
health restoration. 
In the past, the practice of medicine has generally been oriented more 
towards the curative than the preventive approach. However, this balance 
is gradually changing, and more than a decade ago the shift of emphasis 
was endorsed by the Government in a consultative document entitled 
'Prevention and Health: Everybody's Business'. The need for a change away 
from the curative, towards the preventive approach to ill health, in all 
sectors of the health service, was stressed in this document; not least 
because, "curative medicine may be increasingly subject to the law of 
diminishing returns". Also, a need was recognised for individuals to 
assume a greater responsibility for their own health, since "the greatest 
potential, and perhaps the greatest problem for preventive medicine,now 
lies in changing behaviour and attitudes to health" (HMSO, 1976). 
As indicated above, preventive medicine entails the early detection of 
latent disease, or susceptibility to a disease; and the implementation of 
measures which are known, or believed to, hold off the development of the 
disorder. Public preventive health behaviour, is an essential part of 
the successful application of any preventive medicine programme. It has 
been def ined as "any ac t i v i ty undertaken by a person who be 11 eves 
himself to be healthy, for the purpose of preventing disease or detecting 
disease in an asymptomatic stage" (Kasl and Cobb 1966). Participation in 
screening is, therefore, an important preventive health behaviour. 
Screening may be understood as "medical invest igat ion which does not 
ar ise from the pat ient I s request for advice for a spec i f ic compla int" 
(Nuffield Provincial Hospitals Trust 1968). However, most screening 
services are offered for the detection of fairly specific problems, 
though more general health checks 'multiphasic' screenings are 
becoming more common, especially in the USA. In Britain, multiphasic 
examinations are usually confined to checks for employment or insurance 
purposes and the validity and cost-effectivness of routine application of 
this type of health check have been questioned (eg The South-East 
London Screening Study Group, 1977; Holland, 1982), 
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Nevertheless, the case for several specific screening services has been 
established for both children and adults. These include antenatal 
screening checks and infant screening programmes, such as the Guthrie 
test for phenylketonuria, and health visitor testing of speech, vision, 
hearing, and motor and intellectual development. Rubella tests for older 
girls (and women) are also fairly common. In adults, screening for 
tuberculosis used to be the most widely applied screening service, but 
developments in the prevention of tuberculosis have become so effective 
that mass screening for this disease has now ceased. 
Currently, the Papanicolaou smear test for cervical cancer is probably 
the most common type of screening, but other programmes, such as those 
for the early detection of breast cancer, and general practice screening 
for cardiovascular risk, are rapidly becoming more widespread. Screening 
for all the above mentioned conditions is justified by the fact that they 
are common and/or potent ially dangerous condi t ions which can be easi ly 
and economically detected and for which effective treatments are 
avai lable. 
Once screening reveals a person to be at risk, appropriate preventive 
measures should be instigated. The establishment of preventive measures 
comes about as a resul t of cl inical research. In some instances the 
appropriate preventive treatment is almost entirely dietary, in others 
surgical intervention may be indicated, but in many cases the treatment 
employed involves drug therapy and the value of drugs can only be 
determined through proper clinical trials. 
• Cl inical trial' may refer to assessment of any therapeutic procedures, 
but the term is commonly associated with the testing of drugs and it is 
defined here as a scientific test of a drug whereby its postulated 
effects, and its side-effects, may be evaluated. A variety of research 
designs may be employed in clinical trials and the final choice of design 
will depend upon such factors as the type of drug involved, the reason 
for the testing of the drug and the type of subjects on whom the drug is 
being tested. However, to be effective and scientifically sound, the 
design used must involve some sort of control group who are as similar as 
possible to the experimental group in all respects except that of the 
drug administered. 
Clinical trials of drugs have long been an important, if often 
controversial aspect of medical research. They have been undertaken 
within the settings of hospital treatment, general practitioner care, and 
with special volunteers paid by pharmaceutical companies. These trials 
may involve new drugs or they may involve drugs which are already well 
established medicines for certain treatments being tested for other 
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therapeutic value. Where new drugs are concerned clinical trials are a 
legal requirement. It is to be hoped that clinical trials are conducted 
only on participants aware of the fact that they are participating in 
clinical trials, and, who do so having given their I informed consent'. 
However, it is evident that this is not always the case (Faulder, 1985) 
and it must be conceded that on some occasions, especially within 
hospital and general practice settings, trial entrants may be unawarl:! of 
their research-subject status. 
Nevertheless, it remains true that properly conducted clinical trials 
using human subjects represent the only reliable method of determining 
the value or otherwise of any given drug for any particular condition. 
Without screening programmes to detect incipient health problems and 
clinical trial research to determine appropriate treatments; morbidy and 
mortal i ty due to numerous causes, would be far greater than it is at 
present. Continued endeavours in preventive research and the effective 
application of resultant knowledge hold the promise of further improving 
the nation's health. Thus, it would seem that the need for screening 
programmes and clinical trials is a very real one. 
However, their potential value can only be realised if people take 
advantage of screening opportunities and agree to participate in clinical 
trials. Also, although the arguments for screening and clinical research 
are strong, there are several factors which may operate to prevent their 
effective application. These represent issues of particular imporL~nce to 
screening and clinical research and will be considered in the following 
section. 
2. SPECIAL ISSUES RELATING TO SCREENING AND CLINICAL RESEARCH 
The special issues which relate to screening and cl inical trials are 
basically methodological concerns of participant recruitment and 
compl iance wi th research regimens. These concerns represent the cor·1:! 
methodological issue relating to research of this type, and other 
important issues of ethical concerns, volunteer bias and anonymity relate 
back to this key problem. 
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2. 1 PARTICIPANT RECRUITMENT AND COMPLIANCE WITH RESEARCH REGIMENS. 
As stated earlier, although the arguments for preventive research and 
associated clinical trials are strong, they can only be effective if 
people participate in such projects. The very best designed research can 
only be of value if it is able to attract complying participants. Thus an 
immediate problem facing researchers engaged in projects which entail 
screening or clinical trials, is that of attracting appropriate people 
who will effectively co-operate. 
Even well established screening procedures suffer inadequate utilisation, 
so the prospects for new research programmes may not be particularly 
bright. For example, two decades of screening for cervical cancer have 
failed to have much impact on the incidence of the disease, not becau~~ 
the test is ineffective, but because it has failed to attract 
sufficiently wide application (Fowler 1985). There are indication~ that 
responsibility for the failure of application resides, to some extent, 
with both doctors and patients (Chamberlain, 1984). However, since GPs 
receive extra payments for the performance of cervical smears, it does 
not seem unreasonable to suggest that responsibility for ineffective 
application may rest quite heavily on the patients. 
Similarly, whilst patients may express verbal support for the concept of 
screening (eg O'Brien and Hodes,1979; Cartwright and Anderson 1981), 
actual attendances achieved rarely match up to such high levels (O'Brien 
and Hodes, 1979; King, 1982). What is more, there is evidence (eg. 
Goodman, 1973) that it is those who would most benefit from scre~ning who 
are the least likely to take advantage of such services. 
Just why people do not make full use of the screening services available 
is not entirely clear, especially since there does seem to be popular 
favourabi I ty to the concept of check-ups. I t would seem that there are 
some factors operating to influence participatory decisions which tu·e not 
yet understood, or which have not been adequately addressed. If more 
people are to be encouraged to participate in screening, further attempts 
to identify such influential factors are clearly required. 
In respect of cl inical trials, recrui tment and compliance may pose major 
methodological problems. Trial entrants need to be representative of the 
population to whom eventual administration of the drug is envisaged and 
they need to be commi t ted to co-operate wi th research regimens. Even 
under normal therapeutic conditions compliance with drug regimens is far 
from optimal (eg. Peck 1978, Ley 1982), and Porter (1969) found this to 
be equally true of cl inical trials. Indeed he concluded thaL ~~t::very 
patient is a potential defaulter. Compliance can never be assumed." 
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Compliance is clearly very important to research results and its 
assessment would seem to be essential. But regardless of POl-ter's 
warning, the issue of compliance has rarely been adequately addressed in 
subsequent published studies of clinical trials. 
For trials conducted within in-patient populations, thorough monitoring 
of drug administration may be fairly easily achieved. But, within general 
practice settings, adherence to prescribed regimens is much harder to 
ensure since GPs must rely almost exclusively on their patients to 
properly carry out instructions. Apart from the obvious problem of 
patients deliberate mis-reportings of their compliance, there is also a 
very real problem of patients believing that they are carrying out 
'doctors' orders', when in fact they may have forgotten or misinterpr~L~d 
regimen instructions (Ley et al. ,1976). 
Furthermore, although much work has been undertaken in the area of 
regimen defaulting, there is still no profile of the 'classic (;omplier' 
or the 'classic defaulter' to assist the clinician in assessments of who 
may, or may not, be entrusted to carry out regimen instructions. If W~ 
knew more of what people feel and believe about clinical trials we would 
be in a better position to understand both the influences on 
participation and compliance and their implications for research outcome. 
Therefore, unless or until adequate research is undertaken, problems of 
adequate recruitment and compliance cannot be effectively addressed. 
Regretably, little research has been published relating to this issue or 
indeed of public attitudes towards any medical research using human 
subjects. Saurbrey et al. (1984) undertook an investigation into 
patients attitudes towards the use of human subjects in medical 
research; and reported that 98% of their respondents "considered patient 
and doctor collaberation on new therapeutical methods both necessary 8ud 
desirable". They also stated that over 80% of their sample would agree 
to participate in certain specified research projects solely on the 
guarantee of the doctor. However, theirs was a hospital-based ~tudy 
undertaken in Denmark, and no comparable work seems to have u~en 
performed in England, or relating to research run in general practices. 
If people hold unfavourable attitudes towards such projects the 
attraction rate of subjects will be small and possibly biased, and unless 
particular aspects of concern are identified they cannot be given 
consideration. Therefore, the problem of securing participation in 
screening programmes and clinical research is not resolved and the need 
for assessment of general attitudes towards this type of research is 
obvious, though as yet unmet. 
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Another unresolved problem which has special relevance for screening 
programmes and clinical research is that of determining the 
most appropriate target population. For projects like cervical cancer 
screening, the population is clearly limited to one sex. Equally, since 
the age group of those most at risk was also established,the parameters 
of the target populat ion were further determined <though these a1-e now a 
matter of controversy and are 
clinical research programmes 
easily defined. 
currently under review). However, in other 
the selection population may not be so 
A growing problem facing many clinical researchers is that of whether or 
not to include the elderly in their target population. The proportion of 
elderly people within the general population is progressively 
increasing, and this sub-group represents a large proportion of those 
requiring medical attention. There are many health problems ~ltendent 
upon advanc ing age which detract from the qual i ty of 1 i fe whi 1st not 
posing threat to life. Routine screening of elderly people in general 
practice has been found both to benefit the patient and be cost-
effective in the long term <Pike 1978). 
Regarding clinical research, where study aims are the identification of 
trea tmen ts for genera 1 usage, the se lect ion popul at i on should inc 1 ude 
elderly people if a representative sample is to be acheived. However, 
many randomised clinical trials have systematically excluded the elderly 
from research programmes designed to answer theraputic questions which 
are of particular relevance to older people (Miller,S. 1985). For 
example, the treatment of hypertension is an important clinical issue for 
elderly people, yet most major trials relating to this have not included 
participants over the age of 60. 
It has been suggested (eg by Miller) that perceived problems of poor 
comprehension and non-compliance may have been responsible for researcher 
decisions to exclude the elderly from clinical trial projects. However, 
other work in this area has indicated that poor comprehension and non-
compliance may not be a prerogative of the elderly. 
Stanley et aI, (1984) investigated the competence of elderly patients to 
give informed consent to research participation, and found thc1t 
comprehension of consent information was considerably greater among 
younger than older patients. Nevertheless,there were no differences 
between the young and the elderly in respect of their choices about 
projects in which participation was 'reasonable'. 
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However, Philip Ley and his colleages have shown that poor comprehension 
of med i ca 1 i nformat i on is a problem ina 11 sec t ions of the popul a t ion. 
Furthermore, they demonstrated that lack of comprehension of information 
imparted by doctors was an important factor in pat ient dissat isftlL lion 
with communications, andonncompliance with medical advice and 
regimes (Ley et al., 1976; Ley, 1977). 
Encouragingly, Ley at al. have also demonstrated that comprehension and 
retent ion of medical informat ion can be fac iIi tated by gi ving pat leni~ 
suitable written 'back-up', as well as verbal information (Ley et 
a1.,1975). In addition, Myers and Calvert (1978) found that providing 
patients with written information about side effects had the effect of 
decreasing regimen defaulting. As long as 'back-up' material is 
presented in a manner appropriate to the visual accuity of the elderly, 
benefits to comprehension and retention would be just as applicault:! to 
them as to younger people. Since understanding and remembel- ing 
instructions are necessary factors for 
compl iance is a fundamental problem 
impl icat ions of these findings for 
participants are clear. 
2.2 ETHICAL CONCERNS 
compliance and since non-
for clinical research, tilt:! 
doctors sol ic i t ing resecu·ch 
In any research, ethical concerns must govern methodological design, not 
only for moral reasons, but also because ethical concerns often have 
methodological implications. This is particularly so in clinical 
research on human participants where the most fundamental ethical issue 
is that of informed consent. For example, if people are involved in 
research projects for which they have not given proper informed consent, 
they may not fully understand the relevance or importance of regimen 
instructions. Equally, they may harbour unaddressed worries (founded or 
unfounded) about participation. 
Either way, frank discussions between researcher and participant are 
essential for· both individual rights and study validity. Without the full 
informed consent of participants, sample attrition may be considerable 
and/or non-compliance with experimental instructions may obtaill. Work 
which supports this proposition has already been cited (eg Ley et 81., 
1975, 1976, section 2.1 above), 
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The Saurbrey study also mentioned previously (Saurbrey et aI, 1984), 
highlighted the importance of informed consent from the point of view of 
p<>tent ial part ic ipants. In an "interview study focusing theraput Ic 
trials" 114 in- and out- patients from a department of internal medicine 
in a Danish hospital were interviewed on the basis of a questionnaire 
with 4 key questions. These questions related to attitudes to medical 
trials with humans as subjects; patient emphasis on informed consent; 
attitudes to the inclusion of patients who could not give informed 
consent; attitudes to tentative participation in 4 concrete projects. 
Their results revealed that patients were generally in favour of medical 
trials being performed, as outlined earlier, but that they should be 
conducted in the I ight of informed consent. I t was reported that tl8% of 
informants considered information of patients participating in trials a 
prerequisite, and that 86% accepted participation in scientific Lrials 
based on the guarantee of the doctors responsible. Inclusion of patients 
unable to give informed consent ego children and the mentally 
handicapped, was supported by 75% of people interviewed, though of these, 
77% added the proviso that the consent would have to be gi ven by the 
relatives of these patients. 
Patient attitudes towards the need for informed consent were evident from 
this study and British patients' desires for full information about their 
conditions and treatment have been demonstrated by several other 
researchers (eg Cartwright 1967, Ley and Spelman 1967, Cartwright awl 
Anderson 1981, Ley 1982). 
However, • informed consent· is a rather i ll-def ined phrase and may mean 
di fferent things to di fferent people. Doctors may bel ieve they have 
obtained informed consent because they have given patients the relevant 
information and the patient has agreed to participate in the project. 
However, Ley has shown in various studies that the amount and quality of 
information given to patients, as well as patient comprehension and 
retention of such information is often far from optimal (eg Ley 
1977,1979, 1982). 
If patients do not understand what their doctors say to them, and feel 
dissatisfied with the quality of their communications with him or her, 
then by definition, these patients cannot give informed consent, and the 
consequent methodological implications apply. 
Unfortunately, failure of comprehension by the patient may not be the 
only bar to securing informed consent. In a recent study of physicians' 
perspective of informed consent, Taylor and Kelner (1987) reported that 
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"Physician responses indicate that they regard informed consent as an 
intrusion into the doctor-patient relationship". 
These physicians also felt that the need to obtain informed consent to 
scientific experiments contributed to "decreasingly effective doctor-
pat ient communicat ions". The physic ians interviewed in this study were 
all breast cancer specialists from 8 different countries, including 
England and Scotland. One of their major objections to a research conseI1L 
form was that it accentuated their dual role as care-givers cwu 
scientific investigators, making them uneasy in their relationship with 
the patient. If this is true of specialists, it must also be considered a 
potential problem for general practitioners who involve their patients 
with medical research. 
The issue of whether or not GPs should be involved in clinical trials is 
an area of content ion. On the one hand people 1 ike Porter (1969) have 
argued that GPs are particularly well placed to run clinical trials since 
they have a special knowledge of, and relationship with their patients 
which may minimise regimen defaul t ing. On the other hand, others <ego 
Coulehan 1985), have pointed out that there may be ethical objections to 
GP involvement with clinical research since the family doctor "has the 
heal ing power of persuasion, which might 1 imi t autonomy and informed 
consent." 
In support of Porter, Cartwright and Anderson (1981) reported that 
approximately 3/4 of their respondents felt that it was easy to talk to 
their doctor and to ask him/her questions. Similarly Ley found that 
people expressed greater satisfaction with the quality of communication 
they experienced with their general practitioners than with hospital 
doctors. If proper informed consent and subsequent compliance with 
regimens is dependent upon good doctor-patient communications, it would 
seem that GP involvment in clinical trials might be scientifically and 
ethically quite sound. Conversly, if consent is obtained as a function of 
, 1 imi ted autonomy', ethical and possibly methodological val idi ty would 
have to be questioned. 
The many aspects of the controversial issue of informed consent are 
likely to remain unresolved for some time. In the meantime it poses a 
potential obstacle to clinical research participation and further 
investigation of public attitudes to GP involvment with research, and of 
the extent to which people feel that they can; should; and want to; 
question their doctor, appears to be warranted. 
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2.3 VOLUNTEER BIAS 
Clinical trials are most commonly conducted so that the suitability of 
drugs for general usage may be ascertained. 
Clearly, if research results are to be at all generalisable beyond the 
sample serving as subjects, that sample must be representative of the 
population to whom the results are to be applied. Equally clearly, in the 
type of research projects under discussion, subjects must be drawn from 
consenting volunteers. But, as Rosenthal and Rosnow (1969) have pointed 
out, volunteer subjects constitute a "strikingly unrepresentative 
sampling of people." 
In their review of a wide range of studies indicating the peculiarities 
of volunteers, Rosenthal and Rosnow found that volunteers tend to be 
better educated, have higher occupational status, higher need for 
approval, higher IQ, and be less authoratarian and better adjusted than 
non-volunteers. However, Sheridan (1979) reported that participants in an 
autogenic training experiment which he conducted, proved to be far above 
norms in authoritarianism. 
Rosenthal and Rosnow were reporting on people who said they would 
participate in experiments and those who said that they wouldn't, and 
they did admi t that their 'volunteer effects' were flawed since many 
people who say that they will participate do not actually turn up for the 
experiment. Even so, the probability of a qualitative difference between 
volunteer participants and non-participants must be acknowledged. 
Whilst both the Rosenthal, and the Sheridan examples of differences 
between volunteers and non-volunteers refered to participation in 
psychological experiments, it seems at least equally 1 ikely that such 
differences will apply to medical research programmes. Support for this 
supposi t ion was offered by Bergstrand et al. (1983) who found that there 
were some very important risk-factor differences between participants and 
non-participants in a Swedish study of cardiovascular risk factor 
screening. 
Evaluation of the relevance of volunteer bias to research outcome can 
only be made if the bias is identified. Of course, identification of bias 
in a sample does not necessarily lead to rectification of the bias, 
especially in clinical research where truly voluntary participation must 
obtain. However, it does allow for an assessment of the 1 imi tat ions uf 
the sample and enable determination of the parameters within which study 
results can be applied. Therefore, whilst acknowledging Rosenthal's 
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point that reported participatory intention is not necessarily ~ynonymous 
with actual participatory behaviour, it would seem important to try to 
identify any differences between potential participants and non-
participants in clinical research. 
2.4 ANONYMITY 
Closely allied to the issue of volunteer bias is the issue of anonymity. 
Clearly, in some areas of clinical research anonymity is not a viable 
option. For example it would be a nonsense to conduct screening 
programmes anonymously if the aim of screening is to identify those at 
risk with the objective of implementing measures to reduce the risk. 
Anonymous entry into clinical trials would be equally untenable. However, 
in studies of attitudes and intentions relating to clinical resetlrch, 
anonymity of participation is an option which should be considered in 
terms of its costs and benefits to both participants and study results. 
The main costs of true anonymity, which is perceived as such by potential 
participants, are preclusion of follow-up approaches and comparisons of 
individual participants and non-participants. Bearing in mind the problem 
of bias, it may be considered imperative that individual participants and 
non-participants be identifiable for bias assessment. Furthermore, given 
that it is generally accepted that bias decreases as response rate 
increases, it may be considered necessary to allow for follow-up contacts 
to be made in attempts to increase response rates. 
On the other hand, if a good response rate can only be achieved by 
employing non-anonymous participation and the use of follow-up contacts, 
the achievement may be due to some feelings of coercion to comply, 
especially if the study is associated with the potential participant's 
own doctor. There is some evidence to suggest that people are more likely 
to respond to a questionnaire if it comes from their own GP. than if it 
comes from a research unit doctor (Smith et al., 1985). This may reflect 
a chance result, or relatively unfavourable attitudes to research units. 
Alternatively, 
Kirsch t (1983) 
it may reflect 
stated in his 
a re 1 uc tance to 'cross' one's GP. As 
paper on 
research, "There are spec ial problems 
quest ioning may imply a possible impact on 
retention of negative information in a 
caregivers." Even where the implication is 
is perceived by potential participants, so 
coercion to respond. 
preventive health behavior 
of threat to people when 
future heal th care, or the 
record that is seen oy 
a false one, if the threat 
too might be a feel ing of 
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Apart from the obvious moral objections to such an approach, there are 
also methodological implications. If participation itself is achieved by 
coercion - perhaps because a person does not wish to jeopardise her/his 
relationship with the doctor by a refusal to participate - the suspicion 
that similar feelings may influence given reponses, cannot be (:1:1~::iily 
dismissed. An assurance of participant anonymity will not guarantee 
against sample bias, but it should minimise bias of this sort. 
3. CARDIOVASCULAR RISK REDUCTION 
So far, the introduction to the thesis has been rather wide, considering 
aspects of relevance to the general area of preventive medicine and 
associated screening and clinical trials. However, the research to be 
presented was specifically focused on attitudes and beliefs relating to 
cardiovascular risk reduction programmes and attention will now be 
narrowed to this particular field. 
3.1 EXTENT OF THE PROBLEMS CAUSED BY CARDIOVASCULAR DISEASE AND THE 
POTENTIAL FOR CARDIOVASCULAR RISK REDUCTION 
Every year cardiovascular diseases (CVD) exact a heavy toll of premature 
death and disability. Circulatory diseases are the single most common 
cause of death in Britain today and in 1981 they accounted for half of 
all deaths in the Uni ted Kingdom. Of these 54% were due to ischaemic 
heart disease and 25% to cerebrovascular disease (strokes). Amongst males 
circulatory diseases are responsible for the greatest number of certified 
incapacity days. In 1981/82 this was 56.44 millions - more than 20% of 
the total working days lost through illness. 
Furthermore, almost 60 million prescriptions for cardiovascular diseases 
were dispensed, the number being second only to presciptions for central 
nervous system treatments such as sleeping pills, sedatives and 
tranquillisers, anticonvulsants, analgesics and anti-depressants. 
However, whilst the number of prescriptions for central nervous system 
treatments went down by 3% between 1975 and 1982, the number of 
cardiovascular prescriptions rose by 47% over the same period (Compendium 
of Health Statistics, 1984). 
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Although the mortality and morbidity figures apply to all sectors of the 
population, the incidence of cardiovascular events, is greater among the 
lower socio-economic groups. These groups also tend to have dietry and 
smok ing habi ts which increase their vulnerabi 1 i ty to cardiovascular r" i~k 
(eg. Inequalities in Health, incorporating The Black Report and The 
Hea 1 th D i v ide, 1988). 
The real tragedy behind these figures is that many of them could have 
been avoided. Indeed, to quote the Prevention of Arterial Disease Report 
from the Royal College of General Practitioners (1981):- "about half of 
all strokes and a quarter of all deaths from coronary heart disease in 
people under seventy are probably preventable by the appl icat ion of 
exist ing knowledge. It Much of this knowledge takes the form of the 
ability to detect those most at risk of suffering a cardiovascular event 
and of establ ished benef ic ial 1 i fe-style changes which can be pub! ic Iy 
disseminated via health education. 
There are also establ ished drug therapies which could help to hold off 
cardiovascular events in those known to be at risk, and work continues to 
establish other effective pharmaceutical interventions which could help 
in the fight against these terrible diseases. But as has already been 
discussed, in order to effectively apply existing knowledge, people must 
first be screened so that those at risk may be identified. Equally, the 
effects of chemical intervention cannot be determined without the use of 
clincal trials on human subjects to indicate the efficacy, or otherwise, 
of any particular drug for any specific condition. 
Within the specialist field of cardiovascular risk reduction much 
research, from both medical and psychological viewpoints, has been 
undertaken to investigate risk factors and preventive measures. As 
indicated above, the research has been quite successful and many risk 
factors and preventive measures have been identified. These include both 
physiological and psychological factors and to give some indication of 
the extent of this work, a brief overview of some of the psychological 
research, and an out 1 ine of some of the combined studies wi 11 be 
presented in the following section. 
3.2 PSYCHOLOGICAL FACTORS IN HYPERTENSION 
Hypertension has been identified as a major risk factor in the 
development of other more serious cardiovascular disorders such as 
ischaemic heart disease, myocardial infarction and cerebrovascular 
acc idents (strokes). Approximately 90% of all chronic hypertension is 
essential hypertension ie. hypertension for which no physiological bases 
are known, and for which psychogenic origins are assumed. Once this 
condition is established, changes in the vasculature occur which 
exacerbate and perpetuate it <Folkow 1971). 
However, there is now a considerable body of evidence from aetiological 
studies on both animals and humans, which implicates an influential role 
of psychological factors in the initial development of essential 
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hypertension ( eg Obrist, 1981; Steptoe, 1981), Similarly, there is a 
large and growing body of 1 i terature which detai Is the use of 
psychological techniques such as relaxation, stress management training, 
meditation, and bio-feedback in the treatment of this disease (eg 
Agras,1981; Basler et al,1982; Kallinke et al,1982; Crowther,1983; Patel 
et al 1981; Johnston,1982;); and many results indicate that some of these 
techniques, especially relaxation and stress management training, may be 
a valuable adjunct to more traditional drug based therapy (Wadden et 
al,1980; Steptoe, 1982). 
If, as it would appear they do, psychological factors influence the 
development of essential hypertension,the further identification of these 
factors, and of their role in hypertension development, must represent a 
priority research area. Only when it is known precisely what, and how, 
psychological factors influence this morbidity can any hopes be held of 
preventing the initiation of this disease. Likewise, given that interest 
in psychological treatments for hypertension is expanding within both 
the psychological and medical professions, a preliminary investigation of 
public attitudes towards the role of psychological factors in the 
aetiology of hypertension and to the use of psychological techniques in 
the treatment of hypertension would seem to be appropriate. 
3.3 RESEARCH INTO PHYSIOLOGICAL AND PSYCHOLOGICAL RISK FACTORS 
Several studies, from various countries, have been undertaken to 
investigate the risk factors associated with cardiovascular disease. For 
example, investigation of general risk factors has been undertaken in 
America (eg Kannel et al 1976) and Britain (eg Shaper et aI, 1985). Other 
studies concerned with particular risk factors and their ecological 
correlates have been undertaken elsewhere. These studies include 
investigations of: hypertension and urban stress amongst blacks in 
Nigeria and America (Akinkingbe & Akinkingbe, 1977); hypertension and 
occupational stress (eg Cobb and Rose, 1973); hypertension and 
overcrowding in an American prison (O'Atri et al.,1981); and comparisons 
of coronary heart disease, obesity and serum cholesterol levels in Japan 
and in Japanese emigrants in Hawaii and California (Marmot et al., 1975). 
The efficacy of special life-style change counselling (Multiple Risk 
Factor Intervention Trial Research Group, 1982), and of pharmaceutical 
intervention in the prevention of CVO development (Medical Research 
Counci I Working Party, 1985) have also been investigated. Four of the 
studies mentioned above represent major works tackling specific aspects 
of research into CVO risk factors and risk reduction and because of 
their importance to the area they will be discussed in a little more 
depth below. 
3.3.1 The Framingham Study 
A classic medical study in this field is the Framingham study which was 
first published in 1976, and represented the first major study of 
cardiovascular risk factors. From 1948 onward, a sample of over 5000 men 
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and women residing in Framingham, Mass. USA, were followed up in an 
attempt to identify factors which put people at risk of cardiovascular 
diseases. Clinical examinations were conducted every 2 years on all 
participants and there was continuous surveillance of morbidity and 
mortality The results of this study showed that the chances of 
developing a cardiovascular disease by age 65 were 37% for a man and 18% 
for a woman. They also indicated that people at high risk of CVD can be 
effectively identified from a few factors -ie a measurement of serum 
cholesterol and blood pressure, a smoking history, an electrocardiogram 
(E.C.G.), and a determination of glucose intolerance. 
This general function for identifying people at high risk of CVD was 
also found to be effective in identifying people at risk for each of the 
specific diseases, coronary heart disease, atherombotic brain 
infarction, hypertensive heart disease and intermittent claudication -
even though the variables used have a different impact on each particular 
disease. The 10% of people indentified as being at highest risk by the 
use of this funct ion accounted for approximately 20% of the 8 year 
incidence of coronary heart disease in Framingham, and about a third of 
the 8 year incidence of stroke, hypertensive heart disease and 
intermittent claudication. 
This study was a milestone in the area of research into CVD prevention. 
It showed that people in need of preventive medicine for cardiovascular 
disorders could be identified by an economic and efficient method, and it 
set the way for several research projects which followed. 
3.3.2 The Multiple Risk Factor Intervention Trial 
In this study, the Multiple Risk Factor Intervention Trial Research Group 
in America, investigated the effects of special lifestyle counselling. It 
represented a "randomised primary prevention trial to test the effect of 
a multifactor intervention programme on mortality from coronary heart 
disease(CHD)". 12,866 high risk men aged between 35 and 57 years were 
studied over an average follow-up period of 7 years. These men were 
randomly assigned either to the usual sources of health care in the 
community or to a special intervention programme in which they were 
given graduated care for hypertension, counselling for cigarette smoking 
and dietary advice for lowering serum cholesterol levels. 
In both groups risk factor levels decreased over the follow up period, 
but this decrease was greater in the special intervention group men. 
Simi larly the incidence of mortal i ty due to CHD was lower for the 
special intervention group though this difference was slight, and not 
statistically significant. It was concluded by the authors of the report 
that whilst the overall results did not show a beneficial effect on CHD 
mortality, they did show that it is possible to apply an intensive long-
term intervention programme against CHD risk factors, with considerable 
effect on risk factor changes. 
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3.3.3 The Prospective Phase of the British Regional Heart Study 
Perhaps of greater relevance to our nat ional heal th was the Bri t ish 
regional heart study undertaken by Shaper et al and published in 1985. 
This set out to determine "the impact that elevated levels of commonly 
accepted risk factors make on the risk of major ischaemic heart disease 
in British men." It also aimed to evaluate the relative importance of 
the di fferent risk factors, and to assess whether such factors cont inue 
to exert an effect on those who have already mani fest ischaemic heart 
disease. The risk factors studied were essentially the same as those 
identified in the Framingham study, and the subjects consisted of 7735 
men aged between 40 and 59 years, who were drawn from the registers of 
group general practices in 24 British towns. 
Risk factors were assessed individually and in combination, and the main 
findings were that the annual heart attack rate was considerably greater 
for men with pre-existing ischaemic heart disease than it was for men 
free from this condition. Apart from this influence, serum cholesterol, 
blood pressure and cigarette smoking were found to be the risk factors of 
greatest value in the prediction of risk of major ischaemic heart 
disease. Indeed,there was at least a twofold independent increase in risk 
associated with anyone of these factors. Of the 202 major incidents of 
ischaemic heart disease observed during the study, only 5 men had non~ of 
these risk factors and over 2/3rds had at least 2. Of the 5 men who 
showed no evidence of raised serum cholesterol,elevated blood pressure or 
cigarette smoking, 3 had pre-existing ischaemic heart disease. 
The sobering conclusions drawn by Professor Shaper and his colleagues, 
were that "the levels of the major risk factors commonly encountered in 
British men have a marked effect on the risk of ischaemic heart dise~~e. 
Modification of these risk factors in the general population constitutes 
an important national priority." 
3.3.4 NRC Trial of Treatment of Mild Hypertension 
Again in Britain, and perhaps one which could almost be seen to follow on 
from the British regional heart study, another study published in 1985 
was that undertaken by the Medical Research Council Working Party on 
anti-hypertensive clinical trials. In this study the primary objectiv~ 
was to determine whether drug treatment of mild hypertension reuuced the 
incidence of strokes, coronary events and early death due to hypertension 
in men and women aged 35-65 years. Secondary objectives were comparisons 
of the two drugs used in respect of their effects on the course of blood 
pressure, and their side effects. 
Over 17,000 patients were recruited almost entirely from general 
practices in Britain, and a single blind, placebo-controlled design was 
employed. The principal resul ts of the MRC trial showed that 
statistically significant lower rates of strokes, and all cardiovascular 
events, were associated with the active than the placebo treatment 
conditions and that the reduction in stroke rates was greater for 
pa t i en ts on bendrof 1 uaz i de than on proprano 1 0 1. However, the benef i cia 1 
effects of active treatment on the reduction of all cardiovascular events 
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was due primarily to a reduction enjoyed by Hun-smokers taking 
propranalol. 
At first glance these results seem to indicate an encouraging role for 
the drug treatment of mild hypertensives in the prevention of strokes 
and all cardiovascular events, but it must be remembered that statistical 
significance is not necessarily equated with material significance. As 
the authors pointed out in their conclusions "if 850 mildly 
hypertensive patients are given active antihypertensive drugs for one 
year about one stroke wi 11 be prevented. It Indeed, al though morbidi ty 
rates were lower in the active drug than the placebo conditions, for all 
categories of cardiovascular events the incidence was lower amongst non-
smokers than smokers in both groups. 
3.4 THE HEALTH MAINTENANCE STUDY (HMS) 
The Health Maintenance Study is a current cardiovascular risk-reduction 
project which is being undertaken by a research team based at Oxford 
University in conjunction with the Royal College of General 
Practitioners. An outline of the HMS will be given below because it is 
of specific relevance to the research reported in this thesis. Indeed, 
the HMS was in its pre-pilot phase when the reported research commenced 
and the needs of the HMS provided the impetus for the first study. 
The main aim of the HMS is to investigate ways of reducing cardiova~~ular 
risk within general practice settings. The accumulated evidence of 
previous research suggests that the effective application of preventive 
measures may reduce the inc idence of heart at tacks and strokes by at 
least 25% in those showing particular risk factors <ego The Prevention of 
Arterial Disease Report, 1981>. If the prediction of a 25% reduction in 
cardiovascular events is correct, and if one third of those most at risk 
can be identified prior to the heart attack or stroke, about 15,O()() 
premature deaths could be prevented for every year of treatment. How~ver, 
the evidence on which such predictions are based, has come from a variety 
of studies and it was the aim of the HMS to conduct a major nationwide 
study to test the prediction. 
Factors to be explored in the HMS include the effects of lifestyle 
changes, such as the implementation of a low fat diet, regular 
exercising, and the cessation of smoking; and of prophylactic drug 
intervent ion. Al though previous studies invol ving drugs have not been 
particularly encouraging, researchers involved in the HMS, believe that 
chemical intervention may be an appropriate form of prevention in certain 
cases. 
The two major drugs being tested are atenalol and low dai ly dosages 
(50mgs) of aspirin to ascertain their effectiveness as deterents to the 
development of cardiovascular events in people showing particular risk 
factors associated with CVD. The risk factors are thos~ which are now 
already quite well established, and identification of people at increased 
risk will be achieved via screening which will include physical 
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examinations by practice nurses and the use of 
questionnaires. 
comprehensive 
All people who attend for screening will be given advice about healthy 
lifestyles. On the basis of risk-factor criteria, the 25,000 identified 
as being most at risk of a heart attack or stroke will be selected for 
invitation to entry into the placebo-controlled, randomised, double-blind 
clinical trials. Patients invited to participate in clinical trials will 
also have had to meet other medical criteria to determine their 
sui tabi 1 i ty for trial entry. The trials wi 11 run for about 5 years. 
Apart from the particular drugs to be used in this study, it differs from 
the other studies outlined above in that whereas they have monitored only 
middle-aged people, the HMS will include a sizable proportion of people 
over 60 in whom the risk of a cardiovascular death within the 5 year 
trial period is greater. 
3.5 BARRIERS TO THE REALISATION OF CVD RISK-REDUCTION POTENTIAL 
To date it seems research has established that those at increased risk 
of a cardiovascular event can be identified by fairly economic and 
effective means. Also, there is a strong possibility that identified 
risk may be reduced, both by health education and pharmaceutical 
interventions. However, a recurring theme in this introduction has been 
the observation that the effective application of existing risk-reduction 
knowledge requires public participation in screening programmes to 
identify those at risk. 
A similar observation has been made regarding clinical trials - ie that 
the potential value of a drug can only be established if it can be 
properly tested on compliant trial entrants. It has also been observed 
(section 2.1) that recruitment to screening and research programmes and 
compliance with prescribed regimens represent special problems for this 
aspect of preventive medicine. Therefore, problems associated with 
securing effective participation in screening programmes and clinical 
trials must be considered as possible barriers to the realisation of 
risk-reduction potential. 
3.5.1 Barriers to Screening Participation 
It has been suggested that "fascination with health maintenance is 
strict ly American" (Oppenheim, 1980), so one might be tempted to 
postUlate that a general lack of interest in preventive medicine is 
responsible for our relatively low utilisation of screening services. 
However, there are indications that the British public are becoming more 
like their transatlantic fellows in both their interest in preventive 
medicine generally and in their awareness and concern about 
cardiovascular risk particularly. 
For instance, 
doctors and 
that 64% of 
in her seminal work on British patients' attitudes 
the services they offer, Anne Cartwright (1967) 
her respondents said they would like a regular 
to their 
reported 
general 
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check up. Thirteen years later, in a repeat study, the proportion of 
respondents saying that they would like a preventive health check rose to 
78% (Cartwright and Anderson, 1981). On both occasions two thirds of 
those who expressed a desire for screening checks stated that they would 
prefer the check to be carried out by their own GP. Furthermore, as 
well as reporting a greater desire for check-ups in the second study, 
Cartwright's respondents also expressed a greater desire for specific 
tests for heart disease. The proportion who spontaneously specified 
checks for heart disease more than doubled from 5% in 1964 to 11% in 
1977. 
Further evidence of popular support for the concept of CVD screening 
came from a study by O'Brien and Hodes (1979). These researchers 
invest igated pat ients' views on screening for hypertension amongst a 
group of people who had been invited to be screened for this disease by 
their GP. All the respondents came from a single group practice and 
included both screening attenders and some people who had declined the 
screening invitation. 
Of the people who took part in the survey, check-ups for people over 45 
years were deemed to be a good idea by 82% of non-screened, 93% of 
screened and 96% of those screened who were found to be hypertensive. 
Even so, it was interesting to note that in spite of the general 
favourability expressed towards screening, attendance at the particular 
service concerned was only 60% of all invi tees (an at tendance rate of 
this magnitude is considered to be relatively high - ego King, 1982). 
So, it seems that the national spirit is willing to endorse preventive 
medicine in the form of screening, even if the participatory flesh is 
still rather weak. Thus the earlier proposition that participant 
recruitment must be acknowledged as a major barrier to the realisation 
of cardiovascular risk-reduction potential still stands. 
In addition to the recriutment barrier, another obstacle which might 
hinder the realisation of cardiovascular risk-reduction potential is that 
of doctors' reluctance to 'label' asymptomatic people. 
It was stated in section 1.1 -background to research area- that popular 
medical criteria for the value of screening tests are that the 
conditions being investigated are those which are common and/or 
potentially dangerous and for which effective treatments are available. 
Not all conditions are unanimously believed to fulfil these criteria, 
but the foremost candidate is generally recognised to be the condition of 
hypertension and its associated cardiovascular risk (Bayliss, 1981). 
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Even so, not all medical professionals are totally in favour of screening 
for hypertension and it has been suggested (Hayes 1978) that the 
identification of disease in asympotmatic people and the subsequent 
labelling of these people as hypertensive, may induce more anxiety than 
the benefits of detection justify. Hayes based his proposition on a study 
of Canadian men which showed increased absenteeism from work as a result 
of hypertensive labelling. However, Benfari <1978 - cited in Kasl, 1978) 
found no such effect and O'Brien (1979), in a study of British people 
screened for hypertension, found the reverse to be true. She found that 
participation in screening was associated with a reduction, rather than 
an inducement, of anxiety. 
Be that as it may, current knowledge in this area is sparse and Mann 
(1984), in a psychological study related to the MRC mi ld hypertension 
study outlined above, reported that lito look at the psychological effects 
of screening programmes meant starting from a scientific zero point". 
Thus it will probably take more evidence than is currently available to 
persuade some physicians that the benefits of screening for 
cardiovascular risk outweigh its costs. 
3.5.2 Barriers to Clinical Trial Participation 
As argued above, effective application of current knowledge requires 
public participation in programmes designed to identify those in need of 
this application so that appropriate preventive measures can be 
instigated. However, whilst current knowledge may be sufficient to 
effect a considerable reduction of cardiovascular events, it is far from 
complete and further research into preventive agents must continue. Yet 
again, in this area, as in that of screening, the problem of participant 
recruitment may pose a barrier to the realisation of risk-reduction 
potent ial. Even if ini t ial recrui tment is achieved, there is an 
addi t ional problem of securing compl iance wi th research regimens which, 
if not resolved, could invalidate research results and hamper progress in 
the field of preventive medicine. 
In section 2.2 - ethical concerns - it was argued that true informed 
consent should be a prerequisite for clinical trial entry, although it 
was also suggested that such consent might not always be obtained. In 
addition it was proposed that lack of true understanding of the project 
and prescribed regimen instructions, could have detremental effects on 
proper compl iance wi th the research programme. The issue of informed 
consent is therefore an important issue to be considered when potential 
barriers to research are investigated. 
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Another issue considered in the ethical concerns section was that of 
whether or not GPs should involve their patients in clinical research. 
Physicians' views about this are very important and will influence their 
decisions as to whether or not they engage in research activities within 
their practice. Patients' views are equally important, although they may 
be in a less secure situation than their doctors when it comes to 
deciding whether or not they should participate in trials if asked to do 
so. 
Very little is known about public attitudes to GP involvement with 
cl inical research, or to the bel iefs people hold about cl inical trial 
participation. But, if attitudes are unfavourable and/or if there are 
common worries or misconceptions relating to participation in clinical 
trials, the implications for effective trial entry are bleak. 
Furthermore, unt i 1 more is known about them, perc ieved problems which 
may be acting as deterents to compliant participation cannot be addressed 
or resolved. 
Therefore, factors influencing participation in screening programmes and 
clinical trials must be investigated if barriers to the realisation of 
cardiovascular risk-reduction potential are to be broken down. This issue 
will be considered in the following section. 
FACTORS INFLUENCING PARTICIPATION IN SCREENING AND CLINICAL TRIALS 
4.1 ATTITUDE RESEARCH 
"There is now a general consensus that health care utilisation cannot be 
understood on the basis of health status alone, but that social, 
economic, demographic, attitudinal and motivational variables must also 
be taken into account when any predictions of take-up are made" (Leavitt 
1979) . 
This intuitively sound observation suggests a fairly straightforward 
approach to the understanding of health care utilisation, but the 
apparent simpilicity of it is deceptive. One of the major problems it 
presents is how atti tudinal variables should be defined and measured. 
From Allport to Zanna attitude researchers have offered different 
definitions of what 'attitudes' represent, and some writers have counted 
over 30 different definitions of the word (Berkowitz 1980). 
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The simplest conception of an attitude was offered by Thurstone in the 
early days of attitude measurement. It holds that attitude is solely an 
evaluative or feeling reaction so that a person's attitude towards an 
object or issue represents the favourableness or unfavourableness that 
(s)he or she feels towards it. Thurstone's own definition of an attitude 
was that it is; "the affect for or against a psychological object" 
(Thurstone, 1931). 
A more complex definition was provided by Allport (1935) who defined an 
attitude as a readiness to respond in a particular way to the attitude 
object or issue. More recently, some social psycologists have offered an 
even more complex definition of an attitude which they conceived to be 
"a constellation of cognitive, affective, and conative components" - ie. 
a combination of how people understand, feel about, and act towards, a 
given object or issue (Berkowitz, 1980). 
In this latter definition, as with Allport's, there is an implicit 
assumption that there is a necessary link between attitude and action and 
indeed that actions are an outward manifestation of attitudes. However, 
the literature on attitude research is littered with evidence against a 
simple attitude-behaviour correlation (eg LaPiere 1939, DeFleur & Westie 
1958, Tittle & Hill 1967, Wicker 1969). This is not to say that there is 
no causal relationship between attitudes and behaviours. 
For example, evidence for such a relationship was offered by Bentler and 
Speckhart (1981) who reported experimental results that "unambiguosly 
support the proposition that attitudes have causal priority over 
behaviours". Moreover, such a claim is not isolated but has been 
reiterated by other experimental researchers (eg. Cialdini et al., 1981; 
Fazio and Zanna, 1981; Katz,1985;). Nevertheless, although there is now 
ample evidence to suggest a close relationship between attitudes and 
behaviours, there is nothing to indicate that attitudes must be expressed 
in act ions, or that cogni t ions and act ions are inherent components of 
attitudes. On the contrary, the evidence suggests that they are distinct 
ent it ies and of part icular interest 
above, is the fact that a clear 
attitudes, beliefs and actions. 
in the more recent studies cited 
differentiation is made between 
The need for such a di fferent iat ion was advocated in the sixt ies by 
Mart in Fishbein. He also suggested (Fishbein, 1967) that one reason for 
the common failure to find attitude-action correlations was lack of 
specificity of attitude to the action. For example knowing how someone 
feels about infant immunisation in general, is not an adequate measure 
for predicting whether or not that person will have her or his own child 
immunised. Knowing how they feel about hBving their own child immunised 
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would be a much more appropriate predictive measure to use. 
Even so, attitudes may not always be translated into actions, for other 
extraneous variables may intercede and exert their own influence on 
manifested behaviour. For instance, one might hold very positive 
attitudes towards infant immunisation, but not have one's own child 
immunised for lack of opportuni ty. Equally, even if the opportuni ty is 
presented one might be reluctant to take advantage of it because the 
child has a cold or other minor illness when the opportunity for 
immunisation arises. Yet again, one parent may feel very postive towards 
immunisation whilst the other holds negative attitudes and the influence 
of the latter may weigh more heavily than that of the former in terms of 
decision-making and actions taken in this context. 
According to the more complex definitions of attitude this apparent lack 
of 'readiness to respond' would imply that the attitude towards infant 
immunisation was not really very positive. However, this failure to 
respond in the expected way to the attitude object on this occasion, does 
not really justify such a conclusion, for it does not invalidate the 
general positive feeling that one has towards infant immunisation. 
Of course, feelings cognitions and actions commonly overlap and 
interact, but they are independent processes. Individuals may well like 
or dislike an object, yet have cognitions about the object which 
conflict with their feelings, and they may variously behave in accordance 
with their affective or cognitive influences. Therefore, whilst 
cognitions and connations may be important correlates with, or even 
influences on, affect, they are distinct from it and Thurstone's simple 
definition of attitude would seem to be the best. Certainly it is the 
definition which is implicitly assumed by most models of attitude 
measurement which seek to assess how favourably or unfavourably 
particular objects or issues are regarded. 
4.2 SOCIo-DEMOGRAPHIC AND ATTITUDINAL ASSOCIATES OF PARTICIPATION 
In spite of the problems of determining operational definitions of 
attitude, and of assertions against a causal attitude-behaviour 
relationship, various studies have been conducted to identify attitudes 
and beliefs associated with non-utilisation of various screening 
services. Investigations have also been made of sociodemographic 
variables associated with screening participation and these will be 
considered first below. 
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4.2.1 Soclodemographlc Correlates of Participation 
In a review of psychosocial correlates of preventive health behaviours in 
America, Kirscht (1983) reported that people in higher socioeconomic 
groups are more likely than those in the lower socioeconomic groups to 
attend screenings for breast cancer, cervical cancer and asymptomatic 
check-ups such as those for cardiovascular risk. He also found that women 
were more 1 ikely than men to attend for asymptomat ic check-ups where 
attendance is voluntary rather than an employment/insurance requirement. 
Utilisation of screening services was found to be greatest amongst 
middle-aged people and those with social support. 
Most British studies which have explored demographic correlates of 
attendance at breast and cervical cancer screenings have also found 
attandance to be associated with higher socioeconomic groups. But, in 
this country, it is younger women rather than the middle-aged who are 
the most likely to utilise these services (eg.French et aI, 1982; Lloyd, 
1983; Chamberlain, 1984; Maclean et al., 1984). Interest ingly, 0' Brien and 
Hodes (1978) found no differences in terms of social class, age, marital 
status or education between attenders and non-attenders at a general 
practice screening for hypertension. 
Because so little research into factors influencing participation in 
clinical trials has been published, there is a paucity of details of 
demographic correlates with the activity. However, studies of compliance 
wi th ordinary therapeut ic drug regimens have found no sociodemographic 
variables which reliably differentiate between compliant and defaulting 
pat ients (eg. Peck, 1978; Mi ller et a1., 1982). Rather, Porter's (1969) 
assert ion that "every pat ient is a potent ial defaul ter" seems to have 
been borne out. 
4.2.2 Attitudinal Influences 
Attitudes and beliefs identified as influencing screening participation 
differ between the various types of services on offer. Furthermore, 
reasons given for non-participation do not always tally with empirical 
evidence. For example, lack of time and inconvenience of clinic 
attendance are commonly-given reasons for non-attendance. Yet French 
(1982) found that, in Edinburgh, significantly more attenders than non-
attenders at a breast screening clinic were working women; and for 43% of 
attenders working hours and clinic hours were mutually exclusive. 
Furthermore, more at tenders than non-at tenders had other commi tments on 
their time such as dependent children or elderly relatives. Similarly, 
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al though ci ted as reasons for non-attendance, Fink et al. (1968) found 
lack of time and inconvenience not to be significant factors influencing 
attendence at an American breast cancer screening programme. 
For both breast and cervical cancer screening the major reasons for non-
attendance seem to be fear of the examination itself, and of the possible 
outcome of test results (Wookey, 1971; French et a1. 1982; Maclean et al 
1984). Indeed, French found that, in general, non-attenders viewed 
screening clinics as places of risk, whilst attenders viewed them in a 
more positive light. 
Of those who said they did not want check-ups in the Cartwright and 
Anderson (1981) study, only 12% stated that they would not want to be 
screened because they were nervous or afraid of outcome. Just 7% of 
unscreened respondents in the O'Brien and Hodes (1978) hypertension 
screening study, gave simi lar reasons for non-attendance. Rather, the 
main reasons given for non-attendance in both the Cartwright and O'Brien 
studies were that people were already under medical supervision; that 
they had recent ly had a check-up for work purposes; or that it was a 
waste of the doctors' time. 
Differences in the reasons given for non-attendance at different types of 
screening are not surprising. After all, screening for both breast and 
cervical cancer entails rather intimate examination, and if cancer is 
detected the possibility of disfiguring surgery and psychological trauma 
is always present. Added to this, there is now the possiblity that cancer 
of the cervix might be perceived as being evidence of promiscuity which 
may further compl icate at t i tudes to screening. Therefore, it would be 
imprudent to regard findings from studies of this sort as necessarily 
generalisable to other types screening, ego that for cardiovascular risk. 
Unfortunately, although the O'Brien and Hode's study was directed at 
screening for hypertension specifically, there are certain features of 
the study design which would make it unwise to unquest ioningly accept 
their findings as generalisable beyond the study sample. Firstly, the 
study sample was drawn from a narrow band of pat ients (45 to 54 years 
old) at a single group practice, and secondly it represented a 
retrospective investigation of attitudes to screening. 
Because the practice already offered screening for hypertension it may be 
assumed that the partners were committed to preventive medicine, at least 
in this respect, and their attitudes to screening may well have had its 
own inf 1 uence on pat ients' at t i tudes. Also, no group pract ices are 
exactly alike and this one may have been atypical in any number of ways. 
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The problem with a retrospective study of this sort is that it only 
really tells us what people who have had a screening test feel about that 
test with the benefit of hindsight and experience. It does not give any 
real indications of what influences people in their intentions to 
participate in screening. 
Admi ttedly, 0' Brien and Hodes did also investigate those who decl ined 
screening, thus offering some insight into why they refused 
participation, so the study must be given serious attention. In addition, 
as well as addressing the problem of what influences non-attendance, they 
also explored reasons behind positive attitudes to screening. 
The major reasons for thinking screening was a good idea were: 
(1) can discover illness in early stages; (2) it gives peace of mind; (3) 
health deteriorates as people get older; (4) people would not go to the 
doctor otherwise; (5) prevention is better than cure. 
Knowing what encourages people to participate in screening may be just as 
important as knowing what deters them from taking part when it comes to 
devising appropriate promotional campaigns. 
4.3 PREDICTIVE MODELS OF PREVENTIVE HEALTH BEHAVIOUR 
As discussed in section 4.1 -attitude research- above, the prediction of 
behaviour from attitudes has not always been very successful. However, 
two major predictive models have evolved as very useful tools in the 
prediction of preventive health behaviour. The first model, the Health 
Belief Model was developed specifically for application in this field. 
The second model, the Behavioural Intent ion Model was designed for more 
general application but has been used quite widely in the area of 
preventive health behaviour. 
4.3.1 The Health Belief Model 
The Health Belief Model (HBM) was first suggested by Rosenstock (1966) 
and later modified by Becker and Maiman (1975). The model was based on 
the work of Lewin et al. (1944) and represents a 'value-expectancy' 
approach which describes behaviour or decision-making when conditions of 
uncertainty apply. Essentially, this approach suggests that behaviour can 
be predicted from a combination of the individual's expectations that a 
particular action will result in a given outcome and her/his evaluation 
of that outcome. 
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Within this framework the HMB purports to predict preventive behaviours 
from 4 key elements ie. (1) Motivation, (2) Percieved Vulnerability, (3) 
Perceived Severity, (4) Percieved Benefits and Costs. Briefly, the 
implications of the HBM are that, given cues to action (such as symptoms 
or publicity), people are most likely to engage in preventive actions or 
comply wi th medical advice if they : "(a) feel concerned about their 
health and 'motivated' to protect it; (b) feel susceptible to the disease 
in question; (c) believe that the consequences of the disease would be 
serious if left untreated; (d) believe in the benefits of the 
recommended treatment or advice, and that these outweigh the costs of 
following this advice (eg pain, time, side effects)' (King, 1983). 
Paradoxically perhaps in the 1 ight of the evidence for pat ient desires 
for information (see section 2.2-ethica1 concerns), it has been suggested 
that often, people do not want to know about the health risks they face 
as such information makes them anxious. It has also been postulated that 
it is fear and anxiety which underlie much resistance to health warnings 
and medical advice. Therefore, this possible deterrent to preventive 
behaviour must also be considered in the cost-benefit analysis of (d) 
above. 
Although the 4 elements outlined above are deemed to be the most 
influential factors in determining preventive health behaviour, Becker 
and Maiman also acknowledge the influence of other "modifying and 
enabling factors" such as sociodemographic variables, financial costs of 
the action, and prior experience of the action, condition or therapeutic 
regimen. A diagramat ic representat ion of the HBM, is shown in figure 1 
over. 
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Figure 1 Diagramatic Representation of the HBM 
Derived from: The Original Formulation of the HBM (Becker and Maiman 1975) 
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The HMB has been given considerable application in the field of 
preventive medicine and the key variables outlined above have been shown 
to influence a wide range of health behaviours. These include attendance 
at screenings and immunisations, compliance with drug and treatment 
regimens, and mothers' acceptance of medical advice for their chi Idren 
(eg. Becker et aI, 1977). It has also been applied in attempts to 
predict, and differentiate between causal explanations of, attenders vs 
non-attenders at a hypertension screening programme (King, 1982). 
Regarding its predictive qualities, study results indicate that the HBM 
is qui te effect i ve. However, its success in ident i fying spec i f ic 
differentiating factors has been less well documented. Indeed, whilst the 
efficacy of the HBM has been praised by many preventive health 
researchers (eg. Janz and Becker 1984), it has been questioned by others 
(eg. Tirrell and Hart, 1980; Calnan and Rutter, 1986). Furthermore, the HBM 
has been criticised on the grounds that it treats beliefs, attitudes and 
intent ions as synonymous rather than as interrelated (eg. Mi ller et al. 
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1985); and that it does not afford consistency of measurement because it 
is not a formal theoret ical model, but rather a conglomerate of 
variables, each of which may be open to various interpretation (eg. 
Oliver and Berger 1979). Thus at present the HBM cannot be considered 
the definitive approach to predicting and understanding preventive health 
behaviours. 
Also, as a caut ionary note, it should be remembered that the HBM has 
enjoyed widest application in America where primary health care provision 
is very different from that found in Britain. Therefore, it may be wise 
to bear in'mind the circumstantial differences of primary health care in 
the two countries, when research into primary health care is considered. 
Resul ts of Amer ican research relat ing to this area may not transfer 
easily to the British situation, where both economic and cultural 
differences apply. 
4.3.2 The Behavioural Intention Model 
Like the HBM, the Behavioural Intention Model (BIM) represents a 'value-
expectancy' approach to the prediction of behaviour. Unlike the HBM, the 
BIM represents a formal theoretical model. It is based directly on 
Fishbein and Ajzen's Theory of Reasoned Action which was introduced in 
1967 and has been further developed since. Stated concisely, the Theory 
of Reasoned Act ion "is based on the assumpt ion that human beings are 
usually quite rational and make systematic use of the information 
available to them."(Ajzen and Fishbein 1980) It proposes that humans 
actions are not performed 'willy nilly', or as the result of unconscious 
motives,but rather that they are the outcome of thoughtful considerations 
of the implications of such action. 
The precepts of the theory are reflected in the BIM which states that a 
given behaviour is a function of intention to perform that behaviour. 
Intent ion, in turn, is stated to be determined by a combinat ion of 
attitudes towards the behaviour, subjective norms, and motivation to 
comply with normative influences. 
In other words, in the first instance, a person may be expected to 
perform a given behaviour if (s)he intends to do so. Likewise, intention 
to perform an action may be assumed if a person feels favourably towards 
performing the action, believes it to be well thought of by her important 
others and is motivated to comply with their wishes or opinions. 
-32-
This part of the model has been symbolically summarised as follows: -
Where B = the behaviour of interestj I = intention to perform B; 
As = attitude towards performing B; SN = subjective norm concerning Bj 
and Wr and W2 are empirically determined weighting parameters that 
reflect the relative importance of As and SN (Ajzen, 1985). 
A further premise of the BIM is that causal explanations of attitudes may 
be effected by examinat ion of the sal ient bel iefs which underly the 
attitudes. The equation that expresses this aspect of the model is:-
.:lL ==-: 71 
Where As=attitude to the behaviourj bi=the belief(subjective probability) 
that performing B will lead to outcome ij e i = the evaluation of outcome i 
and the sum is over the n salient behavioural beliefs. 
Subjective norms can be similarly understood by examining normative 
beliefs and motivations to comply with specified referents:-
..::6 -- 71 
Where SN = subjective normj bJ = the normative belief concerning referent 
jj mJ = the person I s mot iva t i on to comp I y wi th ref eren t jj and n = the 
number of salient normative beliefs. 
Fishbein and Ajzen concede that their model is not an infallible tool 
for predicting behaviour. Rather, it is acknowledged that extraneous 
variables may intercede to prevent intentions from being transformed into 
actions. However, according to the Theory of Reasoned Action, there is no 
room for a direct influence of sociodemographic variables in the 
predictive model, since it is argued that if such variables are 
associated with a given behaviour, it will be only by virtue of the fact 
that they have had an influence on, or are associated with, the 
underlying attitudinal and normative determinants. Therefore, unlike the 
HBM. socio-demographic variables do not appear in the BIM. A diagramatic 
representation of the basic BIM is given in figure 2 over. 
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Figure 2 Representation of the Behavioural Intention Hodel Showing The Relations Among 
Beliefs, Attitude, Subjective Norm, Intention and Behaviour 
(taken from Ajzen and Fishbein, 1980 p,100) 
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Within the field of health behaviours, the BIM has had several 
applications. These include studies for the prediction and understanding 
of:- family planning behaviours (eg.Jaccard and Davidson, 1972); mothers' 
infant feeding intentions and behaviours (Manstead et aI, 1983); and post 
myocardial infarction regimen adherence (Miller et al 1985). Results from 
these studies, and from other applications, indicate that the predictive 
qual i ty of the BIM is at least equal to that of the HBM, whi 1st the 
degree of attitudinal understanding it affords is superior. 
However, although both the HBM and BIM offer valuable frameworks for the 
prediction of preventive health care utilisation, neither model really 
fulfils Leavitt's (979) asserted criteria for such prediction. For 
example, a potentially important aspect of 'motivational' variables is 
that of normative beliefs which do not feature in the HBM. Equally, 
social, economic and demographic variables are omitted from the BIM. 
This omission precludes identification of specific sub-groups who may be 
particularly enthusiatic, or reluctant, to use preventive services. 
Fishbein and Ajzen may well be right in their assertions that socio-
demographic variables exert only an indirect influence on behaviour via 
a possible influence on belief systems. But if such an influence exists 
it would seem important to identify groups who share common beliefs if 
appropriate campaigns are to be effectively targeted. 
Therefore, just as it was conluded that the HBM does not offer a 
definitive approach to predicting preventive health behaviours, so too 
is it apparent that the BIM has room for improvement. 
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5. ISSUES OF SPECIFIC IMPORTANCE TO THE THESIS 
As stated in sect ion 1 - general introduct ion - the primary purpose of 
the reported research was to assess public attitudes to preventive 
medicine, with the particular focus of cardiovascular risk-reduction. 
Both studies comprising the thesis research were associated with the 
Health Maintenance Study (HMS) , thus issues that are of specific 
importance to the thesis include some of those which are also of special 
interest to the HMS. In addi t ion, the second study ut i 1 ised the 
Behavioural Intention Model (BIM) and a secondary objective of the 
research was to test the (BIM) for the predict ion and understanding of 
screening and clinical trial participation intentions. Therefore, issues 
relating to the BIM are also of special relevance to the thesis. 
Basically, in terms of its primary purpose, the research was intended to 
address three broad questions: ie. (1) what do people feel about 
preven t i ve med i cine? (2) what do they fee 1 about genera 1 prac tit i oner 
involvement with research? (3) what do they feel about actually taking 
part in screening programmes and clinical trials for cardiovascular 
risk-reduction; and what are the factors that influence their decisions 
in this area? 
It was felt necessary to explore these areas because they have important 
implications for the success or failure of preventive projects and 
current knowledge in this area is inadequate. Problems of participant 
recruitment and of potential barriers to participation in both screening 
and clinical trials were considered in sections 2 and 3.5 respectively. 
Various potentially influential factors were discussed, but the major 
conclusion was that public attitudes and beliefs represent a very 
important factor in preventive health care utilisation and in effective 
clinical trial recruitment. 
Thus it would seem expedient for des igners and promotors of preven t i ve 
medic ine research to be aware, and take account of, publ ic at t i tudes 
towards screening and clinical trials in the planning and recruitment 
phases of their studies. However, partly because of lack of information 
in this area, such considerations do not appear to be commonplace, with 
the consequence that preventive programmes remain under-utilised and the 
effective participation of clinical trial entrants, uncertain. 
Researchers involved in the (HMS) were anxious to maximise effective 
participation. Therefore, they were keen to obtain information which 
could be considered in the formulation of recruitment plans and research 
protocols to enhance the attractiveness of participation in the eyes of 
the target population. They also wanted some indication of how popular 
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the concept of preventive medicine was, and how people felt about GP 
involvement with research. This was especially so in relation to 
clinical trial participation where so very little is yet known. It was 
with this objective in mind that the first study of the thesis research 
was designed. More detailed discussion of HMS specifications will 
therefore be presented in Part II in the specific introduction to the 
preliminary study. 
In respect of the secondary research objective, the main issue of 
importance was considered to be whether the BIM was a useful tool to 
employ in this type of research, and if so, which of the variations of it 
afforded the best predictions and understanding. Because there is 
already a considerable body of evidence to indicate that it is effective 
for pred i ct ion and understand ing of behavioura 1 inten t ions (see sec t ion 
4.3.2), further testing of its utility may seem unnecessary. However, use 
of the BIM does entail employment of a rather repetitive instrument. 
Apart from studies of voting intention, it seems to have received 
relatively little testing in general population samples and even less in 
postal surveys. 
Rather, it seems that most published studies of BIM employment have been 
applied to special groups of people. Furthermore, canvassing of study 
participants has usually been in the form of a personal approach, and 
often the questionnaire instrument has been interviewer-administered, or 
self-administered in the presence of a researcher. Personal recruitment 
of study participants and interviewer-administration of questionnaires is 
a costly practice which may impose quite severe restrictions on the size 
and range of a study sample. Also, whilst personal involvement of 
researchers may enhance survey response rates (eg. Bellizzi and 
Hite,1986), it also poses potential problems of 'experimenter effects' 
due to interviewer-respondent interactions. 
Because of its somewhat complex nature, the BIM was not employed in the 
initial exploration of the area where the main objective was to identify 
the range of variables associated with participation in screening and 
clinical trials .. However, in spite of its possible drawbacks, it did 
seem to offer the best approach for gaining real understanding of 
participatory influences. Therefore, it was decided to use the model in 
the second study where the power of associated variables was to be 
assessed. The general utility of the BIM would also be investigated by an 
assessment of its acceptance by a sample of the general public recruited 
via mail-shot canvassing. More detailed consideration of the BIM and the 
Theory of Reasoned Action from which it was derived, will be given in the 
specific introduction to the second study. 
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An issue of special importance to both studies was that of anonymity. In 
most reported studies of medical interest, questionnaire response rates 
are considerably higher than those attained for many non-medical 
quest ionnaire studies. This is perhaps espec ially true of studies that 
are assoc iated wi th respondents' own GPs (eg. Smi th et al 1984). The 
general superiority of medical response rates may be due to a special 
public interest in medical matters, exceptionally well designed 
canvassing approaches and questionnaires, or perhaps, the survey 
methodology. 
During the literature-review process of the thesis, reports of many 
medical survey studies were read and considered. A striking finding was 
that none of these papers reported anonymous questionnaire completion and 
most gave details of repeated, and quite extensive, follow-up procedures. 
The possibility of such methodological approaches inducing a feeling of 
coercion to respond, and the possible association of such feelings with 
biased responses, was discussed in section 2.4. Therefore, it was 
considered important in the reported research to ensure total anonymity 
of respondents and to compare consequent response rates from GP endorsed 
and non-medical sampling sources. 
6 AN OVERVIEW OF METHODOLOGICAL CONSIDERATIONS 
Given that the objective of the research was to assess current public 
attitudes, it was evident that survey studies would be required. However, 
it was also evident that if the survey results were to be of any real 
value, they must be obtained within research designs that were 
methodologically sound. As mentioned in section 5 above, the two studies 
comprising the research were designed for different priorites. Therefore 
each demanded its own methodological considerat ions. Nevertheless, the 
two studies were similar in many respects and whilst considerations 
peculiar to each study will be given in the appropriate specific study 
introductions, an overview of methodological concerns common to both will 
be presented below. 
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6.1 CONSIDERATIONS OF RESEARCH APPROACH 
The most basic consideration was that of which definition of an attitude 
would be adopted to govern the format of the surveys. Problems associated 
with attitude definition have already been discussed in section 4.1 where 
the prefered definition was stated to be that given by Thurstone. 
To recap, this definition holds that an attitude is an evaluation or 
feeling reaction so that a person's attitude towards an object or issue 
represents the favourableness or unfavourableness (s)he feels towards it. 
It represented the simplest conception of an attitude, the one that was 
most intuitively apt, and the one which accorded most closely with the 
methods employed in the majority of attitude measurements. Moreover, it 
is the definition employed in the Behavioural Intention Model to be used 
in the second study, so it was considered highly appropriate to maintain 
consistency by adopting this definition for the preliminary 
investigation. 
Having determined the guiding attitude definition, consideration was 
given to the most appropriate type of survey to pursue. itA survey is a 
form of planned collection of data for the purpose of description or 
prediction as a guide to action or for the purpose of analysing the 
relationship between certain variables" (Oppenheim 1966), Basically, a 
survey is a special way of asking questions. They can be asked orally, 
as in in-depth interviews and interviewer-administered questionnaires; or 
they can be asked in writing via self-completion questionnaires. These 
question-asking techniques are usually used for slightly different 
purposes, and each may be more appropriate for different subject matters, 
but they are not mutually exclusive. Indeed, they are often used in 
concert, or with the results of interviews being used in the formulation 
of questionnaires. 
In-depth interviews may be structured or unstructured and the main 
benefits of in-depth interviews are that they can be more flexible than 
questionnaires, enable informants to give responses to questions in 
their own words using as many or few as are desired, can be adjusted to 
si tuat ions, and allow for increased rapport and co-operat ion between 
informant and interviewer. In addi t ion they afford the opportuni ty for 
deep probing of responses so that individuals are not restricted to a 
limited choice of preconceived responses and attitudes can be thoroughly 
invest igated. They also provide excellent opportuni ties for knowledge-
testing and obtaining spontaneous responses. 
Because of this, in-depth interviews can offer an 
obtaining detailed and comprehensive information 
excellent method for 
provided that: the 
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subject matter is not too sensitive or likely to cause embarassment to 
the respondent; the quality of the questions asked is good; and the 
interviewer is well trained in this art. 
Another major benefit of the in-depth interview approach is that once a 
sample has been secured, the researcher can be confident that (s)he will 
come away from the interview wi th some react ion to each of the items. 
Even if an informant declines to answer the question, the researcher will 
know that the missing data is due to a deliberate refusal to supply 
information and not just an oversight. More importantly, the interviewer 
wi 11 be able to note the react ions, both verbal and non-verbal, of the 
informant to the item. It can also be ensured that the responses obtained 
are those of a particular informant. Finally, there is the opportunity 
for a continuous assessment of the sample profile so adjustments in 
recruitment can be made to ensure that the sample represents the target 
population. 
Against this, recruitment of in-depth interview respondents may be rather 
difficult. For example, in order to canvass participation from an 
adequate sample, a sui table sampl ing source must be obtained, and this 
may be easier planned than achieved. Even when it is achieved, volunteer 
bias may be particularly pronounced in an in-depth interview sample since 
the technique demands considerable part ic ipant investment in terms of 
time and face to face exposure of one's feelings to a stranger. 
Apart from these problems, our current social climate seems to be 
engendering a suspiciousness that may discourage people from admitting 
strangers into their homes. Some evidence for a growing reluctance of 
people to agree to home-based interviews was offered by the Institute for 
Social Research (1976). So even if an interview is granted, people may 
feel a little ill at ease with the situation and give less than total 
concentration to the actual interview. 
Other drawbacks of in-depth interviews are that they demand a lot of 
research time, may suffer lack of control and consequent ly reI iabi I i ty, 
and are qui te vulnerable to artefactual effects due to respondent-
interviewer interactions. Also, because the results obtained from in-
depth interviews are qualitative rather than quantitative, statistical 
analysis is not really appropriate and probabilistic answers to 
questions cannot be adequately obtained. 
Questionnaires may be interviewer administered or self-completed and the 
level of respondent-interviewer interaction may be considerable, as in 
the first instance, or almost negligable in the latter instance if the 
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questionnaire has been sent to potential respondents through the post 
without prior contact with the researcher. It may also be of an 
intermediate level if a self-completion method is used but co-operation 
is first secured through a personal approach by the researcher. 
Interviewer-administered questionnaires serve as an intermediary between 
in-depth interviews and self-completion instruments. They can provide the 
same type of uniform, easily codeable, quantitative data obtained from 
self completion questionnaires; whilst retaining the benefits of rapport 
establishment and guaranteed returns afforded by the in-depth interview. 
However, they are almost as costly in personnel time and possible 
interviewer effects as in-depth interviews; and may be as tightly 
constrained as self-completion instruments. There is often a very good 
case for using interviewer-administered quest ionnaires - espec ially in 
the pilot stages of a self-completion survey - but, since they also carry 
many of the disadvantages of both methods, without the total advantages 
of either, they should be used with caution. 
What the sel f-complet ion quest ionnaire may lose in reduced f lexi bi 1 i ty 
compared to the in-depth interview, it stands to gain in reduced 
'interviewer effects' on responses, and thus it is similarly less prone 
to, though not exempt from, reliability problems and 'socially desirable' 
answers. Another advantage of questionnaires is that a variety of answer 
options may be afforded in such a way that a wide range of attitudes 
towards a particular object or issue may all be presented as acceptable 
ones for individual respondents to adopt. Of course, the possibility of 
leading questions occuring is not removed and careful wording of items is 
essential if the problem is to be avoided. 
The development of a good self-completion questionnaire may take 
considerably longer than the devising of an in-depth interview schedule. 
But, per respondent, self-completion instuments are far less demanding of 
researcher time than are in-depth interviews. Consequently, in most 
instances many more respondents may be obtained using this method than 
would be possible if just interviews, or interviewer-administerd 
quest ionnaires were employed. Futhermore, if sel f-complet ion instruments 
are distributed by post, the geographical range, as well as the size of 
the sample, may be considerably greater than that achievable by the other 
methods. 
A particular benefit of self-completion questionnaires over in-depth 
interviews is that the former do not require intrusion by a researcher 
into the respondents' homes. Thus, not only do they avoid security 
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problems associated with letting a stranger into one's home; but they 
also allows the informant to answer the questions in his or her own time 
and afford the opportunity for total privacy of completion. Even with a 
sel f-compl et ion instrument, informan ts may be unable to complete the 
questionnaire in the absence of other family members, but at least the 
possibility of private completion is enhanced. 
However, the use of self-completion questionnaires is not without 
problems, especially in the area of response rates. Response rates to 
sel f-complet ion quest ionnaires vary enormously <ego Heber lein and 
Baumgartner, 1978), although quite low response rates are common, 
particularly for postal surveys. Much research has been undertaken in 
attempts to identify factors which influence response rates to postal 
questionnaires, but little in the way of conclusive evidence has yet 
emerged. People have looked at questionnaire length, sponsoring 
organisation, colour of paper used, 1st vs 2nd class postage, stamped vs 
franked envelopes, personalised vs impersonal letter openings, use of 
incentives, follow-ups etc. 
The outcome of such works seems to have been the accumulation of a mass 
of contradictory evidence, since for almost every study that shows the 
influence of a particular factor in one population sample, another study 
will show no such influence on its study sample. Perhaps the most common 
piece of advice given to questionnaire designers is to keep the 
instrument as short as possible. However, in their analysis of the 
publ ished literature on mai led quest ionnaire response rates, Heberlein 
and Baumgartner (1978) offered a case for long questionnaires. They 
proposed that a well designed long questionnaire might elicit higher 
response rates than a less well designed shorter instrument, as it may 
be easier to complete and increase the psychological costs of not 
responding. 
As they put it: "Tossing out a one-page questionnaire may be relatively 
easy to do, but discarding 30 pages of questions is depriving the 
investigator of a good deal of information. Also, if the researcher has 
taken the time to compose 30 pages of questions, it is clear that this 
research is a matter of importance and not merely a passing curiosity." 
Other work in this area that has investigated the effects of individual 
questions, indicates that the inclusion of items relating to education 
and income may decrease response rates <ego Kaplan and Cole, 1970; 
Singer, 1984). However, it is also generally acknowledged that the 
characterist ics of the target populat ion are more important than any 
aspects of the instrument in determining this issue. 
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Whilst potentially low response rates are a major disadvantage of self-
completion questionnaire surveys, they do not necessarily invalidate the 
use of the technique. After all, it is the representat i vness of a sample 
that is of paramount importance not really the overall size of the 
sample. For example, a response rate of 30% may be completely 
representative of the target population, yet a response rate of 85% may 
be very biased if the non-responding 15% happen to represent an ent ire 
sub-group of that population. 
Unfortunately, although potentially low response rates may not 
necessarily discredit the use of self-completion questionnaires, they 
are not the only disadvantages this technique holds. Other drawbacks to 
self-completion questionnaires which are not answered in the presence of 
a researcher, include the preclusion of opportunities to: probe 
respondents or clarify any items they do not fully understand; ask 
knowledge-testing questions or questions requiring spontaneous responses; 
ask complex questions. 
In addi t ion, unl ike the interview si tuat ion, there is no observat ional 
data to supplement written responses, nor is there any researcher control 
over the order in which questionnaire items are read or answered. Thus 
items on the instrument cannot be treated as independent. Similarly, the 
researcher cannot be confident that all items will receive responses, and 
the actual identity of the respondent must always carry some doubt. The 
person who actually completes the quest ionnaire may not be the one to 
whom it was addressed or given. 
Nevertheless, use of self-completion questionnaires is widespread and the 
technique can be extremely valuable for situations in which required data 
can be obtained from simple 'tick-in-the-box' answers to straightforward 
questions. However, the benefits of questionnaires can only apply if the 
questionnaire used is of good quality and has been well designed and 
tested as a suitable instrument for the collection of data for its stated 
purpose. 
To summarise, in-depth interviews offer an ideal method for gaining 
attitudinal information unconstrained by the limitation of rigid 
questions and predetermined answer options. But, they are costly in 
terms of resources and impose severe limitations on analysis of data. Use 
of in-depth interviews are possibly best suited to research for which 
resource allowances are genfH'ous or required sample sizes small. 
However, in the absence of such resources, and when more general isable 
knowledge is desired, a well constructed questionnaire is often a more 
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viable alternative, (pehaps especially so if the construction is based 
upon informat ion gained from prel iminary in-depth interviews). In the 
light of what has already been said about the need for generalisability 
of data (sections 2.1 & 2.3), it was clear that samples for both the 
reported studies would need to be both fairly large and heterogeneous. 
Thus it was indicated that a questionnaire would be the most appropriate 
choice of survey tool. On the other hand, the lack of previous work in 
the area also indicated the need for some prel iminary deep probing of 
attitudes so that attitude items on the questionnaire would be 
appropriate. 
Therefore, a self-completion questionnaire was selected as the preferred 
mode of data collection for both studies, although the instruments would 
be developed from prel iminary in-depth interviews. In this way it was 
hoped that the atti tudes investigated would be sal ient to the study 
objectives; and that the widest possible sample could be reached given 
the constraints of time and resources that applied. This method also 
afforded the collection of data which would lend itself to fairly easy 
cod ing, ini t ia 1 assessment and subsequent stat ist ica 1 test ing. 
6.2 SAMPLING CONSIDERATIONS 
It has already been stated elsewhere in this introduction (sections 2.4 & 
5) that current evidence indicates a superiority of response rates to 
surveys of medical interest when the survey is endorsed by the potential 
respondent's GP. Although it was also argued above that high response 
rates need not necessar i ly yield bet ter resul ts than lower ones, it is 
generally accepted that high response rates decrease the chance of sample 
bias and as such are to be prefered. However, another issue that has 
received previous consideration (section 2.4) is that of a possible 
association between GP endorsement of studies and some feelings of 
coercion to respond. 
Therefore, when determining the sampling sources for the reported 
research, consideration had to be made of whether or not medical sampling 
sources should be used. 
On the one hand, use of practice lists is a well established, valuable 
sampling source for surveys of medical interest. These lists offer 
fairly large sampling pools, and most include people of all age-groups 
and of a good socio-economic mix. Even where a practice serves a fairly 
homogeneous population, a counter for this may be found in another 
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practice with a different preponderance, and sampling from each can yield 
a general mix. <Because each general practice is a peculiar entity and can 
be atypical in so many ways, it is generally advisable to sample from 
several practices unless results are to be restricted to a single 
practice application.) In addition, most general practices keep up-to-
date age-sex registers, thus enabling particular age-sex distributions to 
be selected for sampling. 
On the other hand, potential respondents have a right to know the 
sampling source from which they were drawn. If the source happens to be a 
practice list, they also have the right to a covering letter from their 
GP to verify his or her knowledge of this and to reassure the person of 
medical confidentiality. However, even with clear disclaimers of GP 
involvement with the research, it might appear to the recipient that the 
GP is privy to responses, with consequent implications of perceived 
coercion. 
So, the di lemma 
benefit from its 
or to shun such 
contaminat ion. 
disadantages, it 
was whether to opt for a medical sampling source to 
sampling properties and associated high response rates; 
sources because of possible ethical and methodological 
After careful consideration of advantages and 
was finally decided to use a combination of medical and 
non-medical sampling sources. Identical questionnaire instruments would 
be used for both sampling sources and anonymity of respondents was to be 
an important feature of questionnaire design. 
Where medical sources were to be used, it was determined that all 
canvassing corresspondence should stress the non-involvement of the GP 
wi th the study, and rei terate respondent anonymi ty. By the adopt ion of 
such as approach it was hoped that the benefits of high responses rates 
might be retained whilst the drawbacks of the implications of respondent 
identity might be dispensed with. It would also enable an assessment of 
the relative merits of medical and non-medical sampling sources. 
7. OVER-ALL RESEARCH AIMS AND OBJECTIVES 
The primary aim of the research was to identify attitudinal factors which 
influence participation in screening and clinical trials for 
cardiovascular risk reduction. It was particularly intended to identify 
spec i f ic deterrents to part ic ipat ion, or aspects which gave cause for 
general concern; and/or any sub-groups who might be reluctant to 
participate in such activities. 
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The obj ec t i ve of such ident if i cat i on was to ass ist hea 1 th promot ion and 
clinical research personnel in the development of appropriate recruitment 
campaigns which could, if necessary, be designed for the attention of a 
particular target population. 
In the pursuance of this aim, two studies were undertaken. The first was 
a preliminary exploration of the area to identify the range of variables 
associated with such activities; whilst the second was designed to 
establish the power of associated factors. A secondary objective was to 
test the effectiveness of the Behavioural Intention Model (BIM) as an 
effective tool for the latter purpose. In addition, a by-product of both 
studies was to be an evaluation of medical vs non-medical sampling 
sources. 
Specific study aims and objectives will be detailed in the individual 
introductions to each study, but the broad overall aims of the research 
were: 
(1) To assess public feeling towards preventive medicine, especially as 
it relates to cardiovascular disease (CVD) 
(2) To assess public feeling towards GP involvement with clinical 
research, especially as it relates to clinical trials of drugs 
(3) To assess behavioural intention regarding participation in screening 
and clinical trial research 
(4) To identify any factors influencing participation in screening or 
clinical trials 
(5) To identify any 'reluctant to participate' sub-groups within the 
sample 
(6) To assess the effectiveness of the 
understanding participatory intention; 
of employing the BIM in postal surveys 
BIM for the prediction and 
and to assess the feasibility' 
of a general public sample 
(7) To evaluate the merits of medical vs non-medical sampling sources. 
PART II 
A PRELIMINARY EXPLORATION OF FACTORS 
ASSOCIATED WITH PARTICIPATION IN 
SCREENING AND CLINICAL TRIALS 
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CHAPTER 1 
INTRODUCTION TO THE FIRST STUDY 
It has already been declared that the first study was directly associated 
with the Health Maintenance Study (HMS) , an outline of which was 
presented in Part I, section 3.4. When this association began, the HMS 
was in its pre-pilot phase and the research director, who is also a GP, 
was anxious to understand more about public feeling towards projects such 
as the HMS. 
Informat ion was required regarding: whether or not there was a general 
feeling of favourability towards preventive projects run by GPs; whether 
there was much interest in cardiovascular risk-reduction; how people felt 
about GP involvement with clinical trials of drugs; and what sort of 
worries people associated with taking part in screening and clinical 
trials. Some indication of the sort of take-up rate the project could 
expect to attract was also required. The reasons behind his desire for 
this information were two-fold. 
Firstly, it was hoped that such knowledge would assist in the recruitment 
of GPs to the study. For instance, if, as was suspected, it was found 
that public attitudes to preventive projects were generally popular, it 
might be useful to acquaint GPs with this finding when their 
participation in the HMS was sought. On the other hand, as was mentioned 
in section 2.2 (ethical concerns), wi thin the profession there is some 
controversy as to the appropriateness of GP involvement in clinical 
trials, and minimal knowldege of public feelings towards this issue. 
Therefore, GPs might be interested to know study findings in this area. 
Secondly, if common worries associated with screening or clinical trials 
could be identified, they could be taken into account and addressed when 
public recruitment practices and study protocols were designed. 
The target population of the HMS at that stage, was people over 60 years 
of age. However, whilst the over-60s were to be well represented in the 
study sample, it would not be comprised entirely of older people. A wider 
population was selected so that the results of the study could aspire to 
greater generality and greater utility, and so that the opportunity for 
comparisons amongst various subgroups within the population might be 
afforded. Also, it was considered to be a valuable exerc ise to assess 
both older and younger people's feelings towards the concept of offering 
preventive health services to the elderly. 
-46-
The specific information required, related to particular aspects of 
project participation. Questions included: How do people feel about the 
possibility that screening would reveal the presence of potentially 
lethal disease?; would they want to know if they were at risk of a heart 
attack or stroke?; how do people feel about the imposition of life-stlye 
changes, and would they feel able, or wi 11 ing, to undergo revision of 
dietry and smoking habits?; are people worried about the side effects of 
pills and the prospect of taking them for a long time?; do blood pressure 
tests and blood samples frighten people?; what do people feel about 
giving lots of personal, and potentially sensitive information on 
questionnaires, and how do they feel about having to complete a long 
questionnaire prior to a health examination? 
This last concern 
screening programme 
booklet in which 
was of special 
included the 
much personal 
sensitive nature, was required. 
importance because the ini t ial HMS 
completion of a long questionnaire 
information, some of a potentially 
These issues formed the basis of the study to be reported here, although 
one other issue related to cardiovascular disease was also touched upon. 
The additional aspect related to public attitudes towards the influence 
of psychological factors on both the genesis, and treatment of essential 
hypertension. The importance of psychological influences in the aetiology 
and management of essential hypertension, is rapidly becoming more widely 
recognised wi thin both the psychological and medical professions (see 
again sections 3.2 & 3.3). Thus attitudes towards this area were 
considered to be worthy of at least some preliminary exploration. 
A discussion of methodological considerations was undertaken in section 6 
where it was concluded that a self-completion questionnaire, developed 
from preliminary in-depth interview results, would be the method of data 
collection employed. A commitment to the Thurstone definition of attitude 
was also affirmed. In fact, some of the items to be included on the 
questionnaire would perhaps be better defined as beliefs or opinions than 
attitudes; but in the first study a strict differentiation between the 
two concepts was not observed and all items were to be assessed 
evaluatively on a simple 5 point Lickert-type scale. 
A survey based solely on the Thurstone approach could not be expected to 
offer accurate predictions of behaviour from attitudes expressed, as was 
made evident in section 4.3. However, when attitudes and behaviours are 
important, as it is expected that they are when they relate to people's 
health and well-being, simple attitude measurement can predict future 
conduct at least moderately well (Schuman and Johnson 1976). Furthermore, 
even if no prediction of participation rates from attitudes may be made, 
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knowledge of attitudes towards medical research projects is valuable in 
its own right, as is the identification of their potentially deterrent 
aspects. However, if appropriate attitudes were to be assessed, salient 
factors had to be ascertained, and it was hoped that prel iminary in-
depth interview results would provide the necessary information. 
Because of the importance of interview results to the subsequent study, 
the selection of appropriate informants was essential. 'Appropriate' 
informants would be those who were willing to openly voice their feelings 
about the issues under discussion, and those who would be representative 
of the HMS target populat ion. Therefore, all interview informants were 
to be over 60 years of age, with some being known to have a history of 
cardiovascular disease. It was also felt that small-group interviews 
would encourage greater discussion of atti tudes towards various aspects 
of screening programmes and clinical trials, than would individual 
interviews. Thus it was necessary to devise appropriate recruitment 
approaches, if the desired sample of interview informants was to be 
achieved. 
Two approaches were determined. One method entailed direct approaches by 
the researcher, the other entailed an initial approach by a GP. (the 
recrui t ing GP was in fact also the director of the HMS). Costs and 
benefits were attached to both GP- and researcher-recruitment of 
informants. This was especially so given that the required sample was to 
consist of elderly people. However, it was hoped that employment of both 
methods would enable the benefits to be retained, whilst costs could be 
set off against each other. 
The use of GP-recruited informants had the benefits of:-
(1) Ensuring that some informants would be eligible for trial entry; 
(2) Enabling group discussions to take place in known, comfortable 
surroundings; 
(3) Dispelling informants' worries about the authenticity of the 
researcher, and about letting a stranger into their homes. 
The possible drawbacks of GP recruitment of informants were: ethical 
concerns that recruits may feel unable to refuse if asked to take part by 
their doctor; and methodological concerns of (a) positive bias in 
attitudes due to GP bias in selection; or (b) insincere responses by 
informants, for whom fear of upsetting the doctor, rather than a genuine 
interest in the topic, represented the major motivation for 
participation. 
These ethical and methodological costs could be largely offset by the 
additional use of researcher-recruited informants. But, this method would 
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not offer benefits (1)(2) or(3) afforded by the other approach, nor would 
it necessarily eliminate selection bias. However, problems of GP-
recruitment of informants could also be alleviated by a very low level 
of GP involvement in recruitment, and reassurances that he would not 
know who did or didn't decide to take part. The GP's role in recruitment 
would be merely that of making initial inquiries as to patients' interest 
in taking part in the interviews, and the transmission of contact 
details of potential informants to the researcher. Subsequent interviewee 
recruitment would then be the researcher's job. 
In section 2.4 the issue of anonymity was considered and its advantages 
and disadvantages discussed. On balance, it was decided that in the main 
study, respondent anonymity would be preferable to identifiable 
respondents even though such an approach would preclude follow-ups. 
Finally, in order to secure the required proportion of elderly 
repondents, it was decide that distribution would be effected by personal 
approach at various sites, including GP waiting rooms. Use of waiting 
rooms would confer some degree of GP endorsement, thus allowing 
comparison of 'medical' and 'non-medical' respondents. It would also, 
hopefully, increase response rates. 
The main aims of the study were: 
(1) To determine whether people were generally in favour or against 
screening programmes for CVD; and if they would be likely to become 
participants. 
(2) To assess whether people were generally in favour or against clinical 
trials being undertaken by GPs and, again, whether or not they would be 
likely to become trial entrants. 
(3) To determine public attitudes towards the application of preventive 
medicine for elderly people. 
(4) To identify any particular aspects of screening programmes and 
clinical trials which were causes of worry and potential deterrents to 
participation. 
(5) To identify characteristics of any sub-groups within the sample which 
might represent reluctant participants. 
(6) To assess whether or not people felt that the use of psychological 
techniques were a useful adjunct to drug therapies in the treatment of 
hypertension. 
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CHAPTER 2 
METHOD 
SUMMARY 
A series of semi-stuctured depth interviews were conducted to investigate 
public opinion of preventive medicine and associated clinical trials 
carried out by General Practioners. Because information obtained from the 
in-depth interviews was to form the basis of the attitude section of the 
questionnaire; and because the questionnaire was to be of special 
relevance to the HMS, all interview informants were over 60 years of age. 
Thus information was obtained from representatives of the HMS target 
population. The information obtained related to the general concept of 
preventive medicine and to specific aspects of it, especially those which 
might give cause for concern, or about which people might hold some 
reservations. 
On the basis of these depth interviews, a self-completion questionnaire 
was designed for wider distribution to ascertain the generality of these 
reported attitudes. 
Distribution of questionnaires was effected via personal approach from 
several distribution points in the Milton Keynes area. These included two 
general pract ice wai t ing rooms. 686 quest ionnaires, each of which was 
at tached to a freepost return envelope, were accepted and 442 returns 
were obtained in time for analysis. 
Completed questionnaires were coded for computer analysis and statistical 
tests were performed on the data. Qualitative data, such as the comments 
which people made on the back of their questionnaires, was also given 
consideration when the results were interpreted and discussed. 
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1. IN-DEPTH INTERVIEWS 
Because no questionnaire appropriate to the objectives of this survey has 
been publ ished, the development of a new purpose-designed quest ionna ire 
was necessary. Two main requirements underpinned this development: the 
need for an effective research tool suitable for the reliable collection 
of attitudinal data; and the need for this instrument to be easily 
utilised by respondents, many of them elderly, in self-completion 
situations. A series of in-depth interviews formed the basis of questions 
used in the questionnaire which was modified in the light of pilot 
studies. 
1.1 INTERVIEW INFORMANTS 
Eleven people (6 women and 5 men) participated in semi-structured in-
depth interviews. 4 were interviewed individually and two group 
interviews, of 4 and 3 people respectively, were also conducted. In order 
to obtain attitudinal information from people who were representative of 
the HMS target populat ion, all interviewees were over 60 years of age. 
Some informants would be eligible for entry into the HMS clinical trials 
because of a known history of cardiovascular disease; others just by 
virtue of their age. 
Individual interviewees were all known personally by the researcher and 
were interviewed in their own surroundings. No-one approached refused to 
participate. 
Group-interview participants were initially recruited by their GP who 
asked sui table pat ients if they would be interested in tak ing part in 
discussions about preventive medicine and clinical trials run in general 
practice. Those who agreed were telephoned by the researcher who 
introduced herself, explained her connection to the doctor, and asked if 
they were still interested in taking part in small group interviews. 
Potential informants were reassuranced that they should not feel obliged 
to take part, if they did not really want to. 
Two potential informants did refuse to participate in the interviews, 
saying that they had changed their minds since talking to the doctor. A 
third potent ial informant dec 1 ined on the grounds that the interview 
times clashed with her part-time job hours; and a fourth failed to attend 
her appointed interview session. However, all other people approached in 
this way, expressed a keen interest in the project, and, in having the 
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opportunity to voice their opinions on the matter. Both group-interview 
sessions were conducted in a private room at the doctor's surgery. 
1.2 INTERVIEW PROCEDURES 
Group interview participants were greeted in the reception area and taken 
through to a pri vate room in the pract ice. No names were subsequent ly 
used, and reassurance was given of anonymity and confidentiality. At the 
start of each interview session informants were offered refreshements 
which helped to create an informal, convivial atmosphere in which to 
procede. Similarly, the interviewer was offered, and accepted, 
refreshments by informants who participated in individual interview 
sessions in their homes. 
At the begining of each interview si tuat ion, permission was sought to 
tape-record the interview so that subsequent transcripts of the tapes 
could be made. This permission was readily given on all occasions. Again 
informants were reassured that no-one but the researcher would hear the 
tapes and it was promised that the recording would be erased once 
transcripts had been made. The same general outline of the HMS and 
explanation of the purpose of the interviews was given at each session 
(see appendix 1). 
Before interviews began informants were reminded that there were no right 
or wrong answers to any of the questions asked, but rather that it was 
essential that the researcher discover what people really felt about the 
various issues to be discussed. The same aspects of preventive medicine 
and clinical trials were discussed in all sessions and were always 
approached in the same order (see appendix 2). The topics raised by the 
researcher related to how people felt about preventive medicine for 
cardiovascular diseases - espec ially for the older age groups; and to 
what aspects of this type of preventive medicine might worry them or make 
them disinclined to participate in such a project. The topics included: 
the general concept of preventive medicine for cardiovascular diseases; 
lifestyle changes; 
medical tests such as blood pressure and blood samples; 
regular health check-ups; 
questionnaire completion; 
worries associated with taking drugs, especially long-term; 
worries associated with not knowing whether one was in a placebo or 
active drug condition; 
worries about the discovery of health problems; 
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the use of psychological as well as pharmaceutical treatment techniques. 
(see elaboration of prompt cards appendix 2). 
At the end of each session informants were once more thanked for their 
time and co-operation, and after transcripts of the tapes had been made 
the interviews were erased from the tape in accordance wi th the pre-
interview promise of the researcher. Data from these interviews was 
subsequently analysed and utilised in the formulation of the 
questionnaire. 
2. DEVELOPMENT OF THE QUESTIONNAIRE 
The primary purpose of the quest ionnaire was that of an exploratory 
instrument. However, whilst it was not specifically intended to test a 
predictive model, it was evident that interview elicitation of beliefs 
had provided most of the variables necessary for application of the 
Health Belief Model (HBM) , which does not depend upon a strictly 
prescribed format. As Rees (1985) pointed out, whilst some standardised 
versions of HBM quest ionnaires have been devised for appl icat ions in 
part icular areas <ego treatment compl iance), "operat ional def ini t ions of 
model items are almost as numerous as the studies published .. "; and the 
general recommendation is for authors to devise their own measures. 
One important variable in the HBM that was not available for measurement 
in the study instrument was that of perceived severity of the disease in 
question. However, other researchers (eg. Calnan and Rutter, 1986) have 
argued that inclusion of this item is not necessary when the disease is 
clearly established as one with severe consequences. They therefore 
omitted the item in their study relating to breast cancer, and it is 
proposed that its inclusion would be equally unnecessary in the reported 
study relating to heart attacks and strokes. 
Thus, although the questionnaire was not designed especially for HBM 
application, it was possible to develop the instrument in such a way as 
to enable a tentative application of the model to be made. 
Since the objective of the study was an investigation of attitudes and 
beliefs; such items, measured by Likert-type scales, comprised the major 
part of the questionnaire. However, because other information was 
required if comparisons of sub-groups were to be made, another small 
section was included to collect data relating to sociodemographic 
details; current health status; health history; and health consciousness 
of respondents. 
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In order for the attitude items used on the questionnaire to reflect 
atti tudes expressed by interview respondents, the interview tapes and 
transcripts were scrutinized for common, and/or strongly expressed 
attitudes. They were also examined for evidence of aspects of particular 
concern to informants, especially as they related to the factors outlined 
above (some examples of interview statements are given in appendix 3). 
Statements were selected from the in-depth interview responses to 
represent attitudes and concerns relating to the various topics covered, 
and response options provided were: Strongly Agree; Agree; Uncertain; 
Disagree; Strongly Disagree. 
Unfortunately, it was not possible to include all the topics discussed in 
the in-depth interviews in the questionnaire since it was evident that 
some matters were too complex for reduction to a form amenable to 
inclusion in a simple 'tick-in-the-box' type questionnaire. 
The most obvious area of confusion amongst informants was that of 
at t i tudes towards not knowing whether they would be in a placebo or 
active-drug condition. Considerable explanation of placebo-control 
randomised c 1 inica 1 tr ia Is was necessary before at t i tudes towards these 
could be discussed. Even so, informants were clearly in some confusion 
over the issue. This was typi f ied by one respondent who stated that 
"doctors know sugar is bad for you so why would they gi ve you a sugar 
pill?" Indeed, most respondents asserted that they were sure their doctor 
would always do what was best for them; and that they would not take part 
in such trials if they did not trust their doctor. If, on the other 
hand, they did trust their doctor, as most claimed to do, they stated 
that they would readily accept his or her decisions, whatever they were. 
Given the wide target population of the anticipated sample and the nature 
of the survey, it was essential that the questionnaire be both easy to 
complete, and easy to code for computer analysiS, thus the particularly 
difficult topic of placebo versus active drug conditions was omitted from 
consideration in the questionnaire. Nevertheless, it is evident that this 
issue represents a very important aspect of clinical trial participation. 
It is also clear, therefore, that it is an issue requiring further 
investigation and clarification in future research, perhaps being 
addressed as a single research topic. 
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3. PILOTING OF THE QUESTIONNAIRE 
In all 26 people took part in the pi lot ing of the quest ionnaire. 20 
informants assisted in the process of instrument ref inement and the 
final version was tested on 6 more participants. As with the in-depth 
interviews, all pilot study respondents were over 60 years of age. 
Likewise, those who participated in first stage piloting of the 
questionnaire were comprised of some GP-recruited respondents who were 
interviewed at the surgery, and some researcher-recruited respondents who 
were interviewed in their homes or at a private table in the local Age 
Concern Drop-In Centre. Permission to solicit respondents from the Age 
Concern site was previously given by the manageress. 
GP-recruited informants were canvassed as for preliminary in-depth 
interviews. Other potential respondents were approached by the researcher 
who gave an out 1 ine of the proposed HMS and the purpose of the survey, 
together with assurances of anonymity and confidentiality. Potential 
informants were also informed that this was a prel iminary phase of the 
survey. Early responses to researcher canvassing was a little 
disappointing, but improved remarkably when the introductory explanation 
of the study was condensed and simplified. 
The original canvassing approach was offering too much information and 
people were confusing information about the HMS with the questionnaire 
study. This was made apparent by a respondent who said that she did "not 
want to have anything to do with testing pills right now". The 
introductory letter accompanying the questionnaire was therefore amended 
accordingly. 
During the piloting phase each respondent completed the questionnaire 
alone, except for the presence of the interviewer. Half of the 
questionnaires were interviewer-administered, and half self-completed 
under the supervision of the researcher. In addition to giving responses 
to the questionnaire items, respondents were also asked to comment on the 
style, comprehensibility, and ease of completion of the questionnaire. 
None of the items were reported to be offensive, redundant or difficult 
to answer, though one respondent did state that a couple of items in the 
attitude section were' a bit cheeky' since they suggested one could be 
ruder to nurses than to doctors, and ruder still to receptionists. These 
items were thus removed from the at t i tude sect ion of the quest ionnaire, 
and replaced in a different form at the end of the final version. 
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Another respondent began the session with the statement that whilst she 
was prepared to answer any quest ions put to her, and do anything she 
could to help with medical research, she was not prepared to 'strip off' 
because this was an exercise she found both physically and emotionally 
very difficult to perform. So strong was her objection to this possible 
requirement that it was decided to include this concern as an item in the 
amended instrument so that the generality of it might be assessed. 
Several respondents stated that they liked the style of the instrument 
and the expression of various 'shades of opinion' that it allowed. 
However, two respondents did report that they found the statement format 
unnecessarily confusing, and suggested that a more straightforward set of 
questions would be better. This suggestion was supported by the 
researcher's own experience of administering the questionnaire especially 
to some of the older repondents for whom completion was easier when the 
interviewer rephrased the statement items as questions. 
Accordingly, the instrument was altered to transform the statements into 
questions and the answer options became: Very Much So; Yes; Uncertain; No 
and Definitely Not. In this way the same basic attitudes were 
represented and the opportunity for expressing different shades of 
opinion was retained, but comprehensibility was facilitated. The benefit 
of this change in style was immediately clear during the final pi lot 
test ing of the quest ionnaire when the average complet ion time almost 
halved and in which there was no evidence of the 'double-takes' or 
requests for clarification of some items which had sometimes occured 
during the initial piloting. 
Final piloting provided a check on the suitability of the ammended 
version for easy self-completion by respondents at home. All six of the 
final pi lot study respondents were researcher-recrui ted repondents who 
self-completed the questionnaire in the Age Concern centre. All reported 
that it was easy and interesting to complete, and thus the final version 
was determined (see appendix 4). 
4. 
The quest ionnaire 
attitude items. 
4.1 SECTION ONE 
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THE QUESTIONNAIRE 
was compr i sed of 2 sec t ions - persona 1 de t ail sand 
The first section, pages 1 and 2, related to sociodemographic and health 
details of respondents. Questions 1 to 4, sociodemographic items, were 
included so that comparisons of sub-groups based on age, sex and socio-
economic groups could be made in respect of attitudes expressed. 
Questions 5, 6, and 9 were used as indicants of current health status, 
and questions 10 to 12 related to levels of health consciousness and 
motivation to keep healthy. Questions 7 and 8 were directly related to 
eligibility for entry in the HMS,and perceived susceptibility to 
cardiovascular disease respectively. 
As wi th demographic detai Is, the inclusion of these heal th-related items 
afforded the opportuni ty for subgroup comparisons, in addi t ion, they 
provided information necessary for prediction of utilisation of 
preventive medicine based on the Becker and Maiman Health Beliefs Model. 
The top of page 1 was heavily marked 'CONFIDENTIAL' and instructions for 
the desired mode of answering the items were given. 
4.2 SECTION TWO 
This section, pages 3 to 7, represented the attitudinal questions, which 
were comprised of questions formulated from attitude statements expressed 
by informants during in-depth interviews. They related to the various 
aspects of preventive medicine and associated clinical trials discussed 
during in-depth interviews. Whilst questions relating to specific aspects 
were genera 11 y grouped together, there were some cross-check quest ions 
interspersed in other groupings throughout the questionnaire. Also, use 
was made of apparently repeated questions, which were slightly different 
in their wording (eg: 6 and 42; 8 and 15j 13 and 14; 22 and 43), and 
which did, in fact, ask slightly different things. At the top of this 
sect ion instruct ions for complet ion were rei terated, together wi th a 
reminder that there were no right or wrong answers and that it was 
important for answers to indicate how respondents really felt about each 
quest ion. 
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Attitude Items 
Items 1 to 5, (p.3) and item 25(p.5) related to the respondent's 
relationship with, and trust in his or her doctor. The relevance of these 
quest ions resides in the fact that in-depth interview informants all 
cited a good relationship with a doctor they could trust, as prerequisite 
to participation in any project with which the doctor may invite them to 
become involved. 
Item 6(p.3) was a direct question of willingness to participate in 
cardiovascular disease screening, and less specific questions of desire 
to accept a health check were asked again in items 12(p.4) and 42(p.6). 
Item 7(p.6) was related to items 1 to 5 in that it might give an 
indication of the respondent's relationship with his or her doctor, but 
it was included in the questionnaire to represent comments made in 
interviews that people might find themselves taking part in projects they 
didn't really want to participate in just because they would find it hard 
to refuse something the doctor suggested they should do. Items 35 and 
36(p.6) were included for a similar purpose, though these questions 
related directly to clinical trials rather than to health checks. 
<Interestingly, none of the depth interview informants who supported this 
proposition admitted that it might apply to them). 
Items 8 and 9(p.3) represented attitudes expressed about problems 
associated wi th 1 i festyle changes that might be advised for people at 
risk of cardiovacular disease, with further investigation of these 
provided by items 15(p.4),48 and 49(p.7). The inclusion of these items 
allowed not only an assessment of the general i ty of att i tudes towards 
changes of dietery and smoking habits, but also provided information of 
perceived costs of treatment that could be used in the prediction of 
preventive medicine utilisation based on the Becker and Maiman Health 
Beliefs Model. More information for this purpose was provided by items 10 
and 11(p.3) which related to attitudes towards giving blood samples and 
having blood pressure tests respectively. Items 45 and 46(p.7) were also 
used to invest igate at t i tudes towards medical tests, though in these 
questions the tests were not specified. 
Items 13 and 14(p.4) seem to be different wordings of the same question 
and thus somewhat tautological. However, it was apparent from the 
interviews that it is quite possible for people to be inconsistent in 
their attitudes to this area of having knowledge of their health status. 
There seemed to be a feeling that people ought to want explicit 
information about their health, and that it was in some way wrong not to 
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seek this knowledge. By providing items that phrase the question both in 
terms of wanting to know about latent disease and in terms of prefering 
not to know about it, it was hoped that respondents would find it easier 
to answer in a way which would reflect their true attitudes. A cross-
check quest ion was provided by item 50{p. 7). Informat ion of at t i tudes 
towards knowledge of latent disease was essential for the preventive 
medicine project with which this study was associated. 
Items 16,17,18 and 19{p.4) all related to attitudes towards the concept 
of prevent medicine and the age-groups to whom it should be offered, 
whilst items 20 and 21{p.4) approached the specific question of 
preventive medicine run by general practitioners. 
Items 22 to 24{p.4&5) represented attitudes towards medical research 
conducted in general pract ice expressed by some interview respondents, 
and items 28 to 34{p.5) represented reservations specific to clinical 
trials that were also identified. Assessment of the generality of these 
attitudes is clearly important for doctors engaged in any research, but 
particularly so for that involving clinical trials, whether the drugs 
being tested are new or well established. Information about perceived 
costs of preventive medicine in the form of side effects was also 
afforded by these items and was thus avai lable for use in predict ing 
utilisation of preventive medicine as with items 8 to 11(p.3) above. 
Items 26 and 27{p.5) refered to attitudes towards questionnaire 
completion, and were of particular relevance to the HMS, since 
participation in this will necessitate the completion of a long and 
comprehensive questionnaire which asks for information of a very personal 
and potentially sensitive nature, as well as that related to general 
health and health history. Item 44(p.7) was a cross-check question. 
Items 37 to 41{p.6) related to opinions of the influence of 
psychological factors on both the genesis and the treatment of 
hypertension. In-depth interview informants were unanimous in their 
expressed beliefs that psychological factors play an important part in 
both the aetiology and the exacerbation of hypertension. They were also 
in accord in respect of the opinion that any effective treatment of 
hypertension must involve relaxation. Indeed, most declared that this was 
something people wi th hypertension automat ically try to do for 
themselves. Interesting information would be gained from an assessment of 
the generality of these attitudes, and this information may hold 
important implications for future approaches to the treatment of people 
with essential hypertension. 
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Item 47(p.7) represented the strong reservation held by one pilot study 
respondent who declared a willingness to do almost anything to please her 
doctor or help with medical research as long as it did not involve having 
to 'strip off', an experience she found both physically and emotionally 
hard to do. Although this was an attitude spoken aloud by only one 
respondent, so strongly was it expressed that its inclusion in the 
questionnaire seemed prudent if a true reflection of informants attitudes 
was to be achieved. If this attitude is at all widespread amongst 
respondents, especially those over 60, then clearly it is an attitude 
that needs to be made known to those invol ved in any research that 
entails health checks. 
The last two items on the questionnaire asked respondents to indicate who 
they would prefer to issue participatory invitations and perform the 
health checks respectively. 
Finally, respondents were asked to check that they had answered all the 
questions, and to use the space provided to make any comments they wished 
about preventive medicine, health checks, pill testing, and/or the 
questionnaire. As a footnote respondents were thanked for their time and 
co-operation in completing the questionnaire; and reminded that there was 
no need to use a stamp when posting it back in the freepost envelope. 
5. SAMPLING FRAME AND STRATEGY 
The sample was drawn from five si tes in the environs of Mi 1 ton Keynes, 
over a four week period in June and July 1986. These sites were: 
Site 1 a group practice of 6 doctors in Leighton Buzzard; 
Site 2 a group practice of 5 doctors in Stantonbury, Milton Keynes; 
Si te 3 the Age Concern Drop-In Centre in Milton Keynes; 
Si te 4 the Milton Keynes Shopping Centre; 
Site 5 : Milton Keynes Central Railway Station. 
General practices were chosen as distribution sites because recruitment 
for the HMS will take place in general practices. Also, it was considered 
possible that attitudes expressed about medical projects may be different 
if solicitation of those attitudes occured in a medical setting than if 
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it occured in settings divorced from medicine. Furthermore, it was 
assumed that respondents obtained from GP waiting rooms would include 
several elderly people, and it was hoped that the over sixties would 
comprise about half of the final sample. Finally, as distribution in GP 
waiting rooms would associate the study with the GP, it was anticipated 
that good response rates would be obtained from these sources 
The choice of the Age Concern Drop-In Centre as a distribution site was 
determined by the desire to obtain a large proportion of ambulant elderly 
respondents. 
The Milton Keynes Shopping Centre was used because this is a very large 
complex which attracts many customers and visitors, and it was hoped that 
a good cross-section of the population could be approached in this 
loca t ion. 
Finally, the railway station was selected as a site from which working 
people could be approached since it is used by both commuters and people 
working locally. 
At the Genet-a I Practices, sites 1 and 2, questionnaire distribution was 
effected at both morning and evening surgeries, and all adults entering 
the waiting rooms were approached with a request for participation in the 
survey. At site 1 questionnaires were distributed during Tuesday morning 
and Monday evening surgeries, and at si te 2 the sample was obtained 
during Thursday morning and Friday evening surgeries. 
Distribution of questionnaires at the Age Concern Drop-In Centre was 
effected over two weeks,each day of the week being represented. As with 
the strategy employed at sites 1 and 2, each person entering this site 
was approached . 
The sample obtained from site 4 was achieved over 2 Monday sessions, 
during which every 3rd person who passed the researcher was approached. 
A combination of the sampling strategies used at sites 1 to 4 was 
utilised at site 5 which was attended on two occasions, a Tuesday and a 
Thursday, between the hours of 06.40 and 09.30. 
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6. DISTRIBUTION PROCEDURE AND RETURNS CHECK 
All quest ionnaires were gi ven out 
envelopes were numbered to enable 
different coloured questionnaires 
further facilitated identification of 
in Freepost return envelopes. The 
a check on returns. The use of 
for different distribution sites 
returns from the various locations. 
Prior to the distribution of questionnaires permission for distribution 
was sought, in person, from the authorities associated with each proposed 
distribution site. In addition, letters were sent to the general 
practitioners (copies of these letters are given in appendix 5). 
A standard request for participation was used at all sites 
6). The sex, age group, occupat ion and envelope number 
respondents were noted on a response (see appendix 7). 
estimated age group of outright refusers was also noted. 
approached were thanked for their time. 
(see appendix 
of potent ial 
The sex and 
All people 
When quest ionnaires were returned, the number on the envelope was noted 
and the age, sex and occupation details on page 1 were checked against 
those on the response sheet for tha t number. Responden t numbers were 
then assigned to each questionnaire and returned numbers crossed off the 
1 ist. This method enabled a 1 imi ted demographic compar ison of returners 
and non-returners thus allowing some assessment of sample bias. 
7. STATISTICAL ANALYSIS 
Response rates were computed, and each questionnaire was coded for 
computer analysis. Coded responses were entered into the Vax computer 
using the SPSSX package, and the following stat ist ical analyses were 
performed; 
(1) Frequency counts of all items on the questionnaire 
(2) Principal Components analyses 
(3) Computation of factor scores for metavariables identified from the 
Principal Components analyses 
(4) Anovas using metavariables 
(5) Multiple Regression analyses 
(6) Discriminant Function analyses 
(7) Crosstabulation Chi Square tests on selected variables. 
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CHAPTER 3 
RESULTS 
Quantitative and qualitative data were collected for the study and both 
will be presented in this section. 
QUANTITATIVE DATA 
No hypotheses were put forward for testing in this exploratory 
investigation, therefore the presentation of results will reflect the 
nature of the study and the exploratory data analysis which was 
performed. The format of the presentation will be as follows:-
(1) Details of Response Rates 
(2) Frequency Values 
(3) Principal Components Analysis 
(4) Anovas using Metavariables identified from Principal Components 
Analysis 
(5) Multiple Regression Analysis 
(6) Discriminant Function Analysis 
(7) Chi Square Crosstabulation Tests 
(8) Summary of quantitative results 
QUALITATIVE DATA 
The most important qualitative data collected in the study were 
respondents' comments written on the back of questionnaires, 
summary of these will also be given in this section. 
those of 
and a 
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QUANTITATIVE RESULTS 
1. RESPONDENTS 
A total of 770 people were approached with a request for participation in 
this study and 686 accepted a questionnaire. Of those refusing to 
participate only 4 declined after hearing what the survey was about, the 
remainder giving refusals before the nature of the survey was explained. 
Neither sex and no age group predominated initial refusers. 
Of the 686 who took quest ionnaires, 442 returned completed instruments 
in time for analysis. This represented an overall response rate of 
64.43%. There was little difference in the overall response rates of 
males and females - 63.75% and 65.2% respect ively; and only small 
variation in the response rates from the various sites, the range being 
from 61% site 2 to 68.5 % site 4. 
However, there was some difference in the 
females from within some of the sites with 
site 1 (Doctors surgery, Leighton Buzzard) 
site 3 (Age Concern Drop-In Centre) 
site 4 (Shopping Centre) 
response rates of males and 
the response rates being:-
male 55% female 64% 
male 70% female 61% 
male 60% female 78% 
Compared with national figures (CSO, Annual Abstract of Statistics, 1986) 
people aged 60 and above were over-represented in the sample (371 
against 17.7% nationally), but this was a deliberate strategy. An 
unintent ional discrepancy between the sample and nat ional figures was 
found in respect of sex (all ages), though the difference was quite small 
and it was in the right direction: -
National Figures 
Males Females 
49% 511 
Sample Figures 
Males Females 
431 57% 
Interestingly, this slight over-representation of females in the sample 
as a whole, did not apply in the over 60s. Indeed, wi thin the older 
group, the over-representation is reversed, and considerably so. 
~ MALES AND FEMALES OVER 60 YEARS OLD 
National Figures 
Males Females 
41.5 58.5 
Sample Figures 
Males Females 
50.6 4-9.4 
-63-
From the data obtained, using the Registrar General's Classification 
system, the sample did conform quite closely to the socio-economic 
background of the local population from which it was drawn -ie Milton 
Keynes and Leighton Buzzard. However, the information available as the 
basis for socio-economic grouping of respondents was not very detai led, 
and probably inadequate for confident socio-economic classifications. 
Therefore, no analyses based on socio-economic groupings were performed. 
Approximately one quarter of the respondents in this sample reported a 
history of some cardiovascular disorder. 
1.1 NON-RESPONSE 
237 of the 686 who accepted a quest ionnaire fai led to return it, wi th 
overall non-response rates being approximately 35% for both males and 
females. There was, however, considerable differences in the non-
response rates of various age groups as shown below:-
NON-RESPONSE RATES 
(as % of Qnaire takers 
in each age group) 
18-29 
40.6 
30-39 
36.9 
AGE IN YEARS 
40-49 50-59 60-69 70+ 
28.7 32.1 25.0 41. 1 
Regarding distribution sites, the greatest non-response rate (39%) came 
from site 2 - a general practice in Milton Keynes, and the smallest (31%) 
from sites 3 and 4 - the Age Concern Drop-In centre and the shopping 
centre respectively. 
2. FREQUENCIES 
Frequencies were computed for all variables on both sections of the 
quest ionnaire. From frequency counts, a prof i Ie of soc iodemographic and 
health-related characteristics of the sample was obtained and generality 
of attitudes assessed. Frequencies of all responses to each questionnaire 
item are given on the appended copy of the questionnaire, appendix 4. 
Tables 1 and 2 below show selected frequencies from section one to give 
an indication of the health status and health consciousness 
characteristics of the sample. All values represent respondents own 
subjective assessments. 
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TABLE 1 Selected frequencies relating to the first section of the questionnaire- reported 
health status and health consciousness of respondents, 
Gene r a 1 Hea lth As Fit or History of Not Really Very Interested Very or Quite 
Excellent or Fitter CVD Symptoms Worried re In Own General Careful about 
Good than Developing Health Healthy Habits 
Av~raae CVD ea diet, smokina 
771. 87,51. 24,51. 67,21. 50,51. 86, 11. 
TABLE 2 Percentage of respondents reporting actions taken to improve heal th by changing 
various behaviours in the last few years, 
Changes in 
. t 
54,8~ 
Changes in 
35,3~ 
Changes in Changes in 
15,31. 15,71. 
An omission on the questionnaire was an item about current or past 
smoking habits. 44.6% of respondents were self-declared non-smokers, but 
it cannot be assumed that this figure represented all non-smokers in the 
sample. Therefore, further analysis of the smoking variable was not 
undertaken. 
ATfITUDE ITEMS 
Items for which there were particularly high rates of agreement in 
attitudes expressed included items relating to: (1) percieved doctor-
patient relationships; (2) the general concept of preventive medicine and 
screening programmes; (3) the desire for information about diagnosis; (4) 
undergoing medical tests; and (5) psychological influences on 
hypertension. A summary of frequency data relating to these factors is 
given in tables 3 to 7 below. 
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TABLE 3 
QUESTION No, VARIABLE NAME & CONTENT SUMMARY 
1 (Seton) Do you get on with your Dr, 
3 (Canask) Can you ask for information 
35 (Hrdrfpls) Is it hard to say no to your Dr, 
re testing pills 
36 (Upsetdr) Are you frightened of upset ti ng your 
doctor by refusing to help in testing pills 
TABLE 4 
QUESTION No, VARIABLE NAME & CONTENT SUMMARY 
6 (Wantcu) Would you want a screening check 
16 (Sooduse) Are preventive checks good use of 
NHS resources 
18 (Sxtys) Should P,M,* be offered to people in 
their 60s 
19 (Svntys) Is it silly to offer P,M, to over 70s 
42 (Acceptcu) If offered a check would you accept 
.. 
... . . 
TABLE 5 
QUESTION No, VARIABLE NAME & CONTENT SUMMARY 
13 (Straight) Would you want to know if you were at 
risk of CVD 
14 (Notknw) Would you rather not know 
f--. 
Frequencies of items relating 
to doctor-patient relationships 
YES NO UNCERTAIN 
84,8 2,7 12,4 
84 2 , 6,7 9,1 
11,4 82,2 6,4 
4,3 91,3 4,3 
Frequencies of items relating to the 
concept of preventive medicine etc, 
YES NO UNCERTAIN 
96,4 1,1 2,1 
92,9 4,2 3,0 
83,2 9,0 7,8 
10,8 80,4 8,9 
97,3 ,7 2,1 
Frequencies of items relating to 
desire for diagnosis information 
YES NO UNCERTAIN 
95,7 2,0 2,3 
7,7 88,0 4,4 
* P,M,= Preventive Medicine N,B, full questions appear on the questionnaire in appendix 4 
and variable names appear on top of each coding box in the right hand margin, 
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TABLE 6 
QUESTION No, VARIABLE NAME & CONTENT SUMMARY 
10 (Bldsmp) Do you mind having a blood sample taken 
11 (Bp) Do blood pressure tests worry you 
45 (Fearprob) Would fears of medical tests put you off 
having a health check 
Frequencies of items relating to 
medical tests 
YES NO UNCERTAIN 
7,1 92,3 7,0 
4,6 95,0 ,5 
10,6 86,1 3,2 
TABLE 7 Frequencies of items relating to 
psychological influences on hpertension 
QUESTION No, VARIABLE NAME & CONTENT SUMMARY YES NO UNCERTAIN 
37(Stress) Do you think stress and personal 
problems can affect people's B,P,* 93,8 1 , 1 5,0 
38 (Relax) Can relaxation help B,P, 91,7 2,3 6,0 
39 (Onlymed) If people are at risk of 
developing CVD can only medicines help 7,8 80,9 11,4 
40 (Rlxpls) Might people with B,P,problems need 
help in learning to relax as well as pi lIs 92,2 2, 1 5,7 
41 (Copestrs) Could people with B,P,problems be 
helped by being taught to cope with stress 93,4 0,9 5,7 
• B.P.= Blood pressure 
As well as the general i ty of at t i tudes presented above, a few other 
questionnaire items attracted responses for which there was a high rate 
of agreement. Most of these items were on page 7 of the questionnaire, 
and they related to factors which might put people off booking in for a 
screening check. In all cases the majority of responses indicated that 
these would not be very strong deterrent factors. When the two 'no' 
categories of 'No' and 'Definitely Not' were collapsed, the percentages 
of respondents reporting that they would not be put off by given factors 
were as shown in table 8 
-67-
TABLE 8 Percentage of respondents who would NOT be deterred by the shown factors from 
booking in for a health check, 
FACTOR 
Having to fill in a long form first 
Worries that a check might lead to other tests 
Worries about having tests 
Worries about 'stripping off' for medical examination 
Worries about being told to loose weight/change diet 
Fears of what health problems might be found 
I CLAIMING NOT 
TO BE DETERRED 
7.51 
8:3,.51 
86,11 
8.4,21 
92,91 
77 ,61 
Two other items on the quest i onna i re produced over 80% agreemen t and 
these were: question 15, page 4 (Fearmot) 'would being at risk of a heart 
attack or stroke motivate you to change your habits if the doctor advised 
this, even if you found it hard to change?'; and question 51,page 
7, (Whoask) which asked which of 3 health workers people would prefer to 
invite them to take part in a health study. 'Yes' responses to question 
15 accounted for 88.5% of the responses to this question relating to the 
motivation of fear, and for question 51, from the choices offered- ie. 
'your own doctor',' the pract ice nurse', 'the recept ionist' - opt ion 1, the 
doctor, was selected in 80.65% of responses. 
An interesting finding from these results was the difference in expressed 
attitudes towards participation in clinical trials which was observed in 
the two questions relating directly to this topic. In the first of these 
items, Q.22, (testpls) respondents were asked whether they thought it was 
a good idea for family doctors to invite their patients to take part in 
clinical trials relating to CVD. In the second item ,Q.43, (accptct) they 
were asked if they would participate in such trials if they were 
personally at risk of CVD. The frequencies of these items were: 
Testpls: Yes 49.9%, Uncertain 26.1%, No 24.1%; 
Accptct: Yes 60.3%, Uncertain 29.7%, No 10% 
Thus responses indicated that respondents held more favourable attitudes 
towards participation when the question was asked with a personal focus 
than when it was phrased more generally. The rise in 'yes' responses was 
paralleled by a drop in the 'no' responses whilst the 'uncertain' 
response rates showed little change. 
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3. PRINCIPAL COMPONENTS ANALYSIS 
After the raw data had been processed and an examination of the frequency 
values made, it was decided that the next step in the investigative 
analysis of the data should be that of a factor analysis so that the 
principal components of the data might be identified. 
The main aim of factor analysis and the extraction of principal 
components is to uncover any patterns in relationships among variables 
and to discover any variables wi thin the data set which form coherent 
subsets that are relatively independent of one another. Such a process 
will allow identification of groups of variables which may be subsumed 
under metavariables, thus reducing the number of individual variables 
that have to be considered, and giving a better over-all picture of 
important factors. Principal components analysis may be used as a 
conf irmatory tool if required, but it is ideally sui ted to exploratory 
data analysis, and it was for this purpose that it was employed in further 
processing of the data. 
The first principal components analysis performed on the data entailed 
inclusion of all suitable variables and 16 factors were extracted which 
together accounted for 63.7% of the variance. Of these 16 factors, the one 
accounting for the greatest individual amount of the variance was a 
'stress' factor at 12.7%. The variables with the greatest weighting values 
in this factor were those relating to psychological influences in 
hypertension (items 37, 38, 40 and 41). 
However, whilst 16 factors were considerably more manageable than 60 
indi vidual variables, they st i 11 represented a rather large quani ty of 
metavariables. Also, because 13 of the 16 components each accounted for 
less than 5% of the variance, a second principal components analysis was 
performed with just 30 variables entered. These 30 variables did not 
include those relating to psychological influences in hypertension since 
investigation of this area was a secondary, rather than primary objective 
of the study. 
A summary table of the 9 principal components extracted from this second 
factor analysis is given in table 9, over. 
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TABLE 9 Summary Table of Principal Components Analysis 
Factor No,& 
Metavariable Name 
1, Deterrents 
2, Dr,-Patient Relationship 
3, Questionnaire 
4, Smoking 
S, Information 
6, Health Consciousness 
7, LOIN Health Status 
8, Clinical Trial Worries 
9, Research Worries 
Proportion of 
Variance 
15,5% 
9,1% 
7,S% 
6,3% 
S,4% 
4,7% 
4,2% 
4,1% 
3,9% 
TOTAL VARIANCE ACCOUNTED FOR 60,3% 
Associated Variables (Item Nos) & 
their Factor Weights 
4S,leadmts(,8S); 46,medtsts(,89); 
47,strip(,61); SO,fearprob(,79) 
l,geton( ,81); 3,canask( ,80) 
26,nopinf(,72); 27,longques(,82); 
44,fillfrm(,79) 
49,stpsmk( ,91) 
13,straight( ,83); 14,notknlN(-,67) 
10, intrst( ,73): 11,careful(, 72) 
S,genhlth(-,72); 7,htbp( ,60) 
33,morepls(,74); 34,offgdpls( ,69) 
23,gpigs(,73); 24,respts(,61) 
Although this principal components analysis was an improvement on the 
first attempt, it was still not entirely satisfactory due to the 
relatively low proportion of the variance accounted for by the 9 factors. 
Also, the first component was the only one which accounted for over 10% of 
the variance. Nevertheless, the extracted components were coherent 
factors, and they offered some basis for further analysis. 
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4. ANOVAS ON METAVARIABLES 
The statistical tests which followed most directly from the principal 
components results were analysis of variance (ANOVA) tests in which 
individual metavariables were analysed by sex and age in two way anovas 
(see appendix 8 for rationale behind the use of anovas on ordinal level 
raw data>. The first 3 metavariables identified from the principal 
components analysis were each entered into two way anovas by sex and age, 
age having been previously recoded into 2 levels ie. (1) under 60 and (2) 
60 and above. 
Regarding the first metavariable, the 'deterrents' metavariable, 
statistically significant effects were shown for age, sex, and age/sex 
interact ion. Examinat ion of cell means showed that respondents aged 60 
and above were more likely than younger respondents to have responded 
positively to items 4-5.4-6.4-7 and 50, ie they were more likely than under 
60s to be put off booking in for a screening check by worries that a 
check up might lead to other medical tests, worries about having medical 
tests, worries about having to 'strip off' for a medical examination, and 
fears of what health problems or diseases might be found. 
Similarly, women were more likely than men to have responded positively to 
these deterrent items. Also, women over 60 were the most likely of all to 
be put off, whereas men under 60 were the least likely. Table 10 
represents a summary of this anova result, and tables 11 and 12 represent 
summary tables of the anovas for the metavariables of 'doctor-patient 
relationship' and 'questionnaire' respectively. 
TABLE 10 Summary Table of 2 Way Anova of Deterrents by Age and Sex 
Source Sum of Squares df Mean Square F Ratio Signi f icance 
Ma i n E f f ec ts 212,79 2 106,39 17,26 0,000 
Age 72,68 72,68 11,79 0,001 
Sex 158,12 158,12 25,66 0,000 
2 Way Interaction 29,60 29,60 4,80 0,029 
Explained 242,38 
., 80,79 13,11 0,000 oJ 
Residual 2613,10 424 6,16 
Total 2855,49 427 6,69 
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TABLE 11 Summary Table of 2 Way Anova of Dr,-Patient Relationship by Age and Sex 
Source Sum of Squares df Mean Square F Ratio Significance 
Main Effects 18,64 2 9,32 4,51 0,012 
Age 18,53 18,53 8,96 0,00:3 
Sex 0,02 0,02 <1 NS 
2 Way Interaction 0,15 0,15 < 1 NS 
Explained 18,79 3 6,26 
Residual 887,05 429 2,07 
Total 905,84 432 2,10 
TABLE 12 Summary Table of 2 Way Anova of Questionnaire by Age and Sex 
Source Sum of Squares df Mean Square F Ratio Significance 
Main Effects 17,64 2 8,82 2,28 0,103 
Age 16,72 16,72 4,33 0,038 
Sex 1 ,86 1,86 ( 1 NS 
2 Way Interaction 1 ,52 1,52 (1 NS 
Explained 19,15 3 6 "'0 ,"'v 1,65 0,177 
Residual 1622,64 420 3,86 
Total 1641,80 423 3,88 
As is shown in table 11, there was a significant difference between the 
under- and over- 60s, but not between the sexes in respect of responses 
given to the metavariable of Dr.-patient relationship, and the difference 
was such that respondents aged 60 and over were significantly more likely 
to report a good relationship with their doctor than were the younger 
respondents. 
Similarly, for the 'questionnaire' metavariable, a significant difference 
was found to exist between the two age groups but not the sexes. In this 
analysis cell means were lower for the older age group which indicated 
that they were more I ikely than younger respondents to respond 
unfavourably towards questionnaire completion. 
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5. MULTIPLE REGRESSION ANALYSIS 
Multiple regression analyses were performed to assess the strength of the 
associations between respondents' willingness to take part in screenIng 
and clinical trials, and groups of potential predictor variables. 
This technique yields a multiple correlation coefficient value between a 
dependent variable(DV) and a group of independent variables <IVs). 
Examination of R2 changes also enables an assessment of the relative 
contribution of individual IVs in the prediction of the DV. A further 
feature of multiple regression analysis is that it provides weighting 
values for IVs, so that subsequent prediction of a given DV value can be 
made on the basis of knowledge of appropriate IV values. 
In the first regression relating to screening, the DV was Intention To 
Participate in Screening (Acceptcu) and the IVs were comprised of the 17 
variables directly related to screening participation. These items were: 
Wantcu, Cutbut, Bldsmp, BP, (6,8,10 & 11,p.3); Lkregcu, Straight, Fearmot, 
Gooduse, Toobusy, <12,13 15,16, & 20, p.4) Nopinf, Longques, (26 & 27, p. 5); 
Fillfrm to Losewt and Fearprob(44-48 & 50,p7) The smoking variable was 
omitted because of inadequate measures. 396 cases were analysed so there 
were at least twenty times as many cases as variables. 
Attitude-to-participation items accounted for the greatest proportion of 
the variance, so in a second analysis, the same DV applied, but the IVs 
used were comprised only of attitude-to-participation items (Wantcu, 
Lkregcu, Gooduse & Toobusy). 
The third regression analysis employed the same DV, but utilised the 
questionnaire items of relevance to the Health Belief Model (HBM). As 
described in Chapter I (section 4.3.1), variables important to this 
function are those which relate to (1) a concern with health and a 
motivation to protect itj (2) susceptability to the disease in questionj 
(3) a belief that the consequences of the disease will be severe if left 
untreatedj and (4) a belief that the benefits of preventive measures 
outweigh the costs involved. Accordingly the variables employed in this 
analysis were (1) Intrst and Careful; (2)Htbp; (3) Worry; and (4) Gooduse, 
Cutbut, Bldsmp, Bp, Straight, Fillfrm to Losewt & Fearprob. Summaries of 
these three multiple regression analyses are given in tables 13 to 15 
over. 
For regressions relating to clinical trial participation, the DV was 
Intention to Participate in Clinical Trials (Accptct) and the IVs were the 
12 items pertaining directly to medical research and trial participation, 
, 
-73-
plus 2 items relating to asking for information. These items were: Canask, 
Toomnyq (3 & 5,p3); Medres, Testpls (21 & 22,p4) Gpigs, Respts, Sideffs 
to Offgdpls (23,24, 28 to 34,p5) Hrdrefpls (35,p6). 400 cases were 
analysed, so again the cases to variables ratio was well within regression 
limits. As with screening, attitude to the general concept of clinical 
research contributed most to the equation. Therefore, a second regression 
using just these items was performed (Medres, Testpls, Gpigs, Respts). 
Finally, items of relevance to the HBM model were also tested as predictor 
variables for the DV. These items were as for Screening for the first 3 
sections and for (4) they were Sideffs to Offgdpls. Summaries of these 3 
multiple regression analyses are given in tables 16 to 18 below. 
TABLE 13 Summary of Multiple Regression Analysis With Intention To Participate in Screening 
(Acceptcu) as the Dependent Variable and 17 Screening-Related Independent Variables 
FINAL VALUES 
,649 ,421 ,411 40,447 ,0000 
VARIABLES IN THE EQUATION 
Variables Entered Beta Part !Partial! T Sig, 
Want a regular check (Wantcu) ,220 ,252 ,220 ,278 5,71 ,000 
Like idea of regular check (Lkregcu) ,094 ,227 ,206 ,262 5,3 ,000 
Fear would motivate habit changeCFearmot) ,038 ,166 ,150 ,193 3,89 ,000 
Fear of medical tests 01edtsts) ,028 !-,139 !-,128 !-,166 !-3,33 ,000 
Want to be told 'straight' (Straight)! ,018 ! ,150 ! ,132 ! ,171 ! 3,42 ,000 
Put off by long questionnaire (Longques)! ,012 ! -,125 ! -,114 !-,149 !-2,98 ,003 
Easy to make dietry change (Cutbut) ,008 !-,098 !-,094 ! -,122 !-2,44 ,015 
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TABLE 14 Summary of Multiple Regression Analysis With (Acceptcu) as the Dependent 
Variable and Attitude to Screening Concept IVs 
FINAL VALUES 
2 I 
,561 ,315 ,310 ,0000 
VARIABLES IN THE EQUATION 
Variables Entered R2 Beta Part !Partial! T C' • .... lg, 
Wantcu ,214 ,334 ,306 ,347 7,63 ,000 
Lkregcu ,086 ,271 ,249 ,28S 6,21 ,000 
Gooduse (screening good use NHS resources)! ,014 ,133 , 119 ,143 2,98 ,003 
TABLE 15 Summary of the Multiple Regression Analysis with (Acceptcu) as the DV and 
HBM-relevant Items as the IVs 
FINAL VALUES 
,555 ,30S ,299 35,196 ,0000 
VARIABLES IN THE EQUATION 
Variables Entered R2 Beta Part !Partial! T I S' . 19, 
Straight ,152 ,25S ,240 I ,278 5,75 ! ,000 
Medtsts ,082 !-,244 !-,223 !-,259 !-5,34 ! ,000 
Gooduse ,047 ,202 ,187 ,219 4,47 ! ,000 
IntrstCextent of interest in gen, health) ,019 ,135 ,134 ,159 3,20 ! ,001 
FillfrmCput off check-up by having to fill ! 
in long form first) ,007 !-,085 !-,087 ! -,104 !-2,08 ! ,038 
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TABLE 16 Summary of Multiple Regression Analysis With Intention To Participate in Clinical 
Trials(Accptct) as the Dependent Variable and 14 Clinical Trial related IVs 
FINAL VALUES 
,544 ,296 ,287 33, 11 ,0000 
VARIABLES IN THE EQUATION 
Variables Entered , R2 , Beta , Part 'Partial' T , Sig, 
(in ol'd~r of inclusion) !Chance , , Corr 'Corr , , 
If GPs think pills will hold off CVD , , , , , , 
should they ask their pts, to help test , , , , , ! 
these pills (Testpls) , ,194 , 282 I ,246 , ,281 , 5,82 ! ,000 , 
! , , , , , 
Objection to taking pills for research , , , , , , 
if already on medication (Morepls) , ,054 , - ,196 '-, 178 '-,207 !-4,21 ,000 
, , , , , 
Taking pills for long time could lead to , , , , , 
cancer (Cancer) ,020 '_,143 '-,141 '-,166 '-3,34 ,001 
, , , 
Should GPs involve their pts, with medical ! , ! 
research (Medres) ,016 , ,144 , 132 ,155 ! 3, 11 , ,002 , 
, , ! , 
Objection to taking low dose pills daily , ! , I 
to stay healthy (Lowpls) ,012 '-,112 '-,108 - 127 , '-2,55 , ,011 
TABLE 17 Summary of Multiple Regression Analysis With (Accptct) as the 0, V, ans 
Attitudes to the General Concept of GP-run Clinical Trials as the IVs 
FINAL VALUES 
,442 ,196 ,192 50,58 ,0000 
VARIABLES IN THE EQUATION 
Variables Entered Beta Part 'Partial! T Sig, 
Testpls ,178 ,371 ,346 ,360 7,88 ,000 
Medres ,017 I ,140 ,131 ,US 2,98 ,003 
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TABLE 18 Summary of Multiple Regression Analysis with Accptct as the OV and HBM-related 
Items as the IVs 
FINAL VALUES 
,429 ,184 ,176 22,88 ,0000 
VARIABLES IN THE EQUATION 
Variables Entered R2 Beta Part T Sig, 
Morepls ,139 !-,331 !-,323 !-,337 !-7,20 ! ,000 
Cancer ,022 !-,150 !-,147 ! - I 161 !-3,29 ! ,000 
Worry(extent of worry re getting CVO> ,012 ! ,106 ! , 106 ! , 116 ! 2,35 ! ,019 
Lowpls ,011 ! -,106 !-,104 ! -,115 !-2,33 ! ,020 
6 DISCRIMINANT FUNCTION ANALYSIS 
Because of the near unanimity of reported intention to participate in 
screening, it was not possible to perform discriminant function analysis 
(DFA) in respect of screening. However, DFAs were performed in an attempt 
to identify variables which might serve to differentiate respondents 
who reported a willingness to participate in clinical trials and those did 
not. The groups were determined by responses to item 43, Accptct, (if you 
were at risk of developing a heart attack or stroke and your doctor 
invited you to take part in testing medicines which might hold off these 
possible conditions, would you agree to do so?). It was already shown by 
the frequency values that 'yes' answers accounted for 60.3% of responses, 
'no' answers for 10% and 'uncertain' for 29.7%, so the "priors = size" 
command was used. 
Initial tests using the 3 groups of 'yes', 'no' and 'uncertain' were 
strikingly unsuccessful thus, the 'uncertain' and 'no' groups were 
combined to give rise to 2 groups - 'yes' and 'no', with the no group 
incorporating the 'uncertains'. Subsequent chi square crosstabulation 
tests revealed that there was indeed greater similarity between the 
:1 ',1j ) 
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'uncertain's and 'no's than there was between the 'uncertain's and 'yes's, 
so this artificial grouping was validated to some extent. 
The resul ts of DFAs were rather disappoint ing, in that whereas predict ion 
of group membership was reasonably good for group 1 (participants) it was 
poor for group 2 (non-participants). When all variables of relevance to 
clinical trial participation were entered, the function accounted for 25% 
of the variance. The single variable which contributed most to group 
differentiation was that of Testpls, item 22, which was a more general 
phrasing of item 43, the item on which group membership was determined. 
Even so, correct prediction of group 2 <intended non-participants) was 
only just above the level of chance. When 'Testpls' was eliminated from 
the analysis, the function accounted for 20% of the variance, though group 
predictions remained much the same. 
A discriminant function analysis was also performed using just those 
variables which were suggested to be appropriate in predicting utilisation 
of preventive programmes by the Health Beliefs Model(these variables were 
detailed in the Multiple Regression Analysis section). This function 
accounted for only 17% of the variance, and again, the results indicate 
that prediction of non-participation is not easily achieved. 
Although these results were disappointing in one respect, they were 
valuable investigatory aids, and gave considerable food for thought. 
Therefore, the results of these 3 DFAs will be summarised in tables 19 to 
21 below. 
TABLE 19 Summary of Discriminant Function Analysis Including Item 22 
Wi lks Standardised Pooled 
Actual 6roup Predicted 6roup Lambda Canonical D,F, Within 6roup 
Correlations Correlations 
6royp ] 6royp 2 
Group 1 83,31 ]6,71 ,745 Testpls(22,p4) -,56 -,77 
6royp 2 41,91 58,11 MorepIs( 33, p5) ,38 ,64 
Percent of "grouped" cases correctly Lowp Is (32, p5 ) ,31 ,42 
classified = 73,251 
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TABLE 20 Summary of Discriminant Function Analysis Excluding Item 22 
Actual Group Predicted Group 
Group 1 Group 2 
Group 1 79,61 20,41 
Group 2 43,11 56.91 
Percent of ·grouped n cases correctly 
classified = 70,501 
Wi lks 
Lambda 
,800 
Standa rdi sed 
Canonical D,F, 
Correlations 
MorepIs(33, p5) ,58 
Lowp Is (32, p5 ) , U 
Pooled 
Within Group 
Correlations 
,74 
,49 
Medres (21,p4) -,36 -,49 
TABLE 21 Summary of Discriminant Function Analysis using Health Beliefs Model Variables 
Wi lks Standardised Pooled 
Actual Group Predicted Group Lambda Canonical D,F, Within Group 
Correlations CorrelatioM 
GroYI:> 1 Group 2 
Group 1 80,31 19,71 ,831 Morepls(33,p5) ,70 ,80 
6rouo 2 52 21 47 81 Lowpls (32,p5) ,32 ,45 
Percent of Hgrouped" cases correctly Cancer (29,p5) ,31 ,36 
classified = 67,651 
N,B, GROUP 1=Participants, GROUP 2=Non-participants 
* Nos,in brackets after variable names refer to the questionnaire item no, that variable 
names represent, and the page on which these items appear, 
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7. CHI SQUARE CROSSTABULATION TESTS 
The results of discriminant function analyses did provide some 
interesting information, but they were not conclusive. Therefore, further 
exploratory analysis was performed in an attempt to discover whether any 
significant differences existed between sub-groups of the sample in 
respect of variables identified as important from the discriminant 
function results, and a few other variables subjectively selected by the 
researcher. 
Because the raw data was of ordinal level chi square crosstabulat ion 
tests were employed. One of the requirements of chi square 
crosstabulation tests is that expected frequencies in each cell must be 
at least 5. Because many of the variables tested had attracted few 
responses in the extreme response opt ions of 'very much so' and 
'definitely not',uthe two 'yes' and two 'no' categories were combined to 
form over all 'yes' and 'no' responses. In this new coding opt ion 1 
equated to 'yes', option 2 to 'uncertain', and option 3 to 'no'. 
Sub-groups investigated included the sexeSj age groups«60 years versus 
60+) j respondents wi th a reported history of CVD versus those wi thout 
such a history; respondents who expressed a willingness to participate in 
clinical trials versus those who did not (as for discriminant function 
group criterion); and respondents from different distribution sites. 
This latter group were included mainly because both sets of GPs had asked 
for feedback concerning any differences in attitudes expresssed by their 
pat ients compared to other respondents. (Since it was impossi ble for 
individual patients to be identified this request was considered 
reasonable and not representative of a breach of confidence). 
Many of the crosstabulation tests undertaken revealed no significant 
differences between groups, and of those that did produce statistically 
significant results lambda values were generally very small. Thus, whilst 
association between variables were found, it was not really possible to 
predict values for one variable on the basis of knowledge about the 
other. Nevertheless, it must be remembered that this was an exploratory 
investigation rather than a confirmatory one, and in this respect the 
information gained from crosstabulation tests was useful. 
Statistically significant Chi square tests are reported below in summary 
tables, and more detailed results are given in appendix 9. 
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In the summary tables, the right hand columns of OF)EF are used to 
denote the response options in which observed frequencies were greater 
than expected frequencies for each level of the sub-group being tested. 
In the first set of results the variables of age and sex were combined to 
form a new variable - Sage - in which the 4 levels employed were: 
(1) Male <60, (2) Male 60+, (3) Female <60, (4) Female 60+ 
Table 22 Summary Table of Crosstabulations by Sage 
(details appendix 9 A) Sage levels 
115(60 21560+ 3Q{60 4~60+ 
Variable Name & Item No, 1(2 df P OF>EF OF>EF OF>EF OF)EF 
I 
Willtel (3,p,3) 36,59 6 ,0000 No No No Yes ! 
Cutbut (S,p,3) 31,69 6 ,0000 No No Yes Yes 
l'Iedres (21,p,4) 17,97 6 ,0003 Yes+U:t No Yes+U No 
Dobest (25,p,5) 23,80 6 ,0006 U+No Yes No Yes 
Sidef h (2S,p,5) 31,00 6 ,0000 U+No No Yes No 
Offgdpls(3.4,p,5) 20,98 6 ,0018 U+No Yes U+No Yes 
l'Iedtsts (.46,p,7) 30,76 6 ,0000 No No Yes+U Yes+U 
Strip ('47,p,7) 21,63 6 ,0014 No No Yes Yes 
Fearprob(50,p,7) 2.4,93 6 ,0004 No No Yes Yes 
* U = uncertain 
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TABLE 23 Summary Table of Crosstabulations by Reported History of CVD (htbp) 
(details appendix 9 B) HTBP Levels 
1( yes) 2 (no) 
Variable Name ~ Item No, X2 df P OF)EF OF)EF 
Cutbut (S,p,3) 6,30 2 ,0428 No Unc er ta i n 
Testpls (22,p,4) 10,86 2 ,0044 Yes U+No 
Lowpls (32,p,S) 24,49 2 ,0000 No Yes+U 
Offgdpls (34,p,S) 9,08 2 ,0107 Yes+No Uncertain 
TABLE 24 Summary Table of Crosstabulations by Clinical Trial Participation (Accptct) 
(details appendix 9C) Accptct Levels 
l(yes) 2(uncertain) 3(no) 
Variable name ~ Item No, X2 df P OF>EF OF)EF OF)EF 
Testpls (22,p,4) 116,18 4 ,0000 Yes U+No No 
l'Iorepls (33,p,S) 73,01 4 ,0000 No Yes+U Yes 
Offgdpls (34,p,S) 30,84 4 ,0000 No Yes+U Yes 
NB ~ for testlpls = ,22 with testpls dependent ~ ,06 with accptct dependent, Thus there is 
a 22~ reduction in error associated with predicting attitudes towards clinical trials run 
by 6Ps, if information is available concerning willingness to participate in clinical 
trials, Similarly, when predicting willingness to participate in clinical trial trials, 
the error rate is reduced by 6~ if information about general attitudes towards clinical 
trials run by 6Ps is known, These ~ values are the only ones worth noting from all 
crosstabulation tests, but considering the similarity of the testpls and accptct variables, 
the predictive association between them is remarkably small, 
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TABLE 25 Summary Table of Crosstabulations By Distribution Site (Where) 
(details appendix 90) Where Levels 
1 2 3 4 5 
Variable Name ~ Item No, X2 df P OF>EF OF>EF OF>EF OF)EF OF)EF 
Medres (21,p,4) 17,21 8 ,0280 Yes Yes No No Yes+U 
Dobest (25,p,S) 25,11 8 ,0015 Yes U+No Yes U+No U+No 
Offgdpls (34,p,S) 18,34 8 ,0188 Yes+No U Yes Yes No 
Some of the more interesting aspects of these results were found amongst 
the finer details of the analyses which are given in appendix 9, and 
consideration will be given to these in the discussion section. 
8. SUMMARY OF QUANTITATIVE RESULTS 
In summary it may be said that the results were interesting and 
informative, if not exactly conclusive. An indication of the generality of 
attitudes towards each variable was afforded by examination of frequency 
counts, and it was evident that there were quite high levels of agreement 
on a number of factors. These factors included: 
(1) perceived doctor-patient relationships which were generally reported 
to be good; 
(2) the desirability of screening checks for CVD; 
(3) a reported desire for information about diagnosis and treatment; 
(4) lack of worry regarding blood pressure tests and blood samples; 
(5) the value of psychological techniques as adjuncts to drug treatment 
for hypertension. 
Several metavariables were identified from the results of principal 
components analysis, but whilst these were coherent factors, no single 
factor accounted for a very great proportion of the variance. The most 
influential metavariable accounted for only 15.5% of the variance and this 
was a 'deterrent' component of which the composite variables related to 
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worries about: having medical tests; having to 'strip off' for medical 
examination; and fears of what health problems might be found. 
It was apparent, from the results of anovas on metavariables, that there 
were significant differences between men and women and between respondents 
over and under 60 on responses relating to some of the principal 
components - ie those of deterrents, doctor-patient relationships and 
questionnaire completion. 
Multiple regression analyses relating to intended screening participation 
were quite encouraging in that the best equation accounted for 42% of the 
variance. 7 variables were in this equation, though attitude items 
accounted for 31%. When just HBM varibles were used, 30% of variance was 
accounted for - 23% coming from cost/benefit items. Less variance was 
accounted for in equations relating to intended clinical trial 
participation - the best here being 30%. HBM variables only, yielded an 
equation accounting for 18% of the variance, with cost/benefit items again 
contributing most. 
It was not possible to accurately predict group membership for both 
intending participants and non-participants on the basis of discriminant 
function analyses. Whilst prediction of participants was generally good, 
prediction of non-participants was similar to chance. When just HBM 
variables were used, a majority of non-participants were misclassified as 
intending participants. 
Finally, from a series of chi square crosstabulation tests, significant 
differences were found to exist between various subgroups of the sample in 
respect of a fairly wide range of variables. The subgroups included the 
sexes, 60+ and under 60 age groups, repondents with and without a reported 
history of heart trouble or blood pressure problems, and those who had, 
and had not expressed a willingness to participate in clinical trials. 
However, none of these significant associations were accompanied by high 
lambda values, thus they were of no real predictive value. Nevertheless, 
the breakdown details of sample responses revealed by the crosstabulation 
tests did provide some interesting information which was of value to the 
exploration process. 
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QUALITATIVE RESULTS 
More than 27% of respondents appended comments to their returned 
questionnaires, and both the sex and age-group distributions of comment 
makers were commensurate wi th the sample as a whole. As well as the 
intrinsic value and interest of these comments, the fact that so many 
were made suggests that respondents were interested in the study and that 
they completed the questionnaire with seriousness. 
Comments made were of a wide variety. Some were quite brief and relevant 
to one particular aspect of screening, clinical trials, doctor-patient 
relationships, or the study questionnaire; whilst others encompassed 
several topics. Al though the style and content of comments were wide-
ranging, it was possible to extract a few core themes. Basically, these 
related to : 
(1) the concept of the attitude study and the questionnaire itself; 
(2) attitudes towards doctors(both generally and specifically); 
(3) the concept of preventive medicine; 
(4) drug taking and testing; 
(5) 'alternative medicine'; 
(6) political considerations of preventive medicine; 
(7) receptionists and appointment systems. 
38 comments were made about theme 1 and these included commendation for 
the idea of the study: ego "This survey is an excellent idea, wish I 
could have a check-up" and "It would be marvellous if the results of this 
survey could influence this practice to take the initiative to offer 
health checks as a means of preventive medicine". 
Other comments offered ei ther praise or censure for the quest ionnaire. 
Most of the unfavourable comments made about the questionnaire related to 
the lack of a response box for non-smokers, but other complaints 
included poor phrasing of some items, eg "Question 4 was very badly 
constructed, I had to think hard what to tick to say patients should ask 
questions about their treatment"; inadequate information for some 
questions eg "with some questions, eg 26-32, you'd need to know more 
about them before giving answers"; and repetition of items eg "too many 
questions need the same answer". 
Conversely, favourable comments included: "the questionnaire was very 
fair and comprehensive, nothing difficult to answer"; and "it was a 
pleasure filling in the questionnaire! hope it helps you". 
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The second theme was mentioned by 36 respondents and here opinions were 
equally divided between those who enjoyed good relations with their 
doctor, and those who held little trust in doctors generally. For example 
"I find if you do as the doctor tells you and you trust him you can't go 
far wrong" and "I'm not sure that the GP has the patients' interest at 
heart when pi 11 test ing, as there are incent i ves offered him by the 
pharmaceutical manufacturers which could cloud his judgement. By 
definition the GP is not expert in all things,- he should accept this." 
Some informants reported a good relationship with one doctor but not with 
others eg "I've had a lot of trouble with doctors in the past but I've 
struck gold wi th this one", and "I trust my own GP but mistrust most 
others" 
Several comments were made concerning the apparent lack of time that 
doctors have for their patients and one informant summed up the comments 
of a few when he stated "my doctor works under such self-inflicted 
pressure because he has so many patients on his panel that the idea he 
might be interested in preventive medicine is ludicrous". 
The concept of prevent i ve medic ine together wi th the need to inst i 1 a 
respect for one's body and begin heal th eduction at an early age was 
another popular topic. 35 people gave positive comments on this theme, 
ego "preventive medicine must be one of the best uses of NHS resources", 
and " regular check-ups 1 ike well women clinics should be avai lable to 
all without people feeling guilty about wasting doctors' valuable time. 
Also health education should be taught to all children from an early age, 
and they should be encouraged to respect their own bodies." 
However, some respondents stated an aversion to research, eg "I'm against 
experimentation except for existing, very serious conditions, and then 
only wi th mutual consent"; and a couple of informants did state that 
nature should not be interfered with, especially in old people ego "dying 
is as natural as being born so what is all the fuss about?" 
Several (15) comments relating directly to drug taking and testing were 
made, and indicated a preference for non-drug treatments, as well as the 
need for full patient consent to participation in any clinical trial: 
"people don't like the concept of taking pills on a regular basis, unless 
the situation is life threatening I'd be very worried about the long term 
effects of tak ing any pi lIs"; and, from another informant, "I have no 
qualms about drug testing as long as the 'guinea pigs' are fully informed 
of risks and fully trained people have control of the programme, though 
preventive medicine using proper diet, relaxation, no smoking etc. is 
surely the best medicine". 
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One respondent was so concerned about what she regarded to be a blatent 
over-prescribing of drugs that she offered her own 4 point recipe for a 
good night's sleep so that others might be helped to avoid the perils of 
accepting doctors liberal dispensing of sleeping pills! 
The need for acceptance of 'alternative medicine' was also a topic which 
attracted comments from 12 respondents. The alternative approaches 
suggested included vegetarian, non-smoking, teetotal life-styles "I last 
saw a doctor for a pension fund 23 years ago- I am a vegetarian, non-
smoking teetotaller and walk miles every day"; homeopathic medicine; and 
spiritual healing. 
Another 12 repondents made comments which related to political aspects of 
preventive medicine such as "preventive medicine should be available to 
all through higher taxes and private medicine schemes"; " the NHS is 
underfunded and private medicine should be abolished" and "I'm appalled 
that inspite of government denials there is a strong feeling that 
government policy is towards making this positive activity difficult to 
implement". 
Receptionists and appointment systems also provided material for adverse 
comments, with no postive opinions of them being stated. A typical 
comment relating to this theme was given by the respondent who stated: 
"the most off-putting aspects of going to the GP are appointment systems 
and receptionists who are over-protective of the doctors", and 7 more 
similar observations were made. 
In addition to these relatively popular themes, 6 people commented on the 
fact they they considered GPs not to be the most appropriate 
professionals to run research projects and screening checks. For example: 
"GPs in general have nei ther the time nor the training or expert ise to 
carry out preventive plans or 'research' .The most effective way of 
achieving this is to employ people who have been specially trained to do 
this job"j and "The best people to organise and carry out preventive 
medic ine programmes are nurses in the over 40 age group because (1) 
nurses can often have more relaxed relationships with patients than can 
the doctor and thus does not impede dialogue, (2) there is a large 
reservoir of trained nurses at present not engaged in NHS work available 
for such a project which could thus take place without any extra work by 
doctors." 
Finally, 
patients 
2 respondents 
would go a 
preventive projects. 
also commented 
long way in 
that female doctors for female 
securing female co-operation in 
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CHAPTER 4-
DISCUSSION 
The purpose of the study was to make an exploratory invest igat ion of 
attitudes towards preventive programmes and clinical trials run in 
general practice. To recap, the main aims were: 
(1) To asesss popular attitudes towards both the concept of screening 
programmes for CVD, and participation in such projects. 
(2) To assess popular attitudes towards both the concept of, and 
par tic i pa t ion in, c lin i cal t ria 1 s. 
(3) To determine public attitudes towards the application of preventive 
medicine for elderly people. 
(4) To identify factors which may serve as potential barriers to 
participation in clinical research. 
(5) To identify any subgroups within the sample who may appear to be 
particularly reluctant to participate in clinical research. 
(6) To assess popular attitudes towards psychological techniques as 
adjuncts to drug therapies in the treatment of hypertension. 
In the following discussion of results, and their implications for 
clinical research, the first three aims will be considered together, and 
subsequent aims will be given separate attention. 
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1. ATTITUDES TOWARDS THE CONCEPTS OF, AND PARTICIPATION IN, SCREENING 
PROGRAMMES AND CLINICAL TRIALS. 
1.1 ATTITUDES TOWARDS SCREENING 
From the responses received, it was evident that the concept of screening 
for cardiovascular disease (CVD) represented a popular form of preventive 
medicine. Very few respondents regarded such programmes unfavourably, and 
the overwhelming majority indicated a desire to participate in health 
checks designed to identify people at risk of CVD. 
There was also a strong consensus that older people should be included 
in prevent i ve programmes. Several respondents made addi t ional comments 
relating to this topic, and most felt that preventive medicine should be 
accessible to all age groups, and that all types of preventive medicine 
should be more widely available. 
However, reported intentions to participate in screening programmes do 
not necessarily imply actual participation, as was noted in Chapter 1. 
Also, whilst there was general agreement in positive attitudes towards 
screening programmes , a few potential deterrent factors were identified. 
These potential deterrents were apparent within certain subgroups of the 
sample, and will be discussed further later. Nevertheless, it was 
encouraging to find that there was great generality in the positive 
attitudes expressed towards screening programmes. 
1.2 ATTITUDES TOWARDS CLINICAL TRIALS 
Unfortunately, perhaps, such strong commendation was not found regarding 
clinical tr ials. Two quest ionnaire items were used to assess at t i tudes 
towards the general concept of and participation in clinical trials. 
These were: 'If doctors think certain pills may help in holding off 
possible heart attacks and strokes, do you think it is a good idea for 
family doctors to invite their patients to help with the testing of these 
pills?'; and' If you were at risk of developing a heart attack or stroke, 
and your doctor invited you to take part in testing medicines which might 
hold off these possible conditions, would you agree to do so?', 
Only half of the respondents expressed attitudes which indicated 
favourability towards the concept of clinical tials run by GPs. One 
quarter of respondents indicated that they were uncertain about this 
issue, and another quarter that they were against such projects. These 
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findings were not really surprising, as there is some element of personal 
risk at tached to part i c i pa t ion in c lin ica 1 tr ia Is, whereas no comparab Ie 
risk exists for participation in screening checks. 
Interestingly, responses indicated that rather more people than might be 
expected from responses given to the first item, would agree to take part 
in clinical trials if they were identified as being at risk of CVD. 
Responses to the second item showed that 60% of reported attitudes 
indicated favourability towards participation in clinical trials if they 
were at risk of CVD, 10% unfavourability, and nearly 30% uncertainty. 
Several factors may have been operating to influence this dispari ty in 
expressed attitudes towards the two related items. For example, the major 
di fference between the quest ions is that of focus. In the first item a 
general focus was adopted, whereas in the second item the focus was 
strictly personal. Also, whilst the information content of these items 
may appear to be very similar,in fact it was much more explicit in the 
second item. This difference in information content is obvious with 
hindsight, and with the attention drawn to it by some comment makers. 
Retrospectively, it is plain that the first item lacks the important 
clause incorporated in the second, that testing would be performed on 
those people identified as being at risk of the disease in question. This 
lack of relevant information in the first item may well have been 
partially responsible for the the large proportion of 'uncertain' and 
'no' responses obtained. However, in both i terns it was expl ici ty stated 
that participation would be by invitation. Thus the patient would be the 
one to take the decision as to whether or not he or she would take part. 
Also, although the proportion of 'no' responses was relatively low in the 
second item (10%), there was no real difference in the proportion of 
'uncertain' responses to the two questions. 
The similarity of uncertain attitudes expressed in response to both items 
may represent a genuine reflection of doubt about participation in 
clinical trials. Such doubt may be due to fears of personal safety, or 
reluctance to act as 'guinea pigs'. 
item 23 which asked: liDo you 
The latter issue was addressed in 
think that doctors involved in 
research, of ten use their patients as 'guinea pigs'?" 41% of responses to 
this item were 'yes' responses, and 38% 'uncertains'. However. the fact 
that people think that doctors may use their pat ients as 'guinea pigs' 
does not necessarily mean that they regard this badly. As Saurbrey et al 
(1984) found, the majority of their informants felt that the use of 
human subjects in research was both necessary and desirable. Equally, 
although, in the present study, one comment-maker did state that he would 
resent being used as a 'guinea pig'; several in-depth interviewees and 
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pi lot study respondents stated that 'of course' doctors do, and must 
sometimes use their patients this way. Also, there was no substantial 
predictive association between responses to the 'guinea pig' item, and 
those of the item pertaining to clinical trial participation. 
The greater favourability expressed towards participation in the 
personally-addressed quest ion, may ref lect a real fear of CVD and a 
willingness to try anything to avoid it. Interestingly, in the light of 
this suggestion,it was shown by crosstabulation tests that people with a 
reported history of CVD were significantly more likely than others to 
respond favourably to the general concept of GP trials for CVD 
prevention. 
Given the great similarity of the two questions, in spite of the 
differences discussed above, the predictive relationship between them was 
of great interest. Discriminant function analysis showed that responses 
to the first item were the best predictor variables for responses to the 
second. This result occasioned no surprise, but surprise was occasioned 
by the relat i vely low predict i ve relat ionship between them, which was 
revealed in crosstabulation tests. 
Lambda values showed that knowledge of attitudes towards personal 
participation in clinical trials, would reduce the error in preditl:ting 
attitudes towards GP involvement with clinical research, by 22%. 
Conversly, the predict ion of personal part ic ipat ion would be enhanced by 
just 6% if knowledge of attitudes towards GP involvement in clinical 
research was known. 
The problematic predictive relationship between attitudes and behaviour 
is well known (see again Part I, section 5.3). The peculiar independence 
of atti tudes was further demonstrated from the resul ts of the survey. 
Attempted prediction of preventive behaviour from Health Belief Model 
components was rather unsuccessful. However, the resul ts clearly 
supported Fishbein and Ajzen's (1975) assertion that with simplistic 
measures, it is not only di ff icul t to predict actual behaviour from 
attitudes; but indeed, it may be unwise to attempt to predict intended 
behaviour from attitudes expressed towards that same issue in general 
terms. 
Nevertheless, the fact that there was a 
question of personal participation 
encouraging for the HMS, since people 
clinical trials will be those identified 
greater positive response to the 
inc lin i cal t ria 1 s , mus t be 
invited to take part in these 
as being at risk of CVD. 
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2. IDENTIFICATION OF POTENTIAL DETERRENT FACTORS 
2.1 DETERRENTS TO SCREENING. 
Clearly, there was little evidence of there being any aspects of 
screening programmes which may pose major obstacles to screening 
participation. Rather, both quantitative and qualitative results 
indicated that people were not only wi 11 ing to take part in screening 
programmes, but also that they would like such projects to be more widely 
avai lable. 
Be that as it may, reported attitudes did pertain solely to screening 
checks, and not to any subsequent compl iance wi th advised treatments. 
Also, it must be stated yet again, that people do not necessar i ly do what 
they say they will do (eg. Rosenthal and Rosnow,1969); and earlier 
discussions of screening take-up rates (Part 1) warned that levels of 
expressed favourabl i ty towards screening and ut i 1 isat ion of an offered 
service do not always correspond (eg. O'Brien and Hodes, 1979,). The fact 
remains that most screening programmes are not fully ut i 1 ised, though 
the reasons for this are still unclear. 
Detailed examination of the data did provide some clues as to factors 
which might deter people from part ic ipat ion in screenings, even though 
they were reported as deterrents by a minority of respondents, and 
appl ied mainly to certain subgroups of the sample. For example, nearly 
one quarter of all respondents stated that they would be put off booking 
in for a health check if they had to fill in a long form prior to the 
check. This finding was particularly relevant to the HMS, since 
completion of a comprehensive questionnaire booklet is a prerequisite to 
screening in this project. 
Likewise, 15% stated that they would be put off by fears of what health 
problems might be found, and approximately 12% by worries that a check-up 
might lead to other medical tests. A further 12% cited worries about 
having to 'strip off' for a medical examination as a deterrent to 
participation. These proportions of responses are small, but in a project 
1 ike the HMS which aims to screen 300,000 to 400,000 people, even 1 % 
represents thousands of potential participants. 
Time and again, an apparent inconsistency of attitudes was evident from 
survey results. Often quite different responses were obtained from 
quest ions which appeared to be rei terat ions, but which did, in fact, ask 
slightly different things. One such example was given in the two items 
relating to clinical trials. Another related to desires for knowledge 
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about heal th status. I t was interest ing to note that whi 1st over 95% 
stated that they would want to know if they were at risk of developing a 
heart attack or stroke, 15% stated that fears of health problem discovery 
would deter them from taking part in screening. Similarly, whilst just 1% 
of respondents stated that they would not want a check-up, up to 22% also 
stated that they would be put off from having a check-up by various 
factors. 
This inconsistency was, to some extent, expected, 
the preliminary in-depth interviews. However, 
difficulty of predicting preventive behaviour 
attitude variables, as Oliver and Berger (1979) 
their criticism of the Health Belief Model. 
2.2 DETERRENTS TO CLINICAL TRIAL PARTICIPATION 
since it was evident in 
it does highlight the 
from a conglomerate of 
have already observed in 
With regard to clinical trial participation, the survey results clearly 
indicated that major obstacles did apply. However, the identification of 
these obstacles was not easily made. Discriminant function tests, which 
were employed in attempts to identify variables which differentiated 
potential participants and non-participants, proved to be inconclusive. 
Some variables seemed to serve well in the prediction of potential 
participant group membership, but prediction of non-participant group 
membership was generally poor. Therefore, clear indications of factors 
associated with intended non-participation, were not available. 
The best discriminant function results were achieved when the variable 
relating to the general concept of clinical trials was included. Even so, 
whilst nearly 74% of grouped cases were correctly classified in this 
function, correct classification of non-participants was only 58%, 
compared with 83% correct classification of potential participant groups. 
Interpretation of the function shows that the best way to differentiate 
between those who will and will not participate in clinical trials, is to 
know whether or not they think GPs should run cl inical trials. However, 
it is as easy to determine attitudes towards intended participation in 
clinical trials, as it is to determine attitudes towards the general 
concept of clinical trials. Therefore, in spite of the statistical value 
of the variable in discriminant tests, the practical value of it in 
prediction of participation is not very great. 
Discriminant function tests employing the variables suggested 
Health Beliefs Model (HBM) also proved to be disappointing. 
analysis prediction of participant group membership was good 
by the 
In this 
(80.3%) . 
-93-
Conversly, prediction of non-participant group membership was below the 
chance level (47.8%), thus the majority of non-participants were 
misclassified as potential participants. The artificial grouping of 
discriminant groups, such that 'uncertains' were included with non-
participants, may have been partially responsible for this outcome. 
However, on most of the variables included, the responses of uncertain 
participants were more similar to responses from non-participants than to 
responses from participants. Therefore, the incorporation of 'uncertains' 
and non-participants seemed to be justified. 
The variables identified as being most important in the HBM function were 
those of objection to taking more pills for research if already on 
medication (Morepls); objection to taking low daily dosages of pills to 
keep healthy (Lowpls)j worries that taking pills for a long time might 
lead to cancer (Cancer)j and worries about the possibility of dis-
cont inuat ion of current effect i ve medicat ion (Offgdpls). These were all 
cost factors, and items relating to the other components of the model -ie 
of concern with health and motivation to keep it; susceptibility to the 
disease; and bel ief in severe consequences if untreated; were 
conspicuous by their absence from the function. Findings from other 
studies which have used the HBM in prediction of preventive behaviour 
usually show vulnerability to be the most salient attitude for 
prediction, with cost-benefit beliefs being the second most important (eg 
Lea vi t t , 1979). 
Worries about getting a heart attack or stroke could be perceived as 
representing either the belief that the consequences of cardiovascular 
risk would be severe if untreated; or, perhaps more likely, as 
vulnerability to the disease. In multiple regression analysis using the 
HBM, this 'worry' factor was identified as important to the equation. 
However, it was the third of only four variables within the .05 
significance limits and uniquely contributed just 1% of the variance. The 
other three significant variables were those also identified in the HBM 
discriminant function test (Morepls, Cancer & Lowpls). The whole equation 
only accounted for 18% of the variance. 
The attitude item related to the taking of more pills by people already 
on anti-hypertensive treatment, was a direct reflection of a concern 
raised by interview informants. So too, was that related to worry about 
being taken off effective medication in order to participate in medical 
research. Both concerns were strongly expressed, and both were concerns 
raised by more than one informant. 
It was shown from frequency counts that attitudes towards taking more 
pills were split. Almost half of the respondents (48.5%) indicated an 
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objection to taking more pills, and nearly 20% uncertainty about this 
factor. Similarly, 45.7% of respondents reported a worry that their 
doctor might take them off good pills they were already taking if (s)he 
wanted them to help in the testing of other medicines. Again, uncertain 
responses accounted for 20%. Further evidence that these factors 
represented possible deterrents to research participation was found from 
crosstabulation tests. 
Potential participants were significantly less likely than uncertain or 
non-participants to have reported an objection to taking more pills. 
Also, this first group was significantly less likely than the other 
groups to have reported a worry about being taken off current effective 
medication. However, although the differences were significant beyond 
the .0000 level, the predictive associations were negligable. 
Nevertheless, it would seem that both of these factors might operate to 
deter participation in clinical trials, and reassurances on this count 
appear to be necessary when invitations to participate are extended. 
Worries about possible side effects of drugs represented another 
potential barrier to clinical trial entry, or regimen compliance. Over 
70% of responses to this item were positive ones, indicating that 
respondents were worried about this issue. Further indication of the 
extent of worries about side-effects was provided by the comments made on 
the backs of quest ionnaires. In part icular, respondents stated that more 
information about possible side-effects should be given with 
prescriptions for all drugs. This finding was in accord with those 
reported by Meyers and Calvert (1978), who showed that forewarning of 
side-effects was significantly associated with a reduction in 
discontinuance of medication. Thus, if worries about side-effects do 
represent a potential deterrent factor, both ethical and methodological 
problems may be largely overcome by ensuring that adequate information 
about possible side-effects is given to participants. Furthermore, if the 
information given is supported by a well written information leaflet as 
suggested by Ley and his colleagues, the prospects for regimen compliance 
may be enhanced. 
Apart from specific drug-related worries, preliminary interview 
informants had also indicated other potential deterrents to participation 
in clinical research. Most notably, great emphasis had been lain on the 
fact that they considered a good relationship with their doctor to be 
prerequisite to participation in any research project he or she might be 
involved with. Similarly, Saurbrey et a!. (1984) found that trust in their 
doctor was a major factor in Danish patients' considerations of research 
participation. Despite some adverse comments made about GPs on the back 
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of questionnaires, there was generally good agreement in positive 
attitudes expressed towards this issue. The relative lack of variance in 
responses meant that it was not really possible to investigate 
differences in this respect in relation to attitudes towards trial 
participation. 
However, it was interesting to note a considerable difference in response 
rates to the item pertaining to trust in doctors between the patients of 
the two pract ices sampled from. The quest ion asked was: "Do you think 
your doctor would always do what I s best for you?" There was a 20% 
di fference in posi t i ve answers to this quest ion, wi th indicat ions of a 
trust in the doctor accounting for 85.7% of responses from one practice 
and only 65.6% from the other. More interesting, in the light of what was 
said above, was the fact that this difference in 'trust' was not 
reflected in differences of how well people felt they got on with their 
doctor, or in intended trial participation. However, it would be unwise 
to dismiss this factor as unimportant in trial recruitment and even more 
foolish to disregard its possible influence on regimen compliance. 
The issue of informed consent was discussed in the Part I (sect ion 2.2) 
as another possible deterrent to participation in clinical research. The 
survey did investigate attitudes towards this matter, but it was 
approached in an indirect rather than a direct manner. Respondents were 
asked if they thought they could ask for any information they required, 
and if they felt that they should ask for information. Most respondents 
reported that they could ask for whatever information they required. 
Because there was 1 itt Ie variance in responses to this quest ion, it was 
not really possible to investigate the influence of this factor. 
However, there was more variance in responses given to the question of 
how much people felt that they should ask for information. Unfortunately, 
this item was badly worded, as hindsight, and some comment-makers pointed 
out. Thus, responses given may not reflect responses intended to be 
gi ven. 
Nevertheless, al though considerat ion of responses to this item must be 
undertaken with caution, it was found that women aged 60 years and above 
were significantly more likely than all other groups to indicate that 
they should not question their doctor. So, whilst the caution is 
necessary, the effect cannot really be totally dismissed as error. After 
all, it seems unlikely that the majority of misinterpretations should 
occur, by chance, within the older women group. 
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3. IDENTIFICATION OF POTENTIAL DETERRENTS WITHIN SUB-GROUPS 
3.1 SUB-GROUPS INFLUENCED BY SCREENING DETERRENTS 
It was mentioned earlier in the discussion, that within certain subgroups 
of the sample, there was an indication that some factors may have a 
deterrent influence regarding partcicpation in screening programmes. The 
factors identified were worries about having to strip off for a medical 
examination, and fears of what health problems might be discovered in a 
screening check. 
Only 11.9% of responses to the • strip' quest ion indicated that 
respondents would be deterred from participating in screening, but 82% of 
this minori ty were responses made by women. 16.7% of female respondents 
under 60, and an identical proportion of female respondents over 
60, indicated that this factor was a deterrent to screening as far as they 
were concerned. 
Similarly, the overall negative response rate to the item concerning 
discovery of health problems was small (14.9%). However, again there was 
a disproport ionate number of negat i ve responses from women. 80% of all 
responses indicat ing that fears of disease discovery would serve as a 
deterrent to screening participation, were responses made by women. The 
power of this potential deterrent was greatest amongst older women, with 
30% of this group indicating that they would be deterred by the factor. 
Within the younger age group 16% of women indictated a similar deterrent 
influence. These findings echo findings from studies of deterrents to 
cervical and breast cancer screening (see again Part I, section 4.2>. 
Given the target population of the HMS, the implications of these 
findings are not very encouraging. It has already been noted that small 
proportions represent large numbers when target sample sizes are very 
big, as they are for the HMS. Thus if nearly 17% of the HMS target 
population will be deterred from participation in screening by fears of 
having to undress, and 30% by fears of disease discovery, a lot of 
potential participants will be lost. 
Recognition of the first potential deterrent factor does mean that 
reassurances that screening will not involve a 'strip' examination could 
be given at initial recruitment. In this way it is possible that many 
potential partiCipants would be retained, who might otherwise be lost. 
However, little can be done at present to resolve the deterrent influence 
of the other factor. The fact that it is a deterrent influence which 
appears to be operating mainly in older women, is a part icular problem 
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for the HMS, which aims to include high proportions of elderly people in 
their sample. For every year of age over 65, women comprise a 
progressively greater proportion of the population. Thus women will 
represent a considerable proportion of the target population of the HMS. 
If older women are reluctant to participate in screening, the HMS will be 
faced not only with problems of obtaining required sample size, but also 
of unrepresentativeness. 
Further suggestion that screening programmes may suffer 
unrepresentativeness due to reluctance of older women to participate, was 
offered by an examination of response rates. Within the 60 and over age 
group, non-responses were considerably greater for women than for men. 
The national figure for sex distribution in the over 60s is: Males 41.5%, 
females 58.5%. Within the over 60s to whom questionnaires were 
distributed the proportions were 45.3% to males and 55.7% to females. 
However, the proportions of responses were 50.6% male, and 49.4% female. 
Of course, the survey was a relatively small one, and it was conducted 
wi thin a very local area. Qui te possibly, di fferent resul ts would have 
been obtained had the survey been conducted elsewhere or nat ionwide. 
Thus, it would be unwise to assume that survey resul ts are necessari ly 
general isable to the populat ion as whole. Also, it must be remembered 
that response rates achieved for an attitude survey do not necessarily 
predict participation rates in a screening project. 
Nevertheless, responses to surveys about screening participation tend to 
be greater than actual participation <ego O'Brien & Hodes ,1979; 
King, 1982), and non-responses to the survey did imply a lack of interest 
in the project, or a reluctance to complete a questionnaire. In either 
case, the relatively low response rate of older women did not auger 
particularly well for the HMS. Furthermore, the higher non-response rate 
of elderly women in the survey was consistent with Pike's (1976) reported 
finding that refusals in his Birmingham practice elderly screening 
project, were consistently higher amongst women than men for all 5 year 
age groups between 65 and 80 plus years. 
Alternatively, it may just be that older women are less inclined to 
refuse a personal request for participation in a survey in which they do 
not really want to take part. Thus, some may have accepted a 
quest ionnaire wi thout ever really intending to complete it. I t would be 
interesting to know how many older women respond positively to a personal 
invitation to screening, but decline to make, or keep, an appointment for 
the actual check. 
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3.2 SUB-GROUPS INFLUENCED BY CLINICAL TRIAL DETERRENTS 
As with deterrents to screening participation, some potential deterrents 
to clinical trial participation were also found to exist primarily within 
certain sub-groups of the sample. Generally, deterrent factors in 
clinical trials were less exclusively operant within sub-groups than were 
screening factors. However, there was evidence that some sections of the 
sample were more likely than others to be deterred from trial entry by 
the influence of particular factors. 
For example, a majority of respondents reported worries about possible 
side effects of drugs, but close examination of the data showed that 
women reported more worries than men, and younger women most of all. 83% 
of responses by women under 60 indicated a worry about this issue, as 
did 70% of women aged 60 and over. This compared with 63% of responses by 
younger men, and 56.4% by men in the older age category. 
One possible reason for this particular worry in younger women may relate 
to worries associated with contraceptive pills, or to fears of side 
effects in drugs given to children. Much publicity has been given to a 
possible link between contraceptive pills and cancer, or CVD. Also, fears 
of sequalae to infant immunisations are well entrenched, and serve to 
deter many mothers from taking advantage of the paediatric immunisation 
service. Both the contraceptive pill and drugs for children are of 
special relevance to women in their reproductive years. In addition, the 
survey was conducted at a time when 
the withdrawal of Junior Aspirin 
Syndrome. 
much media attention was focussed on 
due to its association with Reyes 
An indication that such factors might have influenced responses from 
younger women was found in comments appended to questionnaires. One young 
female respondent commented that she knew there was a risk of cancer 
at tached to contracept i ve pi lIs; and another that she was increasingly 
concerned about the number of drugs, like Junior Aspirin, that are being 
taken off the market. Nevertheless, as was suggested in the earl ier 
discussion of this 'side effects' factor, it represented a potent ial 
deterrent that is not beyond some degree of resolution. 
A potential deterrent factor that was of more direct concern to the HMS, 
was that of worries about the discontinuation of current effective 
medication. There was a statistically significant difference between 
older and younger people on this issue, with more than 58% of older and 
38% of younger people indicating a worry that participation in clinical 
trials might result in them being taken off 'good pills' they were 
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already taking. Again, the implications of this finding for the design of 
research recruitment protocols are clear. 
In section 2.2 above, it was noted that one sub-group differed from the 
rest concerning the question that related to whether or not people felt 
that they should ask their doctor for information. Evidence for this 
difference came from statistically significant chi square crosstabulation 
tests. The sub-group which di ffered was, once more, older women. More 
than half the responses from this sub-group indicated an attitude that 
doctors should not be questioned, whi 1st only 26.3% of older men. and 
well under one quarter of responses from younger people, also indicated 
attitudes of this type. 
It may be that this finding represents a great trust in doctors by older 
women. Thus, it may indicate that these women would be quite prepared to 
effectively participate in research if the doctor requests their co-
operation. Alternatively, it may indicate poor conditions for the 
achievement of proper informed consent, and carry wi th it consequent 
impl icat ions of non-compl iance. If older women, who represent a large 
proport ion of the HMS target populat ion, feel that they should not ask 
their doctors questions, they may not obtain sufficient information on 
which to base participatory decisions. 
As was discussed in Part I, the work of Philip Ley and others has amply 
demonstrated that without proper informed consent to research 
participation, compliance with prescribed regimens may well be 
jeopardised. This may be especially so if these women do not ask all 
they would like to know about side effects, since 70% of older women 
reported worries about side effects and previous work <ego Meyers and 
Calvert,1978) has shown that inadequate information in this area is 
associated with drug defaulting. 
4. ATTITUDES TOWARDS PSYCHOLOGICAL TREATMENTS FOR HYPERTENSION 
Evidence for the popularity of psychological treatments for hypertension 
was overwhelming. Over 90% of responses indicated a belief that stress 
and personal problems could affect blood pressure. Similarly, more than 
90% of respondents expressed positive attitudes towards the benefits of 
relaxation and stress management in hypertension therapies. These results 
reinforced the attitudes reported by preliminary in-depth interview 
informants on this issue, and several comment-makers remarked on the 
special importance of these psychological techniques in preventive 
behaviour. 
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Obviously, the terminology employed in the quest ionnaire did not equate 
directly to the terminology as it is applied in psychological treatment 
techniques. Also, the adjective 'psychological' was assiduously avoided 
since it does tend to be confused with 'psychiatric' and carry with it 
stigmatic connotations. It would be interesting to conduct a similar 
survey in which the term 'psychological techniques' was used and made 
explicit, and to compare the results of such a survey with those obtained 
from the present study. 
Nevertheless, the results were encouraging, and whilst it must be 
reiterated that attitudes do not necessarily predict behaviour, it was 
suggested that anti-hypertensive treatments which included psychological 
techniques would be accepted by the public. In addition, given the worry 
expressed about drug treatments, and the popular i ty of, and fai th in, 
psychological treatments for hypertension that the survey respondents 
portrayed; doctors may do well to think hard about the approaches they 
take in hypertension management. 
In summary, it may be said that the main aims of the preliminary study 
were, basically, met. Study findings indicated considerable public 
support for the concept of cardiovascular-risk screening by GPs, for all 
age groups. They also suggested that most people would welcome the 
opportunity to be screened. This finding of the popularity of preventive 
medicine and screening checks, concurred with previous findings in the 
area <ego O'Brien and Hodes, 1979; Cartwright and Anderson, 1981). 
Wi th respect to clinical trials, there was a rather di fferent picture. 
There was no real consesus, either for or against GP involvement in 
clinical research. Rather there was a fairly even split between those 
who were in favour of GPs being engaged in such projects, and those who 
were against it, or uncertain about the issue. Some identification of 
potential deterrents to participation, and of sub-groups who might be 
particularly influenced by these factors, was achieved. However, because 
of the exploratory nature of the study, such ident if icat ion was only 
tentative. Also, due to the paucity of previous work in this field, the 
generality of these results was difficult to asess. 
Therefore, if any real understanding of influencing factors was to be 
obtained, it was clearly necessary to probe the area more deeply, by a 
more formal approach. This was pursued in the second study, which wi 11 
be presented next, in Part III. 
PART III 
INVESTIGATION OF THE POWER OF 
FACTORS INFLUENCING PARTICIPATION 
IN SCREENING AND CLINICAL TRIALS 
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CHAPTER 1 
INTRODUCTION TO THE SECOND STUDY 
The second study was intended to serve as a more searching follow-up of 
the preliminary investigation. Findings from the exploratory study 
provided some interesting information regarding public attitudes to 
preventive medicine and GP involvement with clinical research. They also 
yielded some useful indications of factors that might influence 
participation in screening and clinical trials for cardio-vascular risk. 
However, the study was very much a preliminary exploration of the area, 
designed to investigate the range of variables associated with such 
behaviours. Predictive equations using these variables were not 
particularly successful, and it was felt that more understanding of their 
power could be achieved wi thin the framework of a formal theoret ical 
model. 
Also, the initial study sample was relatively small, and weighted in 
favour of the elderly. This, coupled with the limited extent of previous 
research in the area, made it difficult to assess the representativeness 
of the findings. 
Therefore, the follow-up study was designed to assess the reI labl i ty of 
preliminary findings, and to evaluate the relative importance of factors 
associated with behavioural intention. These objectives were pursued with 
the aid of an established predicitive model and a larger, more 
representative, sample. 
1. CHOICE OF PREDICTIVE MODEL 
Although the preliminary study was not specifically designed to accord 
with a particular predictive model, the instrument employed did include 
variables used in the- appl icat ion of Becker and Maiman's (1974) Heal th 
Belief Model. Statistical tests employing these variables yielded rather 
disappointing results in terms of predictive associations and 
differentiation of group membership. However, it must be conceded that 
since the preliminary study questionnaire had not been specifically 
designed for HBM application, the results obtained may not be a fair 
reflection of the model's utility. 
Nevertheless, this was by no means the only reported study in which use of 
the HBM has failed to account for much of the variance. Calnan and Rutter 
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(1986) who applied the HBM in their study of Breast Self Examination 
behaviour, found that, at best, the model accounted for no more than 25% 
of the variance in their findings. Furthermore, they cited Langlie (1977) 
as providing evidence that explanation of just a small proportion of the 
variance appears to be a common finding in studies using the HBM. 
Apart from the disppoint ing resul ts obtained, it was discussed in Part I, 
section 4.3, that the HBM is not a formal theoretical model, and its 
stated purpose is purely that of a predictive tool. 
Whi 1st predict ion of intended behaviour was one purpose of the second 
study, another very important purpose was gain deeper understanding of 
factors associated with intention to participate in screening and clinical 
trials, and to assess their relative influences. Therefore, the 
Behavioural Intention Model (BIM), based on the Theory of Reasoned Action, 
was chosen as the predictive model to be employed in the project. 
Issues of importance to the identification of factors influencing 
participation in screening and clinical trials have already been 
discussed in considerable detai 1, and some considerat ion of the BIM was 
undertaken in section 4.3.2. However, because of its essential role in 
the second study, the Theory of Reasoned Ac t i on and the pred i c t i ve mode 1 
it generated, will now be discussed in more detail. 
2. THE THEORY OF REASONED ACTION 
The Theory of Reasoned Action (TRA) began from 
understanding the determinants of traditional 
relat ions to behavior." (Ajzen and Fishbein, 1980). 
"an initial interest in 
attitudes and their 
I twas deve loped over 
many years and underwent several revisions before it was described in its 
most recent form in 1980. The TRA relates solely to volitional behaviours 
and was founded on the assumption that people are rational beings who 
consider available information and the implications of an action when 
deciding whether or not to engage in a given behaviour. Considerations of 
the implications may be explicit or implicit but, according to the theory, 
they are important influences on behavioural decisions. 
The TRA is claimed by its authors to offer a single theoretical framework 
wi thin which virtually all types of vol i t ional human behaviour can be 
explained. The purported universality of its application differentiates it 
from most previous attempts to explain social behaviour, since these 
tended to assume that there were very different causes for different types 
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of behaviour and thus restricted themselves to a single behavioural domain 
(Ajzen and Fishbein 1980). 
The diversity of previous behavioural explanations resulted from the 
variety of causal variables employed, many of which were 'external' 
variables applicable only to specific behaviours. Apart from behaviour-
specific variables such as political party membership and religious 
affiliations; 'external' variables include sociodemographic 
characteristics, personality traits, traditional measures of attitudes 
etc. A common feature of previous measures was a failure to distinguish 
between beliefs, attitudes, opinions and intentions. 
In contrast, Fishbein and Ajzen argued for a clear differentiation of 
these concepts, and in their formulation of the TRA eschewed a direct 
influence of 'external' variables on behaviour. Rather, they postulated 
that prediction and understanding of almost any volitional action can be 
achieved by the application of limited number of constructs which remain 
constant across all behavioural domains. Furthermore, although attitudes 
do represent one of the constructs in the theory, attitudes measured are 
purely affect reactions and are those pertaining directly to performance 
of the behaviour. They are not, as is usually the case, attitudes towards 
the general concept of the relevant object or issue. Beliefs and 
intentions represent other theory constructs. 
The bare bones of the TRA are that behaviour can be predcited from 
intention to perform the behaviour and that the behavioural intention can 
be predicted from attitudes and subjective norms. Further to this, it 
states that attitudes and subjective norms can be understood by 
examination of behavioural and normative beliefs. Flesh will be added to 
the bones below. 
The TRA states that a person's intent ion to perform (or not perform) a 
behaviour is the immediate determinant of that behaviour. However, it is 
conceded that behaviour is not an inevitable consequence of intention 
since there is always the possiblity of intervention by some extraneous 
variable which might prevent the translation of intention into action (an 
example of this was given in section 5.1- attitude research- where it was 
suggested that one might feel favourably towards, and indeed intend to 
take advantage of, infant immunisation, yet be prevented from having one's 
child immunised by lack of opportunity etc.). Nevertheless, excepting such 
unforseen events, it is expected that people wi 11 behave in accordance 
wi th their behav ioura 1 intent ions. In fac t, it is a maj or tenet of the TRA 
that the most accurate prediction of a person's behaviour is to be gained 
from knowledge of that person's intention to perform the behaviour. 
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According to the theory, behavioural intention is governed by personal and 
social influences. The personal influence is that of attitudes (affective 
responses) to the behaviour; the social influence is that of subjective 
norm - ie individuals' perceptions of the social pressures put on them to 
perform, or not perform, the act ion. In general, a behavioural intent ion 
may be infered if people evaluate the behaviour positively and believe 
that their important others would also be in favour of them performing the 
ac t ion. 
The relative importance of attitudes and subjective norm in determining 
intention may be expected to vary within individuals and across 
situations. For example, some people may tend to be more influenced by 
personal than social influences, whilst for others the tendency may be 
reversed. Likewise, a person may be almost entirely influenced by personal 
evaluations when chosing a library book, but be more strongly influenced 
by perceived social influences when buying party food. The relative 
weights of these intention determinants can be statistically assessed. 
Fishbein and Ajzen argue that for most practical purposes this level of 
explanation may be sufficient. However, they also acknowledge that it 
does not offer complete understanding and claim that deeper comprehension 
of intention may be achieved by examination of the salient beliefs that 
underlie attitudes and subjective norms. Regarding attitudes, each salient 
belief is a behavioural belief that links the attitude with an attribute 
or outcome. The strength of these bel iefs - ie. the extent to which the 
person believes the outcome is a function of the action; and the 
evaluation of the belief outcomes - ie. how positively or negatively each 
outcome is regarded; will combine to influence the attitude towards the 
behaviour. Thus if a person generally believes that a given action will 
result in outcomes which (s)he regards mainly positively, (s)he may be 
expected to hold favourable attitudes towards the action. 
In the case of subjective norms, the underlying beliefs are normative 
beliefs -ie beliefs that specific groups or individuals (referents) think 
that the individual should, or should not perform the action. In this case 
normative belief strength - the extent to which the person believes each 
referent would be for or against them performing the action; and the 
individual's motivation to comply with the referents, combine to influence 
the subjective norm. Thus if a person believes that their salient 
referents would be against him or her performing a given action, and if 
that person is generally motivated to comply with those referents, it may 
be expected that (s)he would have a negative subjective norm concerning 
that behaviour - ie. a perception of social pressure not to perform the 
action. 
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3. APPLICATION OF THE TRA TO THE BEHAVIOURAL INTENTION MODEL 
To recap, the Behavioural Intention Model (BIM) may be represented as: 
Behavioural beliefs Attitude toward 
i=1 
I 
Relative importance 
of a tt i tude and 
r 
I Intention i r I Behavioyr I 
BN lac[w 1Ae+w2 SNJ 
Nor~ati:e beliefs and I : Subjective 
norm 
SN« I b,tlN,t 
.1=1 
Where: 
B 
I 
As 
SN 
b j 
e j 
b.t 
m.1 
n 
r 
R 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
the behaviour of interest; 
intention to perform B; 
attitude towards performing B; 
subjective norm concerning B; 
the belief that performing B will lead to outcome ij 
the evaluation of outcome i 
the normative belief concerning referent jj 
the person's motivation to comply with referent j; 
the number of salient beliefs. 
the correlation coefficient between linked variables 
the multiple correlation coefficient 
WJ and Wz reflect the relative importance of As and SN in predicting I. 
As can be seen, all the elements of the theory are represented in the 
model, but a few further points should be clarified. 
First ly, al though the end-point on the model is a behaviour, its authors 
have proposed that only unforseen circumstances will intervene to prevent 
the translation of intentions into actions. Therefore, for the majority of 
prac tical purposes, a cr iter ion of behavioural intent ion wi 11 suff ice 
(Ajzen and Fishbein, 1980). However, they do also proffer the caution that 
intentions may change over time and that the greater the time lapse 
between measures of intention and behaviour, the lower will be the 
predictive value. 
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A major contribution of the TRA to the measurement of attitudes for the 
prediction of behaviour, is its insistance on congruity between attitudes 
and intentions or behaviours assessed. That is to say, if the criterion 
behaviour or behavioural intention is the purchase of a brand X tea from 
shop Y wi thin the next week, the at t i tude measured must be that towards 
buying brand X tea from shop Y within the next week. General attitudes 
towards tea, brand X tea, or even buying brand X tea from somewhere at 
some stage, are inadequate measures for the prediction of the critrion 
action. Rather, all measures must be consistent in terms of Action 
(eg.purchasing) Target (brand X tea) Context (shop Y) and Time (within the 
next week). This consistency is required not just for the criterion action 
or intention and attitudes; but it must also apply to measures of 
subjective norm, behavioural beliefs and normative beliefs. It must also 
be stressed to the informant that it is evaluations of his or her 
performing of the behaviour which is required. 
The model may be applied to prediction and understanding of an 
individual's behaviour or it may be used to compute predictions of 
aggregate behaviour. Often the latter use provides better predictions 
since wi thin a group of people, changes of intent ion occur both ways and 
tend to cancel each other out. When individual prediction and 
understanding of behaviour is sought, the salient beliefs and referents 
assessed are those peculiar to the individual. When prediction and 
understanding of aggregate behaviour is the goal, a set of modal sal ient 
bel iefs must be devised. In ei ther case, the sal ient bel iefs employed in 
the model must be directly elicited from the individual, or a sample 
representative of the target population of the study. 
Fishbein and Ajzen have described a method for eliciting salient beliefs 
that is both simple and effective. Informants are asked to list the 
advantages, disadvantages, and anything else they associate with their 
performing the criterion action. Each aspect is treated separately so that 
both positive and negative outcomes are encouraged. The elicitation of 
modal salient referents is achieved similarly by asking informants if 
there are any groups or individuals who they think would approve or 
disapprove of their performing their action, or if there is anyone else 
who comes to mind when they consider their performing the action in 
question. The most commonly occuring beliefs and referents are selected 
for the modal set (full details of the technique for eliciting and 
devising modal salient beliefs are given in Ajzen & Fishbein's 1980 book). 
The assessment of behavioural intention, attitudes and subjective norms 
entai Is straightforward measurement on a bipolar seven-point scale 
with a midpoint of 'Neutral'. Assessment of behavioural and normative 
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beliefs entail more complex computations, although measurements are mainly 
as before. Regarding behavioural beliefs, measures are taken of the 
belief strength and comparable measures are taken of outcome evaluations. 
For example, given a list of outcomes associated with the behaviour, 
informants are first asked to rate how likely or unlikely they think it 
is that their performing the behaviour would lead to each outcome, and 
secondly to rate how good or bad they believe each of the outcomes to be 
for them. Strength/evaluation crossproducts are then calculated. 
Examination of belief strength and outcome evaluation scores aid 
understanding of why people hold the attitudes they express. 
In some applications of the model, it has been found that differential 
values afford even greater prediction. To obtain differential values, 
informants are required to perform the same ratings in respect of 
performing the behaviour and of not performing the behaviour; or for two 
different behaviours. The values of the latter are subtracted from those 
of the former and a differential value is achieved. 
In the case of normative beliefs a similar two stage process is applied. 
Here, informants are first asked to rate how favourably or unfavourably 
they believe each of the referents would regard the informants' performing 
of the behav i our j and then to rate how mot i va ted (s) he is to comp 1 y wi th 
each referent's wishes or opinions. Motivation to comply is the only 
measurement taken on a unipolar scale. Again, examination of these scores 
affords understanding of the important influences on subjective norm. 
The need for understanding is not just academic interest since in almost 
all cases, understanding of the determinants of behaviour is desired for 
the purposes of changing behaviour. Discussions of the morality of this 
position, and of theories of attitude/behavioural change are beyond the 
scope of this thesis. But, if beliefs do determine attitudes; attitudes 
determine intention; and intentions determine behaviour, it is clear that 
ultimately, beliefs will have to be taken into consideration if attitudes 
and/or behaviours are to be changed. 
The previous assert ion hints of sinister psychological manipulat ion, but 
this need not necessarily be the case. For instance it may be that people 
hold untrue bel iefs about an object or issue that need to be ident if ied 
before they can be rectified. After all, if people are to make valid 
decisions based on available information it is essential that the 
informat ion be true. The BIM would seem to offer a very good method of 
uncovering influential beliefs. 
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4. RECENT AMENDMENTS TO THE BEHAVIOURAL INTENTION MODEL 
Numerous studies employing the BIM in a variety of behavioural domains 
have testified to its predictive utility and its qualities of affording 
understanding of behavioural intention (eg. Bentler & Speckart,1979 -
drug taking behaviour; Budd et al.,1984-seat belt use; Calnan & 
Rutter, 1986-breast self-examination; Kantola et al.1982-water 
conservation intentions; Manstead et al.1983-mothers infant-feeding 
intent ions and behaviours; Mi ller et al.1985-post myocardial infarct ion 
regimen adherence; Presthol t et al. 1987-nurse turnover; Schwartz, 1973-
helping behaviour; Young & Kent,1985-camping behaviour). However, even 
whilst offering support for the basic model, most of the researchers 
mentioned above have suggested various amendments to the model which 
they believe would increase its predictive value. 
An amendment which has enjoyed considerable support was that of the 
addition of a 'past behaviour' variable. This was first proposed by 
Bent ler and Speckhart (1979), and gi ven further credence by the resul ts 
of another study they conducted in 1981. Manstead et a1. (1983) employed 
the extended Bentler & Speckhart version of the BIM in their study. They 
too found that "the previous behaviour of multiparous mothers explained 
an independent and significant proportion of variance in their 
behavioural intentions." The relative importance of attitudinal and 
normative components were also found to be related to past experience in 
this study. Other support for the inclusion of past behaviour as a 
component of the model has been offered by Budd et al. 1984; Budd and 
Spencer, 1985; Fazio & Zanna,1981; and Raden, 1985. The evidence offered 
by these researchers is qui te compel 1 ing, thus it seems important to 
assess past experience of a behaviour in future application of the BIM. 
Another variable that has been advocated as a valuable addition to the 
basic model, is that of personal normative belief (eg. Budd et al. 
1984,85). This variable was included in the early drafts of the BIM, but 
was dropped from the model as it was considered to be a rei terat ion of 
behavioural intention. Budd and his colleagues cogently argue that 
personal norm is not synonymous with intention, and offer evidence to 
show that in respect of drinking behaviour at least, inclusion of 
personal norm increases predictive value. They suggest that the variable 
be reconceptualised as 'ideal behavioural intention' and reinstated in 
the BIM. They also maintain that personal norms are more salient to 
behavioural decisions than subjective norms and suggest that nothing 
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would be lost from the model if the former, together with measures of 
past behavior, were included, and the latter omitted. 
Interestingly, in an introduction to a new theory of planned action, 
Ajzen (1985) also indicated that personal normative beliefs should be 
reinstated in the TRA and BIM. He suggested that personal norms may be 
formed by other normative beliefs and thus offer adequate measurement of 
subjective norm on its own. Most researchers using the BIM, do not 
appear to be quite so disenchanted with the utility of subjective norm, 
but others (ego Young & Kent,1985) have questioned the value of the 
'motivation to comply' variable. The strength of the arguments for 
assessment of personal norm, and an intuitive feeling for its importance, 
led to its inclusion in the reported research model. 
One more amendment to be considered here was intimated by Ajzen's Theory 
of Planned Action mentioned above. This theory asserts that because 
people can never be absolutely sure that they wi 11 be in a posi t ion to 
carry out their intentions, every behaviour is really a goal, 
the attainment of which is subject to some uncertainty. Ajzen therefore 
recommends assessment of behavioural expectat ions and of bel iefs 
pertaining to probabilities and consequences of success and failure 
regarding attempts to perform the action. This actual amendment was not 
considered for use in the reported study, but it was decided to assess 
respondents' expectat ions that the opportuni ty for performance of the 
action would arise. 
5. POTENTIAL LIMITATIONS OF THE BIM 
Once again, it must be noted that whilst support for the utility of the 
BIM is plentiful, there is little published evidence of the model 
receiving application in postal distribution to a general population 
sample. Ironically perhaps, the major strength of the model - its very 
thoroughness and specificity - might also be a considerable drawback to 
such general application. After all, use of the BIM does require repeated 
assessment of the same variables, as in measurements of belief strength 
and outcome evaluations. When differential values are obtained, the 
instrument has to become even more repetitive. 
It is relatively easy to obtain full reponses when the instrument is 
interviewer-administered. Good co-operation may also be expected where it 
is appl ied to spec ial ist groups 1 ike students (a common study sample 
source), or expectant mothers where their infant-feeding intentions are 
of great current importance and interest to them. However, where 
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responses are not elicited from an interviewer who can retain the 
informants' interest and compl iance; or where the study topic may not be 
perceived as immediately relevant and important to all those sampled; it 
may be that the instrument is too repetitive and cumbersome for effective 
appl icat ion. 
Therefore, because understanding of intended behaviours is not always 
required of spec ial ist groups; and because research resources wi 11 not 
always stretch to interviewer-administration of questionnaires in large 
scale surveys; some assessment of the general ut iIi ty of the BIM would 
seem warranted. 
6. CONSIDERATION OF SAMPLING TECHNIQUES 
As stated earlier, as well as by the use of a theoretical model, the 
second study was also intended to differ from the first in terms of the 
sampling techniques employed. Although the attitudes and beliefs of the 
elderly were of special interest in the first study, the unrepresentative 
age distribution of the sample limited further generalisation of results. 
Also, the weighted sample may have gi ven a distorted picture of the 
relevance of age as an associate of certain factors. Thus it was decided 
that a wider sample, more representative of the national adult population 
would be the target for the second study. 
Another problem with the sampling technique employed in the first study 
was that of potential bias introduced by personal distribution. Several 
factors come into play wi th this approach which may jeopardise 
representation. Firstly, the sampling pool is limited to those who are 
out and about in given locations at given times. If the target population 
is such people, the approach is perfectly adequate. However, if the 
target populat ion is wider than this, it is an inadequate approach to 
employ as it disenfranchises all members of the target population who are 
not in a given locale at a given time. 
If distribution is effected in a public place during working hours, many 
unemployed people wi 11 be exc 1 uded from the pool. If it is effec ted at 
work places or near public transport stations at times when workers are 
going to or from their jobs, many unemployed and home-based people will 
be excluded. 
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A wider sample may be reached by evening 'door-step' canvassing, but some 
potential respondents will still be missed if they are not at home when 
the canvasser calls. 
In addi t ion, al though a random sampl ing strategy may be planned, and 
although, in theory, such a strategy may be executed; in practice this is 
seldom properly achieved. With all the will in the world, some grumpy or 
harrassed-looking people will be 'missed'. It takes a particularly 
insensitive canvasser to approach a busy woman laden with shopping, 
pushing a pram and trying to cope with a lively toddler, just because she 
happens to be the third person to pass. 
On the other hand, if postal distribution is used, unless the addressee 
has moved, the researcher can be fairly conf ident that a truly random 
sample of a given sampling source will at least be canvassed for 
participation. Postal distribution also has the advantage of being much 
less cost ly in terms of personnel time, thus enabl ing a much larger 
sample to be reached. 
7. STUDY AIMS AND OBJECTIVES 
As stated at the begining of this section, the aims of the study related 
to two main areas. Firstly, they represented a follow-up of the initial 
study, to both confirm the association of identified factors, and to 
assess their relat i ve importance. Secondly, they related to the test ing 
of the BIM for the first purpose. Also, the issue of anonymity remained an 
important aspect of the study and it was considered necessary to assess 
the value of medical sampling sources - in respect of increased response 
rates- when anonymity is clearly applied (see again Part I sections 2.4 & 
4.4). 
The particular aims of the study were: 
(1) To assess the reliability of preliminary study findings 
(2) To assess the power of factors influencing participation in screening 
and clinical trials for cardiovascular risk reduction 
(3) To identify any socio-demographic variables associated with attitudes 
beliefs or participatory intentions 
(4) To assess the value of the BIM for the prediction and understanding of 
screening and clinical-trial participation intentionsj and its utility 
for a postal survey of a general public sample 
(5) To compare response rates, and responses, from medical and non-
medical sampling sources when survey participation and questionnaire 
completion is anonymous. 
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CHAPTER 2 
METHOD 
1. SUMMARY OF METHOD AND SAMPLING STRATEGY NOTE 
SUMMARY OF METHOD 
A sel f-complet ion quest ionnaire survey was used to 
attitudes and intentions regarding participation 
clinical trials for cardiovascular risk-reduction. 
explore beliefs, 
in screening and 
The questionnaire was comprised of two main sections, relating to 
screening and clinical trials respectively. Each of these sections 
incorporated a set of modal salient beliefs and referents elicited from 
participants in preliminary in-depth interviews. Both sections were 
prepared in accordance with the Fishbein and Ajzen(1980) prescription for 
utilisation of the Behavioural Intention Model; but also included a 
personal normative belief variable, as suggested by Budd et al (1984). A 
few extra items of part icular interest to the Heal th Maintenance Study 
were also included, though these are not fully considered in the thesis. 
Questionnaire distribution was effected by mail shots to a total of 2000 
potential respondents drawn from the electoral roll and the practice 
lists of four group practices in Northampton. In addition to the 
standard covering letter and freepost return envelope, a covering letter 
from the GP was included in the package sent to each potential respondent 
sampled from practice lists. Obtained data were statistically analysed. 
SAMPL I NG STRATEGY NOTE 
Preliminary interview informants were drawn from medical sampling sources 
primarily because these afforded ease of quota sampling on age/sex 
bases. Also, the use of a covering letter from GPs helped to 
authent icate the research and thus help overcome potent ial problems of 
gaining admittance into people's homes for interview purposes. 
For the main study, Northampton was chosen as the location for the sample 
population because in addition to the benefits associated with its 
proximity to the research centre, its population quite closely 
corresponds to the national profile in terms of sex, age and socio-
economic distribution. 
The choice of sampling sources reflects several considerations. The first 
consideration was to reach the widest possible potential sample and the 
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electoral roll offered the best available source for achieving this end. 
However, a second cons i dera t i on was to ach i eve the grea t es t poss i b 1 e 
response rate and postal surveys using this sampling source are often 
associated with rather low returns. A commonly used sampling source for 
health related surveys that is associated with very good response rates, 
is that of general practice lists. Response rates from this source are 
particularly good when they carry an endorsment by the GP (eg. Smith et 
a!. 1984>' 
Unfortunately, al though this is a well establ ished approach, it does 
harbour flaws which may diminish the confidence with which results can be 
held. The main problem posed is potential bias, both from selection of 
co-operative GPs and from failure to stress respondent anonymity (these 
problems were discussed in detai 1 in Part I section 2.3 - Volunteer 
Bias). Nevertheless, in spite of the drawbacks, the lure of a potentially 
high response rate was strong and it was decided to use the medical 
source but to try to minimise bias by using several pract ice 1 ists and 
emphasising respondent anonymity. It was decided to use the electoral 
roll too, since responses from this source would clearly be free of 
influence by GP co-operation and response rates and responses from the 
two sources could be compared. 
Four practices were selected with the help of the registrar of the local 
Family Practitioner Committee. Six practices from different parts of the 
town were suggested as possible sources. One refused co-operation and as 
four agreed, the last practice was not contacted. The electoral roll used 
was prepared from information gathered 4 months prior to its use. 
OUTLINE OF METHOD SECTION 
In the following sect ion, detai Is of the methodology employed wi 11 be 
presented as follows: 
(1) In-depth Interviews 
(2) Development of the Questionnaire 
(3) Piloting of Questionnaire 
(4) The Main Study Instrument 
(5) Sampling Sources and Strategies Employed in the Main study 
(6) Distribution of Questionnaire 
(7) Statistical Analyses Performed 
-114-
2. IN-DEPTH INTERVIEWS 
In-depth interviews were used to provide the basic information required 
for the development of an appropriate questionnaire. Two main topics were 
investigated. These were: (1) participation in health checks for the 
identification and possible reduction of cardiovascular risk; and (2) 
participation in c:ltnical trials for cardiovascular risk reduction. 
Interviews were used to elicit the salient beliefs and referents from 36 
informants and all were conducted during the summer of 1987. 
2.1 SELECTION OF POTENTIAL INFORMANTS 
Because the resul ts of in-depth interviews were to provide the modal 
salient beliefs and referents used in the questionnaire, it was essential 
to interview a representative sample of the target population - ie 
members of the general populat ion aged between 25 and 75 years. The 
sampling sources used to obtain this representative sample were the 
age/sex registers of two local group practices, one in Bedford and the 
other in Leighton Buzzard. Pract ice I ists are well establ ished sampl ing 
sources for health-related surveys and the two chosen provided a 
relatively large sampling pool which included people of all socio-
economic groupings. 
2.1.1 Sampling Procedure 
To ensure adequate coverage from different groups within the target 
population, selection of potential informants took the form of systematic 
random sampling within a quota system. The quota system stipulated that 
equal numbers of potential respondents be drawn from each of 12 
age/sex/socio-economic groups which are detailed below in table 1. 
Eventually, 3 people from each cell served as interview informants. 
Sampling was effected by the researcher in conjunction with practice 
managers and recept ionists. Full detai Is of the sampl ing procedure are 
given in appendix 10. 
TABLE 1 
SOCIO-ECONOMIC 
GROUPINGS 
Group A 
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SAMPLING CATEGORIES 
SEX 
MALE FEMALE 
25-44 years 25-44 years 
~-------------~-------------
45-64 years 45-59 years 
~------------- -------------
'middle class' 65-75 years 60-75 years 
__ ~~:~~_l~~!~_ _~~:~~_l~~!~_ 
Group B 45-64 years 45-59 years 
-------------- -------.-----
'work i ng class' 65-75 years 60-75 years 
The three age divisions used in the sampling matrix correspond to those 
used by the Off ice of Populat ion Censuses and Surveys <OPCS) for the 
adult population over 25. The two broad socio-economic groupings crudely 
represent 'middle class' and 'working class', with Group A incorporating 
groups I, I I, and I I I of the Registrar General's c lassi f icat ion scheme; 
and Group B groups IV and V of the same system. These broad categories 
were chosen because heart attacks and strokes are more prevalent amongst 
the lower socio-economic groups, particularly the unskilled manual 
workers <ego Townsend & Davidson,1982; Whitehead, 1988), so it was 
considered possible that this may be reflected in differential attitudes 
and beliefs relating to preventive health behaviours. People not 
currently employed were categorised according to their usual occupation, 
or where applicable, that of the head of the household. 
The sampling sources used did not provide details of occupation so 
initial determination of socio-economic groupings were based largely upon 
addresses and the receptionists' knowledge of individual patients. 
Accurate assessment of this variable could be made only at time of 
interview, but the address/receptionist estimates proved to be remarkably 
good guidelines. 
Finally, when select ion was complete the full I ist of 
informants was submi t ted to the pract ice doctors for vet t ing, 
sending canvassing letters to anyone who might find such 
insensitive. Exclusion criteria were: 
potential 
to avoid 
a letter 
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1. Known current illness 
2. Known recent bereavement 
3. Known recent experience of a heart attack or stroke suffered by self, 
spouse or other close family member 
4. Language difficulties 
5. Psychological problems. 
2.1.2 Canvassing Of Interviewees 
Canvassing of informants raised several ethical/methodological issues. 
Firstly, potential informants had a right to know the sampling source 
from which they were drawn, which meant that they were also entitled to 
an endorsement of the study and a reassurance of medical confidentiality 
from the GP. However, another major consideration in the canvassing of 
informants was that they should not be alarmed by the canvassing letter, 
nor experience any feelings of coercion to take part if they did not 
really wish to participate. 
The experiences of the prel iminary study showed that many people place 
great importance on a good relationship with their GP and would not want 
to jeopardise this relationship in any way - perhaps by refusing a 
request to participate in a research project. Apart from the ethical 
issues involved, there are also methodological implications since if 
people feel obliged to take part in order to please their doctor, they 
may also feel obliged to give similarly influenced responses (see again 
Part I section 2). 
It was essential therefore, that the canvassing approach acknowledge the 
involvement of the GP to some extent, whilst also giving reassurance that 
selection was not related to medical history; and that personal decisions 
re participation would remain unknown to the GP. Thus, it was decided that 
two letters should be sent together. The first letter was a 
straightforward canvassing letter from the researcher and the second 
letter was a covering note from the GP. 
The canvassing letter outlined the purpose and format of the interviews 
and reported the sampling source. It was also made clear to recipients 
that they had been selected at random and that their acceptance or 
refusal to be interviewed would not be made known to the GP. The GP's 
covering note was basically used to authenticate the researcher's letter 
and to reassure potent ial informants that medical conf ident 1a1 i ty had 
-117-
been preserved. It also reiterated the GPs' non-involvement with the 
research, though, due to an additional line added by the GP, gave some 
endorsement to the study. In order to participate in interviews, 
informants had to return a 'consent to contact' form, direct to the 
researcher, in the freepost envelope provided (copies of both letters are 
given in appendix 11). 
2.2 INTERVIEWING PROCEDURE 
On receipt of consent forms, volunteers were telephoned by the researcher 
to arrange interview appointments. All interviews were carried out in the 
informants' own homes and each interview lasted for approximately 1 hour. 
In every case a standard introduction was given and a standard interview 
schedule used. This conformed to that prescribed by Ajzen and Fishbein 
(1980), which was described in Part III, Chapter 1, section 3 (see 
appendix 12). At the begining of each interview informants were asked if 
they would object to the discussion being taped so that the interview 
could procede smoothly and all informat ion be recorded. Informants were 
assured that the tape would be erased as soon as a transcript had been 
made and this is exactly what occured. Only 9 of the 36 interviewees 
expressed a preference for the tape not to be used and their wishes were 
readily observed. 
2.3 IN-DEPTH INTERVIEW RESULTS 
2.3.1 Response To Canvassing Letters 
The first set of canvassing letters were sent to a sample drawn from just 
one of the group pract ices, and the ini t ial response rate was 
disappointingly low (31.8%). In addition to the paucity of responses, 
there was a bias in favour of people from the higher socio-economic 
groups. Discussion with interviewees showed that there was some 
confusion as to the purpose of the interviews, and where they would be 
conducted. The confusion about purpose was evident from respondents who 
began the interview by stating that they did not wish to take part in 
the testing of any medicines. Confusion about interview location was due 
to an oversight in the preparation of the letter which bore an Oxford 
address (that of the HMS) and did not specify that interviews would be 
conducted in informants' own homes. Accordingly, the canvassing letter 
was amended to rectify these problems and another sample was obtained. 
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This time both practice lists were used. However, in spite of the 
increased sampling pool and the amendments to the canvassing letter, 
response rates to the second canvassing were not greatly improved and the 
problem of bias remained. Even after the second canvassing there was 
inadequate representation of 'working class' males so three men from the 
lower socio-economic groups were finally canvassed by the personal 
approach of a project supervisor who is also a GP. 
The cont inued poor response to interview requests suggested that the 
original reluctance was not due entirely to confusion about factors 
mentioned, but perhaps also due to lack of interest, or some suspicion as 
to the real purpose of the interview. 
2.3.2 Analysis of Interview Responses 
In spite of the apparent unattractiveness of interview participation, all 
informants were very ready to give full vent to their feelings and 
opinions during the interviews. Both positive and negative comments were 
readi ly forthcoming and informants seemed very pleased wi th the 
opportunity to express their feelings about both screening checks and 
clinical trials. 
After each interview, a transcript was made of the tape recording and 
notes were made of all beliefs expressed (for non-taped interviews full 
written notes were taken at the time). Subsequent examination of the data 
revealed considerable homogeneity of beliefs, both within sampling-
category cells, and between them. There were, of course, except ions to 
the general rule, but these were not found to be exclusively related to 
any particular category cell, so it was deemed unnecessary to extend the 
interview stage to more informants. A breakdown of el ici ted bel iefs is 
given in appendix 13. 
Finally, data from all respondents were pooled and, as suggested by Ajzen 
and Fishbein (1980), sets of modal salient beliefs were derived from the 
10-12 most commonly expressed items. The first set pertained to 
participation in heal th checks to identify people at risk of a heart 
attack or stroke; the second set to participation in clinical trials. 
Corresponding sets of modal salient referents were similarly obtained. 
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3. DEVELOPMENT OF THE QUESTIONNAIRE 
The primary consideration was to design an instrument, or instruments, 
that would incorporate the modal salient beliefs and referents elicited 
from in-depth interviews; and enable effective utilisation of the BIM for 
the predict ion and understanding of intent ion to part ic ipate in 
screening and clinical trials for cardiovascular risk reduction. It was 
also intended to collect a little additional information which would be 
of value to the HMS. 
Because a large sample was required, and because of possible 
contamination of responses by 'experimenter effects', it was decided that 
the questionnaire should be a self-completion instrument. Therefore, the 
quest ionnaire had to be easy to understand and to complete. I t was also 
intended that the instrument should be as short as possible. 
However, in the introduction to the second study it was stated that some 
researchers have found differential measures of component variables to 
produce better predictive equations than straightforward single measures. 
Since the objective was to achieve good predictions of behavioural 
intention, it seemed appropriate to gather data that could provide 
differential values. Unfortunately, this approach entailed a lengthening 
of the questionnaire, which might have detrimental effects on both 
response rates and quality of responses. Nevertheless, it was decided to 
develop the pilot questionnaire in this format and to assess its 
acceptance by pilot studies. 
Another major problem to be addressed in the early stages of development 
was whether or not it would be feasible to use a single questionnaire 
instrument for the collection of all required data. 
Clearly, participation in screening and participation in clinical trials 
represent two dist inct act ions, each of which would require an 
independent measuring instument. But, because of the study's association 
with the HMS, in which participation in screening and clinical trials 
were interlinked; it was considered preferable, if possible, to obtain 
measures pertaining to both activities from the same individuals. 
Therefore, the best way of achieving this end had to be determined. 
Three main options were considered. These were: 
(1) Send potential respondents one of the questionnaires and ask at the 
end if they would be wi 11 ing to complete the other one. Respondents who 
completed the first questionnaire and responded positively to the request 
could then be sent the follow up instrument. 
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(2) Send potential respondents both questionnaires together. 
(3) Combine the two instruments in a single questionnaire format. 
The first option was quickly dismissed on several grounds. Firstly such 
an approach would rule out any possibility of truly anonymous completion. 
This was a major drawback since true anonymity was considered to be 
important, especially for respondents selected from medical sampling 
sources. The reason for this has already been out 1 ined and relates to 
ethical and methodological concerns that non-anonymous participation in 
the study, may yield responses that are influenced by a perceived 
possibility of repondent identification by the GP. Also, it posed a 
problem of what to do with responses from people who completed the first 
questionnaire, but did not wish to complete the second; or what to do 
about people who did not complete the first questionnaire but expressed a 
willingness to complete the second one. Lastly such an approach would be 
very time-consuming and expensi ve in terms of stat ionary and postage 
required. 
The second option posed almost as many problems as the first. 
Intuitively, it seemed that this approach was both cumbersome and very 
vulnerable to either no response at all or to return of only one 
questionnaire. Also, if anonymity was preserved, it was considered 
possible that the two questionnaires might be completed by different 
members of a household. 
This left the third option which would allow anonymity and which seemed 
more likely to elicit completion by a single individual, albeit not 
necessarily the one to whom it was originally addressed. However, the 
main drawback of this approach was that it would further increase the 
length of the questionnaire. Nevertheless, research has indicated that 
questionnaire length may not decrease response rates (see again Part I 
section 6.1) and this option was considered to be the best one available. 
Therefore it was decided to produce a single instrument combining 
measurements for both activities and to pilot this approach first. If 
pi lot ing showed the dual purpose quest ionnaire to be too long or too 
cumbersome, separate instruments would be prepared. 
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•• PILOTING OF QUESTIONNAIRE 
Piloting of the questionnaire represented a major part of the study and 
consisted of several stages. 
The initial version of the questionnaire was piloted in September 1987. 
As well as measuring intentions, attitudes, subjective norms, behavioural 
and normative beliefs; this version also included personal normative 
variables and several questions relating to past behaviour of relevance 
to study topics. 
Six people who had agreed to initial interviews, but whose inclusion 
would have exceeded cell requirements, were invi ted to take part in the 
pilot study instead. All six agreed, and four more people, known 
personally to the researcher, also participated. The age range of this 
sample was 23 to 71 years and it included both manual and non-manual 
workers. Questionnaires were sent to informants for self-completion, and 
follow-up interviews were conducted in their homes to discuss the 
questionnaire and any problems encountered. The major findings from 
this phase were the identification of a few awkwardly phrased items; 
recogni t ion of 'unsure' as a more appropriate midpoint than 'neutral' in 
the BIM's 7 point scale; and the need for inclusion of a 'not applicable' 
category in the normative beliefs section. 
After appropriate amendments had been made, the questionnaire was 
piloted by personal distribution of questionnaires to a random selection 
of the publ ic wi thin Mi 1 ton Keynes Shopping Centre. The procedure used 
was identical to that employed in he distribution of questionnaires for 
the preliminary study (see again Part II, Chapter 2 sections 5 & 6). 
For this stage two return addresses were used. One was the address of the 
HMS in Oxford and the other was the Cranfield Applied Psychology Unit 
address. The two addresses were used because it was found in Study One 
that there was some suspicion of 'psychology', and it was felt people 
might be more inclined to respond to a survey from the Radcliffe 
Infirmary which is a locally respected institution. If the anticipated 
superiority of response rate from 'Oxford instruments' was realised, the 
main study would employ this address. If not, the Cranfield address would 
be used as it would be more convenient to the researcher. 
Compared to the response rate achieved in the previous study, the 
response rate from this piloting session was poor. Just 39.4% of 
distributed questionnaires were returned, with no difference in responses 
from Oxford (39%) and Cranfield (39.7%) return addresses. Given that the 
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survey topic and distribution procedure were identical to those of Study 
One; and that the site used was that which had provided the best returns 
from Study One; it was decided that the instrument itself was probably to 
blame for low response rates. Support for this inference was found in 
comments made on returned questionnaires. Four respondents stated that 
the questionnaire was repetitive and rather boring, and they had actually 
completed and returned the instument. So, it did not seem unreasonable to 
assume that others had failed to respond for this reason. 
Accordingly, revision of the instrument was undertaken and changes to 
both the format, and distribution of the questionnaire were considered. 
Firstly, in an attempt to overcome problems of repetition and boredom, 
the screening and clinical trial sections of the questionnaire were 
separated to become independent instruments. These two questionnaires 
were then piloted as before, on a random sample of people canvassed in 
the Milton Keynes shopping centre. All return envelopes bore the 
Cranfield address. 
The response rates for both quest ionnaires were even lower than that 
achieved for the initial dual-purpose instrument - 37% for the clinical 
trial instrument and 28% for screening. This low response rate caused 
particular concern, since it was planned to distribute main study 
instruments by post, and it has been suggested that response rates are 
greater from personal, than mail shot, distribution (eg. Bellizzi and 
Hite, 1986), Although postal distribution had been selected to overcome 
problems associated with the personal approach (see again Chapter 1 
section 6 above), it was also important to obtain a reasonable response 
rate. Thus it was decided to test the effectiveness of postal 
distribution to a random sample drawn from the electoral roll. 
Three versions of the questionnaire were piloted in this way. 
(1) The full version - incorporating both screening and clinical trial 
sections 
(2) Screening only 
(3) Clinical Trials only 
There was little difference in response rates for the three versions -
30% for the full version; 27% for screening; and 32% for clinical trials. 
Al though the response rate from the electoral roll was slight ly lower 
than that of the personal approach method, the difference was slight. 
Furthermore, postal distribution yielded a more representative response 
in terms of age/sex distributions. Therefore, it was decided that the 
full version of the questionnaire would be used in the main study, and 
that distribution of the instrument would be effected by post. 
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Before the final instrument was designed some preliminary statistics were 
performed on pilot study data. It was found that differential measures 
gave no better predictive values than straightforward measures. 
Therefore, the questionnaire was refined and shortened by the removal of 
items that had been included to afford calculation of differential 
values. It was also found that there was much 'missing data' for the 
items relating to past behaviour, so these items too were refined. 
In this way problems of repet i t ion were reduced and improved response 
rates were anticipated. Another cause for optimism regarding subsequent 
response rate was given by the fact that much of the piloting had been 
undertaken between November and January when people may have been too 
preoccupied with seasonal activities to give attention to the survey. 
5. THE QUESTIONNAIRE 
The questionnaire (appendix 14) was comprised of four main sections. The 
first and last sections related to demographic and health details 
respectively, whilst the two centre sections provided the data for 
testing the theory of reasoned action. Section 2 pertained to 
participatation in screening, and section 3 to participation in clinical 
trials, both specifically for cardiovascular risk reduction. 
5.1 SECTION ONE - SOCIo-DEMOGRAPHIC DETAILS (PAGE 1) 
The first section consisted of 8 items which provided information about 
respondents' age, sex, marital status, whether or not they lived alone, 
whether or not they had chi ldren, and, employment detai Is. The lat ter 
were used to determine crude estimates of socio-economic status. Data 
obtained from this section were used to provide a demographic profile of 
the sample and to enable comparison of various subgroups of the 
population. 
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5.2 SECTION TWO - INTENTIONS, ATTITUDES, BELIEFS AND NORMS PERTAINING 
TO PARTICIPATION IN SCREENING (PAGES 2-5). 
All items in this sect ion related to part ic ipat ion in screening for the 
identifcation of cardiovascular risk, and the format complied with that 
prescribed by Fishbein. Answer options were comprised of a 7 point scale 
but Fishbein's 'neutral' centre point option was replaced by an 'unsure' 
option as early piloting had shown this to be more appropriate. Thus the 
range of answer options available for measurement of intention or belief 
strength were: 'Very Likely', 'Quite Likely', 'Slightly Likely', 'Not 
Sure', 'Sl ight ly Unl ikely', 'Qui te Unl ikely', 'Very Unl ikely'. Answer 
options for attitudes and belief evaluations similarly ranged from 'Very 
Good' to 'Very Bad' with the same 'Not Sure' midpoint. 
PAGE 2 
Item 1 was a direct elicitation of intention to participate in screening 
for cardiovascular risk, if such an opportunuity was presented. Item 2 
represented a measure of general attitude, item 3 a measure of attitude 
to personal participation, and items 4. and 5 measures of social and 
personal norms respectively. The final item on this page, item 6, was a 
measure of respondents' perceived likelihood of a screening offer being 
made. Although Fishbein's model does not include items 5 and 6, Budd 
(1984) and others have demonstrated the importance of item 5 to 
behavioural prediction and Ajzen's(1985) paper indicates the wisdom of 
ascertaining item 6, especially where intentions, rather than behavioural 
outcomes are the final measures. 
PAGE 3 
The i terns on page 3 represented the modal sal ient bel ief set obtained 
from in-depth interview responses. Measures of belief strength for each 
item were obtained from this page. 
Item 7 represented the belief that participation in screening would give 
a definite indication of the presence or absence of cardiovascular risk. 
Items 8 to 11 were subsidiary to item 7 in that they represented beliefs 
associated with risk assessment. Item 8 relates to being given a frank 
diagnosis; item 9 the bel ief that a 'good resul t' would offer peace of 
mind; item 10 the bel ief that 'forewarned is forearmed' ie that if a 
person knows (s)he is at risk (s)he can take preventive measures; and 
item 11 that the screening procedure would include information about the 
best preventive measures to take. 
Items 12 and 13 are really two sides of the same coin in that they both 
represent the belief that particpation in screening would help avoid 
later infirmity. Item 12 was a positive statement Of this belief whilst 
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13 was a negat i ve approach. Both were inc I uded because both were put 
forward by preliminary interviewees and highlighted the fact that some 
people would be encouraged to attend screenings by the hope of 
maintaining current good health whilst others would be more inclined to 
participate for fear of what might happen if they didn't. As one 
informant succinctly put it,' There are different sorts of donkeys - I'm 
the sort who responds best to the stick, not the carrot. ' 
There is some controversy in the literature as to the benefits of fear 
arousal in heal th promot ion messages <ego Leventhal,1965; McGuire, 1968). 
Some <ego Leventhal 1973; Kirscht and Haefner, 1973) have suggested that 
threat may be a useful adjunct to health promotion campaigns. Others <ego 
Kasl, 1978) have argued that threat may be less effective than positive 
appeals to participate in health screening. By using both items it was 
intended to assess which approach would be most effective for encouraging 
participation in cardivascular risk reduction programmes. 
Items 15-18, represent bel iefs about lifestyle changes ie that 
participation in screening would be accompanied by a directive to stop 
smoking, drinking, change diet, or take up exercise. The preceding item, 
14-, was a straightforward bel ief that doctors are inc I ined to 'lecture' 
patients. Finally, item 19 was the belief that participation in screening 
and confrontat ion wi th current bad habi ts would act as a spur to more 
healthy living habits. 
PAGE 4-
Items on this page were used to assess respondent's evaluation of each 
belief outcome and they correspond exactly to those set out on page 3. 
PAGE 5 
The second half of page 5 
instrument. It represents 
interview informants and 
mot iva t i on to comp I y wi th 
was the final part of the Fishbein assessment 
the modal sal ient referents el ici ted from 
comprises both normative beliefs and the 
indi vidual referents. The final item on the 
page provides a measure of compliance with the individual's own personal 
norms. Answer opotions for normative beliefs were grouped under two 
headings ie 'In Favour' and 'Against'. Under each of these headings were 
the options: Very Much, Quite a Lot, A Little. The two groupings were 
separated by a 'Not Sure' option and a further option of 'Doesn't Apply' 
was also provided. Motivation to comply was measured on a unipolar 4 
point scale of Very Much, Quite a Lot, A Little, Not At All. Again a 
'Doesn't Apply' option was provided. Measures of self compliance were 
guaged from the answer options: Almost Always, Most of the Time, Some of 
the Time, Almost Never. 
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The first part of page 5 was not directly related to the Fishbein 
assessment, but it was included because of its relevance to the HMS. In 
this section assessment was made of how important people perceived 
various cardiovascular risk factors to be. This information was required 
because it was clear from the interview data that some people do not 
really believe some risk factors to be very 'risky' at all. Clearly, if 
people do not believe that a risk factor is a risk factor, they cannot be 
expected to respond to advice to address a particular problem. Therefore 
it was considered important to make some evaluation of people's 
percept ion of risk factors so that any common misconcept ions might be 
identified and given greater emphasis in health promotion. 
5.3 SECTION THREE - INTENTIONS, ATTITUDES BELIEFS AND NORMS PERTAINING 
TO PARTICIPATION IN CLINICAL TRIALS (PAGES 6-12). 
Section three was really a repetition of section two except that it 
related to clinical trials rather than screening and necessitated a more 
complex assessment of intentions and attitudes. It was evident from 
preliminary interviews that most informants differentiated between 
'brand new pi lIs' and other already establ ished pi lIs, so the 
questionnaire had to allow for this. It was also apparent that, unlike 
screening, people did not regard clinical trial participation from a 
single perspective. Rather, informants stated that participation would 
depend upon a variety of circumstances including their own state of 
health at the time, their perception of the value of testing a given 
drug, and the attitude of the soliciting doctor. 
Accordingly, al though a final overall measure of intent ion was obtained, 
the first part of this section was designed to acknowldege the complex 
nature of participatory intention and to give people the opportunity to 
express their intentions under differing circumstances. 
PAGES 6 - 8 
In these pages, identical answer options were provided for both 'new 
pills' and 'other pills'. Both ranged on a 7 point scale from Very Likely 
to Very Unlikely with Not Sure as the midpoint. The attitude answer 
options similarly ranged from Very Likely to Very Unlikely for outcome 
measures and Very Good to Very Bad for evaluations. All participatory 
scenarios assessed were reported by interview informants and all refered 
to participation in clinical trials for cardiovascular risk reduction. 
Items 1 to 3 assessed intention to participate in clinical trials if 
certain health conditions applied. These were: i-if the respondent was in 
severe health danger and the trial drugs were a last resortj 2-if the 
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respondent was at high risk of a heart attack or stroke; 3-if the 
respondent was at any extra risk of a heart attack or stroke. Item 4 
assessed intention to participate in order to benefit others and item 5 
related to participation if the respondent was already on other 
medication. Item 6 was used to measure requirements for information prior 
to participation whilst item 7 measured the probablity of participatory 
consent being nulified by non-compliance. 
Items 8 and 9 both asked for an overall intention to participate in 
clinical trials. 8 measured intention to agree to participation and 9 
measured intention to refuse to participate. The two measures were 
obtained so that a differential value for participatory intention could 
be computed as pilot results had shown this to be the only variable to be 
more sensitive in differential than straightforward measures. Items 10 to 
12 measured attitude, social norms and personal norms respectively, 
whilst item 13 measured respondents' perceived likelihood that their 
doctor would ask them to take part in clinical trials. 
PAGE 9 
Page 9 was compr i sed of 11 items wh i ch were used to ga i n measures of 
belief strength. In this section there was no differentiation between 
'new pi lIs' and 'other pi lIs' because interview el ic i tat ion of bel iefs 
had indicated that it was only at the stage of deciding whether or not to 
take the pills that the newness of the drugs exerted an influence. Once 
taking pi lIs, the same concerns appl ied however new or well establ ished 
they were. As before, measurement was on a 'Very Likely' to 'Very 
Unlikely' 7 point scale. 
The first two items on page 9, items 14 and 15, respectively assessed the 
beliefs that the respondent's doctor would give her/him all the 
information (s)he wanted about the trial study, and about the pills being 
tested. Item 16 measured the extent to which people bel ieved that they 
could ask for any information they wanted. Items 17, 18 and 22 related to 
beliefs about side effects and items 19 and 20 related to beliefs about 
contributing to knowledge that might benefit self or others. Item 21 
measured the belief that to take part in clinical trials was to serve as 
a 'guinea pig'. The last belief assessed, item 24, pertained to worry that 
participation in clinical trials might result in discontinuation of 
current effective medication. This belief was not, in fact, expressed by 
many interviewees, but it was mentioned by a few and as it was found to 
be a major worry for people who took part in study one, its inclusion in 
this study seemed justified. 
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PAGE 10 
Items on this page were used to assess the outcome evaluation of beliefs 
and as before, they corresponded exactly to those on the previous page. 
PAGE 11 
As with the first half of page 5, the items on page 11 were not required 
for the theory of reasoned action model. However, again they did elicit 
data of relevance to the HMS, so they were included. The 8 items on this 
page were all taken from interview responses and they related to 
conditions which might influence non-compliance with prescribed drug 
regimens. 
PAGE 12 
The final part of section 3 equated to the second half of page 5. The 
same format was 
comply, but in 
participation in 
used to assess normative beliefs and motivations to 
this case normative beliefs were measured for both 
trials of new drugs and in trials of established drugs. 
5.4 SECTION FOUR - HEALTH DETAILS (PAGES 13 and 14) 
The last section of the questionnaire elicited information about 
personal health and past experiences of screening tests and clinical 
trials. These measures were obtained to enable sub-group comparisons of 
intentions, attitudes and beliefs; and to give an indication of both the 
extent to which people would like regular blood pressure and cholesterol 
tests and by whom they would prefer them to be done. This information was 
of specific interest to the HMS. 
Different coloured papers were used to facilitate identification of 
respondents from the various sampling sources. 
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6. THE MAIN STUDY 
6.1 SAMPLING SOURCES 
Two main sampling sources were used for the main study ie. - the practice 
lists of four Northampton general practicesj and the Northampton 
electoral roll. The rational for using these sources was given at the 
begining of this section in sampling strategy note. 
The four practices which took part in the study were selected with the 
help of the Family Practioner Committee registrar, who chose practices 
from different areas of Northampton to give a representation of all 
types. 
The firs t samp 1 i ng prac t ice was a very new one, ina new deve 1 opmen t 
area of south-west Northampton. Its catchment area included lots of 
expensive modern housing, and several outlying villages to the south and 
west of the town. At the time of sampling it consisted of just 2 
partners. 
The second practice was a well established one situated in the North of 
the town and it had a well mixed practice list of people from both local 
authority and private housing. Five doctors practiced in this group. 
Practice no. 3 was part of a very large health centre complex of several 
group practices located in another fairly new development area. However, 
this area had a much greater proportion of local authority housing within 
its catchment area and was to the east of Northampton. It was also 
considerably larger, accomodating 4 partners. 
Practice No.4 was a well established practice in the middle of the town 
with a well mixed catchment area which included flats and hostels as well 
as local authority and private housing. 
partners. 
The group was compr i sed of 5 
The electoral roll used was a draft version of the latest edition. It was 
issued in February 1988, having been complied from information obtained 
in October 1987. Sampling took place in February and March 1988. 
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6.2 SAMPLING STRATEGY 
In each medical pract ice 250 potent ial respondents were drawn from the 
sampling pool by systematic random sampling. At practices 1 and 2, 
sampling was effected from age/sex registers. At practices 3 and 4 the 
notes-stacks were used. Systemat ic random sampl ing was also employed in 
the selection of potential respondents from the electoral roll (see 
appendix 15 for details of the sampling stategies used). 
7. QUESTIONNAIRE DISTRIBUTION 
Questionnaires were distributed via mail shots during March and April 
1988. For potential respondents drawn from medical sampling sources, a 
covering letter from the GP was also included. This covering letter was 
the same for all practices, with each bearing the appropriate letter 
headings and being signed by one or more of the partners (see appendix 
16 for a copy of the letter). 
A freepost return envelope was included with every questionnaire sent. 
8. STATISTICAL ANALYSIS 
Returned questionnaires were coded for statistical analysis and submitted 
to the following statistical tests: 
(1) Frequency counts and chi square 'goodness of fit' tests 
(2) Multiple regression analyses 
(3) T-tests 
(4) Discriminant function analyses 
(5) Chi square crosstabulation tests. 
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CHAPTER 3 
RESULTS 
The data collected for study two were almost entirely quantative, 
although a few respondents did add some comments to their questionnaires. 
Data were submitted to analyses in accordance with study aims and results 
will be presented as follows:-
(1) Details of response rates and sample characteristics 
(2) Summaries of frequency counts pertaining to intention, attitudes, and 
beliefs regarding (a) participation in screening for cardiovascular 
risk; (b) participation in clinical trials for cardiovascular risk -
reduction. 
(3) Correlations and Multiple Regression Analysis to test the predictive 
associations described by the Behavioural Intention Model (BIM) 
(4) T-tests to identify beliefs that differentiate intending participants 
from intending non-participants 
(5) Discriminant Function Analysis to test the differentiation of 
potential participant and non-participant groups 
(6) T-tests and Chi Square Crosstabulations to test for differences 
between sample sub-groups. 
(7) A summary of comments appended to questionnaires 
(8) Summary of results 
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1. RESPONSE RATES AND RESPONDENTS 
Of the 2000 questionnaires sent out (1000 each from electoral roll and 
medical sampling sources), 695 were returned in time for analysis. 
Taking into account undelivered instruments, the overall response rate 
was 36.2%. There were 23 'return-to-senders' from the electoral roll 
sample and 57 from the medical sample, thus yielding individual response 
rates of 33% and 39.4% respectively. This represented a statistically 
significant difference( X2 =8.68 df=1 p=(,Ol). However, of the whole 
sample, 323 respondents came from the electoral roll and 372 from 
medical sampling sources (46.5% & 53.5% respectively>. These proportions 
were not significantly different (X~=3.31 df=l p= >.05). 
RESPONDENT CHARACTERISTICS 
TABLE 1 Sex and Age Profile of the Sample 
SEX ! ! AGE GROUPS 
, 
II 1 
, 
Male Female ! ! 18-44 45-Pensionable Pensionable Age 
!! Age(9 60; d 65) and Over 
! ! 
47,3~ 52,7% !! 56,61 261 171 
II 
Sex dis tr i but i on of the samp Ie ~70.s vet-y simi 10"- t.o t.ha t obser ved 1 n 
Northampt.on as a who]e, but. there was a significant difference in the 
distribution of ages between the obtained sample and the adult population 
of Northampton <X2 =10.06 df=2 p<.01.). The difference was described by 
an under-representation of people in the oldest age group <17% of the 
sample, against 22% of the Northampton adult population - comparison 
source OPCS Census 1981). 
Wi thin the sample, there were fewer young men and more middle-aged men 
than would be expected by chance; with correspondingly more young, and 
fewer middle-aged, women. Within the oldest age group, sex distributions 
were more or less as would be expected <see table 2). 
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TABLE 2 Summary of Crosstabulations Sex (l=Male; 2=Female) by Age Groups 
TABLE 3 Civil Status and Cohabitation Profile of the Sample 
CIVIL STATUS !! LIVING 
II 
Single Marriedl Divorcedl Widowed ! ! Alone With 
II 
! ! 
15,41 74,51 5,8% 4,2% ! ! 12,2% 86,6% 
! I 
These figures conform quite well to those provided by the opes 
Household Survey of 1985, though there may be a slight 
representation of single and widowed people. 
TABLE 4 Current Employment Status and Usual Occupation Profile of the Sample 
CURRENT EMPLOYMENT ! ! 
II 
USUAL 
Self Full Part Unemployed Retired Other-eg ! !Non-Manual Manual 
6,6l 46,51 14,2l 3,51 15l 
! ! 
14 , 21 !! 58 , 91 
II 
32,51 7,2% 
General 
under-
The proportion of unemployed and retired respondents (18.5%) corresponded 
quite closely to the proportion of 'economically inactive' household 
heads in Northampton (20%). However, the distribution of social classes I 
to V in the sample, was very different to that obtaining for Northampton 
as a whole. 
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When 'armed forces' and 'economically inact i vel are removed from the 
figures for the Northampton population, the resultant proportions of non-
manual(classes I II & IlIa) and manual (classes IIIb, IV & V) occupations 
of househo 1 d heads are 40. 8% and 59. 2% respec t i ve 1 y. 635 responden t s 
(91%) indicated a usual occupation within classes I to V. Of these, 64.4% 
were non-manual and 35.6% manual. This difference in social class 
distribution between Northampton as a whole and the study sample, was 
highly significant( )(2 = 139 df = 1 p<'OOl) with an obvious under-
representation of manual workers in the sample (OPCS Census, 1981). 
TABLE 5 Reported Health Status & Consciousness and Cardiovascular Risk Behaviour 
Current health Very or Quite Very or Quite!! Current Drinks Alcohol No Regular 
Excellent or Interested in Careful re 
SO,3~ 90~ 61,S~ 
!! Smoker 
, ! 
! ! 
!! 29,.U 
! I 
At Least Once Exerci se 
45, 1 ~ su 
According to the OPCS General Household Survey for 1984, 31% of the 
population in this area are current smokers. Alcohol consumption was less 
easy to compare with GHS figures, but a survey of knowledge attitudes and 
behaviour relating to heart disease (Lifestyle and Heart Disease> 
conducted in 1986, found 57% to drink alcohol at least once a weeki and 
46% to take no regular exercise. 
TABLE 6 Personal and Family History of Cardiovascular Disease 
PERSONAL HISTORY ! ! FAMILY HISTORY 
II 
!! 
S,U 15~ ! ! 34,5~ 17,7~ 
, , 
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2. fREQUENCIES 
Frequenc ies of reponses to each quest ionnaire item are detai led on the 
questionnaire in appendix 14) 
SCREENING 
In respect of almost all items relating to participation in screening for 
cardio-vascular risk, there was a remarkable consensus of responses 
emitted by the sample. Therefore, only positive responses will be 
summarised below. Uncertain and negative responses can be seen in 
appendix 14. 
TABLE 7 Percentages of Informants Indicating Positive Responses to Intention, Attitudes, 
Subjective and Personal Norms re Participation in CVD Screening, 
I! 
II Very Qyite Slight !Total . , 
Participatory Intention !! 5.4,2 22,3 14,0 90,S 
Atti tude to General Concept ! ! 70,8 21 ,4 4,2 96,4 
Attitude to Personal Participation !! 62,3 25,2 6,0 93,S 
Subjective Norm !! 48,3 30,S 11 , 1 89,9 
! I 
However, just 29,71 indicated that they thought there was some likelihood that their GP 
would offer a screening check for CVD within the next year, 
TABLE 8 Percentages of Informants Indicating Positive Beliefs that Items Would Be 
Associated With Paticipation in CVD Screening 
II 
!! Very Quite 51 ight! Total 
Could take preventive measures if at risk II 69,S 20,6 4,5 94,6 
Would be told best preventive measures to take ! ! 64,0 24,7 4,9 93,6 
Would improve chances of staying fit & healthy longer !! 57,4 28,3 7,9 93,6 
Get peace of mind if got the lall clear l !! 73,2 16,3 3,3 92,8 
Would lessen chances of becoming infirm in later years! ! 42,0 30,8 10,5 83,3 
Would definitely find out whether or not at CVD risk II 36,8 38,1 7,8 82,7 
Would spur me to more healthy style of living ! ! 34,S 32,9 15, 1 ! 82,5 
I I 1 
In addition 94,5% stated that they would want to be told 'straight' if at 
cardiovascular risk, with 80.4~ giving the strongest positive response. 
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TABLE 9 Percentages of Informants Indicating Positive Evaluations of Outcome Beliefs 
Associated With Paticipation in CVD Screening 
! I 
!! Very Qyite Slight !Total 
Being told best preventive measures to take !! 71.5 19.3 4.5 95.3 
Improving chances of staying fit & healthy longer !! 69.1 20.3 5.9 95.3 
Being able to take preventive measures if at risk !! 68.2 21.6 5.2 95.0 
Having peace of mind by getting the 'all clear' !! 74.7 14.8 3.7 93.2 
Lessening chance of becoming infirm in later years!! 63.5 21.2 4.2 88.9 
Finding out whether or not at CVD risk !! 59.9 21.6 4.6 86.1 
Being spurred on to more healthy style of living !! 37.7 30.8 12.8 81.3 
t I I 4 
In add! t ion, 89.9% stated that it would be good for them to be told 
'straight' if they were at cardiovascular risk, with 70.11% giving the 
strongest positive response. 
Other outcome beliefs tested in the study related to lifestyle items of 
smoking, drinking, diet and exercise. 67.2% of the sample claimed to be 
non-smokers, and 60.9% claimed to be non/rare drinkers. 25.6% claimed to 
be 'healthy eaters'; and 27.8% regular exercisers. Of the remaining 
respondents, most indicated bel iefs that screening would entai I being 
told to change lifestyle habits and most evaluated such advice 
positively. 
TABLE 10 Percentages of Respondents Indicating Beliefs That Advised Lifestyle Changes 
Would be an Outcome of Screening Participation (non-smoker/drinkers and 
'healthy eaters' and regular exercisers excluded) 
~iry Quih Sl igbtly IQtil 
Be told to give up smoking ! 74.8 16.8 3.7 95.3 
Take-up exercise! 29.4 37.4 15.0 81.8 
Change diet ! 31.2 28.7 15.2 75. 1 
Reduci dl'ink ing I 27.0 26.2 12.3 65.S 
• 
TABLE 11 Percentages of Respondents (as above) Indicating Positive 
Outcome Evaluations re Lifestyle Changes 
~ery Quite Sligbtly Iotal 
Being told to give up smoking 37.8 18.7 10.7 67.2 
Take-up exercise 27.3 34.3 18,8 80,4 
Change diet 28,0 30,2 16,1 74,3 
Riduci drinking ! 20,7 19,Q 17,3 57,0 
93% of respondents reported experience of blood pressure tests, but only 
17% reported experience of a blood cholesterol level test. 
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CLINICAL TRIALS 
Compared with responses to screening items, responses relating to 
clinical trials were much more varied. Because of this, the three 
pos i t i ve and three nega t i ve reponse cat agor i es have been co 11 apsed for 
presentation in the summary tables below. 
TABLE 12 Percentages of Informants Indicating Positive, Uncertain and Negative 
Responses to Intention, Attitude, Subjective and Personal Norms, re 
Participation in Clinical Trials 
II 
II Positive Uncertain Negative . , 
Participatory Intention - new pills =(A) ! ! 43,3 21,2 34,1 
other pi 11s=(B) ! ! 48,0 18,7 30,9 
Attitude to Personal Partic ipation (A) !! 37,2 33,7 27,7 
(B) !! 41,3 31,7 24,8 
Subjective Norm (A) ! ! 23,2 29,9 45,4 
(B) !! 25,9 29,S 42,0 
Personal Norm (A) II 41,4 20,0 37,S 
II 
74.3% of respondents indicated that they thought it unlikely their doctor 
would ask them to test new pills and 72.6% felt the same about other 
pi lIs. 
TABLE 13 Percentages of Informants Indicating Positive,Uncertain and Negative 
Beliefs that Items Would Be Associated With Clinical Trial Participation 
Contribute to knowledge that might benefit others 
Serve as a IGuinea Pigl 
!! 87,8 
! ! 87,1 
Could ask for any information wanted ! ! 
Poss ible long-term side eff ec ts ! ! 
Contribute to knowledge that might benefit self !! 
If loff colour I might worry re effects of pills !! 
Dr, would give all info, wanted re the study !! 
Dr, would give all info, wanted re pills being tested!! 
Risk health eg, by possible side effects !! 
!! 
85,4 
82,3 
82,2 
80,3 
77,4 
75,1 
73,4 
If testing pills for prevention might not work if 
ever really needed !! 48,7 
Might be taken off good pills already taking !! 38,8 
7,8 
6,5 
6,0 
10,1 
11,5 
6,2 
9,8 
10,6 
16,0 
27,2 
26,0 
3,0 
4,6 
7,1 
6,1 
4,6 
11,4 
11 ,A 
12,6 
9,0 
22,6 
32,1 
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TABLE 14 Percentages of Informants Indicating Positive,Uncertain and Negative 
Outcome Evaluation of Items Associated With Clinical Trial Participation 
Contribute to kno~ledge that might benefit others 
Serve as a IGuinea Pigl 
Could ask for any information ~anted 
Possible long-term side effects 
Contribute to kno~ledge that might benefit self 
t, t, 83 1 , 
!! 22,2 
!! 96,0 
!! 9,3 
!! 81,0 
If loff colour l might ~orry re effects of pills !! 20,6 
95,8 
94,4 
12,8 
Dr, ~ould give all info, ~anted re the study !! 
Dr, ~ould give all info ~anted re pills being tested!! 
Risk health eg, by possible side effects !! 
If testing pills for prevention might not ~ork if 
ever really needed 
Might be taken off good pills already taking 
!! 
!! 10,7 
! ! 10,5 
12,7 
26,2 
1,4 
17, 1 
14,0 
18, 1 
2,3 
3,0 
14,1 
29,2 
29,2 
1,2 
49,6 
0,2 
70,4 
1,9 
59,1 
0,2 
0,2 
70,5 
57,7 
56,6 
Just 16 informants stated that they had previously taken part in clinical 
trials, and 14 of these stated that they would be wi 11 ing to do so 
again. 
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3. PREDICTIVE ASSOCIATIONS BETWEEN BEHAVIOURAL INTENTION MODEL VARIABLES 
Following initial examination and processing of the raw data, the 
predictive associations between variables were tested as prescribed by 
the Behavioural Intention Model (BIM). Firstly, Mul tiple Regression 
Analysis (MRA) was performed to assess the relationship between the 
variables of attitude & subjective norm with that of behavioural 
intention. The relative importance of each independent variable was also 
evaluated. 
Response options had allowed for the computation of differential measures 
of intention re clinical trial participation, but the predicitive values 
obtained from these measures were less than those obtained from 
straightforward measures of intent ion. Thus the lat ter were used in all 
subsequent analyses involving measures of intention. 
The relationship between principal BIM variables was quite high for both 
Screening intention and intention to participate in Clinical Trials -
(R=.687j R=.732 respectively). In both cases attitude to participation 
was considerably more important to the equation than subjective norm. 
Further MRAs were performed to assess the relationships between: -
(a) behavioural beliefs and attitude; and (b) normative beliefs and 
subjective norm. In both instances crossproduct values of beliefs were 
employed. Crossproduct values of behavioural beliefs were computed for 
each outcome by multiplying the belief strength measure by its 
corresponding outcome evaluation measure. Crossproduct values for 
normative beliefs were obtained by a similar process of multiplying 
values pertaining to respondents' assessments of the feelings of their 
referents, by respondents' motivation to comply with that referent. 
In fact, the BIM states that the strength of association between beliefs 
and their successors in the model should not be assessed by regression 
techniques, but by correlations of primary components (attitudes and 
subjective norms) with the sum of belief crossproducts, thus using equal 
weights. However, the coefficient values obtained by the prescribed 
technique were slightly lower than those obtained from multiple 
regression analysis. 
Explanation of this finding may be found in Cattin's (1978) paper where 
he states that "regression will outweigh equal weights if sample size is 
large enough, or the N to P ratio is large enough" - where N = number of 
respondents and P = number of predictors. 
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In the reported study, both the sample size and the N to P ratio were of 
considerable magnitude. 
Therefore, although both BIM prescribed unit weight coefficients and 
regression coefficients are shown in figures 1 and 3 (for screening and 
clinical trials respectively), details of the regression analyses are 
also presented in tables 17 & 19 (screening); and 22 26 & 27 (clinical 
trials> . 
These relat ionships were not so high as those found in the previous 
tests, al though they were st ill reasonably high wi th the lowest 
accounting for 18% of the variance. However, because not all referents 
were applicable to all respondents; and because some respondents marked 
'not appl icable' in respect of mot i vat ion to comply even where they had 
indicated a referent's opinion; the number of cases processed in the 
subjective norm/normative beliefs equation was less than half that 
applying to behavioural bel iefs. Therefore, interpretat ion of the 
relative relationships must be made with extreme caution. 
When personal normative belief values were added to those of attitude and 
subjective norm as predictor variables, the predictive value of the 
equation was increased quite substantially. Because of the importance of 
personal norm to the prediction of intention, regression analyses were 
performed using cross-product measures of behavioural beliefs, to predict 
personal norm. The values for these were similar to those obtained for 
MRAs in which attitude was the dependent variable. 
The predictive associations of the model, for both screening and clinical 
trial intention, are shown in figures 1 and 3 respectively. Corresponding 
predictive associations and relative weights of attitude, subjective norm 
and personal norm are shown in figures 2 and 4. MRA summaries are given 
in tables 15 to 27. 
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SCREENING 
Figure 1 Predictive Associations Using the Basic BIM 
Behavioural beliefs 
& outcome evaluations 
R=.424 Attitude to 
the behaviour 
r=.407 
(cases=608) 
p=.OOO 
Relative importance 
of attitude and 
sub ective norm 
!Normative beliefs and motivation to com 1 R=.54-0 
r=.4-78 
(cases=226) 
p=.OOO 
Subjective 
norm 
R=. 6871 Intent Ion 
Figure 2 Predictive Association of Intention From Attitude, Subjective 
Norm and Personal Norm 
Attitude Towards 
The Behaviour 
Subjective Normative 
Belief 
Personal Normative 
Bel fef 
W-1 =.498 
---~R=. 753 Intention To Perform 
The Behaviour 
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MULTIPLE REGRESSION ANALYSES 
SCREENING 
TABLE 15 Summary of MRA with Intention to Participate as the DV and Personal Attitude and 
Subjective Norm as the IVs, 
FINAL VALUES 
Variable Entered R2 B IBeta!Part Partial T 1 P 
I r I 
Multiple R ,687 Personal Attitude (Gdhave) ,419 ,741 ,541 ,56 17,71,000 
R Square ,471 1 1 
Adjusted R ,470 Subjective Norm ,052 ,301 ,25! ,23 ,30 8,3! ,000 
F Value 307,002 
Significance ,000 
TABLE 16 Summary of MRA with Intention as the DV and Attitudes j Subjective Norm and 
Personal Norm as the IVs 
FINAL VALUES 
Variable Entered R2 B IBeta Part Partial! T p 
I 
Multiple R ,753 Personal Norm (Persn) ,472 ,561 ,43 ,31 ,42 12,3 ,000 
R Square ,567 1 
Adjusted R ,565 Personal Attitude ,090 ,SO! ,36 ,29 ,40 11,6 ,000 
F Value 299,644 ! 
Significance ,000 Subj ec ti ve Norm ,004 ,10 ! ,08 ,06 ,10 2,6 ,009 
NB, Percei ved 1 ikel ihood of screening invi tat ion being issued did not 
contribute to the functions. This variable did not reach the .05 limit in 
any analysis in which it was included. 
TABLE 17 Summary of MRA with Attitude to Participation as the DV and Behavioural 
Beliefs (strength/evaluation cross-products) as the IVs 
FINAL VALUES 
Variable Entered I R2 B Beta Part Partial T 
r 
Multiple R ,424 Help keep fit for longer ,130 ,07 ,22 ,18 ,20 4,94 
R Square ,179 
Adjusted R ,175 Definitely find out if at 
F Value 43,189 1 risk ,040 ,46 ,20 ,18 ,19 4,92 
Significance ,OOOO! 
Get peace of mind from an 
"all clear" ,010 ,37. , 11 ,10 ,11 2,64 
p 
,OOO! 
,OOO! 
,008' I 
!.l 
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TABLE 18 Summary of MRA ~ith Personal Norm as the DV and Behavioural 
Beliefs (strength/evaluation cross-products) as the IVs 
FINAL VALUES 
Variable Entered R2 I B Beta Part!Partial! 
r I 
Multiple R ,448 Help keep fit for longer ,144 ,06 ,20 ,16 ! ,18 
R Square ,201 ! 
Adjusted R ,196 Definitely find out if at ! 
F Value 37,258 risk ,033 ,04 ,16 ,14 ! ,16 
Significance ,0000 
Get peace of mind from an ! 
"all clearl! ,015 ,04. ,13 , 11 ! ,13 
! ! 
Spur to healthier Ii vi ng ,007 ,02! ,09 ,08! ,09 
T ! P 
I 
4,44! ,OOO! 
! 
! ! 
3,95! ,OOO! 
! I 
! 
3,12! ,O02! 
! 
2,29! ,022! 
TABLE 19 Summary of MRA ~ith Subjective Norm as the DV and Normative Beliefs Products 
(perceived opinion of referent by motivation to comply ~ith referent) as IVs 
FINAL VALUES 
Referent Entered R2 B Beta!Part Partial T p 
Mul tiple R ,540 Friends ,197 ,07 ,33! ,31 ,35 5,50 ,OOO! 
R Square ,291 ! 
Adjusted R ,284 Spouse/Partner ,093 ,15 ,32! ,30 ,34 5,42 ,OOO! 
F Value 45,806 
Significance ,0000 
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CLINICAL TRIALS 
The following figures pertain only to 'new pills'. Results relating to 
'Other Pills' were very similar and are shown in appendix 17. 
Figure 3 Predictive Associations Using The Basic BIM 
R=,554 
r=,428 
(cases=628) 
p=,OOO 
Relative importance 
of attitude and 
sub ective norm 
Normative beliefs and R=.467 Subjective 
motivation to com I ~-=n=o~r=m ______ ~ 
r=.4BO 
(cases=196) 
p=.OOO 
1=.672 
R=.732 I Intent lonl 
Figure' Prediction of Intention from Attitudes, Subjective Norm and 
Personal Norm 
Attitude Towards 
The Behaviour 
W1 =·361 
I Subjective Normative r-W2=. 144 Bel ief I 
Personal Normative 
Be lief 
R=.BOO Intention To Perform 
The Behaviour 
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TABLE 20 Summary of MRA ~ith Intention to Participate in Clinical Trials of 'Ne~ Pills' 
as the DV and Attitude and Subjective Norm as the IVs 
FINAL VALUES 
Variable Entered R2 B !Beta!Part!Partial T ! P 
r I I I 
Multiple R ,731 Atti tude ,478 ,63! ,53! ,45! ,55 17 , 1 O! ,OOO! 
R Square ,536 ! 
Adjusted R ,534 ! Subjective norm ,057 ,31 ! ,28! ,24! ,33 9,13! ,OOO! 
F Value 388,746 ! 
Signi f icance ,OOOO! 
TABLE 21 Summary of MRA ~ith Intention to Participate in Clinical Trials of 'Ne~ Pills' 
as the DV and Attitude, Subjective Norm and Personal Norm as the IVs 
FINAL VALUES 
Variable Entered R2 B Beta!Part Partial! T p 
, 
Mult iple R ,800 Personal Norm ,563 ,47 ,47! ,48 ! 14,18 ,OOO! 
R Square ,640 ! 
Adjusted R ,639 Atti tude ,067 ,36 ,31 ! ,22 ,3S 9,66 ,OOO! 
F Value 398,515 ! 
Significance ,0000 Subjective Norm ,011 ,14 ,13 ! ,10 ,17 4,48 ,OOO! 
I 
As wi th screening analyses, respondents· expectat ions re the 1 ikel ihood 
of being asked to participate in clinical trials did not prove to be a 
significant variable in any of the tests in which it was included. 
Corresponding anaylses pertaining to cl inical trials of 'Other Pi lIs' , 
yielded remarkably similar results to the previous two tables. Summaries 
of these analyses are given in appendix 17. 
In the last three regression analyses - prediction of attitude from 
behavioural beliefs; prediction of personal norm from behavioural 
beliefs; and prediction of subjective norm from normative beliefs - there 
were some differences in the items entered in the equations produced for 
'new' and 'other' pills. Therefore, summaries of all these equations are 
presented below. 
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TABLE 23 Summary of MRA with Attitude to Participation in Clinical Trials of 'Other Pills' 
as the DV and Behavioural Beliefs (strength/evaluation cross-products) as the IVs 
FINAL VALUES 
Mul tiple R 
R Square 
Adjusted R 
F Value 
Signi f icance 
,286 
42,703 
,0000 
Variable Entered 
Serving as a 'guinea pig' 
Contributing to knowldege 
to benefit others 
Getting adequate info, re 
pills being tested 
Endangering health by 
possible side effects 
Contributing to knowledge 
that might benefit self ! 
! ! 
!Risking acquired resistance! 
! I 
,163 
,099 
,011 
,007 
B Beta Part!Partial! T ! P 
I 
,27 6,90! ,OOO! 
, 1 0 , 20 ,12 ! , 14 
! ! 
,03! ,09! ,09! ,11 
! ! 
! ! 
, 05 ! ,1 2 ! ,1 0 ! , 12 
! ! 
3,51 ,OOO! 
! 
! 
2,69 ,007! 
! 
! 
3,081,002! 
,007 ,06! ,03! ,08! ,09 2,34! ,020! 
! ! 
,006 -,04!-,08!-,08! -,09 !-2,26! ,024! 
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TABLE 24 Summary of MRA with Personal Norm ('New Pills') as the DV: 
and Behavioural Beliefs (strength/evaluation cross-products) as the IVs 
FINAL VALUES 
Variable Entered ! R2 B !Beta!Part!Partial! T ! P 
~ 1 ! 
Multiple R ,528 Contributing to knowldege ! 
R Square ,279 to benefit self ,163 ,12 ! ,20 ,12 ! ,14 3,53 1,000 ! 
Adjusted R ,273 ! ! 
F Value 48,342 Serving as a 'guinea pig' ,089 , 10! ,24 ,21 ! ,24 6,08 ,OOO! 
Significance ,0000 ! ! ! 
Setting info, re the pills ,015 ,05 1 , 12 , 11 ! , 13 3,34 ,001 ! 
! 
Contributing to knowledge ! ! 
to benefit others ! ,006 ,07 ,13 ! ,08! ,09 2,30 ,022! 
! ! ! ! 
!Bisking beAltb-side effe~ts! ,QQS ,Q~ ,QS! ,QZ! ,Qe 2,Q6 ,QQQ! 
TABLE 25 Summary of MRA with Personal norm ('Other Pills') as the DV: 
and Behavioural Beliefs (strength/evaluation cross-products) as the IVs 
FINAL VALUES 
Variable Entered R2 B !Beta!Part Partial! T p 
1 
Multiple R ,518 Contributing to knowldege ! ! 
R Square ,268 to benefit others , 161 , 11 1 ,18 ! , 11 ,13 3,18 ,001 
Adjusted R ,263 ! 
F Value 57,011 Serving as a 'guinea pig' ,086 ,12 ,29! ,28 ,31 8,12 ,000 
Significance ,0000 
Setting adequate info, re 
pills being tested ,012 ,04 ,10 ,10 , 11 2,86 ,004 
Contributing to knowledge 
tbat migbt benefit self ,QQ~ ,Q~ ,]5 ,Q~ , ] ] 2,ZQ ,QQZ! 
TABLE 26 Summary of MRA with Subjective Norm ('New Pills') as the DV: and Normative 
Beliefs('New Pills' )/Motivation To Comply Crossproduct Measures, as the IVs 
FINAL VALUES 
Referent Entered R2 B !Beta!Part!Partial! T p 
1 
Multiple R ,467 ! 
R Square ,218 Parents ,199 ,08! ,26! ,15! ,17 2,39! ,018! 
Adjusted R ,210 ! 
F Value 26,960 Fr iends ,020 ,08! ,24! ,14 ! ,16 2,20! ,029! 
Significance ,000 
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TABLE 27 Summary of MRA ~ith Subjective Norm ('Other Pills') as the DV; and Normative 
Beliefs('Other Pills')/Motivation To Comply Crossproduct Measures, as the IVs 
FINAL VALUES 
Referent Entered B !Beta!Part!Partial! T p 
Multiple R ! ! ! ! 
R Square Parents ,221 ,17! ,47! ,47! ,47 7,46! ,OOO! 
Adjusted R 
F Value 55,719 
Signi ficance ,0000 
(. T-TESTS TO DIFFERENTIATE BELIEFS BETWEEN INTENDING PARTICIPANTS 
AND NON-PARTICIPANTS 
I 
A series of t-tests were performed in order to gain some understanding of 
the underlying reasons behind different behavioural intentions. The tests 
were intended to demonstrate differences in the associated beliefs of 
intending participant and non-participant groups. 
Because of the missing data problems associated with normative beliefs, 
and because subjective norm played such a minor role in the prediction of 
intention, no further analyses of normative beliefs were worth presenting. 
Therefore only resul ts pertaining to behavioural bel iefs are summar ised 
below. 
Regarding clinical trial participation, the devising of participant and 
non-participant groups was relatively straightforward. Participants 
included all respondents who had indicated some degree of positive 
intention -ie had stated that it was 'Very' 'Quite' or 'Slightly' Likely 
that they would agree to take part in the testing of pills. Non-
part ic ipants were def ined as respondents who stated that it was 'Very' 
'Qui tel or '51 ight ly' Unl ikely that they would agree to take part. 'Don't 
Knows' were excluded from analysis. 
The proportions of 'participants', 'non participants' and 'don't know's 
were 43.3%, 34.1%, & 21.2% respectively for 'new pills'; and 48%, 30.9% 
& 18.7% for 'other pills'. 
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However, it was not possible to repeat this procedure for devising 
comparison groups in respect of intended participation in screening. 
In all, 90.5'% of respondents indicated some degree of posi t i ve intent ion 
to participate in screening. Of these, 54.2'% had stated that they would 
'definitely' have the check if it were offered (group 1); 22.3% that they 
would have the check (group 2); and 14'% that they would 'possibly' have 
the check <group 3). It was considered possible that there might be a 
difference between those who had expressed the stongest degree of 
intention and those who had expressed weaker intentions. 
Therefore this was explored by a series of t-tests comparing all relevant 
variables between groups 1 & 2; groups 1 & 3; and groups 2 & 3. It was 
found that there were indeed, significant differences on almost all 
measures, between groups 1 & 2 and between groups 1 & 3; but almost no 
signi f icant di fferences between groups 2 & 3. Thus it was dec ided to 
nominate group 1 as the 'participant' group, and combine the respondents 
of groups 2 & 3 into 'non-part ic ipants'. Detai Is of these t-tests are 
given in appendix 18. 
In all subsequent comparisons of 'participant' and 'non-participant' 
groups relating to screening, these groupings were used. 
In this section, summaries of 
strength, outcome evaluations 
screening intention in tables 
trials in tables 28 to 30. 
t-tests exploring differences in belief 
and crossproduct measures are given for 
25 to 27 respectively; and for clinical 
Results relating to 'new' and 'other' pills were very similar, so those 
pertaining to 'new' pills only, are given in the main text, whilst those 
relating to 'other' pills are given in appendix 19. 
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SCREENING BELIEFS 
Group 1 = 'Participants' : Group 2 = 'Non-Participants' as defined above. 
TABLE 28 Summary of T-Tests For All Behavioural Belief Variables (Belief Strength 
Measures) Between Groups 1 & 2 as Detailed Above 
VARIABLE BELIEF STRENGTH 
GP _1 GP _2 
D l!; ~iid} D l!; ~~d} t ~ fIl2 
Find out if at risk 364 2.16 (1.15) 244 1.66 ( 1.30) 4.82 ! .OOO! ,03 
! ! 
Want to be told 'straight' 367 2,79 (0,73) 244 2,62 (0,82) 2,59 l,Ol 1<.01 
Get peace of mind from , 
"all clear" 358 2.75 (0,71) 240 2,50 (0.96) 3.46 , ,001 ,02 
Could take precautions 366 2.71 (0.69) 245 2.36 (1.12) 4,39 ! .000 .03 I 
Be told best precautions 363 2,65 (0.74) 244 2.33 ( 1,02) 4,17 ',000 .03 
, 
Stay fit for longer 366 2,64 (0,72) 245 2. 11 ( 1,06) 6,76 , ,000 .07 
! 
Less chance of later 
infirmity 361 2,23 (1,09 ) 245 1,73 ( 1 .27) 5,07 ,000 ,04 
Get lecture from doctor 
doctor 352 0.80 (2,08) 242 0.39 ( 1.98) 2,41 ,016 <.01 
Spur to healthy living 361 1,97 ( 1,39) 244 1,52 (1.55 ) 3.76 , ,000 ,02 
Stop smoking 94 2,58 (1.04 ) 78 2.61 (0.81 ) 0.21 NS - , 
Cut drinking 107 1,10 (2.05) 76 0.99 ( 1.92) 0.39 NS , -
Change diet 247 1,59 ( 1,53) 193 1.28 ( 1 ,69) 1,96 NS , -
! , 
Exercise 252 1,81 ( 1,31) 176 1,41 ( 1,53) 2,74 , ,006' ,01 
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TABLE 29 Summary of T-Tests For All Behavioural Belief Variables (Outcome Evaluation 
Measures) Between Groups 1 & 2 as Detailed Above 
VARIABLE OUTCOME EVALUATION 
GP _1 GP _2 
D x (sd) n x (sd) t I j;l I ,2 . 
1 I Find out if at risk 364 2,54 ( 1, 10) 244 2,01 ( 1,37) 5,02 ! ,000 ,04 
! 
I Want to be told 'straight' 367 2,67 (0,91 ) 244 2,29 <1,18) 4,20 ! ,000 ,03 
Get peace of mind by 
"all c lear" 358 2,80 (0,55) 240 2,58 (0,78) 3,72 ,000 ,02 
Could take precautions 366 2,76 (0,61 ) 245 2,43 (0,78) 5,45 ,000 ,04 
Be told best precautions 363 2,83 (0,44) 244 2,48 (0,76) 6,42 ,000 ,06 
Stay fit for longer 366 2,76 (0,62) 245 2,44 (0,78) 5,36 ,000 ,04 
Less chance of later 
infirmity 361 2,60 (0,84) 245 2,20 (1,04 ) 5,00 ,000. ,04 
Get lecture from doctor 352 1,38 (1,65 ) 242 0,81 (1,68 ) 4,08 ,000 ,02 
Spur to healthier living 361 2,01 <1,31) 244 1,61 (1,37) 3,84 ,000 ,02 
Stop smoking 94 1,63 <1,71) 78 0,97 ( 1,85) 2,39 ,02 ,03 
Cut drinking 107 1,08 (1,51) 76 0,57 (1,50 ) 2,29 ,02 ,04 
Change diet 247 1,73 (1,34 ) 193 1. 23 (1,54 ) 3,54 1,0001 ,02 
! ! 
Exerci se 252 1,78 ( 1,25) 176 1,46 (1,26 ) 2,57 ! ,01 ! ,01 
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TABLE 30 Summary of T-Tests For All Behavioural Belief Variables (Strength/Evaluation 
Crossproduct Measures) Between Groups 1 & 2 as Detailed Above 
VARIABLE OUTCOME STRENGTH/EVALUATION CROSSPRODUCTS 
GP _1 GPJ 
n x (sd) n x (sd) t I ~ (e I 
! ! 
Find out if at risk 364 5,77 (3,87) 244 3,70 93,91) 6,44 ! ,OOO! ,06 
! ! 
Want to be told 'straight' 367 7,54 (3,27) 244 6,40 (3,46) 4, 11 1,0001 ,02 
Get peace of mind by 358 7,92 (2,31 ) 240 6,83 (3,20) 4,51 ! ,OOO! ,03 
"all clear" 
! ! 
Could take precautions 366 7,69 (2,33) 245 6,16 (3,27) 6,30 ! ,OOO! ,06 
! ! 
Be told best precautions 363 7,56 (2,52) 244 6,04 (3,08) 6,38 I,OOO! ,06 
Stay fit for longer 366 7,46 (2,46) 245 5,55 (3,23) 7,85 ,000 ,09 
Less chance of later 
infirmity 361 6,29 (3,34) 245 4,56 (3,61) 6,05 ,000 ,06 
Get lecture from doctor 352 1 ,49 (3,03) 242 0,47 (2,49) 3,54 ,000 ,02 
Spur to healthier living 361 4,39 (2,99) 244 2,64 (2,70) 4,97 ,000 ,04 
Stop smoking 94 4,47 (4,96) 78 2,82 (5,12) 2,10 ,036 ,02 
Cut drinking 107 1 ,51 (3,68) 76 0,72 (3,00) 1 ,70 NS ! -
! 
Change diet 247 3,07 (3,82) 193 1 ,93 (3,73) 2,40 ,02 ,01 
! 
Exercise 252 3,69 (3,47) 176 2,14 (3,37) 3,64 ,OOO! ,03 
68,85 49,96 7,78 ,000 ,10 
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CLINICAL TRIALS ('NEW PILLS') 
Group l=respondents who answered Very, Quite or Slightly Likely to Q8,p7 
Group 2=repondents who answered Very Quite or Slightly Unlikely,to Q8,p7 
'Don't Know's were excluded from analysis. 
TABLE 31 Summary Of T-Tests On All Behavioural Belief Variables (Belief Strength 
Measures) Between Groups 1 & 2 as Detailed Above 
VARIABLE BELIEF STRENGTH 
GP _1 GP -.2 
n x (sd) n x (sd) t ~ 11)2 
Getting info, re the study 296 1,94 (1,45 ) 228 1,18 (2,OO)! 4,48 ! ,OOO! ,03 
Get info, re the pills 294 1,84 (1,49) 228 1,13 ( 1,96) ! 4,53 ! ,OOO! ,04 
Could ask for any info, 295 2,32 (1,19) 220 1,73 (1,72)! 4,36 ! ,OOO! ,03 
Worry if felt 'off colour' 291 1,48 (1,70) 226 1,83 (1,73)!-2,28 ! ,02 ! <. 01 
Worry re side effects 291 0,91 (1,55 ) 225 2,06 ( 1 ,23) ! -9 , 38 ! ,OOO! , 14 
Contributing to knowledge ! ! 
which might benefit self 291 2, 11 (1,02) 227 1,28 (1,60) ! 6,79 ! ,OOO! ,08 
Contributing to knowledge ! 
which might benefit others 294 2,29 (0,89) 227 1,63 (1,55) ! 5,70 ! ,OOO! ,06 
Serving as a 'guinea pig' 294 1,89 (1,42) 227 2,47 (1 ,09) ! -5 , 26 ! ,OOO! ,05 
Worry re long-term effects 294 1,36 (1,44 ) 224 2,19 ( 1 , 12) ! - 7 , 32 ! ,OOO! ,09 
Worry -acquired resistance 294 0,31 (1,71) 224 0,66 (1 ,72) ! -2 , 33 ! ,02 ! <,01 
Worry re 'being taken off 
~S 1 good ~i lIs' 294 0,12 (2,10) 222 0,15 (2,OJ)!-O,20 -, 
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TABLE 32 Summary Of T-Tests On All Behavioural Belief Variables (Outcome Evaluation 
Measures) Between Groups 1 & 2 as Detailed Above 
VARIABLE OUTCOME EVALUATIONS 
GP _1 GPJ ! ! 
n ~ ~5d~ n ~ {5d~ ~ Q ! 612 ! I Setting info, re the study 296 2,75 (0,61 ) 228 2,63 (0,77) 1,89 NS ! - I 
Getting info, re the pills 294 2,76 (0,58) , 228 2,66 (0,83) 1,79 , NS ! -
\ 
I Could ask for any info, 295 2,80 (0,61 ) 220 2,78 (0,57) 0,25 , NS , -
Worry if felt loff colour l 291 -0,48 (1,86 ) 226 -1,17 (1,82 ) 4,23 ! ,OOO! ,03' 
Worry re side effects 291 -0,99 (1,72) 225 -1,86 (1,630 5,80 ! ,OOO! ,06! 
Contrib,to knowledge(self) 291 2,19 (0,94) 227 1,29 ( 1,31) 8,64 , ,OOO! ,12 , 
II II II (others) 294 2,29 (0,96) 227 1,48 ( 1,23) 8,18 , ,OOO! , 11 ! 
Serving as a IGuinea Pigl 294 0,15 (1,71> 227 -1,63 ( 1 ,54) , 12,27 ! ,OOO! ,22! 
Worry re long-term effects 294 -1,10 (1,69 ) 224 -1,97 (1,55 ) 5,99 ! ,OOO! ,06! 
Worry-acquired resistance 294 0,74 (1,56 ) 224 -1,42 ( 1,49) 5,02 ! ,OOO! ,04! 
Worry re Ibeing taken off ! 
good pi lIs I 294 -0,85 (1,62 ) 222 -1,41 (1,55) 3,97 , ,000' ,03! 
TABLE 33 Summary Of T-Tests On All Behavioural Belief Variables ( Strength/Evaluation 
Crossproduct Measures) Between Groups 1 & 2 as Detailed Above 
VARIABLE OUTCOME STRENGTH/EVALUATION CROSSPRODUCTS 
, GP _1 , GPJ , ! , ! 
I n x (5d) I n x (5d) I t I Q ! 14 2 , . , , , 
Getting info, re the study ! 296 5,43 (4,40) , 228 3,30 (5,56) , 4,70 ! ,000' ,04! 
Getting info,re the pills , 294 5,19 (4,38) , 228 3,05 (5,62) ! 4,75 , ,000' ,04! 
Could ask for any info, ! 295 6,55 (3,72) ! 227 4,79 (5,10) , 4,40 , ,OOO! ,03! 
Worry if felt loff colour l , 291 -0,76 (4,75) ! 226 -2,28 (5,45) ! 3,32 ! ,001 , ,02' 
Worry re side effects , 291 -1 ,07 (3,84) , 225 -3,94 (4,91) ! 7,23 ! ,OOO! ,09! 
Contrib, to knowledge(self)! 291 5,04 (3,28) ! 227 2,50 (3,59) , 8,40 ! ,000' ,12 ! 
II II II (others) ! 294 5,62 (3,28) ! 227 3,28 (3,69) ! 7,63 ! ,OOO! ,10 ! 
Serving as alGuinea Pigl , 294 0,67 (4,50) ! 227 -3,97 (4,93) ! 11 , 18 ! ,OOO! ,19 ! 
Worry re long-term effects , 294 -1 ,89 (3,87) ! 224 -4,51 (4,64) ! 6,83 ! ,OOO! ,08! 
Worry-acquired resistance , 294 0,01 (3,27) ! 224 -0,92 (4,24) ! 2,74 ! ,O06! ,01 ! 
Worry re Ibeing taken off ! ! ! I I I 
good pi lis I ! 294 0,39 (4,19) 222 0,23 (4,80) ! 0,39 ! NS ! - I 
25.18 1. 53 ,0000 
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5. DISCRIMINANT FUNCTION ANALYSIS 
The resul ts of mul t iple regression analyses and t-tests suggested that 
participant and 'non-participant' groups could be quite accurately 
predicted and distinguished on the basis of attitude, norms, and 
behavioural bel iefs. Therefore, it was decided to test this by means of 
discriminant function analysis (DFA). 
In respect of screening, the discriminant groups were those created for 
t-test comparisons -ie. strongest positive intenders vs weaker positive 
intenders. Three analyses were performed, the 'Priors = size' command 
being entered for each. 
The first DFA included the variables of attitude, subjective norm, 
personal norm and the crossproduct values of behavioural beliefs. Almost 
50% of the variance was accounted for by this function, in which 
prediction of group membership for both groups was high. 
However, behavioural belief variables contributed little to the overall 
function so a second analysis, including only attitudinal and normative 
variables was performed. Again 50% of the variance was accounted for by 
this function, but whilst accurate prediction of group 1 was slightly 
increased, prediction of group 2 was less effective. 
The third DFA included only behavioural beliefs variables. The results of 
this function were disappointing in terms of both variance accounted for 
and group membership prediction. Wilks lambda was .840 and whilst 83% of 
group 1 were accurately predicted, the success rate for group 2 was 49%. 
Summaries of the first two functions only are therefore given in this 
section (tables 34 & 35). 
Regarding clinical trials, discriminant functions were first performed on 
3 groups - positive intenders, negative intenders, and 'don't know's. 
These functions were totally unsuccessful, so as with t-tests, the 'Don't 
Know's were exc I uded and the pos it i ve and nega t i ve compar i son groups 
employed. 
The same 3 DFAs were performed as for screening and again the 
'Priors=size' command was used. Once more the functions employing 
attitudinal and normative variables proved to be the most successful. 
However, the function including only behavioural belief variables was 
considerably better for clinical trials than screening and is thus 
included in the following summary tables. 
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SCREENING 
TABLE 34 Summary of DFA with IStrong Intention
' 
V 'Less Strong Intention ' as the 
Discriminant Groups; and Attitude, Subjective Norm, Personal Norms, and 
Behavioural Beliefs (crossproducts) as the IVs 
Actual Group Predicted Group 
Groyp 1 Groyp 2 
Group 1(n=316) 91 ,8~ S,2~ 
6rQYP 2(n=225! 21, Sl ZS,2' 
Percent of "grouped" cases correctly 
classified = 86, 14~ 
Wi lks 
Lambda 
,509 
Standardised 
Canonical D,F, 
Correlations 
Personal Norm ,698 
Personal Att, ,376 
Pooled 
Within Group 
Correlations 
,868 
,600 
TABLE 35 Summary of DFA with Discriminant Groups as above; and Attitudes, 
Subjective & Personal Norms as the IVs 
Actual Group Predicted Group 
Groyp 1 GrQYQ 2 
Group 1(n=375) 93, 1~ 6,9~ 
6rQYP 2(n=250) 2S,n 71,6% 
Percent of "grouped" cases correctly 
classified = S4,48~ 
Wi lks Standardised 
Lambda Canonical D,F, 
Cor relat ions 
,495 Personal Norm ,616 
General Attitude,376 
Personal Att, ,266 
Subj ec ti ve Norm ,186 
Pooled 
Within Group 
Correlations 
,836 
,639 
,583 
,476 
NB. Where discriminant variables were few in number (tables 35 & 37), all 
entered variables are presented in the summary tables. For functions in 
which several discriminant variables were entered, only those achieving 
standardised canonical correlations of .300 and above have been reported 
in the summary tables (tables 34, 36 & 38). Full details of results 
showing values for all entered variables are given in appendix 20. 
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CLINICAL TRIALS 
TABLE 36 Summary of DFA with 'Positive Intention' V 'Negative Intention' as the 
Discriminant Groups; and Attitude, Subjective Norm, Personal Norms, and 
Behavioural Beliefs (crossproducts) as the IVs 
Actual Group 
Group ](n=271) 
Groyp 2( n=214) 
Predicted Group 
Group 1 
91,61 
16,81 
Group 2 
8,41 
83.21 
Percent of "grouped" cases correctly 
classified = 76,271 
Wi lks 
Lambda 
Standardised 
Canonical D,F, 
Correlations 
POI,led 
Within Group 
Correlations 
,404 Personal Norm ,625 ,866 
Atti tude ,342 ,730 
TABLE 37 Summary of DFA with discriminant Groups as Above and Attitude, Subjective 
& Personal Norms as the IVs 
Actual Group 
Group ]( n=298) 
Group 2 (n=231) 
Predicted Group 
Group 1 
90,91 
16,51 
Group 2 
9,U 
83,51 
Percent of "grouped" cases correctly 
classified = 87,711 
Wi lks 
Lambda 
,411 
Standardised 
Canonical D,F, 
Correlations 
Personal Norm ,657 
Atti tude ,402 
Subjective Norm,216 
Pooled 
Within Group 
Correlations 
,896 
,733 
,583 
TABLE 38 Summary of DFA with Discriminant Groups as Above and Behavioural Beliefs 
(Crossproduct Measures) as the IVs 
Actual Group Predicted Group 
Group 1 Group 2 
Group 1 (n=276) 82,21 17,81 
erQup 2~D=2]Zl ~] ,~I 6S,ZI 
Percent of "grouped" cases correctly 
classified = 76,271 
Wi lks 
Lambda 
,716 
Standardised 
Canonical D,F, 
Correlations 
XFGPIG 
XFEFFS 
,624 
,387 
XFCONTI'IE ,376 
Pooled 
Within Group 
Correlations 
,774 
,528 
,584 
The outcome beliefs represented by crossproduct variable names were as 
follows: 
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To take part in clinical trials would mean:-
XFGPIG = Serving as a Guinea Pig 
XFCONTME = Contributing to knowledge that might benefit self 
XFSEFFS = Risking health by possible side effects 
6. COMPARISONS OF SAMPLE SUB-SUBGROUPS 
Study aims included the identification of any socio-demographic variables 
associated with behavioural intention or deterrent factors; and a 
comparison of responses from medical and non-medical sampling sources. 
Sociodemographic profiles of respondents expressing the strongest 
intention to participate in screening and those expressing weaker 
intentions are given in tables 38A. Corresponding profiles of intending 
participants and non-participants in clinical trials are shown in table 
39A. 
A series of sub-group investigations were performed using chi square and 
t-tests. However, because mul t iple t-tests wi 11 tend to produce some 
significant differences purely by chance, the acceptable alpha level was 
lowered to .01 or less for these analyses. Therefore, only di fferences 
reaching this level will be reported. 
6.1 SOCIa-DEMOGRAPHIC DIFFERENCES 
Major socio-demographic characteristics investigated were: age, sex, and 
manual vs. non-manual occupations. The latter groupings were explored 
because manual workers suffer a higher incidence of cardiovascular events 
than non-manual workers, so it was considered important to assess whether 
they were less likely to attend screening, and if so, what factors served 
as the major deterrents to their participation. 
In fact, there were no significant differences between these occupational 
groups in terms of their intentions, attitudes or norms, regarding 
screening participation. Neither were there any differences, in these 
respects, between the sexes. However! there was an age difference in 
reported screening intentions, as summarised in table 39 below. 
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Regarding clinical trial participation, although age did not seem to be 
associated with intention, attitudes, norms, or behavioural beliefs, there 
was evidence of some se~ differences. 
Women e~pressed significantly more negative attit.udes and subjective 
norms than men, and there were significant differences in the strength 
with which males and females held certain behavioural beliefs. Also, 
whilst both se~es reported that it was unlikely they would agree to trial 
entry then change their minds and default, women regarded this possibility 
as significantly less unlikely than did men. All these differences are 
summarised in table 40. 
SCREENING 
TABLE 38A Sociodemographic Profile of Strongest (group 1) And Weaker (group 2) 
Intenders to Participate In Screening 
PARTICIPANT SEX AGE GROUP OCCUPATION 
GROUP Male Female 18-44 45-RetireNent Reiirement+ Non-Manual Manual 
1 49% 51% 4n 32% 21% 60% 33% 
2 44% 56% 68% 20% 12% 59% 30% 
TABLE 39 Summary of Crosstabulations Screening Intention (l=Strongest; 2= Weaker Positive) 
By Age 
AGE GROUPS 
!ROW TOT NB, 
SCBEE~I~G I~IE~IIQ~! ]S-44 ! 4S-~eDi, ! eeDi+, Pens. = pensionable age -
!Observed 176 120 ! 79 ! 375 ferules 60 
!Expected 206.9 102,3 65,8 ! (59,8%) males 65 
!Observed 170 51 31 I 252 Pens+ = fe~ales over 60 
2 !Expected 139,1 68,7 44,2 !(40,2%) flales over 65 
COL, TOT 346 J 71 110 ! 627 
X2 = 25,75 df=2 p=,OOO ~=,OOO 
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CLINICAL TRIALS 
TABLE 39A Sociodemographic Profile of Intending Paricipants (group I) And 
Non-Participants (group 2) 
PARTICIPANT SEX AGE GROUP OCCUPATION 
GROUP Male Female 18-44 45-RetireMent Retirement+ Non-Manual Manual 
1 53% 47% 51% 30% 18X 55% 36% 
2 46% 54% 61% 22% 17% 64% 27% 
TABLE 40 Summary of T-Test Differences Bet~een Males(Group 1) and Females(Group 2) 
VARIABLE T-TEST VALUES 
GP _1 GP ....2 
n ~ ~id~ D ~ ~id~ i ~ 1112 
! 
Atti tude !325 0,34 (1,88) 360 -0,58 (1,65) 2,93 ! ,O04! ,01 
Subjective Norm 324 -0,38 (1,94) 360 -0,89 (1,86) 3,50 ! ,001 ! ,02 
Might agree to help test pills 
but change mind & not take them 323 -1,52 (1,81) 363 -1,05 (2,06) -3,09 ,002 ,01 
Dr, ~ould give adequate info,-
re the study 326 1,45 (1,87) 359 1 ,81 (1,54) -2,73 ,006 <,01 
re the pi 11s .325 1.36 (1,85) 359 1,73 (1,57) -2,77 ,006 <,01 
Would ~orry if felt off colour 323 1 ,48 (1,79) 357 1,92 (1.53) -3,42 ,001 ,01 
Would be risking health by -
possible side effects 325 1,16 (1.55) 358 1.63 (1,39) -4,21 .000 ,01 
unforseeen lonq-term effects 325 1,52 (1,44) 359 1 ,93 (1,24) -3,95 ,000 ,02 
There were no differences between the sexes in outcome evaluation measures 
and the only beliefs which showed significant differences on the basis of 
strength-evaluation crossproduct measures, were those of getting 
adequate information 3bout the study (t = 2,85, P =.005), and about the 
pills being tested (t = 2,75, P =.006). In both cases the higher 
crossproduct values came from women. 
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6.2 SAMPLING SOURCES 
Respondents were grouped according to their sampl ing source wi th those 
sampled from the electoral roll comprising group 1, and those from medical 
sampling sources, group 2. 
Chi square tests revealed no significant differences between the groups in 
terms of sex, age groups, or usual employment. 
Regarding screening, t-tests showed statistically significant differences 
in respect of intention, attitude, norms and a few behavioural beliefs. In 
each case, the more positive reponses were given by respondents from the 
medical sampl ing sources. The di fference in screening intent ion was also 
demonstrated by the less powerful chi square test. 
In respect of clinical trials, neither chi square nor t-tests showed a 
significant differences in respect of intention to participate in trials 
of 'new pills'. However, chi square tests did reveal a significant 
difference between the groups regarding established pills, as summarised 
in table 41. 
Signi f icant di fferences shown by t-tests, were those of personal norm, 
percieved likelihood of trial invitation and some behavioural beliefs. It 
was also found that 'medical' respondents were significantly more likely 
than electoral roll respondents to indicate a willingness to participate 
in trials if at high risk of a heart attack or stroke. 
No other differences were observed for any other circumstances under which 
trial entry would be accepted. Resul ts for 'new' and 'other' pi lIs were 
very similar. The results of significant tests relating to sampling source 
groups are summarised in tables 42 to 47. 
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SAMPLING SOURCE T-TESTS 
SCREENING 
TABLE 41 Summary of Crosstabulations Screening Intention (l=Strongest; 2= Weaker Positive) 
By Sampling Source (l=electoral roll; 2= medical sources) 
SAMPLING SOURCE 
!ROW TOT 
SCBEE~I~e I~IENIIQ~! ] 2 
!Observed 1,s0 136 ! 286 
!Expected 171,4 114,6 !(4,s,,sI) 
!Observed 227 116 ! 343 
2 !Expected 20,s,6 137,4 !(,s4 , ,sl ) 
COL, TOT 377 2,s2 ! 629 
X2 = 11,68 df=l p=,OOl X=,069 (with source dependent) 
TABLE 42 Summary of T-Tests on Intention, Attitudes ~ Normative Beliefs Between 
Group 1 (electoral roll respondents) ~ Group 2 (medical source respondents) 
VARIABLE T-TEST VALUES 
GP _1 GP _2 
n x (sd) n x (sd) t ~ (,)2 
Intention to participate 323 1,93 (1,35 ) 371 2,27 (1,22 ) -3,46! ,001' ,02 
General attitude 323 2,49 (0,85) 369 2,68 (0,68) -3,24! ,001' ,01 
Subjective Norm 322 2,03 (1,11) 370 2,25 ( 1,03) -2,67! ,O08!('01 
Personal Norm 323 2,23 (1,06 ) 371 2,44 (0,98) -2,83! ,O05! ,01 
Likel ihood of invitation 322 -0 61 , (2,10) 370 -0 12 , (1,95 ) -3, 18! ,O02! ,01 
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TABLE 43 Summary of T-Tests Showing Significant Differences Between Groups & 2 (Above) 
Regarding Behavioural Belief Strength 
VARIABLE BELIEF STRENGTH 
n x (sd) n x (sd) t 
Be told best precautions !321 2,37 (0,99) !362 2,58 (0,81) -3,08! ,002! ,Ol! 
TABLE 44 Summary of T-Tests Showing Significant Differences Between Groups 
Regarding Outcome Evaluations 
& 2 (Above) 
VARIABLE OUTCOME EVALUATION 1 
GP~ 
n x (sd) n x (sd) t 
aetting peace of mind-Itall clear" !314 2,57 (0,85) !360 2,72 (0,63) -2,61! ,009!<,Ol 
etting lecture from doctor !315 0,90 (1,71) !3.57 1,26 (1,68) -2,74! ,006!<,01 
TABLE 45 Summary of T-Tests Showing Significant Differences Between Groups 1 & 2 (Above) 
Regarding Belief Strength/Evaluation Crossproducts 
VARIABLE STRENGTH/EVALUATION CROSSPRODUCTS 
~old best precautions 
~pured to healthier living 
n x (sd) n t 
!31.5 6,40 (3,10) !353 7,11 (2,85) -3,09!,002! ,01 
!312 3,97 (3,74) !355 4,77 (3,72) -2,77! ,006!<,Ol 
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CLINICAL TRIALS 
TABLE 46 Summary of Crosstabulations Intention To Participate in Clinical Trials 
Of Established Pills (l=positive; 2=negative) By Sampling Source (as above) 
SAMPLING SOURCE 
!ROW TOT 
N! , 
!Observed 136 109 ! 245 
!Expected 148,9 96,1 1(44, 7~) 
!Observed 197 106 ! 303 
2 !Expected 184, 1 118,9 ! (,55, 3J) 
COL, TOT 333 215 ! 548 
X2 = 4,74 df=1 p=,029 A=,OI2 (with source dependent) 
TABLE 47 Summary of T-Tests on Personal Norm and Perceived Likelihood of Trial Invitation 
Between Sampling Source Groups 1 and 2 as Detailed Above 
VARIABLE T-TEST VALUES 
GP _1 GP _2 
1 n x (sd) n x (sd) t I:> (,)2 
Personal Norm 319 -0,29 (2,06) 367 0,11 (2,04) -2,57! ,010! (,01 ! 
Like I ihood of invitation 319 -1 ,96 ( 1,38) 368 -1,30 ( 1 ,8O) -5,49! ,OOO! ,04! 
Corresponding tests regarding 'other pills' were very similar and are given in appendix 21) 
TABLE 48 Summary of T-Tests Between Groups 1 & 2(Above) Re Intention to Participate in 
Clinical Trials If At High Risk Of A Cardiovascular Event 
VARIABLE T-TEST VALUES 
"I'd be willing to hell:> test pills" 
n n t 
If personally at high risk of a 
cardiovascular event - 'New Pills' 321 1,02 (1,89) 367 1,40 (1,63)!-2,78!,006!<,OI! 
'Other Pills' 319 1,52 (1.69) 366 1,88 (1,39)1-3,06' ,002! ,01! 
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TABLE 49 Summary of T-Tests Showing Significant Differences Between Groups & 2(Above) 
Regarding Behavioural Belief Strength 
VARIABLE 
Getting info, re the study 
Getting info, re the pills 
Risk acquired resistance 
Might be taken off good pills 
n 
!318 
!318 
!318 
!316 
BELIEF STRENGTH 
GP _1 GP -2 
x (sd) n x (sd) 
1,40 (1,82) !367 1,84 (1,59) 
1 ,34 (1,85) !366 1 ,74 (1,58) 
0,72 (1,68) !366 0,32 (1,66) 
0,46 (1,99) !358 -0,12 (2,01) 
t P ,2 
-3,36! ,001 ! ,01 ! 
-3,09! ,002! (,01 ! 
-3, 13! ,002 ! ,01 ! 
3,83! ,OOO! ,01 ! 
TABLE SO Summary of T-Tests Showing Significant Differences Between Groups 1 & 2 (Above) 
Regarding Strength/Evaluation Crossproducts 
VARIABLE STRENGTH/EVALUATION CROSSPRODUCTS 
n x (sd) n t 
Getting info, re the study ! 313 3,96 (5,20) ! 365 5, 13 (4,68) -3,07 ! ,002 ! ,01 ! 
There were no other significant differences «.01) between the groups in 
terms of belief strengths, outcome evaluations, or crossproduct measures. 
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7. QUALITATIVE RESULTS - SUMMARY OF ADDED COMMENTS 
Approximately 20% of respondents made additional comments on their 
questionnaires. All of these comments related to clinical trials. 
The issue that generated the most comments (36) was that of possible drug 
side effects. A typical comment of this type was: "It would all depend 
upon what the possible side effects might be". Three more people asserted 
that "Bad press has put me off pi 11 test ing" and another respondent 
stated that "New pi lIs taken by my spouse ended in 12 months of sheer 
misery and life-long medication." 
Possibly allied to worries about side effects, were comments which 
indicated a general dislike of drugs. 33 people made comments of this 
sort, for example: "I don't like taking pills at all, for anything, if 
they can possibly be avoided." One respondent also said "we don't believe 
in chemical poisons, we rely on healthy living and herbal remedies." 
A third type of comment related to personal awareness of the need for 
trials, but reluctance to become trial entrants. Such comments were 
typified by the respondent who stated "I'm basically selfish - I know 
these things have to be tested, but preferably not on me." In all, 24 
people asserted such feelings. Two women stated that they would not put 
themselves at risk by trial entry until their children were grown up, and 
one 76 year old fel t that the over 75s should be exempt from pi 11 
test ing. 
However, 9 respondents commented that it was better to test pills on 
humans than animals, though one fel t that "all new pi lIs should be tested 
out on sex attackers and viscious murderers." 
Other comments related to the circumstances under which trial entry might 
be considered. Six people made remarks to indicate that it was very 
di ff icul t to gi ve answers to such a hypothet ical quest ion, and some 
suggested that it would boil down to the force of argument and 
personality of the person asking for co-operation. Fifteen people also 
commented that they would be more likely to agree to help test pills if 
they felt sure that their doctor would give them all the information 
(s)he had. 
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Only two people made direct comments on the extent of the faith they had 
in their GPs. One said "my doctor is a responsible person and wouldn't 
ask me to test pills unless he thought they were pretty safe," The other 
said "I don't have a lot of faith in doctors and what they tell you, or 
what they know. Look at the problems with Debendox." 
In all 15 people made comments to the effect that their own health status 
would influence their decisions re trial entry. Eight stated that they 
would do anything to help their current problems (most ly arthri tis), or 
to improve their quality of life. A further 7 supported the views of the 
respondent who said "If I was really ill I'd probably have a more co-
operative attitude and do anything I thought might help." Another 
respondent said "If I was seriously ill, I'd have nothing to lose - even 
if the pills wouldn't help me I'd help test for side effects." 
Interest ingly, one person commented that it is inval id to test pi lIs on 
healthy people as they may well react differently to people in whom the 
pill would be used - ie the unhealthy. 
Four people asserted that the thought of being able to help someone who 
was very ill would be a great incentive to help in pill testing -
especially if that person was a member of their own family. 
Finally, a few comments were made concerning financial remuneration and 
compensation in the case of trial-related sequalae. Eleven people 
suggested that they might consider trial entry if they were paid a lot of 
money for their services, though as many again were concerned about the 
need for adequate legal cover and current lack of organisation for 
compensation if things go wrong. 
-166-
8. SUMMARY OF RESULTS 
The results of this study showed a very similar pattern to those of the 
previous study in respect of attitudes and participatory intentions 
towards screening and clinical trials for cardiovascular risk reduction. 
For both screening and clinical trials, attitudes and subjective norm 
were found to be qui te strongly assoc iated wi th behavioural intent ion. 
However, in each case, the predictive association was strengthened by the 
inclusion of personal normative beliefs. 
T-tests showed that respondents indicating the strongest positive 
intention to participate in screening, differed from those expresssing 
either of the two weaker positive intentions to participate, on almost 
all behavioural bel ief var iables. Furthermore, the two groups were very 
well differentiated by discriminant function analysis which accounted for 
approximately half the variance. 
In respect of clinical trials, t-tests again showed significant 
differences on almost all behavioural belief variables, between 
respondents who had indicated some degree of positive intention and those 
who had indicated some degree of negative intention to participate. 
Discriminant function analyses between the two groups yielded very good 
resul ts. 
There was no significant difference in response rates, or socio-
demographic characteristics, between medical and non-medical sampling 
sources. However, other important differences were found. 'Medical' 
respondents expressed more positive intention, attitude, subjective and 
personal norms in respect of participation in screening. They also 
indicated a more positive personal norm in respect of clinical trial 
participation. 
Other sub-group investigations revealed a difference in screening 
intentions between different age groups and a few other differences for 
clinical trials between the sexes. 
Qualitative results were comprised of the additional comments people had 
appended to their questionnaires. They pertained only to clinical trial 
participation, and basically served to substantiate quantitative 
findings. 
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CHAPTER 4-
DISCUSSION 
The main objectives of the second study were to assess the reliability of 
the previous study findings; and to gain deeper understanding of the 
influential role of factors associated with participation in screening 
and clinical trials. It was also intended to explore the utility of the 
Behavioural Intention Model (BIM) for a postal survey of a general public 
sample; and to investigate sampling source influences. 
To recap, the specific aims of the study were: 
(1) To assess the reliability of preliminary study findings 
(2) To assess the power of factors influencing participation in screening 
and clinical trials for cardiovascular risk reduction 
(3) To identify any socio-demographic variables associated with attitudes 
beliefs or participatory intentions 
(4) To assess the value of the BIM for the prediction and understanding 
of screening and clinical-trial participation intentions; and its 
utility for a postal survey of a general public sample 
(5) To compare response rates, and responses, from medical and non-
medical sampling sources when survey participation and questionnaire 
completion is anonymous. 
In the following discussion of results and their implications, the first 
study aim will be given first consideration. 
Secondly, attention will be paid to the immediate determinants of 
behavioural intention, as prescribed by the Behavioural Intention Model. 
Because of a great level of similarity, measures pertaining to both 
screening and clinical trials will be discussed here, as will a common 
problem with normative belief measures. 
In subsequent discussion of study resul ts, independent focus wi 11 be 
given to specific factors identified as influencing participation in 
screening, and clinical trials. This will include consideration of socio-
demographic differences. 
The penultimate section of the discussion will concentate on sampling 
source differences, and finally some contemplation of the BIM itself will 
be undertaken. 
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1. RELIABILITY OF PRELIMINARY STUDY FINDINGS 
1. 1 OVERV lEW 
Perhaps the first point to note, was the similarity of unprompted beliefs 
elicited from interview informants of the second study, to those 
deliberately raised for discussion with preliminary study informants. 
This suggests that relevant questions were asked on the first instrument, 
and that most salient beliefs were tapped. 
The main findings of the preliminary exploratory study were: a widespread 
favourability towards the general concept of, and participation in, 
screening for cardiovascular risk; but more diverse feelings about 
clinical trials. Also, whilst lack of opportunity seemed to represent the 
major barrier to screening participation, several factors associated with 
participation in clinical trials were identified as potential deterrents. 
These resul ts were broadly repl icated in the follow-up study, in terms of 
both direction and degree. 
Al though the response rate to the second study was substant ially lower 
than that achieved for the first study, the sample was still 
considerably larger <695 compared to 442); and more representative of the 
general population in terms of age distributions. The over-representation 
of elderly which obtained in the preliminary study, was countered in the 
follow-up investigation. Thus it would seem that the preliminary findings 
were not distorted by the age characteristics of its respondents, but 
fairly representative of the views of people prepared to contribute to 
this type of survey. 
1.2 FINDINGS RELATING TO PARTICIPATION IN SCREENING 
In the preliminary study, more than 90% of respondents indicated positive 
attitudes towards: the general concept of screening for cardiovascular 
risk; personal participation in such screening; and frank diagnostic 
information regarding risk status. These proportions were echoed in the 
second study where corresponding items also elicited positive responses 
from over 90% of the sample. In these respects, the findings of both 
studies accorded with previous finding <ego by O'Brien and Hodes, 1979; 
Cartwright and Anderson, 1981; Ley, 1982). 
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It was also apparent from the first study, that being at cardiovascular 
risk would motivate most people <88%) to follow advice about lifestyle 
changes. Again these findings were supported by those of the follow-up 
study where 82% of respondents indicated that a screening check would act 
as a spur to change to healthier habits. 
In fact, the evidence shows that the degree of favourability expressed 
towards screening is rarely matched by take-up of screening services 
offered <ego 0' Brien and Hodes 1978; King 1982). Nevertheless, it was 
reassuring to observe such similarity in reported intentions and 
attitudes between the two studies. 
Preliminary study findings showed no evidence of any factors which might 
represent widespread deterrents to participation in screening, neither 
did the second study. Rather, results again suggested that survey 
respondents, at least, would be keen to participate if given the chance. 
1.3 FINDINGS RELATING TO PARTICIPATION IN CLINICAL TRIALS 
As wi th screening, the resul ts of the second study also offered broad 
support for those of the first, concerning intentions and attitudes 
towards participation in clinical trials for cardiovascular risk-
r'educ t ion. However, there were some d iff erences be tween the two stud i es 
which made direct comparisons between them a little difficult. 
Firstly, in the preliminary study, respondents were asked to indicate 
their general attitude towards GP involvement in clinical trials; and 
their personal intentions to participate if 'at risk' of a cardiovascular 
event. In the second study, the attitude measured was that towards 
personal participation in trials; whilst for participatory intentions, 
two 'risk' options <high risk and any extra risk) were explored. 
Not surprisingly, the general attitude item of the first study elicited 
more positive responses than those obtained for the corresponding second 
study item of at t i tude to personal part ic ipat ion (50% compared to 37% 
'new pills' and 41% 'other pills'). 
Because no degree of risk had been stipulated in the preliminary study, 
it was dec ided that the most comparable measures of intent ion in the 
second study would be those pertaining to intention if at any extra risk 
of a heart attack or stroke. Although this option corresponded most 
closely to that of the first study, it also yielded the greatest 
difference in intentions regarding 'new' and 'other' pills. Nevertheless, 
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the proportion of respondents indicating a positive intention, was 
simi lar for both studies (60% in the first; 58% and 70% for 'new' and 
'other' pills respectively, in the second). 
The similarity of study findings was even greater in respect of reported 
attitudes to clinical trial participation if already on other medication. 
Approximately half the respondents in each study indicated objections to 
trial participation, if already on other medication (48.5% in the first 
study; 49.5% 'new' and 45.4% 'other' in the second). 
Another area of difference between the two studies related to the 
specification of 'pill type'. Whereas there had been no distinction 
between 'new' and 'other' (established) pills in the first study, this 
differentiation did apply in the follow-up investigation. Therefore, 
analysis of variables pertaining to clinical trial participation, 
necessitated separate tests for 'new' and 'other' pills. 
Most of the analyses performed for the two pi 11 types were remarkably 
similar, although BIM values relating to 'new' pills were generally 
marginally higher than those for 'other pi lIs' . However, these 
differences were so slight that, in most cases, only tests pertaining to 
'new' pills were presented in the main text. Except where notable 
differences applied, it was decided to let 'new' pills represent both 
types, because unless specified as otherwise, people typically equate 
'pill-testing' with new drugs. Since no specification of drug type had 
been made in the preliminary study, it was considered prudent to adopt 
this approach if comparisons were to be made between the two study 
findings. 
Therefore, in 
in the main, 
However, where 
be discussed. 
the following discussion of resul ts, data discussed wi 11, 
be those pertaining to clinical trials of 'new' pills. 
differences did apply, all results were presented and will 
In spite of the problems posed by study differences, it was possible to 
make some assessment of the reliability of other preliminary findings. In 
particular, support was found for the initial identification of potential 
deterrent factors - ego worries about side-effects, acquired resistance 
and possible discontinuation of current effective medication. In the 
original study, worries about possible side effects of drugs represented 
the major potential deterrent to clinical trial participation. This 
finding was replicated in the subsequent investigation. 
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71% of initial study respondents expressed worries about possible side 
effects of drugs, whilst 73% of subsequent respondents indicated a belief 
that participation in clinical trials would entail a risk to health by 
possible side-effects (70% evaluated such risk negatively). 
Regarding acquired resistance, 64% of preliminary respondents felt that 
pills taken prophylactically, might not work when really needed. This 
belief was expressed by 49% of second study respondents, and evaluated 
negatively by 58%. 
Another potential deterrent to trial entry identified in the first study, 
was that of worries about being taken off 'good' pills already being 
taken. Although less than half the initial study respondents (46%) stated 
that this would be a worry, a further 20% expressed uncertainty regarding 
the issue. In the follow-up study 40% of respondents indicated a positive 
belief that discontinuation of current medication might be an outcome of 
trial entry, and 26% expressed uncertainty. This outcome was evaluated 
negatively by 57% of respondents. 
In both studies, most respondents (84.2% & 85.4% respectively) indicated 
that they felt able to ask their doctors for any information they wanted. 
2. DETERMINANTS OF INTENTION AND THEIR RELATIVE IMPORTANCE 
In addition to testing the reliability of the findings from the first 
study, the second study was intended to provide deeper understanding of 
the relationship between influencing factors and behavioural intention. 
Since this understanding was sought within the framework of the 
Behavioural Intention Model (BIM), a series of investigative analyses 
were performed. In the first instance measures of association were 
obtained for behavioural intention and its immediate determinants - ie 
attitudes and subjective norms. In line with Budd's (1984) suggested 
amendment of the BIM, the role of personal normative belief in intention 
was also investigated. Subsequent analyses were undertaken: (a) to 
provide measures of association between attitudes and norms and their 
antecedents; and (b) to explore the relative power of individual beliefs 
in the evolution of intention. The same analyses were performed for both 
screening and clinical trial participatory intention. 
Before continuing with independent discussion 
screening and clinical trial participation, 
should be noted and considered together. The 
of factors associated with 
two points of simi lar i ty 
first applied to both the 
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pattern of relationships between model components and the weightings 
assigned to the immediate determinants of intention. The second was a 
substantial level of missing data for normative belief measures which 
essentially precluded meaningful interpretation of these elements. 
2.1 INTENTIONS, ATTITUDES AND NORMS 
Firstly, there was a striking similarity of the two activities 
investigated, regarding the strength and patterns of association between 
model components. Multiple regression analyses (MRA) showed that in each 
case, the strongest relationships were between intention, attitudes and 
norms. Predicitive associations between behavioural beliefs and 
attitudes, and between normative beliefs and subjective norms, were 
weaker, but still of a reasonably high level. More detailed consideration 
of the behavioural belief/attitude relationship will be undertaken later 
(section 3 below), in the separate discussions of factors influencing 
participation in screening and clinical trials. 
Within the orthodox BIM, attitudes and subjective norms together 
accounted for 47% of the variance in screening intention (R=. 687); and 
54% of the variance in intention to participate in clinical trials 
(R=.732). In both cases, weightings and R2 changes showed that attitudes 
contributed substantially more than subjective norms to the prediction of 
intention. 
When measures of personal normative beliefs were added to those of 
attitude and subjective norm, the prediction of intention was 
considerably enhanced. In these functions, 57% (R=.753) of the variance 
in intention to participate in screening was accounted for, as was 64% 
(R=.800) of the variance in intention to participate in clinical trials. 
Equation values showed that personal norm contributed most to the 
prediction of intention, whilst the importance of subjective norm was 
greatly diminished. 
The high contribution of personal norm and the low value of subjective 
norm as discriminants of behavioural intention, was further demonstrated 
by the results of discriminant function analyses (DFAs). 
, 
)'1 
, 
!' ,.' 
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This similarity of influencing factors may have been a function of the 
fact that the same people provided the responses for both topics, and 
that these informants were peculiarly uninfluenced by subjective norms. 
~AlternativelY, it seems equally likely that subjective norm really does 
,playa minor role in determining behavioural intentions of this type;- or 
r that it adds nothing to the model if personal norms are included. 
In the introduction to this chapter, various recent amendments to the BIM 
were considered. Amongst these, arguments were offered for the inclusion 
of personal norm at the expense of subjective norm. 
Fishbein and Ajzen dropped the personal normative belief item from their 
original model because it seemed to represent a reiteration of intention. 
~ However, Ajzen (1985) later proposed its reinstatement on the grounds that personal norms were probably determined by normative beliefs, and thus represent adequate measures of subjective norm on their own. 
Other work (eg. by Budd et aI, 1984i 1985) has also offered convincing 
evidence for the importance of personal norm (as independent of 
intention), whilst casting doubt on the value of subjective norm. Indeed, 
Budd and his colleagues proposed that nothing would be lost from the 
model if personal norm was included and subjective norm omitted. 
Certainly, the results of this study would appear to offer support for 
this proposition, although the disparate weightings of personal and 
subjective norms do not support Ajzen's suggestion that they are repeated 
measures of the same thing. 
Rather, it would appear that subjective and personal norms are distinct 
ent i ties, and, as Budd suggested, that personal norms are more sal ient to 
behavioural decisions than subjective norm. These two norms may well be 
influenced by common factors - ie. normative beliefs - but when formed 
they represent different concepts. Once people have established their 
personal norm, this would seem to take precedence over subjective norm 
as a determinant of behavioural intention. 
It is possible that this apparent distinction between subjective and 
personal norms is an artificial one, which reflects little more than a 
reluctance to admit (even to oneself) that one's actions are influenced 
by others. Alternatively, it may be that it is a real distinction, 
whereby normative beliefs are a partial determinant of personal norm, but 
not the sole influence. 
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If this is so, it might be expected that congruence of the two norms will 
vary according to the nature of the intended behaviour, and the extent to 
which the opinions of 'important others' coincide with those of the 
individual. Just as some behaviours may be expected to be influenced 
more strongly by attitudes than subjective norms <and vice versa); so 
some behaviours must be expected to be under a considerably greater 
influence of personal than subjective norms. This may be especially so 
when the behaviour has very personal consequences, as in screening or 
clinical trial participation; and/or when there is a clash of opinion 
between the individual and his or her important others. 
When no such clash exists, measures of one norm may adequately represent 
measures of the other. However, when there is a difference between the 
two norms, a single measure may not suffice. Thus, although the evidence 
i nd i ca tes the super i or it Y of persona 1 norm over subj ec t i ve norm as an 
influence on behavioural intention; it does not necessarily justify the 
exclusion of the latter from the BIM. After all, for some people, or 
under some circumstances, the need to comply with subjective norm may be 
greater than the influence of personal normative beliefs. 
Of course, it may be that for such people, personal norm will closely 
reflect subjective norm, but this may not necessarily be the case. It is 
quite possible for people to hold personal norms which differ from their 
subjective norms, yet be in situations which demand compliance with their 
perceptions of the feelings of their important others. 
This is perhaps particularly so when the action may have direct 
consequences for those others, or when the individual is dependent upon 
them. In such situations, subjective norms might be expected to exert a 
stronger influence on behavioural decisions than personal normative 
bel iefs. Thus, if measures of subjective norm were dropped from the 
model, we might be left with a strange situation in which personal norm, 
and probably behavioural beliefs, indicated a behavioural intention, 
contrary to that actually expressed. By including measures of both norms, 
and a measure of motivation to comply with the conglomerate' important 
others', a better understanding of intention might be achieved. 
As a final point about personal norm, it should be noted that these study 
results also support Budd's earlier assertion that it is not merely a 
rei terat ion of intent ion. Al though in the study reported here, personal 
norm was by far the strongest influence on intention, it was not 
synonymous with it. Thus it would seem that personal norm should be 
included in the BIM, but as an addition to intention and subjective norm, 
not as a substitute for either. 
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2.2 NORMATIVE BELIEFS 
The second point of similarity between measures pertaining to screening 
and clinical trial participation, was that of a substantial level of 
missing data for normative belief items. Several respondents declined to 
answer these items at all, and considerable use was made of the 'not 
applicable' option. This problem applied to both screening and clinical 
trial measurements. 
It is inevitable that in a heterogenous sample of the type obtained, some 
referents in the modal set wi 11 be inappl icable to some respondent. Not 
all will have a spouse/partner, living parents, or children. Similarly, 
the children of some respondents will be too young to apply as referents. 
Therefore, the 'not applicable' option was offered in an attempt to 
differentiate missing values due to oversight or deliberate answer-
refusal, from missing values due to the referent being inapplicable to 
the respondent. However, it was evident that the option had not always 
been used as intended. For example, some respondents indicated an opinion 
for a given referent, but marked the 'not applicable' option for 
motivation to comply with that referent. Also, a few respondents 
commented that they dec ided their own act ions and that the opinions of 
others were irrelevant to their decisions. 
In the light of these findings, it is not surprising that personal norm 
contributed so highly to behavioural intention, and subjective norm so 
little. Certainly, they add to the doubt about the value of estimating 
motivation to comply with referents, expressed by Young and Kent (1985). 
Regretably, this high level of missing data precluded any meaningful 
interpretation of the relationships between normative beliefs and 
subjective norms. It also effectively prevented any real comparisions of 
normative and behavioural beliefs; either in relation to participatory 
intention, or their immediate successors in the model. 
However, as subjective norm played such a small part in determining 
behavioural intention for both screening and clinical trials, this lack 
of data did not pose such a major problem for prediction and 
understanding as it might have done, had subjective norm been a more 
influential factor. 
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3. FACTORS INFLUENCING SCREENING 
It has already been said that personal norms and attitudes were the most 
important factors influencing intention to participate in screening for 
cardiovascular risk. This was shown not only by MRA results, but also by 
the resul ts of DFAs performed to assess how well behavioural bel iefs, 
at tit udes and norms, different i a ted respondents express ing the strongest 
intention to participate, from those expressing weaker intentions. 
It was necessary to investigate these two groups rather than intending 
participants and non-participants,because of the very skewed distribution 
of intention measures. Approximately 90% of respondents indicated some 
degree of positive intention to participate in screening for 
cardiovascular risk, against just 6% who indicated some degree of 
negative intention. 
On reflection, it was not really surprising that such high levels of 
part ic ipatory intent ion were gi ven. After all, screening of this kind 
does not require a visit to hospital or specialist clinic, and entails 
little personal discomfort or embarassment. Although it does carry with 
it the possibility of risk identification, it was evident from other 
responses that informants evaluated such identification positively and 
associated it with the prescription of preventive measures. Thus from a 
hypothetical standpoint, such screening offers 'something for nothing' 
and is likely to attract widespread approval. 
Nevertheless, only half the respondents indicated the strongest degree of 
intention to participate, so it was considered possible that there might 
be some differences between these respondents and others who had 
indicated weaker positive intentions. Therefore, as described in the 
resul ts sect ion, such di fferences were invest igated and found to obtain. 
Consequently, respondents expressing either of the two weaker categories 
of intention, were classified as 'non-participants' for the purposes of 
subsequent investigation of the power of influencing factors. 
From DFAs it was found that the two groups could be well differentiated 
on the basis of attitudes and norms. 93% of respondents indicating the 
strongest participatory intention were accurately predicted to fall into 
this category and 72% of weaker intenders were accurately predicted to 
I fall into the second group. As before, personal norm was found to be the 
I most important variable in the prediction of intention, and subjective 
norm the least important. 
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Similar levels of accurate predictions were achieved by DFAs employing 
behavioural bel iefs as well as measures of at t i tudes and norms, but 
personal norm and attitude were the only variables which yielded 
standardised canonical correlation values greater than .300. No 
behavioural beliefs appeared to be of any substantial value to group 
differentiation. Rather, when behavioural belief items were used as the 
only discriminant variables, a majority of 'non-participants' were 
misclassified as potential participants. 
Indeed, al though att i tudes clearly played an important part in 
determining screening intention, attempts to identify the most important 
behavioural beliefs underlying attitudes were not very successful-
yielding differences in degree, rather than direction. Of course, the two 
groups also differed only in terms of degree, and not direction, so this 
was, perhaps, to be expected. 
MRA showed that just 18% of the variance in attitudes was accounted for 
by behavioural bel iefs, and only 3 of the 13 bel ief items entered were 
included in the final equation. These were beliefs that screening 
participation would: (1) help the individual to stay fit and healthy for 
longer; (2) give a definite indication of risk status; (3) give peace of 
mind if no increased risk were detected. 
Because personal norm was so highly associated with intention, it was 
decided to explore the association of behavioural beliefs with personal 
norm, in an attempt to identify bel iefs influencing this component. In 
fact, the results of this MRA were almost identical to that obtained for 
the prediction of attitude. 19% of the variance in personal norm was 
accounted for by the same 3 behavioural beliefs of significance in the 
prediction of attitude, and a further 0.7%, by the inclusion of the 
additional belief that participation would act as a spur to healthier 
1 i v ing. 
The direct influence of individual beliefs on intention was also 
invest igated by independent examinat ion of di fferences in bel ief 
strength, outcome evaluations, and crossproduct measures, between 
intending 'participants' and 'non-participants'. 
Analysis of belief strength measures showed that the 'participants' group 
(those expressing the strongest participatory intention) I also held the 
strongest beliefs that each outcome would be associated with 
participation. The difference in belief strength between the two groups 
was statistically significant for all items except those pertaining to 
advice about changes to drinking, smoking and dietary habits. 
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Further, the two groups differed significantly in their evaluations of 
each outcome, with 'participants' showing consistently more positive 
evaluations than 'non-participants'. 
Belief strength-evaluation crossproduct measures, showed significant 
differences between the two groups for every item except that pertaining 
to the reduction of drinking; and the overall difference was significant 
beyond the .000 level. 
However, because of the large sample size, and the fact that multiple t-
tests were performed, statistical significance alone, could not be taken 
as evidence of the discriminating power of individual behavioural 
beliefs. Although the difference in sum of beliefs between the two groups 
was highly significant, the predicitve association was not very great. The 
omega square value was only. 10 indicating that just 10% of the variance 
in intention could be accounted for by belief differences. 
Most individual omega square values were very low, the greatest 
accounting for 9% of the variance. This came from the item of most 
importance in the behavioural beliefs MRA - namely the belief that 
screening participation would help the individual to stay fit and healthy 
for longer. The two bel lefs which el ic i ted the highest mean scores for 
outcome evaluations in both groups, were those of peace of mind by an 
'all clear' verdict; and being told the best preventive measures to take. 
Both of these items fit snugly with that of keeping fit and healthy for 
longer, and suggest the belief that screening will help maintain good 
health, would be a strong inducement to participation. 
These results also concur with the findings of O'Brien and Hodes (1979) 
who found that people cited: 'it gives peace of mind' and 'prevention is 
better than cure' as reasons why they regarded screening as a good thing. 
It was interesting to note that the salient beliefs associated with 
screening tended to be positive ones. Items that may have been construed 
as negative outcomes, ego advice re lifestyle changes and getting a 
lecture from the doctor, elicited substantially more positive than 
negative evaluations. 
In fact, wi th hinds ight, and a re-examinat ion of the bel iefs el ic i tat ion 
sheet (appendix 13), it would seem th6t another negative outcome should 
have been included on the questionnaire. This was a multi-faceted 
'dislike of surgery attendance' item which was indicated by a variety of 
beliefs such as it being difficult or inconvenient to get to the surgery; 
a dislike of going to the doctor at all if avoidable; concern about lack 
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of privacy at the surgerYi a trust only in one's own GP and not liking 
the prospect of being seen by other group partners. Individually, these 
beliefs were elicited from very few respondents, but together, as a 
'meta-item' the constituent aspects were mentioned by sufficient 
respondents to have merited inclusion on the questionnaire. Perhaps, if 
it had been included, differentiation between strongest and weaker 
intending participants would have been even stronger. 
Nevertheless, the general endorsement of these belief items, indicated 
that there was little difference between preliminary interview informants 
and subsequent survey respondents, in terms of f ac tors assoc i a ted wi th 
screening for cardiovascular risk. This may suggest that there really is 
widespread consensus concerning the benef i ts of such screening. On the 
other hand, it may suggest that only those who regard such screening 
favourably, are prepared to give their time to answering questions about 
it. In the light of the low response rate to both initial interview 
requests, and the main survey, this latter suggestion must be taken 
seriously, 
As French (1982) found in her study of breast-screening attendance, 
participants tend to view screening clinics in a positive light, whilst 
non-participants tend to view them as places of risk. The high levels of 
intended participation and positive associations expressed in the survey 
reported here, would seem to confirm her findings in respect of potential 
part i c i pan ts, though they gave negl ig i bl e information about poten t ia I 
non-participants. 
However, it seems reasonable to suspect that such people may associate 
less favourable outcomes with screening participation, or would evaluate 
identified outcomes negatively. Unfortunately, they may also be those 
least likely to give interviews, or to complete a questionnaire, about 
the activity. Thus, there remains a problem of identifying associated 
negative outcomes in the first place, and assessing their generality 
amongst potential non-participants in the second. Maybe, unidentified 
concerns, or an aversion to outcomes such as 'lifestyle change' advice 
are important factors underlying the mismatch between reported attitudes 
towards screening and actual screening attendance. However, until they 
are properly identified they cannot be adequately addressed. 
One factor that consistently arises is any consideration of cardio-
vascular risk, or screening generally, is that of social class. Apart 
from the study by O'Brien and Hodes (1979) which found no social class 
differences between attenders and non-attenders; it has commonly been 
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found that the higher socio-economic groups are the most likely to attend 
screenings <ego Kirscht, 1983). The overwhelmingly positive intentions to 
participate in screening found in the reported study, came from a sample 
which was heavily biased towards the higher socio-economic groups. 
In fact, sub-group analysis yielded no real differences between' middle' 
and 'working class' respondents in terms of screening intention or 
associated beliefs. However, this finding does not negate the supposition 
of a social class difference in beliefs, attitudes and intentions towards 
screening participation. Although the salient beliefs used on the 
questionnaire were elicited from equal numbers of 'middle' and 'working' 
class informants, the latter were considerably more difficult to recruit. 
Thus the similarity of beliefs and intentions expressed by respondents of 
all classes, may have been an artifact of biased samples in which the 
manual workers who repl ied, both to interview requests and the main 
survey, were not very typical of their class as a whole. 
It is a well documented fact <ego Townsend and Davidson, 1982; Whitehead, 
1988; opes General Household Survey, 1984) that the lower socio-economic 
groups tend to engage in lifestyle habits which exacerbate their 
susceptabi I i ty to cardiovascular events. Perhaps, as already suggested, 
an aversion to being' lectured' about these things, keeps those liable to 
such advice away from screenings. Alternatively, it may be that such 
people suspect that evidence of disease will be found, and thus, as 
French found, view screening attandance as a risk in itself. 
Maybe, the reluctance to attend screening or complete questionnaires 
about it, is due to ignorance or misconceptions of what is involved, or a 
fatal ist ic approach to heal th and illness. The possibi 1 it ies are clearly 
plent i ful. All that can be said at present, is that soc ial c lass does 
seem to be a strong correlate of screening participation, though the 
underlying reasons why, remain mysterious to preventive health promotors. 
Thus there is clearly a need for concerted efforts to obtain information 
from reluctant participants if there is to be any hope of devising 
appropr i a te educa t i onal and promot i onal campa igns to encourage them to 
engage in preventive health behaviours. 
As a final point in the consideration of factors influencing 
participation in screening, it should be noted that respondents under 45 
were significantly less likely than expected, to have indicated the 
strongest participatory intention. The reasons for this remain open to 
speculation. However, heart attacks and strokes are most readily 
associated with middle-aged men, and cardiovascular researchers and 
screening services have typically concentrated their efforts on this 
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group. It is therefore possible that younger people have got the 
message that such screening is not really for them. 
If this is so, it is a problem that needs resolution since increased 
vulnerability to cardiovascular disease begins quite early in life, 
particularly for those with a family history of the disease. For these 
people early detection of susceptability, and the implementation of 
habi ts to avoid non-heredi table risk factors, might substant i a 11 y 
diminish their chances of premature death or disability due to a 
cardiovascular event. Given this, and the apparent weakness of younger 
people's intention to participate in screening for cardiovascular risk, 
the need to encourage their participation is obvious. 
4. FACTORS INFLUENCING CLINICAL TRIALS PARTICIPATION 
The potentency of personal norm, and the weakness of subjective norm as 
influences on intention to participate in clinical trials, has already 
been discussed. In addition to the evidence provided by MRA, DFAs also 
showed that potential trial entrants and non-entrants could be very well 
differentiated on the basis of attitudes and norms alone. 91% of 
intending trial participants and 83.5% of non-participants were 
accurately predicted from knowledge of these variables. When behavioural 
beliefs were added to the primary determinants of intention as 
discriminating variables, the levels of accurate prediction remained the 
same, though as wi th screening, only personal norm and at t i tude were of 
more than very moderate importance to the function. 
However, unl ike screening, when only behavioural bel iefs were used as 
discriminating variables, it was still possible to differentiate 
intending participants and non-participants quite well. In this function 
82% of participants and 69% of non-participants were accurately predicted 
from knowledge of their behavioural bel iefs. The most important bel iefs 
to the function were those of: 0) serving as a 'guinea pig'; (2) risking 
health by possible side-effects; (3) contributing to knowledge that might 
benefit self. 
These variables also featured in the MRA equations in which behavioural 
beliefs were used to predict attitudes and personal norms. Other items 
entering the final MRA equation were: contributing to knowledge that 
might benefit others; getting adequate information about the pills being 
tested; and risking acquired resistance. Overall, 30% of the variance in 
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attitude and 27% of the variance in personal norm was accounted for by 
behavioural beliefs. 
Interestingly, although the levels of attitude prediction were the same 
for both 'new' and 'other' pills; and although the same 6 variables were 
entered into the equations, there was a slight difference in the order of 
importance of the items for the two types of trials. The most notable 
di fference was the diminished importance of 'contribut ing to knowledge 
which might benefit self', as a differentiator of attitude to trials of 
'other pi lIs'; compared to its role in the predict ion of at t i tudes to 
'new pill' trials. The same diminution in importance of this variable 
also occured in predictions of personal norm regarding participation in 
trials of 'new' and 'other' pills. 
Beliefs about contributing to knowledge that might benefit oneself, were 
a major differentiator of both attitudes and personal norms regarding 
participation in clinical trials of 'new' pills. Contributing to 
knowldege that might benefit others, played a corresponding part in 
trials of 'other' pills. T-tests showed that for both pill types, 
potential trial entrants regarded these outcomes as significantly more 
likely, and significantly more of a good thing, than did potential non-
entrants. On the basis of cross-product measures, the 'contribution' 
outcomes yielded omega square values of .12 for self, and. 10 for others. 
These were second only to the .19 value obtained for the 'guinea pig' 
bel ief. 
In the presentation of qualitative results when additional comments were 
summarised, it was noted that a few people had stated that being able to 
help others would be an incentive to trial entry, especially if the 
person aided was a member of the family. 
Overall, these results suggested that participation in clinical trials of 
new pills entails a considerable cost-benefit analysis on a personal 
level, whilst participation in trials of established drugs is perhaps 
perceived as less risky, and a venture to be undertaken in a more 
altruistic light. 
Apart from the finding mentioned above, t-tests to establish belief 
differences between intending participants and non-participants were 
quite informative. In terms of total belief strength-evaluation 
crossproduct measures, the two groups were differentiated very well. The 
only bel ief item for which there was no signi f icant di fference between 
groups, was that of the possibility of discontinuation of current 
effective medication. 
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However, problems associated with interpretations of statistical 
significance in large samples and multiple t-tests, were outlined earlier 
when it was stated that significance alone could not be taken as evidence 
of material importance. Thus, close inspection of group means and omega 
square values gave the best indications of items associated with 
participatory intention. 
From this approach it was evident that the major deterrents to trial 
entry were beliefs that participation would incur a risk to health by 
possible side-effects and long-term effects; and dislike of being used as 
a 'guinea pig'. Although both groups felt that trial participation would 
involve some risk due to side-effects and long-term problems, non-
participants held much stronger beliefs that these outcomes would obtain. 
Simi larly, whi 1st both groups bel ieved that they would be serving as a 
'guinea pig' if they took part in clinical trials, non-entrants believed 
this more strongly, and evaluated such service much more negatively. The 
omega square value for evaluation measures of this item was .22. 
Closer inspect ion of the 'off good pi lIs' i tern also proved interest ing. 
Potential entrants and non-entrants did not differ in the strength of 
their beliefs that participation in clinical trials might result in the 
discontinuation of current effective medication. Both thought it only 
slightly likely that this would occur. Both also evaluated such an 
outcome negatively, but the degree of negativity expressed by potential 
non-entrants was significantly greater than that reported by potential 
entrants. 
Worries about 'being taken off good pills already being taken' were 
identified as a potential deterrent in the preliminary study, especially 
amongst older people, who were perhaps, more likely than younger 
respondents to be on long-term drug treatments. Al though crossproduct 
measures did not show this to be important in discriminat ing potent ial 
entrants from non-entrants in the second study, the differences in 
evaluation measures did suggest that it should not be totally 
disregarded. 
This is perhaps especially so in the light of responses given to the item 
in which respondents were asked if they would take part in clinical 
trials if already on other medication. Approximately half the sample gave 
a negative response to this item, and about one quarter expressed 
uncertainty. Thus it would seem that people might well be reluctant to 
participate in clinical trials if they were already on drug treatments, 
perhaps partly because of fears that current prescriptions may be 
rescinded. 
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Another interesting finding, which may relate to the issue just 
discussed, was the general value attached to information. Three items 
related to this area:- getting adequate information about the study; 
getting adequate information about the pills being tested; and being able 
to ask for any information desired. Both groups evalauted these items 
equally highly. However, beliefs that these items would be associated 
with trial entry, were significantly stronger amongst potential entrants 
than non-entrants. Further support for the desire for full informat ion 
was found in the additional comments that respondents made. 
In the general introduction to the thesis <Part I) the importance of good 
doctor-patient communication was considered at some length, where 
part icular attent ion was paid to the ethical and methodological 
implications of inadequate information. It was argued that people cannot 
give truly informed consent to trial participation if they do not have 
adequate information on which to base their decisions. Further, if they 
harbour unresolved worries about participation, or do not fully 
understand regimen instructions, the chances of defaulting will be 
increased. 
However, whilst there was considerable evidence for public belief in the 
need for informed consent and full informat ion about treatments <ego 
Saurbrey et al. 1984; Cartwright and Anderson, 1981; Ley, 1982); some 
doubt about the general application of these principles was also 
expressed <ego Faulder, 1985; Taylor and Kelner, 1987). 
The findings of the reported study, indicated that the majority of 
respondents (in excess of 70%) did believe that they would be given 
adequate information if asked to participate in clinical trials. 
Nevertheless, as mentioned above, this belief was held with significantly 
stronger conviction by potential participants than their non-participant 
counterparts. Thus it must be considered that doubts about rec ieving 
adequate information might pose a barrier to trial entry. 
This is especially so, given the obviously influential role of the 
'guinea pig' factor. Of all bel ief items, it was the single most 
important discriminator in each test of group di fferent iat ion. I twas 
also the most important item in predicting attitudes to trial 
participation; and the second most important in the prediction of 
personal norms. Of course, individual interpretations of 'serving as a 
guinea pig' may well di ffer - certainly study resul ts show that such 
service is not always evaluated negatively. However, it seems reasonable 
to suggest that to many people, it impl ies a si tuat ion in which one is 
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'used' - not necessarily to one's own advantage- and in which one is not 
fully informed of all aspects of the role. 
From other results, it appears that one such aspect could be the possible 
side effects of trial drugs. Over 70% of respondents believed that 
clinical trial participation would involve a risk to health by possible 
side effects, and over 80% believed that trial drugs could have long-term 
consequences. Although just under half the respondents indicated a 
positive belief that prophylactic administration of drugs might lead to 
acquired resistance, more than a quarter expressed uncertainty about this 
issue. 
The level of concern expressed about side effects was almost identical to 
that found in the preliminary study, and confirms this issue as a 
potential deterrent to participation in clinical trials. However, it was 
noted in the discussion of preliminary study results, that this need not 
represent an insurmountable problem. It has already been shown that 
adequate information and forewarnings of possible side effects can help 
decrease regimen defaulting (eg. Myers and Calvert, 1978), especially if 
information is given in both verbal and written forms. 
Apart from the fact that potential trial entrants have a right to all 
available information about trial drugs, the willing impartation of such 
information might well diminish the 'guinea pig' feeling that trial 
participation seems to entail. Certainly, such a practice would enhance 
the chances of obtaining real informed consent and, on available 
evidence, would not detract from regimen compliance once participation 
was secured. If, in the recrui tment process, the issues of acquired 
resistance and discontinuance of current effective medications were also 
addressed, initial recriutment and continued compliance might be further 
increased. 
Last, but not least, there were some interesting statistically 
significant differences between males and females which are worthy of 
note. 
The first difference pertained to attitudes and subjective norms. Whilst 
the mean score for males showed a slightly favourable attitude towards 
trial participation, that for females showed a slightly negative 
attitude. Also, whereas both sexes indicated that their important others 
would be against their taking part in tri3ls, women perceived this 
antipathy to be significantly greater than did men. It was not altogether 
clear why this should be so, but a comment by one woman, to the effect 
that she would not jeopardise her health until her children were grown, 
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might give some clue to the finding. 
Another interesting difference between the sexes was found for the item 
which asked about the possibility of initial agreement to trial entry, 
with subsequent non-compliance. Mean scores showed that both sexes 
thought it unlikely that they would agree to entry then change their 
minds and not take the pills, but women found this possibility 
significantly less improbable than did men. Women were also significantly 
more likely to associate trial entry with side effect and long-term risk, 
and worry if they felt 'off colour' during the course of the trial. 
Interestingly though, they had greater faith that their doctors would 
give them adequate information about the study and pills being tested. 
Perhaps, their greater faith regarding information countered their 
greater concern about side effects, so that the overall intentions were 
equalised. However, it is also possible that their less staunch denial 
of possible non-compliance represented a forwarning of what might occur 
if their faith in receiving adequate information was not met. 
5. COMPARISON OF RESPONSES FROM MEDICAL AND ELECTORAL ROLL SUB-SAMPLES 
In the general introduction to the thesis <part !), it was stated that 
published medical surveys typically achieve high response rates. It was 
also stated that research has shown there to be a greater response rate 
to such surveys when they are associated wi th the sampl ing pool's GPs 
(Smith et aI, 1984). However, another observation made, was that use of 
follow-up is frequently qutte extensive, and true anonymity rarely seems 
to apply. It was further argued that this approach may induce some 
feelings of coercion to respond, or yield artefactually positive 
responses due to patients' reluctance to jeopardise their relationship 
with their doctor. 
If the high response rates associated with GP-endorsed studies are a 
function of patients' perceptions that they may be identified, such study 
results must be regarded with some scepticism. Under these circumstances 
the value of even very high response rates would need to be re-assessed. 
Therefore, it was decided to test the superiority of response rates to 
GP-endorsed studies when true anonymity, precluding follow-up, applied. 
In order to pertorm this test, halt the potenti31 respondents ;·]ere drawn 
from the electoral roll and half from the practice lists of four group 
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practices. All respondents were informed of their sampling source on the 
canvassing letter, and all were assured of complete anonymity. In 
addition, potential respondents drawn from GP lists received a covering 
note from the doctor reiterating respondent anonymity and stressing the 
doctor's non-involvement with the study. 
Analysis revealed some very interesting differences between those sampled 
from medical and non-medical sources. Firstly, although the response rate 
from medical sampling sources was superior to that from the electoral 
roll, and statistically significantly so, the actual difference was not 
very great - just 6%. More importantly, there were differences between 
the groups for individual response items which implied an effect due to 
sampling source. These differences could not be attributed to age, sex 
or occupational categories, since the sampling source groups did not 
differ in any of these respects. Therefore the differences observed may 
be assumed to have been under the direct influence of repondents' 
knowledge of the sources from which they were drawn, even though it was 
made very clear that individual respondents could not be identified. 
Regarding screening, the differences were quite informative. Intention 
and its immediate determinants according to the 81M, were all 
significantly different. Also, 'medical' respondents expressed 
significantly stronger beliefs that screening participation would result 
in them being told the best preventive measures to take; and they 
evaluated a 'lecture from the doctor' significantly more highly, than 
respondents drawn from the electoral roll. Cross-product measures also 
showed them to score more highly on the belief that they would be spured 
to a healthier lifestyle. 
It must be acknowledged that omega square values were minimal, and that 
it is possible that the powerful t-test may have picked up marginal 
effects which, though statistically significant, were materially 
insignificant. However, without exception, respondents drawn from medical 
sampling sources reported more posi tive responses. Furthermore, 
differences in screening intention were also demonstrated by the more 
robust non-parametric test of chi-square. Again, lambda values were not 
very great, (only .07 with source dependent). Nevertheless, it suggested 
that sampling source did have an effect on responses, albeit a rather 
weak one in terms of predictive value. 
Sampling source had no effect on reported intentions to partiCipate in 
clinical trials of new pillS. However, chi square tests showed that 
'medical' respondents were significantly more likely than their electoral 
roll counterparts, to have indicated a positive intention to partiCipate 
in trials of established drugs. This difference also applied, for both 
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drug types, in relation to the specific circumstance of participation if 
at high risk of a cardiovascular event. 
Respondents sampled from medical sources clearly reported stronger 
feelings that they ought to take part in trials if asked to do so. 
Interestingly, whilst both groups considered an invitation to trial entry 
to be unlikely, the 'medical' group considered such an invitation to be 
significantly less unlikely than did the electoral roll group. 
In the light of previous findings, it was very interesting to note that 
whilst there were no differences between the groups regarding evaluation 
of associated outcomes, there were significant differences in the 
strength with which important beliefs were held. Respondents sampled from 
medical sources reported significantly stronger beliefs that they would 
receive adequate information about the trial and drugs being tested; and 
significantly weaker beliefs that acquired resistance or discontinuation 
of current effective treatments would be a consequence of trial 
participation. 
A simple, immediate explanation for these observed differences is 
difficult to provide. Overall, they would seem to suggest that 'medical' 
respondents were reassuring their doctors that they were 'good patients' 
who had great faith in them and would follow their advice, 
It is tempting to propose that these findings reflect a bias due to fear 
of recognition, but such a simplistic argument is not really tenable. 
After all, questionnaire completion was totally anonymous so, 
theoretically, source should not have had an influence on responses, 
since individuals could not be indentified and were thus immune to any 
possible reprocussions of their answers. In addition to anonymity, 
canvassing letters also stressed non-involvement of GPs. However, the 
results showed that source did have an effect on responses, thus 
something about the sampl ing source of respondents was operat ing to 
influence answers given. 
Perhaps, in spi te of the efforts made to stress anonymi ty, some doubt 
about this issue remained. Alternatively, it might be that the 
association of the GP with the survey, created a slightly different frame 
of reference wi thin which responses were generated. Yet again, it might 
have been that many 'medical' respondents were prompted to respond by 3 
recent satisfactory consultation with their GPs, thus colouring their 
answers. The response rate from medical sources was not dramatically 
superior to that from the electoral roll, so perhaps, there was a bias of 
this sort, which might not have been found had greater numbers of 
'medical' respondents replied, As a final thought, it was also possible 
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that people sampled from medical sources fel t more strongly that GPs 
would be given a summary of study findings, and be spurred into 
appropriate actions. 
Whatever the causes, some doubt must be cast upon the wisdom of 
collecting non-anonymous data in medical studies, and on the benefits of 
using GP endorsed canvassing approaches. These study findings clearly 
indicate a possible biasing of results, which reflect more positive 
reponses than those collected from non-medical sources. If this effect is 
found when questionnaire completion is anonymous, and without the extra 
effects of follow-up, it must be considered that the effect would be even 
more pronounced when response is not anonymous, or is not perceived to be 
such, perhaps by the extentsive use of follow-ups so frequently used in 
medical surveys. 
6. CONSIDERATIONS OF THE BEHAVIOURAL INTENTION MODEL 
Although some problems were encountered, the results of the second study 
justified the choice of the BIM as the adopted predictive model. The 
prediction of intention, for both screening and clinical trial 
participation, was of an encouragingly high level and certainly superior 
to that obtained from a tentative use of the Health Belief Model in l.he 
preliminary study. As well as allowing assessment of the relative power 
of immediate determinants of intention, application of the B1M also 
yielded valuable information regarding the identification of the most 
important beliefs underlying intentions. 
However, with regard to both behaviours, the most potent predictive 
factor was that of personal normative beliefs. In fact, this variable 
does not appear in the orthodox version of the B1M and its inc 1 usion 
represents a recent amendment to the model proposed by Budd et al (1984, 
1985) and Ajzen (1985). Nevertheless, as discussed earlier, the arguments 
for its inclusion are persuasive, and were clearly supported by these 
study findings. 
Another proposed amendment to the model was the addition of a 'past 
behaviour' variable (eg. by Bentler and Speckhart, 1979; Manstead et aI, 
1983). Considerable support for this amendment was presented in the 
introduction to the second study (Part III, Chapter 1), and it was 
originally intended to include it on the study instrument. However, pilot 
studies showed that very few people reported direct experience of 
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screening for cardiovascular risk and even fewer of clincial trials. 
Supplementary questions designed to tap relevant past experience yielded 
a lot of missing data. In an attempt to overcome this problem and refine 
the instrument, it was decided to restrict items relating to screening 
behaviour, to those which would give measures of past experience of 
blood pressure and cholesterol level tests - two major procedures in CVD 
screening. Direct questions relating to clinical trial participation were 
retained. 
Although the information obtained from these items was of value to the 
Health Maintenance Study, with which the research was associated, they 
were not really adequate as measures of past behaviour re screening. The 
majority of respondents had had some experience of blood pressure tests, 
but not of cholesterol tests. Since blood pressure tests are performed 
for many reasons other than the assessment of cardio-vascular risk, this 
could not really be taken as evidence of relevant past behaviour -
especially as it was not known whether such tests were taken voluntarily 
or otherwise. 
Some respondents did volunteer information that they already been 
screened for cardiovascular risk, though they were very few in number. 
Sub-group analyses showed no di fferences between those who had and had 
not had experience of either blood pressure or cholesterol tests, in 
respect of intentions, attitudes or norms. Indeed, results from the 
preliminary study, and information obtained from in-depth interviews, 
suggested that whilst few people had had direct experience of screening 
for cardiovascular risk, many would welcome the opportunity. In the light 
of this, it would seem that past behaviour is not a major influence on 
initial positive intention. However, it may well have some bearing on 
intentions to participate in follow-up screening. 
A third addition to the model was an item, loosely influenced by Ajzen's 
(1985) Theory of Planned Action, which was intended to measure 
respondents' perceptions of the likelihood of a participatory invitation 
being issued. It was included to assess whether people's intentions to 
perform a given behaviour were related to their expectations of the 
opportunity arising. Results showed no such relationship for either 
investigated behaviour. 
As mentioned at the begining of this section, although the application of 
the BIM was, overall, effective, some problems were encountered. The 
major problem related to normative belief measures. This has already been 
discussed quite extensively in section 2.2 of this chapter. All that will 
be said further here, is that the problem may have been minimised by 
interviewer-administration of the questionnaire, or by better explanation 
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of answering instructions. However, as previously asserted, it would seem 
to represent an inevitable problem whenever modal sets of referents are 
used in a heterogenous sample. 
At the outset of the research, two main drawbacks of the BIM were 
projected. These were: (1) a disregard of socio-demographic correlates of 
intention, or other model components; (2) the possibility of a BIM 
instrument being too repetitive for effective application in a postal 
survey of a general population sample. 
From the resul ts obtained, it was apparent that the first concern was, to 
some extent, founded. Findings of age differences in screening intention, 
and sex differences for clinical trial items, were discussed in sections 
3 and 4 of this chapter. The important implications of these findings are 
that they identified particular groups for targetting considerations. 
Wi th respect to screening, it was evident that it might be necessary to 
devise special educational and promotional campaigns directed especially 
towards younger people. Regarding clinical trials, it was clear that 
special attention needs to be paid to the effective recruitment of women. 
Assessment of the second reservat ion was rather more di ff icul t. On the 
one hand, response rates were substantially lower than those achieved in 
the first study which employed a simpler instrument. However, the 
instrument was not the only di fference between the two studies which 
might have influenced this result. The personal distribution approach 
used in the preliminary investigation is associated with higher returns 
than is mai I-shot canvasing <ego Bell izzi and Hi te 1986). Furthermore, 
the response rate achieved for the postal distribution was no lower than 
that achieved by many other studies using the same approach <ego 
Herberlein and Baumgartner, 1979). Against this, personal approach 
piloting of the BIM questionnaire, in a site yielding over 60% response 
rate to the first study, elicited response rates commensurate with the 
mail shot, rather than the preliminary exercise. Thus it must be 
considered that the instrument itself had some bearing on the relatively 
low response. 
On the other hand, apart from the problems associated with normative 
beliefs, returned questionnaires did not suffer major problems of missing 
data. Also, contrary to the first study, the instrument i tsel f el ic i ted 
no adverse comments from respondents. 
Overall, it would seem that the concern about the utility of the BIM in 
postal distributions to a general population sample, might have been 
misplaced. Given its obvious value in the prediction and understanding of 
investigated behaviours, this is a very reassuring finding. 
/ 
PART IV 
RESEARCH OVERVIEW AND CONCLUSIONS 
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CHAPTER 1 
SUMMARY CONSIDERATIONS, CONCLUSIONS AND RECOMMENDATIONS 
In this final chapter, consideration will be given to the combined 
findings of both studies comprising the research, and the conclusions 
drawn from the work will be presented. The chapter will end with 
recommendations. 
The principal overall aims of the research 
public attitudes to GP involvement with 
particular screening and clinical trials 
reduction. They also included assessment 
regard i ng the two ac t i v i ties; and the 
influencing intentions. 
inc 1 uded an assessmen t of 
prevent i ve med i cine, in 
for cardiovascular risk-
of participatory intention 
identification of factors 
A common secondary aim was to 
response rates from GP-endorsed 
canvassing not associated with 
applied. 
evaluate the alledged superiority of 
canvassing, 
GPs, when 
over those obtained from 
anonymity was rigorously 
Further secondary aims pertained to individual studies. In the 
preliminary investigation a very tentative exploration of attitudes 
towards psychological treatments for hypertension was undertaken. The 
secondary aim specific to the second study, was an evaluation of the 
Behavioural Intent ion Model for use in postal surveys of a general 
publ ic sample. 
Essentially, the preliminary study was designed to explore the area. The 
main objective was to guage public feeling towards the general concept of 
GP involvement in preventive screening and research, and to identify the 
range of variables associated with participation in screening and 
clinical trials. The primary purpose of the subsequent study was to 
determine the power of influencing factors. 
By and large, the range of variables identified from interview informants 
and survey respondents of the first study, was reiterated by those of the 
follo~on project. Certainly principal factors were present on both 
instruments and the importance of factors tentatively identified as 
influences in the preliminary study, was confirmed by subsequent results. 
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1. PARTICIPATION IN SCREENING 
The aggregate findings of previous research into screening participation 
indicate that there is a widespread favourability towards preventive 
screening which does not seem to be matched by corresponding levels of 
attendance <ego O'Brien and Hodes, 1979; Cartwright and Anderson, 1981; 
King, 1982). Whilst fears of screening procedure and possible test 
outcome, represent potential deterrents to participation in screening for 
breast and cervical cancer< Wookey, 1971; French et al. , 1982; Maclean et 
al.,1984); they do not seem to be major barriers to more general 
screening, or to screening for hypertension (eg.Cartwright and Anderson, 
1981; O'Brien and Hodes, 1979). Aggregate findings have also shown social 
class and age to be quite strong correlates of screening attendance, with 
the higher socio-economic groups and the young to middle aged being most 
common participants. 
The results of the reported research largely accorded with the 
accumulated evidence. From prel iminary study findings it was apparent 
that there was very popular support for cardiovascular-risk screening. No 
widespread deterrents to participation were detected, though there were 
indications that some women, especially those over 60, might be reluctant 
to be screened for fear of what diseases might be found; or of having to 
fully undress for the examination. However, these represented a very 
small minority of respondents. 
Subsequent results confirmed the popularity of screening, and failed to 
detect any real potent ial deterrents at all. Indeed, in the second study, 
where questionnaire items were largely comprised of unprompted beliefs 
elicited from interview informants, associated outcomes were mainly 
positive, and neither of the minority deterrents mentioned above, were 
included. Rather, results indicated a few 'encouragement' factors. These 
included beliefs that screening participation would: confer peace of mind 
by getting an 'all clear' verdict; improve one's chances of staying fit 
and healthy for longer; and lead to information about the best preventive 
measures to take. 
It may be that fears of disease discovery, or of having to undress for 
medical examination, were peculiar to the preliminary study sample. 
However, it may be that they do represent genuine barriers to screening 
participation by older women. After all, in the first study, because of 
its close association with the Health Maintenance Study (HMS), 
questionnaire items were determined by a sample comprised entirely of 
elderly interview informants. In addition, there was a deliberate over-
representat ion of the over 60s in the survey sample. Conversely, in the 
follow-on study, salient beliefs were elicited from all ages and there 
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was, in fact, a slight under-representation of older people among survey 
respondents. 
Although cardiovascular screening may be less emotive that breast cancer 
screening, the preliminary findings did fit well with those presented by 
French et al. (1982). Their results showed that not only did non-attending 
women regard the screening clinic as a place of risk, but that they also 
tended to be in the older age groups. Both fears expressed by older 
women would suggest that they would regard screening attendance as 
'risky' . 
Thus it might be concluded that although the data did not support the 
proposi t ion of these factors as major deterrents to screening, they may 
well operate as such among older women. Therefore, it might be wise for 
promotors of cardiovascular screening to bear them in mind when 
recruiting older women. It would be very easy to make sure that protocols 
included instructions for recruiters to point out that the procedure does 
not involve a 'strip' examination. In this way, it might be possible to 
secure participation from those who might otherwise decline a screening 
invitation because of this unvoiced concern. It may also be prudent to 
promote screening as a method of health maintenance, rather than one of 
disease discovery. 
With the exception of these potential minority deterrents, the evidence 
from the reported research, in conjunction with earlier findings, 
suggested that there were no real barriers to screening participation. 
Therefore, it may be tempting to conclude that if cardiovascular-risk 
screening is offered, it wi 11 be generally accepted. 
Unfortunately, the behavioural evidence refutes this, and to draw such a 
conclusion would be to grossly oversimplify the issue and to ignore a 
very important factor that is frequently touched upon, but which remains 
under-investigated. 
This vital factor is that of social class, which is one of the strongest 
and most consistent correlates of both ill health and screening 
attendance. Unfortunately, the under-representation of the lower socio-
economic groups at screening clinics, is mirrored by a common under-
representation of them in attitude surveys. Certainly, there was a very 
pronounced bias in favour of the 'middle classes' in the reported 
research. 
Discussions of this factor lead to the suspicion that the 'working class' 
respondents who did contribute to the survey may not have been very 
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typical of their class as a whole. This suspicion was aroused by both the 
lack of numbers, and the fact that initial interview informants from the 
lower socio-economic groups had been particularly difficult to recruit. 
This was in stark contrast to the recruitment of 'middle class' 
informants who volunteered their services much more readily. 
If 'working class' respondents were atypical of their socio-economic 
groups, it must be conceded that the lack of class differences found, may 
not represent the real state of affairs. Rather, it may be that the 
failure to identify screening deterrent factors is a function of failure 
to obtain information from the right people. Thus the simple conclusion 
that there are no deterrent factors which would explain why levels of 
screening attendance do not match reported attitudes, is a false one. 
Indeed, the simple assertion of attitude/behaviour mismatch is somewhat 
misleading. After all, it would appear that the observed incongrui ty 
might be due to overall levels of attendance not corresponding wi th 
reported 'middle class' attitudes, rather than with attitudes expressed 
by all sectors of eligible participants. 
Therefore, a more tenable conclusion would be that research to date has 
found little evidence of any factors which may pose widespread deterrents 
to screening participation within the higher socio-economic groups. 
However, it is clear that some deterrent factors must be operating within 
some sections of the population, though as yet, their indentification has 
not been achieved. Furthermore, such identification will remain elusive 
until the problems of securing adequate representation of the lower 
socio-economic groups in research projects aimed at understanding 
part ic i patory inten t ion, is resol ved. 
It has already been noted that 'working class' people are more vulnerable 
to cardiovascular events, and more 1 ikely to have dietary and smok ing 
habits which exacerbate their vulnerability. Clearly, the need to 
encourage their participation in preventive screening is paramount. Thus, 
the current research priority must be to identify factors operating 
within this group to deter their participation in screening. Only in this 
way can relevant problems be addressed, and appropriate educational and 
promotional campaigns be devised for special application to this 
vulnerable target population. 
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2. PARTICIPATION IN CLINICAL TRIALS 
The paucity of previous work in this area prevented much in the way of 
direct comparison of study results with previous research findings. 
However, as with screening, major findings from the preliminary study 
were replicated and amplified by the results of the second. In neither 
study did the consensus of opinion found for screening apply. Rather 
there was considerable diversity in attitudes and intentions expressed. 
Also, whi 1st 'uncertain' responses were rare for i terns pertaining to 
screening, considerable use was made of this option for reported 
intentions and attitudes regarding clinical trial participation. This 
option was also utilised quite substantially for some of the important 
beliefs underlying intention. Thus it was evident that clinical trials 
represent an area of some controversy, and one about which mixed feelings 
or confusion obtain. 
The major deterrents to trial entry tentatively identified in the 
preliminary study were worries about: drug side effects, acquired 
resistance and the discontinuation of current effective medication. 
Although these potential deterrents applied across the whole spectrum of 
respondents, concern about side effects particularly, was strongest in 
women. Subsequent study resul ts conf irmed the deterrent potent ial of 
these factors, and here too, it was found that side effect worries were 
more pronounced amongst female respondents. 
Other important findings were related to these major deterrents. For 
example, responses from both studies suggested that people already on 
medication might be reluctant to become trial entrants. There were 
probably several reasons for this. Fear of being taken off current drugs 
might be one reason, worries about adverse drug interactions might be 
another. In the light of other findings these do not seem unreasonably 
speculative proposals. 
In add it ion, the second study highl ighted the importance of the 'guinea 
pig' factor, and adequate information, as influences on attitudes, 
personal norms and participatory intention. 
Findings of public desires for information regarding medical treatments 
were not new. Several other researchers, most notably Philip Ley and his 
colleagues, have long been providing evidence of this desire, and of 
publ ic dissat isfact ion wi th the qual i ty of doctor-pat ient commun icat ion 
experienced. They have also provided ample evidence that poor 
communications are associated with non-compliance with prescribed 
regimens. 
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Interestingly, the majority of respondents in both reported studies 
indicated that they were quite satisfied with the level of information 
obtainable from their GPs. In both studies most people reported that they 
felt they could ask for any information they required; and in the second 
study, a majority felt that their doctors would provide adequate 
information about both the trial and pills being tested, as part of an 
invi tat ion to trial entry. Nevertheless, the strength of bel iefs that 
adequate information would be given, was considerably exceeded by the 
value placed upon reciept of information. 
Whilst this finding about information may not be particularly noteworthy 
by i tsel f, it assumed great importance in the 1 ight of other findings 
relating to deterrent factors. Results showed that the best discriminator 
of potential entrants and non-entrants was the 'guinea pig' factor. 
Previous discussions of this, in chapter 4 of Part I I I, highl ighted its 
close interaction with other potential deterrents, which could all be 
regarded as worries that might be associated, not just with trial entry, 
but also with feelings of being used as a 'guinea pig'. 
It was also noted that the 'guinea pig' factor could be largely 
alleviated; and worries about side effects, acquired resistance and 
discontinuation of current treaments minimised; by the effective 
administration of adequate information. Not only would such a recruitment 
practice help to increase initial consent to entry, but it would also 
enhance the chances of cont inued compl inace once entry was secured. As 
work by Ley and by Myers and Calvert (1978) has shown, if initial 
recruitment information is backed up by suitable written information 
about the drugs, the prospects for cont inued compl iance would be even 
brighter. This may be especially so for women, who not only expressed 
greater concern about side effects and worry about feeling 'off colour' 
during trial participation; but also were more likely than men to concede 
the possibility of initial agreement to trial entry, with subsequent non-
compl iance. 
Physicians' fears that obtaining full consent might be an "intrusion into 
the doctor-patient relationship" and contribute to "decreasingly 
effective doctor-patient communications" (Taylor and Kelner, 1987), would 
not seem to be justified. Rather, the evidence from the reported research 
would indicate the direct opposite - at least from the public's point of 
view. Information is a highly prized commodity, and one which may have 
considerable bearing on behaviour. Thus the researcher seeking 
participation should be generous with it for both ethical and 
methodological reasons. 
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In practical terms the message for trial recruiters should be loud and 
clear. Obtaining informed consent demands that potential trial entrants 
be given adequate information on which to base their participatory 
decisions. In particular, it would seem that people require information 
about the study itself and the possible side effects of trial drugs. It 
would also be politic to address concerns about acquired resistance and 
the consequences of trial entry for current medications being taken. In 
addition, when trial entry is achieved, it would seem to be a good idea 
to provide entrants with some written back-up information, particularly 
about possible side effects. 
3 SAMPLING SOURCE DIFFERENCES 
Sampling source differences were investigated because although there is 
some evidence to suggest that GP-endorsed surveys elicit greater response 
rates than those not so blessed; such studies rarely apply respondent 
anonymity. Thus it was considered possible that the observed superiority 
of response rates, might be influenced by concern that non-response could 
be noted by the GP, and perhaps, have some bear ing on the subsequent 
doctor-patient relationship. It was therefore decided to test this 
supposition by comparing response rates from GP-endorsed canvassing, and 
non-GP-endorsed canvassing, when anonymity was applied. 
In both studies, canvassing of some respondents was associated with their 
GP, whilst the canvassing of others had no such association. In the first 
study the GP connection was rather indirect and achieved by distribution 
of questionnaires in practice waiting rooms. It was not known whether or 
not patients and GPs discussed the survey in any way. The other sampling 
sources used in the preliminary study were a shopping centre, a railway 
station and an Age Concern Drop-In Centre. At all sites, medical and non-
medical, distribution was by personal approach and identical canvassing 
procedures were employed 
In the follow-on study, GP-endorsement was greater and more in line with 
other GP-endorsed surveys. Postal distribution was used, and as well as 
the usual introductory page, the survey package for 'medical' respondents 
included a covering note from the GPs, in which the final sentence 
expressed their belief that the study was important. The non-medical 
source in this study was the electoral roll. 
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In both studies, care was taken to stress respondent anonymi ty to all 
potential informants. 
Al though medical sampl ing elici ted a statistically superior response 
rate in the second study, the magnitude of the difference was small, and 
not at all apparent in the preliminary investigation. Therefore, GP-
endorsement alone, would not seem to account for the high response rates 
so frequently achieved by medical surveys. However, respondents whose 
canvassing had been supported by the GPs, did differ from electoral roll 
respondents in their responses to several key items on the second study 
instrument. In each case, 'medical' respondents gave more positive 
answers. These differences could not be attributed to influences by other 
sociodemographic factors, since the two sample groups did not differ in 
terms of sex, age or occupational status. 
The implications of these findings are serious and demand profound 
consideration of the costs, as well as the benefits associated with GP-
endorsed surveys, especially in instances where true anonymity does not 
apply. After all, when anonymity was applied, the expected benefits to 
response rate were minimal, but associated with an unexpected increase in 
positive responses. 
4 ATTITUDES TO PSYCHOLOGICAL TREATMENTS FOR HYPERTENSION 
Because of the growing interest and developments in the area of 
psychological treatments for hypertension, it was decied to make a very 
tentative initial exploration of public attitudes towards this issue. It 
must be acknowledged that the data obtained were insufficient on which to 
base anything but very tentative conclusions. However, the findings were 
quite dramatic, and were thus worthy of note here, and of continued 
research in the future. 
This area was explored only in the preliminary investigation, but the 
ovewhelmingly popular support given to the proposal of psychological 
techniques as adjuncts to pharmaceutical treatments for hypertension 
cannot be ignored. At present, it seems that public appreciation of the 
poten t ia I of psycho logical in tervent ion in hyper tens ion management, is 
considerably greater than that proclaimed by the medical profession. 
However, given the widespread concern about drugs, indicated by study 
respondents, it would seem that physicians ought to be considering 
alternative therapies wherever possible. When they do come round to 
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including psychological techniques in their routine management of this 
common disease, study findings suggest that their patients will readily 
accept the treatment. 
5 UTILITY OF THE BEHAVIOURAL INTENTION MODEL 
Evidence already abounds for the value of the BIM in the prediction and 
understanding of behavioural intention. However, it was noted that most 
published reports of its application have been under conditions of 
interviwer-administration, or to specialist groups of people, highly 
motivated to complete the instrument because of its direct relevance to 
them at that stage. It is not always possible, or desirable to employ 
interviewer-administered instruments. Neither will it always be the case 
that the behaviour of interest to researchers is also immediately 
relevant to all members of their required sample. Therefore, it was 
decided to test the utility of the BIM as part of a self-completion 
questionnaire, postally distributed to a general population sample. 
The already plentiful evidence for the value of the BIM as a tool for the 
prediction and understanding of behavioural intention, was increased by 
the results of the reported research. Furthermore, doubts that its 
repetitive nature might hamper its utility in postal surveys of a general 
population sample appeared, overall, to be largely unfounded. It was 
true that the response rates obtained were substantially lower than those 
achieved by the preliminary study instrument, but as was discussed in 
chapter 4 of part III, this may have been as much a function of the 
distribution approach, as of the instrument per set 
Problems of missing data for normative belief measures were also 
discussed earlier when it was concluded that this may be an inevitable 
outcome of using a modal set of referents for a heterogenous sample. 
However, the main problem with normative belief items came from 
'motivation to comply' measures, the value of which had previously been 
questioned by other researchers. 
Although the orthodox 81M proved very useful for predicting and 
understanding intentions to partiCipate in screening and clinical trials, 
the inclusion of a personal normative belief item (as suggested by Budd 
et aI, 1984, 1985) considerably enhanced the predictive value. This item 
was also that most closely associated with intention. 
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For the behaviours investigated in the reported research, subjective norm 
played a very minor role. Suggestions that this variable might be dropped 
from the model were considered, but dismissed. Rather, it was concluded 
that it should remain as a model component, and perhaps be extended by 
the addition of a variable designed to assess motivation to comply with 
the conglomerate 'important others'. This may well prove to be more 
useful in some instances than separate measures of motivation to comply 
with individual referents. 
One drawback of the BIM was apparent. This was its omission of 
sociodemographic variables. Whilst it is true that the intentions of 
women or 'working class' people will be determined by their beliefs 
rather than their actual gender or occupation; identification of belief 
differences alone is not enough if results are to have any practical 
applications. It is not much use to conclude that some people might be 
put off screening because they are worried about having to undress for 
examination, if this worry applies to a particular group of people who 
are not identified. In this particular instance, non-identification of a 
specific group would not, actually, be of great importance, since all 
people could be reasured on this point as a routine part of recruitment 
protocol. 
However, it is often the case that the identification of particular 
groups is important. This is especially so when results indicate the need 
for particular targetting, and the devising of specific campaigns or 
protocols appropriate for that group. After all, to be effective, such 
campaigns need not only to address relevant issues, but to do so in a 
language that will be understood and accepted by the groups they are 
aimed at. They also need to be undertaken in places where the target 
groups are likely to be reached. 
Of course, application of the BIM does not preclude collection of 
demographic data, as was shown in the reported study. However, some 
acknowledgement of the possible importance of demographic data for the 
effective utility of BIM study findings would only enhance the model. 
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6 ITEMISED SYNPOSIS OF CONCLUSIONS 
(1) Support for cardiovuscular-risk screeninp; HQ.S very stronp; amonp; 
respondents, for most of whom there seemed to be little evidence of 
participatory deterrents. However, some older women might be reluctant to 
attend screening for fears of disease discovery and of having to undress 
for examination. The behavioural evidence and paucity of information from 
'working class' respondents, suggested that deterrents to partiCipation 
by people of the lower socio-economic groups, probably remain to be 
identified. 
(2) Attitudes and intentions towards clinical trial participation were 
diverse and indicated considerable uncertainty about the issue. Major 
potential deterrents identified were: serving as a 'guinea pig'i and 
worries about: drug side effects, acquired resistance and discontinuance 
of current effective medications. Very high value was placed upon 
information, which, if effectively given, could help overcome many 
deterrent concerns. 
(3) Response rates associated with GP-endorsed canvassing were not 
substant ially greater than response rates from other sampl ing sources. 
However, in the second study, 'medical' respondents did provide 
significantly more positive responses than 'non-medical' respondents, for 
many key items. The use of GP-endorsed canvassing for med i ca I surveys 
should be undertaken with caution, especially in instances where true 
anonymity does not apply. 
(4) Data pertaining to psychological treatments for hypertension, were 
insufficient to permit any firm conclusions being drawn. However, they 
did indicate great public support for the concept of using psychological 
techniques as adjuncts to drug therapy in the management of hypertension. 
(5) The Behavioural Intention Model proved to be a valuable tool for the 
prediction and understanding of intentions to participate in screening 
and clinical trials for cariovascular risk-reduction. Overall, it seemed 
to be quite effective for use in postal distributions to a general public 
sample. However, there were considerable problems associated with 
normative belief measures. The suggested reinstatement of a personal 
normnative belief measure was supported. 
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7 RECOMfENDATIONS 
The major recommendations are as follows: 
(1) There is clearly a need for further research into 'working class' 
attitudes and beliefs relating to participation in screening. Attempts to 
secure representative samples of lower socio-economic group members may 
be met with considerable difficulty. However, the need to encourage these 
groups into screening for cardiovascular-risk is essential if any impact 
is to be made upon the incidence of cardiovascular events. Current lack 
of knowledge about the attitudes and beliefs of this sector is a cardinal 
flaw in the research area, and one which is inhibiting the development of 
appropriate educational and screening-recruitment campaigns. Therefore, 
rectification of the problem constitutes a research priority. 
(2) All ied to the first recommendat ion, it was also evident from the 
study findings that more research in this area should be focused on the 
younger members of our society if true prevention of cardiovascualar 
events is to be realised. 
(3) Another area of research for which there is clearly an urgent need, 
is that of the inf luence of sampl ing source on responses. From the 
reported research, it would seem that this is especially required within 
the field of medicine, though the findings do have wider implications. 
Concern about identification could not have been the sole influence, or 
even the major influence, on the positive bias found, since anonymity was 
strictly applied and considerable efforts were made to stress this fact. 
Of course, it could be that this result was an artifactual finding, 
peculiar to the sample obtained. However, since the implications it 
carries are so important, it would seem necessary to undertake further 
investigations in this area to confirm, or refute, this finding. 
(4) The last recommendation is a practical one which has been offered by 
previous researchers. It is that doctors should take pains to give 
adequate information to their patients in terms of both their health 
status and their treatments. The use of back-up written information about 
drugs, especially for patients entering clinical trials, is particularly 
strongly recommended. 
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APPENDIX 1 
oun INE OF THE HMS AND PURPOSE OF I NTERVI EWS 
A large scale Health Promotion study is to be run by family doctors in 
General Practices throughout the country. The main purpose of this study 
is to identify people who are at risk of developing heart attacks or 
strokes so that steps can be taken to try and prevent these major causes 
of suffering and early death. 
People will be invited by their doctors to have a health check, and they 
will be given advice on diet, exercise, smoking and drinking etc. People 
who show signs of being at risk of developing heart trouble or blood 
pressure will be invited to take part in the testing of certain medicines 
which doctors believe will hold off heart attacks or strokes. These 
medicines are not new ones, they are already well established remedies 
which have been widely used in other ways for many years, and only very 
low doses medicines will be used. 
Like all heal th care, prevent i ve medic ine uses resources, and if Heal th 
Service time and money are to be spent in this area it is important that 
we know how people really feel about this sort of study being run through 
family practitioners. Some people are very much in favour of projects 
like these being run by their family doctors, others are very much 
against them, and yet others hold opinions which fall somewhere in 
between. 
There are no right or wrong opinions about this, only different ones, and 
we need to find out as much as possible about different people's views of 
these projects. In order to obtain the information we need, we are 
interviewing people like you, so that we can find out what your attitudes 
are towards projects like these. We also hope to find out what sort of 
things might worry you about taking part, or put you off taking part in 
them. 
All information will be strictly confidential, and no names or addresses 
are required. 
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APPENDIX 2 
INTERVIEW OUTLINE AND DISCUSSION PROMPTS 
(1) Introduction of self and purpose of interview session plus outline 
of HMS. (stress anonymity & confidentiality, request permission to 
record, ask if any questions) 
(2) General concept of the HMS, and any preventive programmes for the 
over 60s (is it a good idea, waste of money, is it silly for people in 
their 70s-) 
(3) Lifestyle changes ego low-fat diet, 
exercise (would it be easy to follow advice 
to, what problems would you face etc. ) 
stop smoking, take more 
1 ike this, would you want 
(4) Blood-pressure tests, blood samples (do they worry/frighten you, do 
you find them uncomfortable, how do you feel when the doctor says he or 
she wants to do a test like this) 
(5) Three-monthly checks (are they too often, is it a problem to get to 
the surgery, etc.) 
(6) Particular attractions and worries (what do you most like about the 
idea of health promotion studies like this, what do you most dislike, 
what would encourage you to take part, what would put you off, why 
would you be put off by this) 
(6) Direct diagnostic information (if you were at risk of a heart 
at tack or stroke would you want to know about it/prefer not to know; 
how would you feel about being told you were at risk, how would you 
want your doctor to tell you) 
(7) Questionnaire (how do you feel about giving lots of personal 
information on forms, do you think your doctor needs to know about your 
personal circumstances, what about sensitive issues such as questions 
about recent bereavements or divorce etc.) 
(8) Pills (how do you feel about taking pills, what worries you about 
tak ing pi lIs, what about pi lIs that are being tested, how do you feel 
about taking low-dose pills for a long time-perhaps for several years-
do you think you'd keep taking them, what would keep you/stop you 
taking them) 
-3-
(9) Placebos ( outline clinical trials, ask, how would you feel about 
not knowing whether you were on a real pill or a sugar pill, do you 
have any particular worries about this) 
(10) Psychological intervention ( what do you think causes blood 
pressure, do you think things I ike stress and personal problems can 
affect blood pressure, can relaxation etc. help blood pressure, how 
would you feel if your doctor advised you to go to a relaxation group 
to help your blood pressure, what do you think is the best treatment 
for blood pressure) 
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APPENDIX 3 
EXAMPLES OF IN-DEPTH INTERVIEW STATEMENTS 
(1) General concept of the GPHMS and prevention for over 60s-
"I t' s an excellent idea and very important for older people. We've 
worked hard all our lives and want to enjoy our retirement, not just 
die, or worse still become incapacitated." "I think its particularly 
important to try to prevent things 1 ike strokes. In the long run it 
must be cheaper to prevent these things than pay for the care that 
stroke vict ims need." "I'm all for this sort of thing, but then I've 
got a good doctor, with some they use their patients as guinea pigs, 
and think more about their research than their patients" "It's a good 
idea, but some doctors are too busy with patients already to spend time 
on things like research." "If doctors think they can solve a problem 
then they must get their patients to help them in their studies. The 
patients will benefit in the long run." 
(2) Lifestyle changes - "I don't drink or smoke but I do like my butter 
and it would be very hard to give up. I've tried these other things but 
they're just not the same. I might limit it, but I'd never be able to 
completely cut it out." "When you're used to having certain kinds of 
food all your life its very hard to change, but I have taken to the new 
margarine since my wife died-mainly because it's easier to use." 
"I wouldn't want to stop having butter,or stop smoking, but if my 
doctor told me I ought to I would. Fear is a great motivator" 
(3) Blood pressure tests and blood samples- "Blood pressure tests don't 
worry me, in fact I feel reassured when my doctor says he's going to 
test my blood pressure" "When you've been in the army 1 ike I have, 
blood samples taken by a family doctor are a treat". 
(4) Three-monthly checks- "No problem at all, I live quite close and 
have nothing else to do wi th my time." "I usually come up here for a 
blood pressure test and check on my pills every month, so coming every 
three months wouldn't bother me, I'd probably be coming up anyway." 
(5) Particular attractions and worries- "I like the idea of finding out 
about problems before it's too late to do anything about them. If you 
know you're at risk, you wouldn't pass off things you shouldn't pass 
off, but you'd know they needed seeing to." "Nothing would put me off-
I'd be the first to sign up." "I think I would be worried about 
possible side-effects of pills. You never know if some problem you're 
having now might be due to pills taken in the past. Sometimes these 
effects are very long-term." "Some people might worry that they don't 
know enough about what is going on, though that wouldn't happen in this 
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practice, here, they all want you to know." "My doctor would always do 
what's best for me, if he asked me to take part in research I wouldn't 
hesitate to agree" "The main encouragement to join in a project like 
this would be the doctor. If you trust him you'd do it, if you didn't 
you wouldn't. It's as simple as that. " "I could ask for any 
information I want, but I don't think you should question your doctor 
too much, he'll tell you all you need to know. Anyway, doctors don't 
like patients who ask too many questions" "To get proper information 
I'd have to change my doctor. He wouldn't tell me much because he 
doesn't know much." "I get on well with my doctor and that's important 
to me. I always see the same one and I wouldn't like it if these check-
ups were done by anyone but her." 
(6) Direct diagnost ic informat ion - "I f I were at risk of a heart 
attack or stroke, I'd want my doctor to tell me straight." "Well, I'd 
certainly want to know, but I suppose some people might prefer not to 
know. " 
(7) Questionnaire- "I don't mind what information my doctor wants, he 
wouldn't ask for it if it wasn't important." "It's O.K. if you can do 
it in your own time, in the privacy of your own home, but I wouldn't 
want to fill in a long form here." "As long as the quest ionnaire is 
clearly laid out and easy to understand it would be alright. If you did 
have problems with it, you could always contact the surgery for help 
with filling it in, they're really very helpful here." "If you've 
nothing to hide you've nothing to fear, but it would all be 
confidential anyway". 
(8) Pills- "The length of time you need to take pills doesn't really 
matter if they're good pills." "There could be a problem with getting 
hooked on pills if you take them for a long time." "Oh, I hate pi lIs, 
they rarely work, and you always run the risk of getting cancer from 
them." "The thing that worries me most is that my doctor might take 
me off my good pills I'm on now if he wanted me to test some new ones." 
"Of course, if you take pi lIs for a long time to try to prevent things, 
they might not work f or you when you rea 11 y need them." "I'm a 1 ready 
taking pills for blood pressure, and I certainly wouldn't want to take 
any more, just to help with some research." 
(9) Placebos - "I wouldn't mind not having a medic ine pi 11, but I'd 
want to know what was in the other one." "What's the point of giving 
people sugar pills when we know sugar is bad for us." 
(10) Psychological intervention- "Everybody knows that stress and 
personal problems can affect your blood pressure. I know mine goes sky 
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high when things start going wrong, and you just have to try to relax 
and take it easy." "When I feel the symptoms of my blood presssure 
going up again, I just go fishing. It's very relaxing" "Some people 
might like to join relaxation classes, but I've had my fill of groups 
now, and I prefer to try to relax by mysel f. Everyone wi th blood 
pressure knows they need to learn to relax, though for some people it's 
harder than others ,and they might need classes for it." 
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APPENDIX 4-
THE QUESTIONNAIRE 
The appended questionnaire is a copy of that used in the main 
preliminary study. Response frequencies are shown in each answer-option 
cell, the numbers in brackets indicate the percentage of the entire 
sample that each value represents. Missing values are also given in 
both raw score and sample percentage values. 
Because analysis code names of variables were sometimes presented in 
the reults section, these too are marked on the questionnaire. 
Applied Psychology Unit 
College of Aeronautics 
Cranfield Institute of Technology 
Cranfield Bedford MK43 OAL England 
Telephone Bedford (0234) 750111 
Telex 825072 ClTECH G • 
Dear Sir/XlJdlJm, 
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o Cranfield 
We are conducting a survey into people's 
opinio~s lJbout their family doctors and some of the services 
that they provide. 
All infor~tion given is strictly confidential, and no nlJmes 
Dr addresses are required. 
It will be greatly appreciated if you will help in this survey 
by filling in the attached questionnaire and returning it to 
me in the enclosed freepost envelope. 
Please respond as promptly as you can, and remember that you 
do not need to put a stlJmp on this envelope when you post the 
form back. 
Thank you for your time and co-operlJtion, 
Yours faithfully, 
Rachel Asch, BSc. SRN. 
I...~<II 
J>l~TR,gUTto~ S IIE-S 
LI'Io 
" 
roNF IDENT IAl 
PIHse answer all quest.ions by writ.ing (;?i answers in Ule spaces provided andlor by 
puting t.icks in the appropriAte boxe6. 
Please .Ark only one box for each quest.ion. 
Persona I De-t-Ci i Is 
'S-l'f = <8). [".,) 5"0-5,) 23f.,(g./) 
3D-3q ::/ob ~l") 1>0-1:l1 .. ' 01 (u.·B) 
( 1) Age 'ltD': 4 ,t=:.' S 7'lii·DJ ' , , '70+'; · ~~ 'ill") 
(3) Occupation - if retired stale previous no,'rnal occupation MY: ~5 (~'b~) 
.~'_~Q~~ __ 1:_3J_Jl~~ _____ ~=_1~P_[iti) _____ ~:_j~_(5~~ ___________________________ _ 
l. -:..8'1 (20'0) 4-~ 4-4 ('l.~) b = 9? (z.z.·4) 
( 4) AIde Ie f t schoo I . , . . , , , , , . . . . . . . . . . , . . . , 
Current Health 1:1 Heal th History 
(5) How would you rate yo ur general health? 
Excellent Good Fair Poor 
t,/1V~ 't go ').. S7 '13 R 
(o·CJ ) . (18'\) {59' I) (2-1 -0) (I-~) 
(6) Compared to other peo pIe your age, do you think you are physically fit? 
Fitter than average Average Not as fit as average 
MV=~ 
(04) ~, ~o.&) ). ~ 2. (6&'1) t;5 (/l-tt) 
(7) Have you ever had any heart trouble or blood pressure problems? 
Yes ~ No g If yes, plea5e spec If y , 
~~ ~ 
(;tlt·~) ("'S·~ 
• I •••••••• I •• I ••• t ••••••••••••••••••••••• " •••• , •••••• I ••• I •••• , •••••• I , • I , •••• , , ••• 
, 
o 
(J~ 
u 
u 
o 
I~~r 
n 
0 
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.. 
(8) Ar. you worried that you Might suffer a heart attack or stroke? 
Very ~orried Slightly ~orried Not really ~orried 
1'3> ( 1, '0) \ !> 1 (~q.,,) lq5 lbb'7) 
19) On average, approximately how often do you visit your family doc lor? 
Every 1-2 months Every 3-6 months Once a year Less than once a year 
bS U4'1) IS\ (4-0'" ) (t)O elZ.·b) ~l (2.0'8) 
(10) ArE you interested 1n your general health? 
----
Vel'y interested Fail'ly interest.ed N.)t int.erested 
,211 (so' 0) loS (4k'4-) 'A (t·') 
(11) Are you careful about your diet, smoking etc, to make sure you keep healthy 
Very careful Quite careful Not careful at all 
~$ (Ig·g) :z.q 7 (b7'3) ~I (,3·8) 
(12) Have you recently - say in the last few years- taken any action to improve your 
general health, eg by changing 
If Yes please specify 
Diet N0r==l-------------------------------------------------
~ 
C43*c.) 
NO~-------------------------------------------------
e!J 
n,(·'l) 
NO~-------------------------------------------------
111 IQo (If-;1,) $elt·tkdar,J non-sty\oke~ 
';"7) 
No r~ ------ -------- --- ------ --------------- ----------- ----r~ 56 (12'7) Stl~- d"'c/t(r,d non-d\"inkers 
(bb·1) 
-2-
Wo~:t 
o 
.. 
.. 
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PleAse aMwer the following questions by putting a tick in t.he appropr iat.e box [ZJ 
For .xa.ple with the first question, if you get on very well with your fAMily doctor put 
• tick in the ·Very ttuch So" box; if you do not get on well wi th hi. put your tick in 
tJw -No- box,etc. 
PleAse answer all ~tions, and tick only one box for .ach answer. 
There are no right or wrong answers, and it is i.portant that your an~wer~ indicat..e how 
you really feel about each question. 
Very 
ttuch So 
Ves Uncertain No Definitely 
Not 
Do you get on well wi th your I~ I l ~8 Sit II I 
~ ~~~~~~_~~~~~:: ______________________ ~L~~~~---- _~~~2___ __~~~)___ __~~~~___ __~~:~ __ _ 
~ ~~_~~~_~~~~~~:~:=~_~~:_~~~~_~~~~~~:_~~~-~7~~L _~~~~1~~_ ~~_~~:~___ ~_~~~:!J__ _~JE~~) __ _ 
Do you fee I you can ask you r 5'3 31 It, ~ Xl 1-
doctor for any information you 
)) want about. your health or treatment'! (1 2.0 ) (7/'S) (9' o) lb,') (0'4-) 
------------------------------------~-------- --------- ----------
Do you think that you shouldn't ask 
your doctor about any treatment he 
~ gives you because he will tell you 
all you need to know? 
----------------------------------- ~--------
Do you think doctors dislike \5 ~) patients who ask too many questions~ (~."') 
------------------------------------~--------
If your doctor offered you a check 
up to find out if you were at risk 9 of developing a heart attack or 
stroke, would you want to have 
this check-up? 
------------------------------------~--------
If you didn't really want ~ check 
~ up like this, would you find it 
easy to say no to your doctor? 
------------------------------------~--------
If you~ doctor advised you to 
change your diet and cut out fatty 
, foods like butt.er, would it be easy 
for you to follow his advice? 
-----------------------------------
3~ 
(B·g) 
~--------
lOS 
(Z:~'7) 
l.q4 
(bb-I) 
---------
;z. g, 
US·",) 
---------
172. 
(bl'S) 
---------
" 
. (2.,C;) 
----------
'32-
(,.1.) 
----------
5"; 
(t,·o) 
----------
s 
u·,) 
---------
8(, 
(.I q. 4) 
---------
bS 
(t~'1) 
---------
II 
(z.·S) 
0 
-
----------
b 
u·~) 
----------
5 
(/. r) 
----------
If your doctor advised you to give V up snlok i ng would you find it very" lq4- 33 8fs ~ 
~~:~_~~_~~_=~: ______________________ ~J'+~~~--- _i~~:.~ ____ (1.:5) ______ \liJJ ____ ~t~ ____ _ 
~ 01:> YI)U n-. i nd ha v i ng a blood samp leg l~ 3 1 S It- 4- g ~ ~:~~~~ _______________________________ lt~) ____ -t~:~i---- _1~~:t) _____ L~_o_·~ __ . _ -,-o:j ____ _ 
Iy Do blood p,'essure tests wor,-y you? ~ lOC".S) '1(0'<") 'lSt~o.S) S"~(r~.\) 
-----------------------------------
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WIlN TZV 
D{;·~ 
rr (0 (2.·3) 
• 
Do you like the idea of having 
\') regular check-ups by y,~ur doctor? 
If you were at risk of developing a 
heart attack or stroke would you 
13) ""ant your doc tor to tell you 
straight? 
If you were at risk of developing a 
H_\ heart attack or stroke, would you 
"'7 rather not kn()w about it? 
Would beIng at risk of heart attack 
or ~troke, motivate you to change 
your habits if the doctor advised 
~ this, even if ybu found it hard to 
change? 
Do you thir-k preventive medicine -
ego regular health checks to help 
prevent heart attacks and strokes,-
~ IS a good use of Health Service 
tIme and money? 
Do you think that preventive 
IV m~dicine should be offered mainly 
to middle-age people? 
Do you think it's ~ good idea to 
I~ offer it to people in their 60s? 
-----------------------------------
Is it silly to offer preventiv~ ~ medicine to people over 701 
-----------------------------------~ 
00 you think that family doctors 
are too busy dealing with people 
~) who are already ill, to spend their 
tIme on preventive medicine and 
health educ.lion? 
-----------------------------------
00 you think family doctors should 
J~ involve their patients with medical 
research' 
-----------------------------------
If doctors think cert~in pills may 
help in holding off possible heart 
ll) attacks and strokes, do you think 
It is a good idea for family 
doctor~ to invite their p~tients to 
help WIth the testing of these 
pi lls 
-----------------------------------
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Very Ves 
filuch So 
S;. (111) 
"- '7 
('7'Z,) 
--------- ---------
I"!>~ 2. g'-7. 
c 30·1) (&,1") 
--------- ---------
if .t" 
(~ ·et) (t.,b) 
--------- ---------
Ito 2-7b (2.4 .~) (b2.·4-) 
--------- ---------
13'+ 173 
( ~o-~) (bl'B) 
--------- ---------
12- ql 
c.z.. 1) (l,D'b) 
--------- ---------5", 
,0'2. 
ll~'3) 
~--------- _.5~!~~ ___ 
b Cf-I 
(I'U 
--- ----
_ ~j':'~L ___ 
2.&:' r Sl 
(S·.,) (~.,) 
~---------
---------
\4 Ib1 ( 3·1-) (~I·2.) 
--------- ---------
10 l08 ('Z..~) t47· o) 
-4-
Uncert.ain No 
"g ;l.b 
(1:,-3) l$~) 
---------- ---------
10 ~ 
l '2,..,!») (t'8) 
---------- ---------
'1 :1..74 (Cf.<~) (bG- 0) 
~----------
---------
Ib '34-(,!t-'-) [7-7) 
---------- ---------
,~ /(;, 
lZ.-~) (l-b) 
~---------- ---------
4-0 2Sb 
("0) CS/. cr) 
~---------- ---------
3~ ~g 
(1·7) l8'''~ 
---------- ---------
~. ,)J/7 
_ ~.:!l ____ -~]-.:?)---
7S 131, 
(17·0) (30·g) 
---------- ---------
l~\ (0, 
a.,.~j (U4o-7) 
---------- ---------
• 
1Ilf- ~2. 
(2..S ·f) ( lO·r) 
Definitely 
Not. 
3 
c.1) '7) 
----------
, 
(0'2.) 
----------
105 
(2.~. 7) 
----------
0 
-
----------
2-
lo'S) 
----------
'3., 
(g.g) 
----------
\ 
(O'L) 
----------
SG-
_~!-:2) _____ 
Ib 
CS'hJ 
----------
10 
(z.~ 
---- ----
J'3 
(l..~) 
U~ II <2.·S) 
• 
00 you think that doctors involved 
in research, often use their 
20 patients as 'guinea pigs'? 
00 you think that when family 
doctors undertake medical research, 
o they may become more co~cerne~ with 
1 their research than theIr patIents? 
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Very Yes 
Pluch So 
)1 IbL. 
(t.') (~l-S) 
--------- ---------
1\ 1)..7 
(t·S) ( lB'7) 
-. ---------
---------
00 you think your doctor would 
~) alw_ys do what's best for you? 
00 you dislike giving a lot of 
~ personal information on forms? 
If you had to fill in a long 
questionnaire before having a 
~ health check ,would this put you off 
II having the health check? 
Are you worried about the possible 
~ 2?-; side effects of pllls? 
00 you think that laking pills for 
~ a long time could give you cancer? 
-----------------------------------
Are you worried that if you take 
~ pills for a long tlme you could get 
addicted to them? 
-----------------------------------
00 you think that if you take pills 
for ~ long time to try.to prevent 11 things, they may not work when you 
re~lly need them? 
----------------------------------
Would you mind taking low dose 
~) pills every day to keep you 
healthy? 
----------------------------------
If you were already taking pills, 
ego for blood pressure, would you 
~~ object to taking more pills to hel 
with medical research? 
----------------------------------
Would you be worried that your 
doctor might take you off good 
~) pliis you are ~lready taking, if h 
w.nted you to help in the testing 
of other medicines? 
----------------------------------
-
-
p 
-
e 
-
5S 1.7'1 
_~~.:!2 ___ -!~~.:Q_--
'Lt , 4-1 
l3'L) 
----- ---
(~, oDtj 
-- --- --
tr bo 
lo.~) (3-") 
--------- ---------
Sir lS7 
_11!: __ ~ __ ( ~,.1) 
---------
b 4-lt 
(I'U __ l..1~:~2 __ 
---- ----
3S ~3C. 
t1''U 
---- ---
_~~}":!l __ 
!tt 2.4-i 
tb '-b) ($b.'.) 
--------- ---------
rb 1'3.0 
(!>.I.) ( 2.'\. \to) 
--------- ---------
16 I '}S 
t~·b) (4ft: I) 
--------- ---------
, 
It ( &!S' 
( z.·S) (~t ·s) 
-s-
Uncert.~in 
{hi, 
(ll'C) 
----------
f4-7 
(~1·Z.) 
----------
E,Z 
1I4-1) 
----------
2.2.. 
IS·o) 
----- ----
1') 
lE,'b) 
----------
4-b 
(\-o) 
----------
2."2 
(4-1'0) 
----------
5'3 
--~!:~---
. 
92-
Ltg·S) 
----------
~7 
ll2..~) 
----------
81r 
(,,-0) 
----------
Sf' 
(,.,-1) 
No Definitely 
Not 
--
S, 3 
{le.l) (0·1) 
--------- ----------
1ll-1.. 5 
c~z.·,) ( "t.) 
--------- ----------
'34- 4-
(1-1) (o .. ~) 
--------- ----------
2.4-1 '7 _lj'_4:.·~J __ (3'V-
---- -----
.2. ~ I 4-~ 
(bS'r) ( lc-l) 
--------- ----------
r?2. 4 
__ (L(:~) __ lO-c=,) 
----- ----
lSI lS-
_J._llt:·~l __ l 'S .~.2 
----- ---
(o~ 3 
(z.~·SJ LO'7) 
---------
----- ----
7~ I (,,,·sJ (1).2.) 
--------- ----------
:ut-. rio 
-~~~-~)-- ( \.1..) 
----------
13e> 10 
(Z1·lt) (2.'3) 
--------- ----------
14-?> 
" ( ;2.·1) C.1-l4-) 
O~"l 
\)~ 
OI'IL'1 
..., 
rJ 
Ua 
B68~ 
( o 
-3) it 
~-I)IY' 
~ 
-
0 
.1 
9 I 
oj) u 
.1: T-
7 (j. 
{J 
I 
(1 
, 
( 
tJ 
rl 
U 
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If your doctor asked you to test a 
~ pill, and you didn't really want to 
Y would you find it hard to say no? 
-----------------------------------
If your doctor asked you to take 
part in pill testing, would you be 
,) frightened to refuse in case you 
upset your doctor? 
V.ry 
"",ch So 
3 
CO'1) 
---------
2-
(oos) 
---------------------------------------------. 
00 you think stress and personal 
~ problems can affect people's blood 
n, pressure? 
104-
(~~·s) 
----------------------------------------------
01:> you think that rela:..-:ation can 
~ help blood pressure? 
-----------------------------------
If people are at· risk of developing 
a heart attack or stroke, do you 
~ think that medicines are the only 
things that can help? 
-----------------------------------
00 you think that people who have 
blood pressure problems might need 
~ help in learning to relax, as well 
as having pills? 
70 
_ ~q~-Jl-----
1 
(0'2..) 
-1----------
/:'7 
liS' .\) 
------------------------------------1----------
00 you think that some pe1jple wi th 
blood pressure problems could be 
o helped by being taught to cope with 
stress? 
-----------------------------------
If your doctor invited you to have 
~ a health check, would you be 
pleased to accept? 
-
7g 
(n.I,,) 
---------
10<- -
C2.lt-,o) 
-----------------------------------
- ---------
If you were at risk of developing a 
heart attack or stroke and your 
o doctor invited you to take part in 
testing medicines ~hich might hold 
off these possible conditions, 
would you agree to do so? 
------------------------------------
3"S 
t7'S') 
-b -
V.s 
~l 
(to'b) 
---------
'7 
(l·i) 
---------. 
30s 
('-G).el) 
--------_. 
'3'30 
_111l:V ____ 
33 
(1'S) 
1----------
'317 
(?b·l..) 
1----------
'330 
C 1~'?) 
~---------
~ ,\ (+,. c. ) 
~---------
231 
(S'2"> ) 
~ 
us~ 
joN"'1 
"-
UncertAin No Oefinit..ly , 
Not 
-- 11.' ) 
28 199 75 (b·l) (b~·l) Ub·S) 
----------. 
--------- ----------
0"1 
~ 
,q '310 b'1 (Ct· !t) (7~'7) (ir'b) 
---------- --------- ----------
(,-, 
l'1 S 0 
c.s.oJ {j.,) -
-----------
---------
-------_._- Lj ;U~ 10 0 
__ 1~~ ___ 
-J1-.:11 ___ -
-------_._-
So :411.. b'2. 
(1\·1) (~.\) (14-- \) 
1---------------------1-------_._-
~,~~ 
1S CJ 0 It. 
(S'7) l. 'L.o) -
~---------- ~--------- ~-------.--
" 
(oft 
l5 3 , 0 ($"7) lO'1) (0'2..) 
~---------- --------- ----------
Fli 
"3 0 " 0 (. 'Z..o) l.o.~ 
----------- 1----------1-----------
All 
130 lrl ( 0 ( 'LC(. 't) ('·7) (O·l.) 
.. 
II 
Worries that your doctor might tell 
h you to lose weight or change your 
'I diet in some way 
~ Warr ies that your doc tor might tell 
~ you to give up sn',ok i ng 
Very 
~ch so 
-14- Q.. 
Yes Uncertain No IMfinitely 
Not. 
3 " (f 3 S', Y-b 
If'.:.?l____ _{}:..!)____ __CJ..:?1____ _(.~~~____ _l!.~·!!:l __ . __ 
~ 
_fo..·~l ___ _ 
If your local surgery was involved in a health promotion study which offered people the 
chance to have a check up by their doctor, who would you most like to ask you if o/0u 
would like to lake part in it 
Your own doctor The practice nurse The receptionist please tick just one box rl~ 
All things considered, including the best use of Health Service time and money: 
who do you think would be the besl people to do the heal th checks for preventive lI'Iedit: in~ 
prlJjec ts? 
Family doctors Practice nurses Health Visitors Other specially trained people 
l 
FInally, please check that you have answered all the questions, and use the space over 
the page to nlake any comments you would like to make about preventive ft\edicine health 
checks,or pill testing that have not been covered here. 
Also please gi ve any comnlents you would 1 ike to mD:& about thi' questionnai re. 
T~nk you for your ti •• and co-q»ration in ca.pleting thiw questionnaire. 
R.lletab.r, there is no need to use a st...., wt.n you post this ~ck in the enc lased 
FREEPOST envelope. 
-7-
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APPENDIX 5 
COpy OF LETTER SENT TO GPs ON CRANFIELD APU HEADED NOTEPAPER 
20th June 1986 
Dear Dr. 
Re your telephone conversation with Dr. John Muir on 
Thursday 19th June, I enc lose, for the a t ten t i on of you and your 
partners, 5 copies of the questionnaire which I would like to 
distribute to patients at your practice. 
The object of this survey is to try to identify factors which may 
influence participation in preventive medicine projects and in 
associated clinical trials. The survey is particularly relevant to the 
Health Promotion study with which Dr. Muir is involved, but the 
questionnaire is also designed to yield some more general information 
about public attitudes towards preventive medicine and clinical trials 
run by GPs. 
The questionnaire was developed from a series of depth interviews and 
represents factors raised by informants in these interviews. The 
questions are quite general, and it is not possible to identify 
individual patients, doctors, or even practices from the questionnaire 
items. 
Should you agree to co-operate with this study, I would like to 
distribute 100 questionnaires to patients in your practice. Because 
proper assessment and analysis of response rates requires that certain 
details be recorded for all people approached, I suggest that I 
undertake this distribution myself so as not to overburden your 
reception staff. The questionnaires are to be completed at home and 
returned to me in Freepost envelopes, so the approaches made to 
potential respondents are brief and should not cause any disruption of 
surgery schedules. 
I look forward to hearing from you. 
Yours Sincerely, 
Rachel Asch 
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APPENDIX 6 
STANDARD REQUEST FOR PARTICIPATION 
Excuse me, we're doing a survey of people's opinions about family 
doctors and preventive medicine run in general practice. We don't need 
your name or your doctor's name, it's just opinions we are after. 
It involves filling in a questionnaire, which means basically just 
ticking boxes, but it does take about 15 minutes to complete, so we're 
asking people to take it home to do in their own time and return to us 
in this freepost envelope. Would you be willing to help us? 
Please remember you do not need a stamp for this, just put your 
finished form back in this envelope, pop it into any post box and it 
will get back to us on the freepost. 
Thank you very much for your time and co-operation. 
-17-
APPENDIX 7 
RESPONSE SHEET 
No. Sex Age Group Occupation Taken Refused 
-----------------------------------------------------------------------
-----------------------------------------------------------------------
-----------------------------------------------------------------------
-----------------------------------------------------------------------
-----------------------------------------------------------------------
-----------------------------------------------------------------------
-----------------------------------------------------------------------
-----------------------------------------------------------------------
-----------------------------------------------------------------------
-----------------------------------------------------------------------
---------------------------
--------------------------------------------
---------------------------
--------------------------------------------
Taken 1 2 345 6 M F M F 
clf c/f------------------
run tot. 
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APPENDIX a 
RATIONALE FOR ANOVAS ON METAVARIABLES 
Analysis of variance tests are parametric tests, for which a basic 
requirement is interval level data. The raw data collected in the study 
was only of ordinal level, but transformation of the data did render it 
suitable for anova testing. The transformation involved computation of 
condescriptive statistics and standardised (Z) scores; and factor 
scores, for every respondent, on each of the variables comrising the 
metavariable. Thus the transformed data was, virtually, of interval 
level, since there was a standard interval between scores. The 
transformation was performed on selected metavariables, and the 
procedure employed for each metavariable was as follows:-
(1) From pr inc i pa I componen ts ana 1 yses, metavar i ab I es were i den t i f i ed 
(each main component represented one metavariable). 
(2)The most highly weighted variables within each component were the 
constituent variables of the metavariable. 
(3) For any given metavariable, Z scores were computed for every 
respondent, for each of the constituent variables. 
(4) The z scores for each variable were then muliplied by the 
appropriate factor weighting value, thus giving a factor score for each 
variable. 
(5) The sum of the factor scores for all consi tuent variables of a 
metavariable, represented the metavariable score. 
(6) The metavariable score for each respondent was then used in the 
an ova test. 
An example of the type of computer commands used to transform the data, 
may clarify the procedure, and one will be presented below. 
Example 
Principal component 1 - constituent variables= Leadmts, medtsts, strip, 
fearprob. The factor weights were: Leadmts .855, medtsts .893, str ip 
.612, fearprob .792. 
Command 1 - Condescriptives on above variables 
Command 2 - save Z scores 
Command 3 - compute metavariable score 
<'893 x Z score of medtsts) + <'612 x 
score of fearprob) 
<. 855 x Zscore of Leadmts> + 
Z score of strip) + <'792 x Z 
The metavariable score is computed thus, for each respondent, and it is 
these scores which are then used in Anova tests. 
- 19 -
APPENDIX 9A 
Details of Crosstabs in Table 22, p80 
OBSERVED 
EXPECTED 
ROW I 
SAGE 
COL I ROW TOT 
TOT I 1 2 3 4 I 
~2~1--~2~1--~37~-4-1-------
WILLTEL 30,1 22,1 46,3 21,5 27,6 
1 17,5 17,5 30,8 34,2 
19,3 26,3 22 52,6 
4,8 4,8 S,5 9,4 
OBSERVED 
EXPECTED 
ROW I 
SAGE 
COL I ROW TOT 
TOT I ~1 :--~2 ~_3~--.;4;.-.~1~_ 
49 33 75 26 
MEDRES 46,7 34 69,6 32,7 2,5 
1 26,8 18 41 14,2 
44,S 41,3 45,7 33,8 
11.4 7,7 17,4 6 
-------- ------------------------ ----------------- -------------------------
2 
3 
12 7 
8,5 6,3 
35,3 20,6 
11 8,8 
2,8 1,6 
76 52 
70,4 51,7 
27 18,5 
69,7 65 
17,5 12 
8 7 
13,1 6,1 
23,S 20,6 
4,8 9 
1,8 1,6 
123 30 
7,8 
108,5 50,4 64,6 
43,8 10,7 
73,2 38,S 
28,3 6,9 
Col Tot 25,1 18,4 38,6 17,9 
OBSERVED 
EXPECTED 
ROW 1 
SAGE 
COL I ROW TOT, 
TOT I 1 2 3 4 I 
CUTBUT ~6"';'2 -""""5';;"'4 -~1 ~33~-6~1-----
1 79,S 56,6 120,3 53,7 71,6 
20 17,4 42,9 19,7 
55,9 68,4 79,2 81,3 
14,3 12,5 30,7 14,1 
2 40 20 53 18 
33,4 24,3 49,8 23,4 
30,S 15,3 40,S 13,7 
36,4 25 32,3 23,4 
30,4 
OBSERVED 
EXPECTED 
ROW 1 
9,3 4,6 12,3 4,2 
21 
29,9 
17,9 
19,1 
4,9 
27 36 
21,7 44,S 
23,1 30,8 
33,8 22 
6,3 8,4 
33 
20, 
28, 
42, 
7, 
25 , 5 18 , 6 38, 1 1 7 , 9 
SAGE 
COL I ROW TOT 
TOT I 1 2 3 4 I 
27,1 
DOBEST ~71:----6":"::5~"':"'::12:":"5---:7:":"1-'T---
1 84,S 59,9 127,6 59,9 76,9 
21,4 19,6 37,7 21,4 
64,S 83,3 75,3 91 
16,4 15 28,9 16,4 
------ ------------------------- ------------------- ------------------------ -------
2 19 11 22 
13,6 9,7 20,6 
35,8 20,8 41,5 
17,1 13,9 13,1 
4,4 2,5 5,1 
1 
9,2 12,2 
1,9 
1,3 
,2 
2 26 9 21 6 
15 , 8 11, 2 23 , 8 11, 2 14 , 4 
41,9 14,5 33,9 9,7 
23,6 11,5 12,7 7,7 
6 2,1 4,9 1,4 
------------------ ------------------------ -------
3 30 14 13 
17,9 12,8 27,2 
42,9 20 18,6 
27 17,7 7,7 
6,9 3,2 3 
13 
12,1 16,2 
18,6 
17,3 
3 
3 
------ ---------------------------------------------
COL TOT 25,6 18,2 38,8 17,3 
13 4 20 
9,7 6,9 14,6 
34,2 10,5 52,6 
11,8 5,1 12 
3 ,9 4,6 
1 
6,9 
2,6 
1,3 
,2 
8,8 
--------------------------------
25,S 18,1 38,4 18,1 
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OBSERVED OBSERVED 
EXPECTED SAGE EXPECTED SAGE ROW I ROW S 
COL I ROW TOT, COL S ROW TOT TOT S 2 3 4 S TOT S 1 2 3 .4 % SIDEFFS 70 44 1.40 S5 OFFGDPLS 40 .48 67 .42 1 78,8 55,4 119,3 55,4 71 1 50,S 35,S 76 35 .45,5 22,7 1.4,2 45,3 17,8 20,3 24,.4 3.4 21,3 63,1 56,4 83,3 70,S 36 61,S .40,1 5.4,5 
16, 1 10, 1 32,2 12,6 9,2 II, 1 IS,S 9,7 
. 
-------
------------------------
------------------ -----------------------,--------
2 17 6 10 7 2 30 9 .40 8 
10,2 7,2 15,4 7,2 9,2 I 22,3 15,7 33,6 15,5 I 20,1 ~ 42,5 15 25 17,5 34,S 10,3 .46 9,2 
15,3 7,7 6 9 27 11,5 24 10,.4 , 
3,9 1,4 2,3 1,6 6,9 2, 1 9,2 1,8 
------- ------------------------- ------------------ ----------------------- --------
3 24 28 18 16 3 41 21 60 27 
21,9 15,4 33,2 15,4 38,2 26,8 57,S 26,S 34,.4 
27,9 32,6 20,9 18,6 27,S 14,1 .40,3 18, 1 
21,6 35,9 10,7 20,5 36,9 26,9 35,9 35,1 
5,5 6,4 4,1 3,7 9,5 .4,8 13,9 6,2 
------- ------------------------------------------- ----------------------- --------
COL I 25,S 17,9 38,6 17,9 25,6 18 38,6 17,8 
OBSERVED OBSERVED 
EXPECTED SAGE EXPECTED SAGE 
ROW 1 ROW 'l 
COL S ROW TOT, COL S ROW TOT 
TOT S 1 2 3 4 I TOT S 1 2 3 .4 S 
MEDTST 4 .4 19 1 FEARPROB 8 5 27 23 
1 11,6 8,1 17,.4 8 10,5 1 16,1 11,3 2.4,3 11,3 1.4 ,5 
8,9 8,9 .42,2 40 12,7 7,9 .42,9 36,S 
3,6 5,2 11 ,.4 23,7 7,2 6,.4 16, 1 29,S 
,9 ,9 4,4 4,2 1,8 1 , 1 6,2 5,3 
------ ------------------------- ------------------ -------------------------~-------
2 0 2 7 5 2 9 4 1.4 6 ! 
3,6 2,5 5,4 2,5 3,3 8,.4 5,9 12,7 5,9 7,6 
0 1.4 ,3 SO 35,7 27,3 12, 1 .42,.4 18,2 
0 2,6 4,2 6,6 8,1 5,1 8,3 7,7 
0 ,5 1,6 1,2 2,1 ,9 3,2 1 ,.4 
------
------------------------- ------------------ -------------------------~-------
3 107 71 1.40 53 3 94 69 127 .49 : ! 
95,8 66,4 143,2 65,6 86,3 86,5 60,8 130,9 60,81 77,9 
28,8 19, 1 37,7 1.4 ,3 27,7 20,4 37,S 14,SJ 
96,4 92,2 84,3 69,7 8.4,7 88,S 75,6 62,8 
24,9 16,5 32,6 12,3 21,6 15,9 29,2 11,3 
------ -------------------------------------------- ------------------------- -------
25,8 17,9 38,6 17,7 25,S 17,9 38,6 17,9 
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APPENDIX 9a 
Details of Crosstabs in Table 23, p81 
OBSERVED OBSERVED 
EXPECTED HTBP EXPECTED HTBP ROW I ROW I 
COL I ROW TOT, COL S ROW TOT TOT I 2 S TOT I 1 2 I CUTBtJT 76 y TESTPLS 67 150 
1 75,9 234,1 71 ,6 1 52,4 164,6 49,9 
24,5 75,5 30,9 69,1 
71 ,7 71,6 63,8 45,5 
17,6 54 15,4 34,5 
------ ------------------- ---------------------- -------------------- ----------
2 7 46 2 21 93 
13 40 12,2 27,5 86,5 26,2 
13,2 86,8 18,4 81,6 
6,6 14,1 20 28,2 
1 ,6 10,6 4,8 21 ,4 
------- ------------------ ----------------------- ------------------- ----------
3 23 47 3 17 87 
17, 1 52,9 16,2 25,1 78,9 23,9 
32,9 67,1 16,3 83,7 
21 ,7 14,4 16,2 26,4 
5,3 10,9 3,9 20 
-------------------------------------------------- ------------------- ----------
24,5 75,5 24,1 25,9 
OBSERVED OBSERVED 
EXPECTED HTBP EXPECTED HTBP 
ROW I ROW S 
COL I ROW TOT, COL I ROW TOT 
TOT I 1 2 I TOT J 1 2 I 
LOWPLS 26 119 OFFGDPLS 53 144 
1 34,2 110,8 33,5 1 46,9 150,1 45,5 
17,9 82,1 26,9 73,1 
25,5 36 51 ,5 43,6 
6 27,5 12,2 33,3 
-------- ---------------- -------------------- ------------------- -------------
2 2 55 2 10 77 
13,4 43,6 13,2 20,7 66,3 21 
3,5 96,5 11 ,5 88,5 
2 16,6 9,7 23,3 
,5 12,7 2,3 17,8 
--------- ---------------- -------------------- -------------------~-------------
3 74 157 3 40 109 
54,4 176,6 3,3 35,4 113,6 34,4 
32 68 26,8 73,2 
72,5 47,4 38,8 33 
17, 1 36,3 9,2 25,2 
------------------------------------------------------------------- -------------
23,6 76,4 23,8 76,2 
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APPENDIX 9C 
Details of Crosstabs Table 24, p81 
OBSERVED OBSERVED 
EXPECTED ACCPTCT EXPECTED ACCPTCT 
ROW I ROW I 
COL I ROW TOT, COL I ROW TOT 
TOT I 1 2 3 I TOT I 1 2 3 I 
TESTPLS 175 34 . 9 110REPLS 98 78 33 
1 131 ,9 64,4 21 ,6 50,3 1 125,8 62,4 20,8 48,4 
80,3 15,6 4,1 46,9 37,3 15,8 
66,8 26,6 20,9 37,8 60,S 76,7 
40,4 7,9 2,1 22,7 18, 1 7,6 
-------- ------------------------ ------------------- ------------------------ -------
2 50 60 4 2 42 40 2 
69 33,7 11,3 26,3 50,6 25,1 8,4 19,4 
43,9 52,6 3,5 50 47,6 2,4 
19, 1 46,9 9,3 16,2 31 4,7 
11,5 13,9 ,9 9,7 9,3 ,5 
-------- ------------------------ ------------------- ------------------------
-------
3 37 34 30 3 120 11 8 
61 , 1 29,9 10 23,3 83,7 41,S 13,8 32,2 
36,6 33,7 29,7 86,3 7,9 5,8 
14,1 26,6 69,8 46,2 8,5 18,6 
8,5 7,9 6,9 27,8 2,5 1,9 
-------- --------------------------------------------------------------------- -------
CoU 60,S 29,6 9,9 60,2 29,9 10 
OBSERVED 
EXPECTED ACCPTCT 
ROW I 
COL I ROW TOT 
TOT I 1 2 3 l 
OFFGDPLS lOS 61 30 
1 117,3 59,1 19,6 45,S 
53,6 31 , 1 15,3 
40,7 46,9 69,8 
2.4,.4 14,2 7 
--------- -------------------------------
2 I .44 .40 3 
52,1 26,2 8,7 20,2 
50,6 .46 3,.4 
17, 1 30,8 7 
i 10,2 9,3 ,7 
I 
---------r-------------------------------
3 109 29 10 
88,6 .4.4,6 14,8 3.4,3 
73,6 19,6 6,8 
42,2 22,3 23,3 
25,3 6,7 2,3 
---------
-------------------------------
59,9 30,2 10 
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APPENDIX 9D 
Details of Crosstabs Table 25, p82 
OBSERVED 
EXPECTED WHERE 
ROW I 
COL I 
TOT I 1 2 3 
MEDRES 43 26 38 
1 38 , 5 25 , 4 41 ,.8 
23,5 14,2 20,8 
47,3 43,3 38,4 
9,9 6 8,8 
4 
33 
35,5 
18 
39,3 
7,6 
1= Drs, L,B, 2=Drs, M,K, 3=Age Concern 
4=Shopping Centre 5=Station 
ROW TOT 
5 I 
43 
41,8 42,3 
23,5 
43,4 
9,9 
-------- ------------------------------------------------~------------2 27 18 21 26 39 
27,5 18,2 30 25,4 30 30,3 
20,6 13,7 16 19,8 29,8 
29,7 30 21,2 31 39,4 
6,2 4,2 4,8 6 9 
3 21 16 40 25 17 
25 16,5 27,2 23,1 27,2 27,5 
17,6 13,4 33,6 21 14,3 
23,1 26,7 40,4 29,8 17,2 
4,8 3,7 9,2 5,8 3,9 
--------
----------------------------------------------- -------------
con 
OBSERVED 
EXPECTED 
ROW I 
COL I 
21 13,9 22,9 19,4 22,9 
WHERE 
TOT I 1 2 3 4 5 
DOBEST· ...... .......;7~8 ---4~0~----:8~8-----:;:;..;61:------::6:-::;-7 -----
ROW TOT 
I 
1 70 46,9 76,2 63,1 77,7 77 
23,4 12 26,3 18,3 20,1 
85,7 65,6 88,9 74,4 66,3 
~ 18 9 , 2 20 , 3 14, 1 15 , 4 , 
------~---------------------------------------------------------------2 .~ 10 13 8 12 19 
,: 13 8,7 14,1 11,7 14,4 14,3 
16, 1 21 1 2 , 9 1 9 , 4 30 , 6 
11 21,3 8,1 14,6 18,8 
2,3 3 1,8 2,8 4,4 
------ ----------------------------------------------------------------
3 3 8 3 9 15 
8 5,3 8,7 7,2 8,8 8,8 
7,9 21,1 7,9 23,7 39,5 
3,3 13, 1 3 11 14,9 
,7 1,8 ,7 2,1 3,5 
-----------------------------------------------------------------------
21 14,1 22,8 18,9 23,3 
- 24-
OBSERVED 
EXPECTED WHERE 
ROIJ I 
COL I ROW TOT 
TOT I 1 2 3 4 5 % 
OFFGDPLS 45 23 51 45 35 
1 41,6 28,4 44,8 38 46,2 45,7 
. 22,6 11 ,6 25,6 22,6 17,6 
49,S 37,1 52 54,2 34,7 
10,3 5,3 11,7 10,3 8 
--------- -----------------------------------------------
I ____________ 
2 12 20 15 16 24 
18,2 12,4 19,6 16,6 20,2 20 
13,8 23 17,2 18,4 27,6 
13,2 32,3 15,3 19,3 23,8 
2,8 4,6 3,4 3,7 5,5 
--------- ----------------------------------------------- -------------
3 34 19 32 22 42 
31,2 21,2 33,6 28,4 34,6 34,3 
22,8 12,8 21,S 14,8 28,2 
37,4 30,6 32,7 26,S 41,6 
7,8 4,4 7,4 5,1 9,7 
--------- ----------------------------------------------- -------------
20,9 14,3 22,S 19, 1 23,2 
SECTION B 
APPENDICES PERTAINING TO 
THE SECOND STUDY 
(APPENDICES 10 21 ) 
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APPENDIX 10 
SELECTION OF POTENTIAL INTERVIEW RESPONDENTS 
Selection of potential respondents was performed by the author with the 
help of practice managers and receptionists. At one practice, the 
age/sex register was kept in a card-index system, whilst at the other 
practice the age/sex register was computerised. Thus the procedure used 
for informant selection was slightly different for the two practices and 
will be described separately. 
In both cases the objective was to obtain a random selection of patients 
within an age/sex/'class' quota system. There was to be numbers in each 
of the 12 categories shown below. 
SAMPLING CATEGORIES 
SOC IO-ECONOMIC 
GROUPINGS 
Group A 
SEX 
MALE FEMALE 
__ ~~=~~_l=~~~_ _~~=~~_l=~~~ _ 
__ ~~=~~_l=~~~_ _~~=~~_l=~~~_ 
'middle class' 65-75 years 60-75 years 
__ ~~=~~_l=~~~_ _~~=~~_l=~~~ _ 
Group B 
__ ~~=~~_l=~~~ ___ ~~=~~_l=~~~_ 
'working class' 65-75 years 60-75 years 
Selection From Card-Index System 
The card-index age/sex register system was comprised of a set of cards 
each bearing the name, address and date of birth of a patient currently 
registered with the practice. The name of the individual doctor with whom 
the patient was registered was also recorded on these cards. The cards 
were filed in small cabinets segregated by sex. For each sex, cards were 
grouped by year of birth and each new birth year was preceded by a card 
on which the number of registered patients born that year was recorded. 
Within each birth year cards were arranged in alphabetical order. 
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Male and female potential informants were selected separately by 
identical procedures which are detailed below. 
Firstly, birth years to be sampled for each age group were determined by 
the use of random number tables. For example, in the first age group, 
25-44, appropriate birth years were those between 1943 and 1962. 
Therefore the required number of years was selected from digits 43 and 
62. Use of random number tables meant that sometimes more than one 
patient was selected from a particular year. 
Secondly, when the sampl ing years had been determined the recept ionist 
looked up the appropriate record cards and read aloud the number of 
patients with that birth year who were currently registered. Again using 
random number tables, the author then selected a respondent from that 
year. For example, if the birth year was 47 and there were 248 women with 
that birth year registered; the first number in the tables between 1 and 
248 was chosen, (say number 036) and the woman whose card corresponded 
to that number was selected as a potential informant. 
To avoid unnecessary intrusion into the privacy of practice registers, 
the searching through cards for the appropriate number was performed by 
the receptionist, so that the author was given names only of selected 
persons and did not have access to the names of anyone else registered at 
that practice. 
Thirdly, the year of birth, name and address were recorded together with 
the name of the doctor with whom the potential informant was registered. 
The recept ionist was then asked to est imate from the address, or her 
knowledge of the patient, whether that person was most likely to be in 
the top or bottom three socio-economic groups, and a mark was made in the 
appropropriate cell of the sampling categories matrix. 
This procedure was repeated until one of the socio-economic group cells 
had x names in it, and was about to be over-represented by the addition 
of another person est imated to fall wi thin it. When this occured, the 
recept ionist was asked to go backwards or forwards one card at a time, 
until a person estimated to be in the corresponding unfilled cell was 
located. This method was continued until both socio-economic cells for 
the given age range and sex were filled. 
The same procedure was followed for all age groups and both sexes. 
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Selection From Computerised Registers 
An abridged printout of the age/sex register was provided by the practice 
manager who assisted in the select ion of potent ial respondents. The 
printout gave very little detail of the patients. All that it provided 
was a series of names listed according to sex and 10-year age bands ie: 
25-34, 35-44, 45-54, 55-64,and 65-75. All registered patients of one sex, 
with birth years within a given decade were listed alphabetically. 
Using these lists, potential respondents were selected as follows:-
Firstly, the practice manager told the author the number of people on a 
given register, and the author, using random number tables, determined 
the selection of a potential respondent. Eg. if there were 365 females 
between 25-34, and the first random number chosen was 147, the 147th name 
on the list was the first one selected. This procedure was continued, 
using all appropriate lists, until the requisite number for each sex/age 
cell was obtained. 
The age ranges of interest to the study, generally spanned two print-out 
age groups. So, to obtain the necessary numbers for each study age-group, 
half the required number of potential informants were selected from each 
of the two corresponding register lists. 
Because the middle age range for women was 45-60, and the pract ice 
1 ists grouped women from 45-54 and 55-64, some women selected from the 
practice lists were too old for inclusion in this cell. When this 
happened, the selected women were allocated to the older age group and 
the selection of woman for the middle age group continued. 
Because these registers did not include addresses, it was not possible 
at this stage to estimate socio-economic status of potential informants, 
un 1 ess the prac t ice manager had persona 1 knowl edge of se I ec t ed peop Ie. 
Therefore, attention was paid only to ensuring equal numbers from each 
sex and age group. I t was hoped that wi th random sampl ing from a large 
register, adequate representation of both required socio-economic 
groupings would be achieved. Fortunately, when selection of potential 
respondents was completed and practice staff obtained addresses direct 
from the computer, it did appear that there was a fairly even spread of 
estimated socio-economic groupings. 
Dear (Name), 
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APPENDIX 11 
COpy OF FIRST INTERVIE~CANVASSING LETTER 
(wrItten on HMS Headed Paper) 
date 
We are conducting research into people's attitudes towards health checks 
and the testing of medicines. 
The type of heal th checks we are concerned wi th are those which are 
carried out to identify people at increased risk of disorders like heart 
attacks or strokes, so that steps can be taken to try to prevent these 
conditions occuring. We would also like to find out just how people feel 
about taking part in the testing of medicines, and we are currently 
developing a questionnaire to be used in a nationwide investigation of 
such attitudes. 
In order to get this questionnaire right, we need to discover the 
important things, both good and bad, that people associate with having a 
health check, and with taking part in the testing of medicines. 
To this end, we are conducting interviews with people who are willing to 
discuss their feel ings about these things, so that we can obtain the 
information we require for the development of our questionnaire. 
The interview lasts for about half an hour. Each one is private, and the 
only people present will be myself and the person being interviewed. No 
names or addresses are recorded in the interviews, and as well as being 
anonymous all information obtained will be treated in strict confidence. 
Your name was selected at random from the 1 ist of patients registered 
with your doctor. Of course, your doctor knows we are using this list, 
but he has no personal involvement in our study. He will not even know 
whether or not you agree to take part, and he will certainly not be told 
anything you say. 
You are, of course, under no obligation to take part in these interviews, 
but if you are willing to help in this matter please complete the 
attached form and return it to me in the envelope provided. 
If you decide not to take part, simply take no action, and we will not 
contact you again. 
Thank you very much for your time. 
Yours Sincerely, 
Mrs. Rachel Asch 
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To Rachel Asch 
I am interested in taking part in the interviews outlined above, and I 
consent to you contacting me again to arrange a convenient interview 
appointment. 
Name ________________________________________________________________________ ___ 
Address 
Telephone No. ____________________________________________________________ _ 
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APPENDIX 11A 
COPY OF AMENDED INTERVIEW-CANVASSING LETTER 
date 
Dear (Name), 
We are conducting research into people's attitudes towards health checks 
and the testing of medicines. 
We are not asking you to have a health check, nor to test any medicines. 
What we are asking for are attitudes and opinions to help us discover 
the important things, both good and bad, that people associate with 
these activities. To get our information right, we are interviewing 
people who are willing to discuss their feelings about these matters. 
We interview people in their own homes, and each interview lasts for 
about hal f an hour. No names or addresses are recorded in the 
interviews, and as well as being anonymous all information obtained will 
be treated in strict confidence. 
Your name was selected at random from the list of patients registered 
wi th your doctor. Of course, your doctor knows we are using this list, 
but he has no personal involvement in our study. He will not even know 
whether or not you agree to take part, and he will certainly not be told 
anything you say. 
You are, of course, under no obligation to take part in these 
interviews, but if you are willing to help in this matter please 
complete the attached form and return it to me in the envelope provided. 
If you decide not to take part, simply take no action, and we will not 
contact you again. 
Thank you very much for your time. 
Yours Sincerely, 
Mrs. Rachel Asch 
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To Rachel Asch 
I am interested in taking part in the interviews outlined above, and I 
consent to you contacting me again to arrange a convenient interview 
appointment. 
Name ________________________________________________________________________ ___ 
Address 
Telephone No. ____________________________________________________________ ___ 
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APPENDIX 11B 
COPY OF GP-COVERING NOTE TO THE CANVASSING LETTERS 
ON PRACTICE HEADED NOTEPAPER 
date 
Dear (Name), 
The enclosed letter is from Mrs. Rachel Asch who is a researcher 
investigating attitudes towards health checks and the testing of 
medicines. She is working with a team of doctors at Oxford University 
studying ways of reducing the number of heart attacks and strokes people 
suffer. 
In order to conduct her research properly, she needs to interview a wide 
range of people so that all sections of the population are represented. 
We agreed to let her see our list of registered patients so that she 
could select from it a random sample of names to approach with a request 
for interview. Apart from this, we have nothing to do with her research. 
Mrs. Asch has not seen your medical notes, nor will she ever do so. 
All she knows about you is your name, address, and age group. 
If you decide that you would like to take part in the interviews, you 
must contact her to arrange an appointment. If you do not return the 
form consenting to further contact, nothing more will happen. 
Whatever your decision, it will be known only to you and Mrs. Asch, but 
we believe this is an important project and hope you will feel able to 
help. 
Yours Sincerely 
(Dr's. Name) 
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APPENDIX 12 
INTERVIEW SCHEDULE 
I woul d 1 ike to ask your opin ions about two ma in issues. First 1 y I I d 
like to talk about health checks - in particular those intended to find 
out whether people are at risk of a heart attack or stroke. The second 
issue is that of clinical trials - medical studies in which people take 
part in the testing of medicines. 
We are really interested in two types of medicine-testing studies. 
The first type is the testing of new medicines,to find out about their 
treatment effects and their side effects. The second type is the testing 
of medicines already in use as remedies for some problems, to discover if 
they are also of value in the treatment or prevention of other problems. 
The questions are not intended to test your knowledge; but to help us 
find out what people really feel about these things. 
There are 3 seperate sets of question, and at the begining of each I will 
give you an outline of the particular aspect we would like to explore. 
The questions all follow the same basic pattern and you will be asked to 
list the advantages, disadvantages and anything else you assoc late wi th 
topic in question. I will also ask you to tell me any groups or 
individuals who may also be relevant to your considerations of that 
topic. 
Please remember that there are no right or wrong answers to any of the 
questions, it is only your personal opinions that are important to us. 
We do not keep notes of any names or addresses in these interviews, so 
everything you say is anonymous. The gist of what you say will help us to 
develop an appropriate questionnaire, but no one will ever know exactly 
what you have said. 
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Although we do not use any names or addressess, we would appreciate it if 
you would answer a few questions about yourself to give us some idea of 
what you are like in terms of age, sex, family and occupational 
background. 
Age: 
Sex: Male I [ Female n 
Marital Status: 
Married! 
Cohabiting o Divorced! Separated o Widowed D Single D 
Children - if you have children please mark how many in each age group: 
0-4 0 5-18 0 over 18 D 
Education and Employment: 
At what age did your full-t ime education 
college, university etc. )? ________________________ __ 
Do you have any professional or trade qualifications? 
If so, please specify 
Are you currently: 
end 
employed 0 
full time 
employed D sel f employed n unemployed D 
part time 
<inc luding 
lat homelparent 0 housewife 0 student 0 disabled 0 retired 0 
or carer __ 
other (please specify) ________________________________________________ __ 
If currently working, what is your job title? 
If you are unemployed or retired, what is (or was) your usual occupation? 
If you are married!cohabiting and do not have paid employment, what is 
(or, for retired people, was) the occupation of your partner(the head of 
the household) 
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The first topic I would like to explore concerns health checks to find 
out whether or not people are at risk of developing a heart attack or 
stroke. Many of the people at special risk of these disorders can be 
identified from fairly simple health checks done by family doctors (GPs) 
or their nurses. Once identified steps can be taken to reduce the risk. 
These checks involve questions about your own heal th and the heal th 
history of your family; and about your diet, smoking, drinking habits 
etc. Usually, all else that is required is for you to give a blood sample 
and have your blood pressure taken. 
I would like to know what you think about having a check-up like this, 
say within the next 3 to 6 months. 
I am not offering you the chance to have a check-up, I just want to know 
what you think about it. 
(1) w.hat do you see as the advantages of your having a check up like this 
to find out if you are at increased risk of developing a heart attack or 
stroke. 
(2) w.hat do you see as the disadvantages of your having this kind of 
check up? 
(3) Is there anything else that comes to mind when you think about having 
a check up to find out if you are at risk of developing a heart attack or 
stroke? 
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I would now like to know what you think other people may feel about your 
having a check up to find out if you are at risk of developing a heart 
attack or stroke. Again, think of you having this check within the next 3 
to 6 months. 
(4) Are there any groups or individuals, who you think would approve of 
your having a check up to find out if you are at risk of developing a 
heart attack or stroke? 
(5) Are there any groups or individuals who you think would disapprove 
of your having a check up to find out if you are at risk of developing a 
heart attack or stroke? 
(6) Are there any other groups or individuals who come to mind when you 
think about having a check up to find out if you are at risk of 
developing a heart attack or stroke? 
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I would now like to ask you what you consider to be the main causes of 
heart attacks and strokes; and what things might put people at risk of 
developing them. 
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In this section, I would like to ask you what you feel about taking part 
in the testing of new medicines. 
When new med i cines are deve loped they mus t undergo s tr i c t sc i en t if i c 
testing before they can be considered for general use. Most of this 
testing takes place in the laboratory, but in the end, medicines that 
are intended for use in humans, must be tested on humans. 
As before, I am not asking you to actually test any medicines, I would 
just like to know how you feel about doing this. 
(7) What do you see as the advantages of your taking part in the testing 
of new medicines? 
(8) What do you see as the disadvantages of your taking part in the 
testing of new medicines? 
(9) Is there anything else that comes to mind when you think about your 
taking part in the testing of new medicines? 
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I would now like to know what you think other people may feel about your 
taking part in the testing of new medicines. 
(10) Are there any groups or individuals who you think would approve of 
your taking part in the testing of new medicines? 
(11) Are there any groups or individuals who you think would disapprove 
of your taking part in the testing of new medicines? 
(12) Are there any other groups or individuals who come to mind when you 
think about your taking part in the testing of new medicines? 
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In this section I am still interested in your opinions about taking part 
in the testing of medicines, but this time we are concerned with the 
testing of medicines for conditions you may be at special risk of 
developing. 
The medicines II m talking about here are not new ones, but medicines 
already in use as treatments for other things. For example, there is now 
considerable evidence to suggest that low daily dosages of aspirin may 
help to hold off heart attacks and strokes in some people who are at 
increased risk from them. 
However, we don I t yet know if it wi 11 be of benef i t to a 11 who show 
signs of increased risk, and there is only one way to find out for sure 
whether or not a part icular medic ine wi 11 be of use in holding off a 
particular disorder. That way is for doctors to test the medicine on 
people who are at special risk of developing the disorder in question. 
I would like to know what you think about taking part in the testing of 
medicines to determine their value in the prevention of a disorder that 
you were at increased risk of developing. Yet again, it is only your 
thoughts I am asking for. 
(13) What do you see as the advantages of your tak ing part in the 
testing of medicines to discover whether or not they may help to hold 
off a condition you were at increased risk of developing? 
(14) What do you see as the disadvantages of your tak ing part in the 
testing of medicines to discover whether or not they may help to hold 
off a condition you were at increased risk of developing? 
(15) Is there anything else that comes to mind when you think about your 
taking part in the testing of medicines, to discover whether or not 
they may help to hold off a condi t ion you were at increased risk of 
developing? 
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I would now like to know what you think other people may feel about your 
tak ing part in the test ing of medic ines, to determine whether or not 
they may help hold off a condition you were at risk of developing. 
(16) Are there any groups or individuals who you think would approve of 
your taking part in the testing of known medicines, to discover whether 
or not they may help to hold off a condition you were at increased risk 
of developing? 
(17) Are there any groups or individuals who you think would disapprove 
of your taking part in the testing of known medicines, to discover 
whether or not they may help to hold off a condi t ion you were at 
increased risk of developing? 
(18) Are there any other groups or individuals who come to mind when you 
think about your taking part in the testing of known medicines, to 
discover whether or not they may help to hold off a condition you were 
at increased risk of developing? 
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I would now like to ask a couple of questions about pill-taking 
generally. 
Firstly, if your doctor prescribes pills for you, what, if anything, 
would encourage you to remember to take the pills as directed? 
What, if anything, would prevent you from taking the pills as directed 
by your doctor? 
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Finally, 
and past 
medicines. 
we would like a little information about your current health 
experiences, if any, of health checks and the testing of 
How would you rate your general health? 
Excellent Good Fair Poor 
How interested are you in your general health? 
Very interested Quite interested Not really interested 
How careful are you about your diet,exercise etc. to make sure you keep 
healthy? 
Very Careful Quite Careful Not Careful at all 
Are you, or have you ever been, a smoker? 
Current Smoker Ex Smoker Never Smoked 
Have you ever suffered any heart trouble or blood pressure problems? 
If 'yes' please specify: Yes 0 No 0 
, 41 41 41 ••••••••••••••••••••••••••••••••••••••• 
Have you ever had a health check involving blood pressure tests and 
blood samples? 
vesD NOO 
Have you ever had any other screening 
cervical cancer, X-Ray tests for TB etc? 
checks, 
If 'yes' please specify: 
eg smear tests for 
vesD NoD 
••••••••••••••••••••••••••• , •• , •••••••• t •••••• 
Have you ever taken part in the testing of any medicines? 
vesD NoD 
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APPENDIX 13 
SUMMARY OF BELIEFS ELICITED FROM INTERVIEWS 
Key to Figures: 
Digits symbolise age group:-
1 = 25-44; 2 = 44-59 (9) 44-64 (en; 3 = 60-75(9) 65-75(~) 
The first letter symbolises sex:- f = female; m = male 
Second letters symbolise socio-economic group:-
a = 'middle class'; b = 'working class' 
Thus: 1fa = young(25-44) 
1fb = " " 
woman, 
" 
'middle class' 
, work ing class' etc. 
The denominator represents total number of informants in each group, 
numerators show how many of each group gave the response. 
SCREENING 
1) Knowledge of risk an advantage 
lfa lfb lma 1 mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
3/3 213 3/3 1/3 213 1/3 3/3 3/3 1/3 3/3 3/3 213 Tot: 27136 
2) Can take preventive measures 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
213 3/3 3/3 1/3 213 1/3 3/3 2/3 2/3 213 2/3 2/J IQi: 25t3~ 
3) Would be told the best preventive measures to take 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
213 213 lt3 1/3 113 213 113 U3 V3 2/J I/J U3 IQi:] 2t3~ 
4) Could find out something you don't want to know 
Ita lfb Ima 1mb 2fa 2fb 2ma 2mb 3ta 3fb 3ma 3mb 
1/3 1/3 3/3 1/3 V3 213 113 -/3 213 -l3 -l~ -lJ IQi:]3tJ~ 
5) Could cause worry which in turn could exacerbate heart trouble 
Ita lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
2[3 ]l~ -[3 -l3 ]l~ -lJ Il3 -l~ ]l~ -n -l~ llJ IQi: ZlJ~ 
- 4-5 -
6) Would allow to make plans 
lfa lfb lma 1 mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
-/3 -/3 -/3 -/3 -/3 -/3 -/3 2/3 -/3 -/3 -/3 -/3 Tot:2I36 
7) Would give peace of mind/would like to get "all clear" 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
2/3 -/3 -/3 1/3 1/3 -/3 1/3 1/3 2/3 1/3 1/2 ]/3 Tot:1J/36 
8) Might help prolong an active life/avoid infirm later years 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
-/3 2/3 -/3 -/3 1/3 -/3 -/3 213 ]/3 1/3 213 1/3 Tot:] 0/36 
9) Would do anything to improve my quality of life 
lfa lfb lma ]mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1/3 -/3 -/3 -/3 -/3 1/3 -/3 -/3 -/3 1/3 -/3 -/3 Tot:3/36 
10) Would make you take stock of the way you are living and focus the 
mind on healthy behaviour- things you are doing wrong etc. 
!fa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1/3 1/3 213 1/3 -/3 -/3 1/3 -/3 1/3 -/3 -/3 1/3 Tot:8/36 
11) Hard to diet/take up exercise 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
-/3 ]/3 -/3 1/3 1/3 1/3 1/3 ]/3 ]/3 3/3 -/3 -/3 Tot:]0/36 
12) Be told to stop smoking/cut drinking 
lfa ]fb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
113 1/3 -/3 1/3 1/3 1/3 2/3 1/3 -/3 ]/3 213 -/3 Tot:]]/36 
13) Nobody really wants to be lectured 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1/3 -/3 -/3 1/3 1/3 -/3 1/3 -/3 1/3 1/3 1/3 213 Tot: 9/36 
14-) Difficult/inconvenient to get to surgery 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1/3 1/3 -/3 1/3 -/3 1/3 1/3 -/3 -/3 -/3 -/3 1/3 Tot:6/36 
15) Don't like going to the doctor at all if I can help it 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1/3 -/3 -/3 -/3 1/3 1/3 -/3 -/3 1/3 -/3 ]/3 -/3 Tot:S/36 
- 4-6 -
16) Insufficient privacy at our health centre- receptionists loud and 
gossip 
lfa 1fb 1ma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 1/3 -/3 -/3 Tot:2I36 
17) Not nice if not own doc- don't trust others so well 
1fa 1fb 1ma 1 mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
-/3 -/3 1/3 -/3 1/3 -/3 -/3 -/3 -/3 -/3 1/3 -/3 Tot:3/36 
18) Could interfere with work/career prospects 
1fa lfb 1 ma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
2[3 1l~ -[~ -/2 -n -n -[~ -[~ -[~ -n -[~ 1[~ TQt:4L~6 
CLINICAL TRIALS 
1) Would only test if in severe health danger myself/ would have to 
actually have the problem, not just be at risk of it 
1fa 1fb 1ma 1 mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
2[3 ][3 ] 13 1[3 213 213 213 -[3 3[3 ]/3 213 -[3 Tot:]7136 
2) Risking own health for no personal benefit 
lfa 1fb 1ma ]mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1[3 -[3 1/3 113 1[3 -[3 ][3 -/3 113 -£3 1[3 -/3 TQt:7136 
3) Would benefit others 
1fa lfb 1 ma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1[3 3/3 3/3 2/3 113 -[3 3L3 3[3 113 ][3 -/3 2[3 Tot:2QL36 
4-) Might benefit me - at the time or in the future 
]fa lfb 1ma ]mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
-[3 1[3 1[3 2[3 -/3 1[3 3[3 2[3 -[3 213 -0 1/3 Tot:1306 
5) Someone has to be the guinea pig to test these medicines (not 
necessarily me) 
]fa lfb 1ma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
-[3 3[3 1/3 2[3 1/3 1[3 1[3 3[3 1[3 113 -/3 213 Tot: 16L36 
6) Anti-vivisection, so if don't want animals used must be prepared to 
test yourself 
1fa lfb 
-L3 -/3 Tot:3L36 
-[3 -[3 
1 ma 
-[3 
1mb 
1[3 
2fa 
-[3 
2fb 2ma 2mb 
-[3 -[3 -£3 
3fa 3fb 
113 1£3 
3ma 3mb 
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7) Might 
lfa lfb 
do it if really pushed for money, but would have to be desperate 
lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1/3 -/3 
-/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 Tot:1/36 
8) Doctor wouldn't ask you to do it if it wasn't pretty safe - boils down 
to how much you trust your doctor 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3tb 3ma 3mb 
-/3 1/3 1/3 -/3 -/3 1/3 -/3 213 -/3 213 ]/3 -/3 Tot:S/36 
9) Don't trust drug companies, and don't think docs always know enough-
too easily swayed by the drug companies and their perks/profits 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
1/3 -/3 -/3 -/3 -/3 -/3 1/3 -/3 ]/3 -/3 1/3 1/3 Tot:S/36 
9a) Reckon the pharmaceutical companies have got it pretty well wrapped 
up, they don't put stuff out until it's already been pretty well tested 
on animals 
1fa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
-/3 -/3 -/3 -/3 -/3 -/3 -/3 1/3 -/3 -/3 -/3 -/3 Tot:]/36 
10) Side effects 
lfa lfb 1ma 1mb 2fa 2fb 2ma 2mb 3fa 3tb 3ma 3mb 
3/3 3/3 3/3 213 3/3 3/3 2/3 2/3 3/3 213 3/3 3/3 Tot: 32136 
11) Could make you worse than you already are 
1fa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3tb 3ma 3mb 
213 2/3 1/3 113 1/3 -/3 1/3 -/3 213 -/3 213 1/3 Tot:13/36 
12) Never know what the long term effects are 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3tb 3ma 3mb 
213 213 1/3 1/3 1/3 -/3 2/3 -/3 2/3 -/3 213 1/3 Tot: 14/36 
13) If you take any drug for a long time when it's not really necessary, 
your body might get used to it so it won't work when you really need it 
lfa lfb lma 1mb 2fa 2fb 2ma 2mb 3fa 3tb 3ma 3mb 
1/3 2/3 1/3 1/3 1/3 -/3 1/3 -/3 1/3 1/3 -/3 1/3 Tot:1Q/36 
14) Being used as guinea pig <pro & anti) 
1fa lfb lma 1mb 2fa 2tb 2ma 2mb 3fa 3fb 3ma 3mb 
-/3 -/3 1/3 1/3 2/3 1/3 2/3 1/3 213 1/3 1/3 213 Tot:] 4/36 
15) You'd have to keep a diary of pills taken, effects experienced etc. 
lfa lfb 1ma 1mb 2fa 2fb 2ma 2mb 3fa 3tb 3ma 3mb 
113 -/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 TQt:1/36 
16) If you 
due to the 
lfa lfb 
213 213 
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had an 'Off day' or headache wouldn't 
pills/might imagine side effects 
lOla 1mb 2fa 2tb 2ma 2mb 3ta 
1/3 -/3 1/3 -/3 2/3 -/3 1/3 
know if it was normal or 
3fb 3ma 3mb 
1/3 -/3 -/3 Tot:l0/36 
17) There's too much emphasis on drugs - should try alternative 
medicine 
lfa lfb lOla 1mb 2fa 2tb 2ma 2mb 3fa 3tb 3ma 3mb 
1/3 -/3 -/3 -/3 1/3 -/3 -/3 -/3 213 1/3 1/3 -/3 Tot:6/36 
18) There should be some form of compensation if things go wrong, not 
like the troubles going on with Opren now, it should be automatic for 
anyone testing drugs 
lfa lfb lOla 1mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
-/3 1/3 -/3 -/3 1/3 -/3 1/3 -/3 -/3 1/3 -/3 -/3 Tot:4/36 
19) Wouldn't want to take any drugs for very long 
lfa lfb lOla 1mb 2fa 2fb 2ma 2mb 3fa 3tb 3ma 3mb 
1/3 1/3 -/3 213 1/3 1/3 -/3 -/3 1/3 -/3 213 -/3 Tot:9/36 
20) Would want an awful lot of info. about the drug first 
lfa lfb lOla 1mb 2fa 2fb 2ma 2mb 3fa 3tb 3ma 3mb 
1/3 1/3 213 -/3 1/3 1/3 1/3 -/3 1/3 -/3 21:3 -/3 Tot;lQ/36 
21) Would have to be a two-way interaction with feedback - not just a 
case of being used as a disposable subject 
lfa lfb lOla 1mb 2fa 2fb 2ma 2mb 3fa 3tb 3ma 3mb 
-/3 -/3 1/3 -/3 -/3 -/3 -/3 -{:3 -/3 -/3 -/3 -/3 Tot:1/36 
22) If I was at risk, I'd feel aggrieved to find out I'd had a placebo 
]fi ltb 1 IDa ]mb 2fa 2fb 2ma 2mb ~h ~fb 3mi 3mb 
-/3 -/3 1/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 -/3 Tot;]/36 
23) If you're testing some drugs, you might not be given other drugs that 
may work- could potentially be putting yourself at a disadvantage 
]h lfb ]mi 1mb 2fa 2fb 2ma 2mb ~fa ~fb ~ma ~mb 
-L~ -L~ 1L3 -/3 ] L3 -n lLa -L3 -[3 -n -[~ ][3 IQ~:!L3~ 
23a) Might have to stop taking current effective medication to test the 
new medicines 
]h lfb ]ma ]mb 2h 2fb 2ma 2mb ~h 3fb 3ma 3mb 
-L3 1 L3 -L3 -L3 lL3 -L3 ]L3 -L3 lL3 -/3 1[3 ]n IQ~:~L3~ 
24) Already taking tablets - wouldn't really want to take many more-
might not mix etc. 
]h ltb ]ma 1mb 2fa 2fb ,ma 2mb 3h 3fb 3ma 3mb 
-l3 -l3 -l3 -l3 ]L3 -/3 -[3 -n -[3 -[3 -[3 In IQ~:2[~6 
Spouse/partner 
lta lfb 1 ma 
3n 2[3 ~[3 
Parents 
lta lfb lma 
2[3 113 1l~ 
Children 
lta 
2/3 
lfb 1 ma 
1[3 -[3 
Siblings 
lfa 
llJ 
lfb 
-[3 
Friends 
lma 
-[3 
1mb 
2[3 
1mb 
3[3 
1mb 
113 
1mb 
]0 
2ta 
-/3 
2fa 
1l~ 
2ta 
113 
2fa 
-[3 
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SALIENT REFERENTS 
SCREENING 
2fb 2ma 
-[3 3/3 
2fb 2ma 
-tJ -[J 
2fb 2ma 
213 -[3 
2fb 
-[3 
2ma 
-[3 
2mb 
3[3 
2mb 
113 
2mb 
113 
2mb 
113 
3ta 3fb 
113 213 
3ta 3fb 
-n -[a 
3fa 3fb 
][3 3[3 
3fa 3fb 
113 ln 
3ma 3mb 
113 3[3 Tot: 23{36 
3ma 3mb 
-fa -[aIQi:~[a~ 
3ma 3mb 
3[3 2[aIQi:]Z[36 
3ma 3mb 
[a -/aIQi:5[a6 
lta 
1/3 
lfb 
1/3 
]ma ]mb 2fa 2fb 2ma 2mb 3fa 3fb 3ma 3mb 
-/3 1/3 1/3 1/3 2/3 -/3 1/3 -/3 -/3 1/3Tot;9/36 
------------------- -------------------------------------------
GP/Consultant 
lfa 
-[3 
lfb 
-[3 
lma 
-n 
]mb 
-/3 
Research Scientists 
lta 
-[3 
lfb 
-[3 
lma 
-[3 
1mb 
-[3 
2fa 
-[3 
2fa 
-[3 
Governor at work/employer 
lfa 
-[3 
lfb 
-[3 
lma 
213 
1mb 
-[3 
2fa 
-/3 
2fb 
-[3 
2fb 
-0 
2fb 
-[3 
2ma 
-[3 
2ma 
-[3 
2ma 
213 
2mb 
-[3 
2mb 
-[3 
2mb 
113 
3fa 3fb 
-/3 -[3 
3fa 
-/3 
3fa 
-[3 
3fb 
1/3 
3fb 
-[3 
3ma 3mb 
1[3 1[3Ioi:2[36 
3rea 
-[3 
3ma 
-[3 
3mb 
-[not: 1136 
3mb 
1/3 TQi: 6/36 
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My decision, doesn't really matter what others think 
lfa 
-/3 
1fb 
-/3 
1ma 
1/3 
Spouse/partner 
1fa 
3/3 
lfb 
2/3 
Parents 
1fa 
213 
lfb 
1/3 
Children 
lfa 
213 
lfb 
-/3 
Siblings 
lfa 
1/3 
lfb 
-/3 
Friends 
lfa lfb 
1/3 2/3 
lma 
3/3 
lma 
1/3 
lma 
-/3 
1 ma 
-/3 
1ma 
-/3 
GP/Consultant 
lfa 
-/3 
lfb 
-/3 
lma 
-/3 
1mb 
-/3 
1mb 
2/3 
1mb 
2/3 
1mb 
-/3 
1mb 
1/3 
1mb 
1/3 
1 mb 
-/3 
Research Scientists 
lfa 
-/3 
lfb 
-/3 
ha 
-/3 
1mb 
-/3 
2fa 
3/3 
2fa 
-/3 
2fa 
1/3 
2fa 
2/3 
2fa 
-/3 
2fa 
1/3 
2fa 
-/3 
2fa 
-/3 
2fb 
-/3 
2ma 
2{3 
2mb 
1/3 
CLINICAL TRIALS 
2fb 
1/3 
2fb 
-/3 
2fb 
2/3 
2fb 
-/3 
2fb 
-/3 
2fb 
-/3 
2fb 
-/3 
2ma 
3/3 
2ma 
-/3 
2ma 
1/3 
2ma 
-/3 
2ma 
1/3 
2ma 
1/3 
2ma 
-/3 
2mb 
3/3 
2mb 
1/3 
2mb 
-/3 
2mb 
1/3 
2mb 
-/3 
2mb 
-/3 
2mb 
-/3 
3fa 
213 
3fb 
213 
3fa 3fb 
1/3 1/3 
3fa 
-/3 
3fb 
-/3 
3fa 3fb 
1/3 3/3 
3ma 
1/3 
3ma 
1/3 
3ma 
-/3 
3ma 
1/3 
3mb 
-/3 Tot: 12136 
3mb 
3/3Tot:23/36 
3mb 
-/3Tot:9/36 
3mb 
2/3Tot:14/36 
3fa 
1/3 
3fb 3ma 3mb 
-/3 -/3 -/3Tot:4/36 
3fa 
1/3 
3fb 3ma 
1/3 -/3 
3fa 3fb 3ma 
1/3 -/3 -/3 
3fa 
1/3 
3fb 
1/3 
3ma 
-/3 
3mb 
-/3 Tot:8/36 
3mb 
1/3Tot:3/36 
3mb 
-/3Tot:2/36 
Pharmaceutical companies 
1fa 
-/3 
lfb 
-/3 
1 ma 
-/3 
1mb 
-/3 
2fa 
-/3 
2fb 
-/3 
2ma 
-/3 
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2mb 
-/3 
3fa 
1/3 
3fb 
-/3 
People who've got the problem pill is being tested for 
lfa 
-/3 
1fb 
-/3 
1ma 
-/3 
1mb 
-/3 
2fa 
-/3 
Govenorl people at work 
1fa 
-/3 
1fb 
-/3 
1 ma 
213 
1mb 
-/3 
2fa 
-/3 
2fb 
-/3 
2fb 
-/3 
2ma 
-/3 
2ma 
3/3 
2mb 
-/3 
2mb 
1/3 
3fa 
1/3 
3fa 
-/3 
3fb 
1/3 
3fb 
-/3 
My decision, doesn't really matter what others think 
1fa 
-/3 
1fb 
]/3 
] ma 
2/3 
1mb 
1/3 
2fa 
3/3 
2fb 
3/3 
2ma 
213 
2mb 
2/3 
3fa 
213 
3fb 
213 
3ma 
1/3 
3ma 
-/3 
3ma 
-/3 
3ma 
1/3 
3mb 
-/3Tot:2/36 
3mb 
1/3Tot:3/36 
3mb 
1/3 Tot: 7136 
3mb 
-/3Tot:19/36 
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APPENDIX 14-
SECOND STUDY QUESTIONNAIRE 
The appended questionnaire is a copy of that used in the main follow-on 
study. Response frequencies are shown in each answer-option cell, the 
numbers in brackets indicate the percentage of the ent ire sample that 
each value represents. Missing values are also given in both raw score 
and sample percentage values. 
Analysis code names are also given for each item. 
Because very slightly different front pages were used for electoral roll 
and practice lists samples, both front pages are given <practice list 
sample page 53; electoral roll sample page 54.) 
The GP-covering letter sent with the medical sampling source package, is 
given in appendix 16. 
Applied Psychology Unit 
Cranfield Institute of Technology 
Cranfield Bedford MK43 OAL England 
Telephone Bedford (0234) 750 III 
Telex 825072 CITECH G 
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o Cranfield 
February 1988 
PREVENTIVE MEDICINE IN THE NHS - AN ATTITUDE SURVEY 
PLEASE HELP US TO HELP GPs GIVE THE SERVICE YOU WANT BY TELLING US HOW 
YOU FEEL ABOUT HEALTH CHECKS AND THE TESTING OF MEDICINES TO TRY TO 
PREVENT HEART ATTACKS AND STROKES. 
WE DO NOT WANT YOUR NAME OR ADDRESS, JUST YOUR OPINIONS AND MOST OF THESE 
CAN BE GIVEN BY SIMPLE 'TICK IN THE BOX' ANSWERS ON THIS QUESTIONNAIRE. 
WE HAVE PROVIDED A FREEPOST RETURN ENVELOPE, SO ALL WE ARE ASKING FOR IS A 
LITTLE OF YOUR TIME TO HELP US UNDERSTAND HOW PEOPLE FEEL ABOUT 
PREVENTIVE MEDICINE AND WHAT SORT OF THINGS MIGHT WORRY THEM ABOUT IT. 
WE NEED INFORMATION FROM AS MANY PEOPLE AS POSSIBLE COVERING ALL POINTS OF 
VIEW. SO, WHETHER YOU HAVE STRONG FEELINGS ON THE MATTER OR NOT, YOUR 
OPINIONS ARE EQUALLY IMPORTANT TO US AND WE WILL BE VERY GRATEFUL FOR YOUR 
HELP. 
Your name was selected at random from the list of patients registered with 
your doctor. We have no record of the people chosen, and as there are no 
names or addresses on the questionnaire, all information given will be 
completely anonymous. 
If you would like any further information about this survey please contact 
Rachel Asch at the above address. 
THANK YOU VERY MUCH FOR YOUR TIME AND CO-OPERATION. 
Applied Psychology Unit 
Cranfield Institute of Technology 
Cranfield Bedford MK43 OAL England 
Telephone Bedford (0234J 750 III 
Telex 825072 C1TECH G 
o Cranfield 
February 1988 
PREVENTIVE MEDICINE IN THE NHS - AN ArTITUDE SURVEY 
PLEASE HELP US TO HELP GPs GIVE THE SERVICE YOU WANT BY TELLING US HOW 
YOU FEEL ABOUT HEALTH CHECKS AND THE TESTING OF MEDICINES TO TRY TO 
PREVENT HEART ATTACKS AND STROKES. 
WE DO NOT WANT YOUR NAME OR ADDRESS, JUST YOUR OPINIONS AND MOST OF THESE 
CAN BE GIVEN BY SIMPLE 'TICK IN THE BOX' ANSWERS ON THIS QUESTIONNAIRE. 
WE HAVE PROVIDED A FREEPOST RETURN ENVELOPE, SO ALL WE ARE ASKING FOR IS A 
LITTLE OF YOUR TIME TO HELP US UNDERSTAND HOW PEOPLE FEEL ABOUT 
PREVENTIVE MEDICINE AND WHAT SORT OF THINGS MIGHT WORRY THEM ABOUT IT. 
WE NEED INFORMATION FROM AS MANY PEOPLE AS POSSIBLE COVERING ALL POINTS OF 
VIEW. SO, WHETHER YOU HAVE STRONG FEELINGS ON THE MATTER OR NOT, YOUR 
OPINIONS ARE EQUALLY IMPORTANT TO US AND WE WILL BE VERY GRATEFUL FOR YOUR 
HELP. 
Your name was selected, at random, from the electoral roll. We have no 
record of the people chosen, and as there are no names or addresses on the 
questionnaire, all information given will be completely anonymous. 
If you would like any further information about this survey please contact 
Rachel Asch at the above address. 
THANK YOU VERY MUCH FOR YOUR TIME AND CO-OPERATION. 
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PART 1 
Health Checks 
In this section of the questionnllire we would like to lIsk you lIbout your 
feelings towlIrds health checks designed to Find out whether or not you Bre lit 
increased risk of developing 1I hellrt attack or stroke. 
The sort of helllth checks we are tlllking lIbout are Fairly simple ones carried 
out by the Generlll Prllctitioner or the practice nurse. People are weighed, 
have their blood pressure and blood cholesterol mellsured, lind are asked to 
give details of their diet, exercise levels, drinking lind smoking habits etc. 
PLEASE NOTE: 
Some of the questions in this section are very similar, but they do ask 
slightly different things which we need to know. 
For example, on page 3 you are asked to show how likely you think It is that 
certain things would happen If you had the health check, and on pllge 4 you 
are asked to show how good or bad you think these things would be For you. 
It is important to our proper understanding of the resul ts that you answer 
every question. 
To answer the questions you just have to put a tick In the box that best 
describes your feelings. 
IF you would llke to make any extrll comments, plellse use the splice provided 
at the end of the section. 
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Although we do not ask for any names or addresses, we would appreciate it if you 
would answer a few questions about yourself. Please answer by ticking one box for 
each question, or, where appropriate, by writing your answer on the lines provided. 
A) 
B) 
C) 
AGE: MV~ ~ to·W 
SEX: Ma 1 e t?2't I 
It,·~) 
MARITAL STATUS: 
Married / 
Cohabiting 
IB-Ut 2.5-44 4-~- Reb"e'~ei\b Re6"reM.et\e -I- A~E-
bi (,.g, 3lS (lIb'B) Ig, l~"'o) lI& (11.0) 
Female I~u, I ~ 
($2,') 
Divorced/ 
Separated 
Widowed ~ 
£4 '2.) 
Single 
D) Do you 1 i ve: ~ lw,-Alone Wi th Others fo2. "v.: 8("') S"b 
E) CHILDREN - if you have children please write in how many in each age group: 
F) 
0-4 lliJ 
(IOol.) .' 
EMPLOYMENT: 
5-18 II:!~ I 
(t1'7) 
Are you curren t 1 y: 
C.t'4IL.~ 
Over 18 !i1J +- 'I ~ (/ N.) 
(31'S) t More. ~ 
~ ~L~~"(' 
Igc, (27.7-) 
t;~ ,,0 
c.1..U~rct\ or 
A4~~ UAI.II~ 
Se 11 J 4h 1 Elp loy~d 13231 Emp loy~d '?9l Unelp I oyed ! 21t-1 Ret! rid !/lIi-l Other 19, ~ G HftlJ1 Elployed Full TIle Part TIme ~ Housewife 
~''') (~$) (t4'1J ~ (IS. 0) fUrl 
If other <please specify> ...............•...............••....•................ 
G) Is (or was) your USUlJl emploflM!nt: td..SC=-M.~V=- (0 (1-4-) 
Professional. .... _ . . . • • . • • . (2..S-~ 
Employer/Manager .....•.. _ .. 92 (n-V) 
Other non-manua 1. . . . . . . . • .. '0 (U-':) 
Skilled manuaL ... _........ ~~ ll~ 
Semi -sk i 11 ed. . . . . . .. . .. . . . . b% (~.$ 
Unsk i 11 ed. . . . . . . . . . . . . . . • . . '5 ~.~ 
Armed Forces............... (0 ~ 
Other ego housewi fe/student lJ.6 b-~ 
(note - if you are unelployed or retired, please answer (6) above by showing what type of work you 
usually do/did) 
H) If you are married/cohabiting, please tick the box that best describes the usual 
occupation of your partner. This includes people whose partners are now retired 
or Wlemployed. 
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Please answer each question to show how you would feel if you were offered a health 
check within the next 12 months, and do so by putting a tick in the box which best 
describes your feelinss. Please tick only one box for each question. 
1. If your doctor was offering health checks to find out if people are at 
risk of developing 8 heart attack or stroke, would you make an appointment 
and go along for the health check? 
No I ~I ~:!initelY ~ 
(3'2.) (oo'f.) 
2. How much, in senera1, are you for or against health checks like these? 
Very Much 
For ~'11 Qui te 114~ I Slightly I l' I For For 
(70.g) . (2.1'4) (""2) 
Not ~ Sl ighUy ihI Quite ifl Very Much ~ 
Sure ~ Agains,t ~ AgainltL!J Against ~ 
(1" 1.) lo~ (o.1) 
3. How good or bad do you feel It would be for you to have the health check? 
Very 
Good 
Not f:4l 
Sure ~I 
£ft·'I) 
SlighU Y ~ Quite 1,1 
Bad ~ Bad ~ (r>,) (0") 
Very 
Bad 
•• Do most people who are important to you think that you should have the health 
check if it is offered to you? 
Delini tely ~3bl' Yes Q Possibly 1771 Not r;l Possibly Iql 
Yes EI Yes Sure ~ Not L!J 
ttg'3 )o'S lI'l 1'3. (.~ 
No ~ ~:!initelY ~ 
1'0 -
5. Do you personally think that you o~t to have the health check if it Is 
offered to you? 
Definitely ~ 
Yes ~ 
(tSt;°7) 
Not 1
'0 I Possibly G:l Sure Not ~ 
(I.",) (o·1i) 
No [QJ ~:!lnlttlY GJ 
(, .~) (b' \) 
6. How likely do you think it is that your doctor will be offering this sort 
health check within the next 12 months? 
Very !ilJ Quite ~ Slightly /31r 1 Not G!J Slightly ~ Quite ~ Very /11,01 LIkely ~t Likely 7 Likely Sure Unlikely' nlikely f Unlikely 
{Il'l) ~l-S) (S~) (U·S) (Si) ((1,·0 (2~'~ 
-2-
of 
SCCN 
L..ic.L. '1 
2. 
{o·V 
I 
(0'0 
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In this section you are asked to show how likely or unlikely you believe the 
following statements would be for .you, if you had the health check. 
Please tick one box for each question. 
I F I HAD THE HEALTH CHECK: 
)t.. ~ ~ ).,)t.. I) )t..- V _I) )t.. IJ~ ).,tI .~ I) 
b= ::J~ >-J O:;j 
7. I'd definitely find out whether or not I was 2Sb ~S 
at risk of developing a heart attack or stroke 
{~1l (~.~ 
8. l' d want to be told straight if 1 was at S'S' 14 risk of getting a heart attack or stroke 
(16'4" (.2.') 
9. l' d get peace of mind if 1 got the "all clear" S'oq Ul 
1 (n·u IIIL.\) 
10. I would be able to take preventive measures 411 ,,,,,> if 1 knew I was at increased risk 
K',·s) (1.6.c.) 
11. I would be told the best preventive measures 
w"S 17'L to take 
~o) , (24:1 
12. 1 would improve my chances of staying fit 
and healthy for longer "¥I 1 J'J7 
l~~ ~g.~~ 
13. I would lessen my chances of becoming infirm 
1i2. in my later years ?.Ilf 
~1LI.~ "\ (J~'1. 
14- • My doctor would give me a lecture 'lf7 IC)~, I (1..1 ~JJ (1.1'7) 
15. I would probably be told to give up smoking Iw 3b (non-s.akers please mark here only: [4b7 ] ) 
(".1.1,) ~13·t1 !~,2.' 
16, 1 would probably be told to reduce my drinking 70 bi" (non/rare drinkers please .ark here only: [42.3]) 
I[ct .g) {"',) ((00 ') 
17. I would probably be told to change my diet 
('healthy' eaters - Ie. those already on low fat,low rsg 14-~ 
sal t, high fibre diets please mark here only: £176 ]) 
l2.S-') IZl.-" (to,,) 
18. I would probably be told to take up some form 
of exercise 143 {gl. 
(regular exercisers please .ark here only:[1'3 ]) 
(7.7·r) (2D~ (u.'~ 
19. It would make me take stock of my unheal thy 1~O 22.9 habits and spur me on to change to a more (~~) (u·fJ health~ st~le of living 
-3-
'-~- ~..:.:. 
.r;.1) ::J .r;. -
"" ~c ~ C :J Vi:::> 
St, 72- 7 
£1·1) (Ib'~ fl.) 
1'+ IS !> 
(1.-0) (~,,'\ (0' It) 
2.l 1411 2.-
l\.\) {1.~ l(~~ 
~, IS '+ 
IlL. 'S) (1.·t) (o·c.) 
3lt 2.3 3 
[~., (J·3) (o·t,.) 
ss ~o 
" (1") (2.,) lb") 
73 ?D 12-
/(0-<;) (Io'/) l(t·}) 
7~ IDS lJ' 
.[".1.,) lIr·,) ""') 
J it- t 
(,,2.) (0''') (bol) 
~2 IS 1'1 
(fJ. .1,) (2·~J (2. '7) 
77 $" ~7 
(If .,) (r·d (1") 
13 lf4- ~ 
IIIO'~) 1(,· ~) (too) 
lOS ~l 17 
If,S'f) (iI'}) (..1:4) 
1)...lC I) 
...lC ~.- ~.~ Sc 
0:::> ~:::> 
" 
10 
(1,·7) (Ht) 
'- 3 
(D'1} (0 .!.t" 
" 
S 
Ilo~ ~~'ll 
l- SI 
(o~ [Lc·n 
'3 .3 
1(0'4) ~'4J 
~ 
" (0 -4-l (0'41 
" 
II 
(1-32 (t.l 
St, "z (7-V) lJS'l) 
2- 3 
: LO''S'' (6'\') 
13 32-
(1'1.) rt .,} 
ZO l~ 
(2") I(~'~ 
10 (3 
(,·It) (,"J) 
~ 2.~ 
1(3'?l (t·1J 
n ~
rvb1-(I 11 ·7) 
p~ M" 
" '''} {( 
I-. ~E- i8 l'b) ~ 
r' 
(t 9 '3) 
~ 
( 
, 2. 
t07) 
ITI1'" ~) ( (. 
l'I'IlU1 
C 
1 it 
2..t»~ 
~I 
'Q 
(~ 
i"::lhb 
-1) 
~ 
I lto) ( 2.. 
D~'Il 3 I 
~) ~ t II· 
I~T' 
I ~ I 
') (J. 
/~l 
,~-
( 
{Z. 
~(JcJl-
I 
(2· 
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In this section we ask you to show how good or bad you consider each of the 
following things to be for you. 
FOR ME. THE FOLLOWING THINGS WULD BE: 
I r\V~ >-. t: 2- I 
>-."8 u~ ~-o :::l ~ v I .~ 0 io-o ~ C-o 004)0 V'I --0 ~ 0 ::J 0 .- 0 c .- ~ ::J ~ >(1 ~l:J Ol:J V)l:J --. Vic!) OCIJ .....J 
20. Finding out whether or not I was at increased ~ 41b ISo ~2 40 13 17 I 0 ~ ( 22) risk of a heart attack or stroke 
C5!~ (2. • .w (fI."'-) ~#) lJ~) tz -4) U-4) , IfI1, 
21. Being told straight (if I ~ at risk) ft.gJ 
I (I'ZI"J I~~ l~ i (0 7' ~~' IbDill ti· ~:Lfl ~(L:!>l fp~ 
22. Having peace of mind by getting the "all clear" 'lJ, 2.It-~,~ '°3 2. j 0 0 ~, (II..~~" (\.,\ I/"tesl llo.~ - - ~. {loD 
23. Being able to take preventive measures if I re6J "."}~ ~o 3" J'I I IS knew I was at increased risk 0 1° . (lo·t.) 
V"'l.) 1/2,.,,) Is·l.) [(Z·]) - - ko.t] ... ~ILl 
24. Being told the best preventive measures to take C44i 1~'1 "51 ~ I ! !I---- - I , 0 b 17 ~ (.:~\ lz.·l-)l/o·') - - (2·«t) 
25. Improving my chances of staying fit and ~it> 
rr,11I 
'4( 4( ,.. 2- I 0 , .. I~o) healthy for longer 
~1'1l (l"'\~ (~..,) (2.-1)[{o.l) - 0.1)' 
26. Lessening my chances of becoming infirm in "NftNt 441 
''*7 17 my later z..., S, ~ ( to (2.'''') years 
"l'S) h,·2,) tt-z.) (g.l-.' {o·~ '(0.1] ~-27. Getting a lecture from my doctor ,., 2- ,S1 lot> 1Z.1 Sf> LIt .JS 13(1' ~1) , ('('I) It"oW il')') (~{) ($0) (u . .., 1~t1DI4" 28. Being told to give up smoking 91 <to 2..~ 2.5 SO I~ 12. II., , (non-smokers please mark here only: [ !!S .! ) If~ (~·l) ( ~ (bS-S) ll~ (S·1l) l"2,.~ " (\.~\ Cl'91 (I'l) [OtINU 29. Being told to reduce my drinking 
;'0 4-(, ttl b2 2.( III 7 (5 (non/rare drinkers please mark here only: [4~K]) ~7'2) (,.,) ("o) r8·~) [(J-o) l'Z. '0) (( 10) U.·~ Lb~'~ 
... -30. Being told to change diet 1...-rT,n my 
'4 ('healthy' eaters-ie those already on low fat,low I), ISo ~o 7b 2.$ 10 '7 (1.0) 
salt, high fibre diets please mark here 00IY:[18~]) 
l'1l~ (,,·s) If,O"}) i(J~) Ill".) l(z .",' (lb'~) 10-0) ~- ~ ... 
, 
- -~ . 31. Being told to take up some form of exercise 132-
'"' " 
bl I~ 7 g' 2.1) (regular exercisers please mark here ooly:[ I~t ]) t t·" 
'11·1) (~,., I( (~.,) (Ii) (1·7) /('0) (t·t) ,/ 11.--r·C;) ~AJt.A 
32. Having to take stock of my unhealthy habits ~bl lJ4- ~~ b; 2.3 8 1 I~ 
and be spurred on to change to a more (1,).7) rlo·~ 11/2..,) (,.,) K3·~) !r,.l.) (2'4-J tt·7) heal thy stYle of 1 ivtn~ 
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How IIWch do you think that each of the following things may put people at extra 
risk of developing a heart attack or stroke? 
33. Being overweight 
34. Eating lots of fatty foods 
35. Regular smoking 
36. Regular drinking <alcohol) 
37. Lack of regular exercise 
38. Stress or worry 
39. Having high blood pressure 
40. Having high cholesterol 
41. Having a close relative who has 
had a heart attack or stroke 
Very 
t1uch 
3<6't 
~~~ 
&?-~ (,,~.~) 
2.2.S-
(:21'1~ 
'3'~ [$'22 
4SZ. 
£fz5.·o} 
~33 
l(zz.·s) , 
IYIt 
rz~'$) 
Qui te A Not 
A Lot Little Sure 
~S?> ~, 2-
(~o/ (i~) ~ (,,..,) {S,02 to"} 
11.7 Sb 1'1 (LI4'o) (k·o) (l·;z.~ 
,itt) ILt- 31 117ss) (~.$J lSIr U" 
-W- (l~'3l -Lfi!l Cf7 
(:!z1-'S) (,.1/) (2'~2 
'7' 34 .23 l.zs'3), (l~ J ¥ ny 
(t.$.(,.) ($'.2.) (~'o) 
170 IZ.Z. It"" 
('2.4'9, (11'~) I (11"7) 
Not Very Hardly Not-
t1uch At All At All 
't- 2- 2-
(o'b) (o'l) (0·"!t2 
r I , 
(o'2} ( o'(l (~ot ) 
lr , 3 { {.t2 (0'( I lQ ·t:l 
" 
yo z.. 
(1.'" ) (o • ... 2 [0·1) 1.1 1- 0 
C~·o2 '·'1) -
" 
0 I 
(o~} - c"· (2 
I .z.. 1-
(0',) (°'12 (0'11 If 0 3 
(o·~) - (f)·v) 
"-It '3 'tf 
{I:.' 3) (I' 'J) (~.,) 
Also. please tick just one box to show which. if any. of the following occupational 
groups you think may be most at risk of getting a heart attack or stroke. 
Other offica 1~91 
Workers 
0.) 
Unnployed I ~71 
( b·i!) 
~~p 
Nona I ~S I ltV .. ~o Ct -,) 
O.·S) 
Flnally,in this section, please show how much you think the following people wouJd 
be for, or against, you having a health check to find out whether or not you were at 
increased risk of developing a heart attack or stroke. 
Your spouse/partner 
Your children 
Your parents 
Your friends 
Very 
t1uch 
ct2.1.. 
(,60 "J 
:;'°1 £~~·~l 
;1.33 
Pl's,l 
2.11. 
'~'ll 
IN FAVOUR AGAINST ~ 
Quite 
Li :tlej A Lot 
lOS 2:2-
"~'I~ ( ~.z.) 
ql 
(11-") 
lot-
(~.,) 
I '!>I S'z. (tr.~ ( 1·SJ 
II. u·S 
O,\") ,,,·s) 
I Not 
Sur~ 
7 
(f-o) 
11 • I Itt)1 
I~ lt~1 
.. 
i..i ttle 
,~-~ 
2 
fo·~ 
2-
-¥-l l2: I} 
Quite 
A Lot 
") 
(D'~) 
, 
,0") 
2.. 
(0'22 
3 
£a'!A:l 
Very 
t1uch 
0 
-
0 
-
0 
-
0 
- I 
Generally speaking. how much do you want to do what these people think you should do? 
Very Quite 
P1uch A Lot 
Your spouse/partner 
Your children 
Your parents 
Your friends 
t~l1tl &~~fl) 
l-¥-4) r¥ {(!. ~~ 
l'j lSI U!·&) llJ.· 2} 
Ill, "( 
£It:i) 121'1::) 
A 
Li HIe 
,7' (£Q.2.) 
7( 
llf1:.l:~ 
12.1 
llZ·tJ 
"9 (Bdzl 
Not 
At All 
i/o) 
I( 
£l'~l 
~". lll:j} 
(?o~g) 
Doesn't I1Vs. 
APP1; co~", If ~ ".S) ~tiO) CCHfC. bl (t'l) 
I 1~1zJ;) ,-~,p 70 (co'9 I :~:~; p t. CDIot:r 1 ~ (!.o) 
Please lark the box which belt delcribes your behaviour regarding th~ followlng 
5 ti talent: 
-I USUiJJy try to do ~h~t 1 think j ought to do· 
Alios t In'!' I 
Always 
(IJ·r; 
"ost of f4iil 
the tileU 
(S"I) 
SOQe of II"" I 
the tille L-J 
(l.o '7) 
CJ lol1tSL1-' Aillost Never 
(/·v 
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PART ? 
PILL TESTING 
In the next section we would like to know how you feel about taking part in 
studies that involve the testing of pills which doctors believe may help to 
prevent heart attacks and strokes. 
We are interested in your feelings about two main types of studies. The 
first type of study involves the testing of brand new pills, the second 
type of study invol ves test ing pi lIs that are already well established 
treatments for other problems, to find out if they would also be useful in 
helping to hold off heart attacks and strokes. 
When any new medicines are developed they must undergo strict scientific 
testing before they can be considered for general use. Most of this 
testing takes place in the laboratory but in the end, medicines that are 
intended for use by humans must be tested by humans. 
Similarly, although there may be strong medical beliefs that a well known 
pill may help to hold off heart attacks and strokes in some people, the only 
way to be sure of its value is to scientifically test the pill in people 
who are already at risk of these problems. 
In the first part of this section you are asked to state your intentions 
regarding taking part in the testing of pills if you were asked to do so. 
Obviously, this decision will depend on a variety of things and so you are 
asked to rate your intentions for several different circumstances. 
There are no right or wrong answers to any of the following quest ions. 
We need to know what the true public opinion is, so please answer the 
questions to show us what you really feel. 
If you feel that there are any other things which may play a part in 
helping you to make up your mind whether or not to take part in the 
test ing of pi lIs, please wri te them in in the space provided below the 
questions. Your comments will be greatly appreciated. 
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First, we would like to know how you feel about taking p~rt in the testing of: (A) 
brand new pi lls ; and (B> Other pills that are BlrelJdy in use as remedies for some 
problems, but which doctors think may ~lso help to prevent heart attacks or strokes. 
Please put a tick in the box which best describes your feelings towards each of the 
following statements, for both (A) New pills, and (B) Other pills. 
1. I would be willIng 
these pills were a 
Very 
Likel y 
A) Ne\1 pills: 3Sl. 
It''''~ 
B) Other pills: (b)") 
to help test pIlls 
last resort 
Quite Slightly 
Likely Likely 
13 3S 
( 22.·p) ,s:- b2 
I~q .1/ 
£'3-9) 
• 
if I 
Not 
Sure 
S, 
(7''),] 
)!' 
(s·s~ 
2. I would be willing to help test pi lIs if I 
attack or stroke 
Very Quite Slightl y Not 
Likel y Likely Likely Sure 
Jet?> u'Z. 100 
A) New pill s : [!3 (Z1.B) (If? .. 11 llfl:·1l:) .2S,} 22.4 glt S1 
B) Other pi 11 s: f'~7'}) (>z·-z.) (/2.·'l {S-S} 
3. I would be willing to help test pills if I 
attack or stroke 
Very Qui te Sl ightl Y Not 
Likel y Likel y Likely Sure 
ILtg lit' t~.'1 I A) New pills: ('2.". -;) (z.o·~) I !J '8~ ,n II q B) Other pills: (:lh'}} (2.1-1) ((1- Q • (".,) 
was in severe health danger and t1V~ 
Slightly Qui te Very 
Unlikely Unlikely Unl ikely ~A7 (I·') 
If So I {s) I (I· ,,) '-:l' 1.2 Jasrf:llZ! ~ (,..3) i "'7 
( .. ~) (,.1.) (l·~) 
was at quIte high risk of a heart 
Slightl y Quite Very 
Unlikel y Unlikely Unlikel y ttes~ lb·~) 2.S I ::.0) t!J HIt< {:!I- b} ~&:,\) HIt, HtlS~ (oll-,,) 13 '1 
(1·"2 (2'42 'L 
was at any extra risk of a heart 
Slightl y Quite Very 
Unlikely Unlikely Unlikely 
711.o) E!J I ::J [!JA~~ (I',ct) ~(,.'S) 2.$ 32 S', ~'1 (3·~) (fI:: &.l (g.r) 
4. I would be willing to help test pills in order to benefit others 
Very Quite Slightl y Not Slightly Quite Very 
Likely Likely Likely Sure Unlikel y Unlikely Unlikely 
Il:~f:! I I ::~: I 12- 1"3 ;~ I lit 6£:,4014 7 {t.o) A) Ne\1 pills: £'0· !t) (~,-g2 (~'~l l~'l) ~& ~ (I'~) U~ " .61 41- 131 B) a the r pills: I - (j 1..'1) (U.-b) (6'~) (]"n (1"1·12 
5. I would be willing to take part in the testing of pills even if I was 
already on other medication 
Very Quite Slightly Not Slightl y Quite Very 
Likely Likely Likely Sure Unlikel y Unlikely Unlikely 
&/tJl"ld)A 7(/-0) f!jlZJ 't3 I 41 7a 2U" A) New pi 11 s : -8 " .1) ". 2,.2 (2.7-8) (~·ctl (II.t) Cl1'~l ()N"I:IJ& 13(/-7) ~4 7' Sit II') 4.1 " J~' B) Other pi lIs : ("'3) (II- l7·J) l~7·1.2 ( ,·,2 { ~·Cf) (21'~~ 
-6-
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6. I would want a great deal of information about the pills and 
side effects before I would agree to help test the. 
Very Quite Slightly Not Slightly Quite 
Likely Likely Likely Sure Unlikely Unlikely 
A) New pills: f!3" 1 :~ I ~l.~') (~,/) 41'1 ~l 2.1. :!. 
B) Other pills: f6r, .. ) (fI.·S) hoi) (polt) 
7 
(I.e) 
S 
their possible 
7. I aight agree to help test pills if .y doctor asked me 
aind when I got home and just not take the pills 
to, but then change my 
Very Quite Slightly Not Slightly Quite 
Likely Likely Likely Sure Unlikely Unl ike I y 
~~~) i~ ~) I ~~ II~! I 
B) Other pills: (~·S) ( . (&.,,) (to,) (B·.) 
A) New pi lIs: Ej' elf's} 113 
((f·J) 
8. On the whole, I think that if Ily doctor asked IDS to take part 
soae pills,' I would agree to do so 
Very Quite Slightly Not Slightl Y Qui te 
Likely Likely Like! y Sure Unlikel y Unlike! y 
'4 
"" 
''ll ali s~ 
A) New pills: ( . "1- ,) ~.:: I l11·~l l~'bl (1''') 10ft- IU Cf3 '30 4-&. fl.S 
B) Other pi 11s: ,'$'0) (I'H,,) (13-k) (IS, 7) ("~l ('-$2 
9. On the whole, I think that 
some pills, I would refuse 
if my doctor asked me to take part 
Very Quite 
Likely Likely 
'fl.'" 3 A) Ne. pills: (2.'-0) (Itl'~) 
1Uf. " 
B) Other pills: (17·i) 
10. On the whole, do you think 
to help in pill- testing 
Very Quite 
Good Good 
~ 'l.~ A) New pills; 0\) (12·"2 11$ B) Other pills: (ct· ~) flf·u\ 
to do so 
Slightly 
Likely 
I 11i; I 
Not 
Sure 
ISo 
(l/,,.> 
ttl 
(21 0) 
Slightly 
Unlikel y 
Quite 
Unlikely 
B7 
~.1'S) 
that it would be a good thing or a 
Quite 51 ightl Y Not Slightl Y 
Good Sure Bad Bad 
'0 73 11". ~, 
flp.S') (!>1-1) l7.}) (,.,) 
9ft 2.l.D ft, S'z 
(/~'~} ill '1) (,,·v2 L"~} 
-7-
Very 
Unlik!ly ~ 11-(1'7' 
,Cf) Y 
(41'4) t./'Htt'6l:b 2..1 (;'0'\ 2.')4 '..J 
(42'$) 
In the testing .Jf 
Very 
Unlikely 
to (Ht) 
, ",3 Y?)fSd) 
£~··l n (2'0 lut YI",ur6 
~i.Z'I.) 
in the testing of 
Very 
Unlikely .---.~7S1A (0(,·4' 
IDO r; 
~~~It) tJ~ l~ (- It) 
OS'o) 
bad thing for you 
Very 
Bad 
41>11tiJOA 10(, o It) B2 
((I.') 40H~ lE,(z..'l.J) 73 
(Jf)' ~J 
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11. Most people who are Important to me think that I should take part In plll-
test log If .y doctor asked 118 to 
Very Quite Slightly 
Likely Likely Likely 
ltS' 7/ I 4S ( '-s) flo -1.) (, .() 
~ Y It 
B) Other pi 115: (,.~) ltD·1. (I'''}) 
A) N •• pills: 
Not 
Sun 
2.l:itr 
(l.,.c't) 
uS 
(z.,·S) (q.O 
Quite 
Unlikely 
72... 
(10'4) 
~4-
(tf· 2.) 
Very 
Unlikel y 
191 
q7'~) 
c.s 
Il.l· ?) 
12. I personally feel that I 
doctor asked lIB to 
oqgbt to take part In the testing of pills If .y 
Very Quite 
Likely Likely 
A) Ne. pills: EE· I ~b; 
'14'14 
B) Other pills: ((l'S) .1. 
Slightly 
Likely 
Not 
Sure 
II, 
(21).0) 
I~o 
Ilg·V 
Quite 
Unlikely 
'5 (2·yJ 
~s 
f7. ,) 
Very 
Unlikely ptJbAJ11J CJ (1·3) 
I~" '~i~) IIVDtJ,46 If:, ("2.~) 
"",,) I 
13. I think that the llkllhood of .y doctor asking .. to take part In a study 
Involving pill testing Is: 
Very Quite Slightly Not 
Likely Likely Likely Sure 
(~~O) It~) I rn) 
2.0 ~s ~3 
B) Other pi 115: (.2.4J.,) ' ''. ().,) 
A) N.w pill s : I ~~ I (U'I) 
Slightly 
Unlikely 
71 
/trrz.) 
17 
Quit. 
Unl ike I y 
lSI 
(2,.-1) 
IfI.$ 
(J,o oCt) 
Please ""..f fe fn the space below, lUJythfn/I else you ClUJ thInk of tlhlch .fsht 
eocourase you to take part In the testf~ of pflls, or put you off dof~ so: 
-8-
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In this section we ask you to rate how likely or unlikely you believe it is that the 
follow1nE statements would be .. true, if you took part in the testinE of any pills. 
IF I TOOK PART IN THE TESTING OF PILLS: 
. ~~ ~ ~ ~)I. U 
-ti tI ~ u~ L. IJ...x lJ ~~ 4J ..)t ..)t ~] :J L.:..: ..... -, .~ tI ~ ·Sc t'.~ :J..lt .~ .~c u·- O~ Vi':; :> Vi:> O:J ~:J ::>-' 
My doctor would give me 411 the information I IN 
I~ JNlc 14. Igs bS b~ II:, 2.7 ~& 10 (J.~) 
wanted about the study 
14J1J ) : ru..L.~ fCf·Q ~.S') 12·~) (1'11) (~'l) A 
15. My doctor would give me 411 the information I ~, ,g7 £b 74- Zi' 2S 3.5 fI~PO II {Hr~ wanted about the pills being tested 
(31·1,) (2J,.,) (1·5) (lb'!:,) (fI-o) (J") (s'D) ~,Nt-I would be able to 4sk doctor for 4ny iii: I~ 
'It 2D 16. my 380 172. ~2. (0 ((.6-) informat~on I wanted 
t9J'7) (24-']) /I.~) {l'~' (~'O) (1,1.) (z.-o) 
-17. If I got a ~eadache, or felt 'off colour' - rlw.n-,~ (1.·1 whilst taking the pills, I wouldn't know if :1Gt~ lif 7' 41 2.3 .2~ ~lt this was normal, or due to the pills and 
this would worry me (yz..~) (2.7·1) flo.q) (iI·J.) f3-?;) 13'l) ly,} 
I;~ I would be risking my health ego by possib,le 18. ~04- 'Sf( 14f ,II 2.S .12 15 12. £11 side effects. 
(J.'N.) (Z?"7) (1.1-3) ('I,'o) tJ-iJ (1'2.) (z..z) 
.~~ 19. I would be contributing to knowledge which 
227 .lSI 107 rD ., , II, 12.. (1.1 might benefit me, now or in the future 
tn·.,) (~". J) 0$'4) (/I-~) (l.l) /I.,,) (,. 3) ~1D 20. I would be contributing to knowledge which lf4 2.~7 ?OJ Sf,. If. S Il. 10 ((-If.) might benefit others 
[('D''') I/J(.~) (1M,) (1.') 10."') (0-7\ ('·7) l-fr4 
'Guinea Pig' ~7" "4 ,~ liS " '+ 17 21. I would be serving as a I~ (I.~ 
VS&·c.) i(u·t.~ ("1) (,.~ //.,) (O~) (2.'4) ~~ 22. have some long term effects 2S'?>. II~ 13' 70 2.0 1/ " The pi lIs might " (/.,,) that no-one has any idea about ~'4) (u..~ (I',') (ID") (1.' '1) (N~) ft·,) 
IIvgfj,,)t 23. If I was testing pills to try to prevent ell IloS /2.1 ,gc, 1,1 S2. *4 ., 1I.~) something, they might not work if I ever 
really needed them 
(n-t) (ll'~ tn·,) (Z.1.t.) (I·') C7.~) (,.~) -""~ b 24. If I agreed to t4ke part in the testing of I'" "1tf 
II' $", SZ 112 2, (l.tI pills, doctor might take me off 11'2. /01 r, some my 
other good pills I'm 41ready taking (/,.,) flf") (7·3) ell.., (8'S) (7'~) 1/.·,) 
-9-
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In thIs sectIon we ask you to show how good or bad you consider each of the 
following things to be, for you. 
FOR MEt THE FOLLOWING THINGS WULD BE: 
>-.. t! ~ 
,...] U-o ~] ~ tJ ·s 8 '"ic,-o '" .. 0 c
:.s 
'" tJ t'-o --0 ~l!> .- "' ~"' '" "' Dl!> inl!> ::> v»ce Dce >co
Being gi ven all the information I wanted ~S ,''' 
pr~~ 25. ~ I~ ( 0 I 12. (I. about the study 
-
/77·0) {/~' ,>' ('~'4) (2.-'t) (0.1) .., '1) 
" 26. Being given all the information I wanted ~'tl 17 , , IrI"1oA qq 2,.1 0 IS (2.-about the pills being tested 
(2.'4-) - (0") 0'1) In-I) (II,.' ~) ("'0) 1~~1\IloA 
21. Being able to ask for any information I wanted ~1' 76 " 10 I 0 , IS (t.-1. V'B2·t,.) lJo·q) (1,.."») (N~) (I)./) - IrO") 
28. Being worried by not knowing if a headache U~LA 
or feeling .~off colour' was normal, or due 73 So ~o Ilb /2.7 /41 ,~ Ib ('.J 
to the pills being tested (,..t;) l7·J) (z,." ) 0"9 (11'3) fU·~) (If H) 
.~ 
29. Risking my heal th, ego by possible side 
effects. /f' 24 17 98 ~ II~Z 22.J 
~'-' ... n 
I (ZA" 
(,.,) (3'S) tz,·Ct) (I~.t) (~'I) ll3'~ (~'I) 
~. 30. Contributing to knowledge which might 2.2.1 ~ 1311 ,~ 14- 3 I> 2Z. (~·2 benefit me, now or in the future 
(31,'J (~") (".,) ("I"~ ("') (0'4) (0") ~TOA 31. Contributing to knowledge which might 2.5$ L'* 1t7 It 3 , ~ lo l2.., benefit others 
11"$&'1) (1-'1") r/~''1) (Il/') (o·ft) (~,,) Coo,) 
ss 40 S, ,Il. 10& II IS? ... PtlJ't. 32. Serving as a 'Guinea Pig' 
(1.,,) -, (I·~) (lb'l) (I!-l) (11'1) (u,) '5 O. (f'I) 
#~'" 
) 
33. long term effects of the I-~"-Possible unforseen 31 
" " "' 
10' 138 '-SD 22.. (1 pill being tested (r·l) (t'II) (/.(.) (17·1) fI".S) (".,) (1'-0) 
~ro 34. The possibility that pills being taken to Il.s lSI ,ee, (1.-try to prevent something, might not work if .2~ I' 3D .tol ,1S I ever really needed them fl·,) (1'7) (I,'J) (2.II'1.) (11-°) (/~") :/2/·7) 
'~IS 
taken off good ~7'f 35. The possibility of being 32- ,., 2.4- 2.01 lo~ 12,.1 "It '2..b (!i pills I'm already taking, if I agreed to 
take part in the testing of some pills (II") (2. • It) (3") (If·l.) (tr·ll (17'7) Cl.Nj 
-10-
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In !his section the questions refer to things th~t might stop people t~kJng any 
tJJed.cines prescribed by their doctor. We lJsk you to show how likely or unlikely 
each .)( the following statements would be for you 
". ~ ~ >..~ '" 2~ ~ >.. u~ ~- ~ OJ .Jt ()~ lL I 
,.." .0: U - U - .r::.~ .... - r ~ I ~ "" .~c SC L.":': ;:,":': c-u'- O~ - i:n:J 0:> :> ~. ::>~ v;~ 
-J J 
would find it hard to remember to take r-36. I 81 '3 loS 1'2. t,.S Iv,- 2JS 11. Cl any medicines if I wasn't in pain or feeling p(orly at the time (/l.f) (f3·4.) (Ir·,) ("7) (,.~) (n·,) (~.,) ·7) 
~" 37. I would stop taking any medicines which made 2.'~ ," 80 1t3 2S ~fr 11 11. (1-1 mL feel worse than I did before ? (~z·z.) (1.1.", (II'~) ".~) (1''') u.,··oJ Uf ·)) 
~. 
--
medicines which I felt IS 
IliiII , 38. I'd stop taking any llC? IBl r, ~ I, Z3 It {(. 
were giving me side effects (~~b) (2J..J' (B.~ l'·,) (1.-7) (2.-1.) ('~'l) 
" ... 14~11 
stop taking any medicines if I heard I~"" 39. I would 
.2J' Iii I 10-, IIf 2'7 31 1) (\ ( /. or read anything bad about them ~3/·S) (z,o'l) (/~-7) (17'0) (1-') (fI.-J) lS'-V 
I felt in ~OTGJ) 40. I would stop taking medicines if 17~ I~ 97 ." 
" 
~ fib IS ( 
myself that they were not doing me any good 
(l$·o) fu..l) at,... (1/'1;) (q.!) (If' /,) ( ,"-) 
I'd stop taking medicines if I didn't think PCU& 41. 
~~ f}~ 75 '0 So 3' t"o (1. t I. I had enough information about them and had 
any doubts 
I\S'?2 lU-, (/~V) (K-.) (7'Z.) (~.z.) C:~'~ 
p.c" 42. I might skip a dose or two if I was going go 7D 73 5, $"' n zit, ~ lIr out for a drink QI.~) ~trt) 11~'5) (1'5) ca-<;) (u-!) vlt,.'~ ~-lf1 
t,.~ 102 ~'" SI " 
I~' 43. I would only stop taking medicines if my 2.Ctl 12.1 ~ (t· doctor told me to stop them vU~ (h''') (I.'!,) 1I~'7) 1"$) (7'~) (JN~ 
~) 
-11-
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In the last fUJrt of this section we would like to know what you think other people 
feel about you takin8 part in the testin8 of pills. 
Please show how strongly for or against you tak Ing part in the test Ing of pills, 
each of the following people would be if you were at risk of a heart attack or 
stroke and doctors thought the pills might help prevent these·disorders. 
44. A) How would these people feel about you helping to test brand new pills 
Your spouse/partner 
Your children 
Your parents 
Your friends 
IN FAVOUR AGAINST 
DOlsnlt 
A I ANt.1d ~4-
q') ('·1) 
~L.;."U.-IItNtt1t.. b1 
lq.,) 
-'=-'~.HJNI.f(P 7/' 
(10-') 
NlIf1- s, 
..1.U.:~_' l,.·S) 
B) How woul.d these people feel about you helping to test other pills which may 
help to hold off heart attacks or stroke? 
Your spouse/partner 
Your children 
Your parents 
Your friends 
Generally speaking, how 
do? 
Your spouse/partner 
Your children 
Your parents 
Your friends 
Very 
t1uch 
111. l{~·r.2 
9' {tJ'lJ 
!rf 
tt3} 
~, 
If'~l 
auch do 
Very 
t1uch 
IN FAVOUR 
Quite A 
A Lot Little 
Il.D (;:,.12 ¥ 1" 
-I{f1- (ID·bl 
" 1fU- a"jl /D (/.Jostl Ii,·tl 
you want to 
Quite A 
A Lot Little 
I 0 ({tI.2 
11Jt, frjO) 
it4'4) 
(~2") 
do what 
Not 
At All 
AGAINST 
A Quite Very 
Little A Lot t1uch 
~'2 !fi1) I~) 
2.lf 3r 
'i'~l l~72 ls.s) Li" II Jl. (t.o) .J.j;fL ir·).) 
ur z. Z,T 
'~,ol {!,z2 {,·l] 
Doelnit 
Apply 
-f]9 
¥ 
az·81 
111-
-P 
lJl·~l 
,~p 4S('·i) 
&-J(",c.. f.7{,.,,) 
6NIJ1P fp (1(-5) 
&ltH=l- b3(~·I) 
these people think you should 
Doelnlt 
Apply 
eTtt1pSP y" {,.~ 
eTCMPt. 1,7 (,.~) 
t-T'tM" It> (u~) 
c:tc.fo\P To S, (r's) 
45. Please aaark 
statement: 
the box which best describes your behaviour regarding the following 
-I usually try to do what I think I ought to do· 
AI.olt V3hl "Olt of ~ So.e of I/~;I AI.ost I70l t!.1lI'II'Ht: 
Always ~ the tile ~ the tille '11, Never I£j1J 14- (l·S J 
II YOII ~ould lii, to .Ii, iny otll'f c() •• ,nt, Ibout pill t"ting, pJe~" do ,() ()n tM blc; 01 Mi, pig', 
-12-
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Fln~lly, we would like ~ little lnform~tion ~bout your he~lth ~nd p~st 
experiences, if any, of health checks and the testins of medicines. 
(A) How would you rate your general health? 
Excellent 19' I 
li~·') 
600d Fair Poor 
(8) How interested are you in your general health? 
Very Interested I~ I Quite Intere.ted I~JrI Slightly Interelted I~ I Not Really Int.r.lt.d 1Jr- I (~') 
(fI~.zJ (4S·?) (e'3) (/'lJ 
(C) How careful are you about what you eat to help yourself stay healthy? 
Very Careful ~ Quite Careful I~I 
(n.~ (SD'~ 
Slightly Careful I~ll 
C~1'4) 
Not R.ally Car.ful 1 981 
(/~'I) 
(D) Do you think you are overweigbt? 
By lore than r~ 
2 stones ~ 
la.:') 
By lore than I"a 1 
1 stone 
Not really 194r l 
overweight 
(2."0) ('0.1) 
(E) Have you ever been a smoker? 
Current Sioker ~ 
(~'-3) 
(F) Do you drink alcohol? 
Ex Sioker 1",1 
(J.J·s) 
Never Sioked 1Z871 
(4"~) 
Ulually, at least I/~I Usually, at lealt ~ Only I~' I ~ days a week once a week ~ Occasionally 
l'S'7) (J4t·V (.~·1) 
(G) Do you take regular exercise of any sort? 
Usually, at least 1"31 
3 tiles a week 
Ulually, at lealt I's,\ 
once a week 
No Regular 13751 
PaUern 
l,13'~) ()J'7) ()'l") 
What lort of exercile do you do""""""" II I'" I. I' .11 II II' II II I I I I' III I I" I" I. II I I '" 
(H) Have you ever suffered any: 
() Heart Trouble ~(2) High Blood Pre.sure Problell 
Ye, I s' I No I"i'/ t~.O) Yes 
(J.') (93") 
If y.s, please specify: •••.•... I •••••••••••••••••••••••••••••••••••••••••••••••••••• 111 •••••• 
Have any of your relatives had a heart attack 
(1) H.art AUack JotA (2) Stroke 
Ye, 1240/ No /ct17/ Ii 
or stroke before they ware 10? 
S~ICE 
~7 
(I> 
Y.s 11131 No 1515/ 
(n-S) (u·CI) (Z •• \.\ (~.~) 
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(J7·1) (7S~) 
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(J) How would you rate your own risk of having a heart attack or stroke before 
you are 70? (those over 70 please go straight to question K) 
( 1) HEART ATTACK ()W1'J~H (2) STROKE 
Qu i te 1..,,_ I [?::I Qu i te ~ '31 C~·b) 
High t?U Average ~ Low ~ .f-.t~("'l> Q~ite 131-1 r.;:::l Quite ("LI HIgh 'f# Average 112~ I Low 2,)Q 
Dc.l » ~tc$. 
7g (1/'1} 
t 2J (I.') 
AlI~ (lO.") (41") (lI's) N/1f (4-' V ~.~ lSr.-~ 
(I) Have you ever had your blood pressure tested?: 
By your t;;:i1 by the practice ~ at work 1.21 I other ~' 
own doctor ~ nurse ~ ~ 
(SJ-J.) (1f>'J) a.. CV s· 9) 
I f I other I please spec i f y: I • I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
(L) Have you ever had your blood cholesterol level tested?: 
C.Ift,L 'fSr 
By your r;:\ bnuVrsthee practice 1 ~21 at work r;.l other 12' I never ~ I ~ ('-V own doctor ~ L.!J been tested I~ 
(B") "'J) (1)04.) (If-l) az,.~ + ll.·o) . 
I f I other I pleas.e spec i fy: I I I • I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I. I I I ••• I •• I I I I I I I I I I ~-" ~ \ op~~ 
(M) Would you like to have these tests done regularly? 
(1) BLOOD PRESSURE ~11)¥ (2) CHOLESTEROL 
NoilO I Not 170 I Already Havel'. 2.1 lit-( , .. \ eslsco I Nol '371 No t JI07I A I rudy H. veil!. I 
Sure Regular Check Sur R.gular Check 
(~-,) (ID-I) (I;" 7) (71-7) (S"'J) {Jr'?J (J.,y 
(N) If you had 8 choice, would you prefer to have these tests done by: 
(1) BLOOD PRESSURE 
Your Own Doctor 
The Practice Nurse 
At Work 
Other 
~ 
(2) CHOLESTEROL 
Your Own Doctor 
The Practice Nurse 
At Work 
Other 
AUV 
( 1-(,) 
(I") 
:to (t-') 
Pt;x,..Ho'-(g (l. .. S) 
I f I other I please spec if y: I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I • I I I I I • I I I I I I I I I I • I I I I I 
(C) 
(P) 
Are you on any long-tera aedication at the .aaent? r::l ,~ 'I 
Yes I'" I No .,1 
(l4-~) 04'S) 
.. (.<4) 
Have you ever been asked 
to help in pill testing? 
~II ... ~-r (, CO" \)U f . Y II ) 
Old you P" .. :m~ Would you do 
Yesl lO I Nol"'1 
ll-,) (,"-l) 
do so? Ye8NO~ 
it agiin? Yes~NJ~ 
77utni you very .uch for helplng In thls survey. Before sendins back your 
questionnaire, please check that you have anstlered all the questions and .,.de 
any co.-ents you tIOuld 1 lie to .aie. 
-14-
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APPENDIX 15 
MAIN STUDY SAMPLING PROCEDURE 
The objective was to secure as random a sample as possible, from both the 
electoral roll and practice lists. 
Sampling from the electoral roll was achieved via a straightforward 
sequential strategy. Firstly, the approximate number of names on the roll 
was ascertained. This number was then divided by 1000 - the number of 
people to be canvassed. The start ing point was determined by use of 
random number tables, after which every nth name was chosen. Names and 
addresses were recorded direct ly onto st icky labels, so no record of 
those canvassed was kept. 
A similar sequential sampling strategy was employed for selection of 
potential respondents from the medical sampling sources. In each case the 
approximate number of registered patients was divided by 250 (the number 
of potential respondents required from each practice), to determine the 
nth number. Again the starting point was decided by use of random number 
tables. 
At two practices names were drawn directly from the note stack. When the 
nth person chosen was too young or too old for inclusion in the sample, 
the next set of notes within the required age range was selected. Because 
the electoral roll includes people aged 18 and above, the age range for 
practice sampling also started at 18. 
Names and addresses were recorded from the notes cover. On no occas i on 
were note envelopes opened, and medical conf ident ial i ty was rigorously 
upheld. 
At the other two pract ices, select ion was made from age/sex register 
cards, though an identical sampling strategy applied. The only difference 
was, that half the names were drawn from males, and half from females in 
these instances. 
Once a complete set of names had been selected, they were presented to 
the GPs for vetting for suitability for canvassing. When GPs had 
approved the I ists, names and addresses were copied onto st icky labels 
and the lists destroyed. 
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APPENDIX 16 
GP-COVERING NOTE FOR POTENTIAL RESPONDENTS DRAWN FROM PRACTICE LISTS 
(WRITTEN ON PRACTICE HEADED PAPER) 
Date 
Dear Si riMa dam, 
Enclosed is a questionnaire about attitudes to preventive medicine in the 
NHS, especially concerning the prevention of heart attacks and strokes. 
The survey is being carried out by a doctor based at Oxford university 
and a psychologist based at Cranfield Institute of Technology, as part of 
a nationwide study investigating ways in which GPs can help to reduce the 
number of heart attacks and strokes people suffer. 
Your name was selected by these researchers, at random, from our list of 
patients. They have not seen your medical notes, nor will they ever do 
so. 
There is no record of the names chosen from our 1 is t and no names or 
addresses are asked for on the questionnaire, so all responses will be 
entirely anonymous and no one will even know whether or not you do decide 
to take part in this survey. 
However, a1 though we are not personally invo1 ved in the survey, we do 
think that it is an important study, and if you feel you would like to 
take part your help would be greatly appreciated. 
Yours Sincerely, 
(Dr. (s)' Name (s». 
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APPENDIX 17 
PREDICTIVE ASSOCIATIONS BETWEEN BIM COMPONENTS 
FOR MEASURES PERTAINING TO TRIALS OF ESTABLISHED DRUGS 
Figure 1 Predictive Associations Using The Basic BIM 
<Relates to figure 3, p143 main text) 
IBehavioural bel iefs R=.541 & outcome evaluation r=.434 
(cases=624) 
Attitude toward 
the behaviour 
p=.OOO 
Relative importance 
of attitude and 
sub ective norm 
Normative beliefs and R=.507 
motivation to comDlv r=.494 
(cases=220) 
p=.OOO 
Subjective 
norm 
o 
r=.680 
Intention 
r=.538 
Figure 2 Prediction of Intention From Attitudes, subjective Norm and 
Personal Norm 
<Relates to figure 4, p143 main text) 
W,=.399 
T
AhttitBude Towards ~_ 
e ehaviour ~ 
S bj t · N t i F.r" 088 ~ 776 Intent ion To Perfor"" u ec 1 ve orma ve I---...... £. =. Jr-". - 11l 
Be lie f LT.!.:h!..!.:e=--.!B:!.::e:.!.h~a~v~i.:::!.o~u!-r -----' 
Personal Normative 
Bel ief 
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The following tables are summaries of multiple regression analyses as 
depicted in figures 1 and 2. Values shown in tables 1 and 2 below are 
those relating to 'other' pills. They correspond to tables 20 and 21, p144 
main text, which give values for trials of 'new' pills. 
TABLE 1 Summary of MRA with Intention to Participate in Clinical Trials of 'Other Pills' 
as the DV and Attitude and Subjective Norm as the IVs 
FINAL VALUES ! VARIABLES IN THE EQUATION 
I Variable Entered ! R2 ! B !Beta!Part!Partial! T ! P 
(In Order of Inclusion) !Change! !Corr!Corr!! 
Multiple R ,707 Attitude ! ,461! ,64! ,55! ,46! ,54 !16,62!,OOO! 
R Square ,500 
Adjusted R ,499 Subj ec ti ve norm ,039 ,26!, 24! ,20! ,27 7 ,23! ,OOO! 
F Value 332,580 
Significance ,0000 
TABLE 2 Summary of MRA with Intention to Participate in Clinical Trials of 'Other Pills' 
as the DV and Attitude, Subjective Norm and Personal Norm as the IVs 
FINAL VALUES ~ABIAe~E~ I~ I~E EQ~AIIQ~ 
Variable Entered R2 B !Beta!Part Partial l T p 
~ID Order Qf ID'ly~iQD) Cbinge !CQU CQrr 
Multiple R ,776 Personal Norm ,524 ,45! ,46! ,32 ,45 13, 18 ,OOO! 
R Square ,602 
Adjusted R ,600 Atti tude ,074 ,40! ,3.4! ,25 ,36 10,07 ,OOO! 
F Value 334,231 ! ! 
Signi f icance ,0000 Subjective Norm ,004 ,09! ,08! ,06. ,10 2,53 ,011 ! 
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APPENDIX 18 
SUMMARY OF T-TESTS TO DETERMINE SUITABLE GROUPS FOR COMPARISON REGARDING 
INTENTION TO PARTICIPATE IN SCREENING FOR CARDIOVASCULAR RISK 
Because the overwhelming majority of respondents indicated some degree of 
intention to participate in screening, it was not possible to make a 
comparison of beliefs between those who did and did not intent to 
participate. However, it was suspected that there might be some 
differences between those who indicated a very strong intention and those 
whose reported intentions were less strong. Therefore, t-tests were 
performed between the following groups, which together comprised 90.5% of 
all responses, to establish whether there were sufficient differences 
between them to justify the formulation of two comparison groups: 
A) Groups 1 & 2 (representing respondents indicating the strongest and 
2nd strongest degrees of intention to participate in screening 
Definitely Yes & Yes respectively) 
B) Groups 1 & 3 (representing respondents indicating the strongest and 
weakest positive intentions - Definitely Yes & Possibly Yes) 
C) Groups 2 & 3 (representing respondents indicating the medium and 
weakest positive intentions - Yes & Possibly Yes) 
Variables tested were all belief measures plus general attitude, personal 
attitude, subjective norm and personal norm. 
As can be seen from the following summary tables, in respect of bel ief 
measures, there were significant differences on almost all belief 
measures between groups 1 & 2, and groups 1 & 3. However, almost no 
significant differences were found to exist between groups 2 & 3. 
Also, although there were significant differences between all groups on 
the variables of attitude, subjective and personal norms, the magnitude 
of difference was much greater between groups 1 & 2, and groups 1 & 3, 
than they were for groups 2 & 3. Omega square values were similarly much 
larger for the first 2 comparison groups than for the 3rd. 
Therefore, it seemed worthwhile to create a psuedo participant/non-
participant group from these three sets by making group 1 respondents 
'participants' and combining groups 2 & 3 into 'non-participants' for the 
purposes of belief investigations. 
1 = Definitely Yes 
2 = Yes 
3 = Possibly Yes 
01=376: 02=154: 03=97 
GENERAL ATTITUDE 
[1 (sd) g2 (sd) t R 
1 V 2 1 ,0 (, 22) 1 ,5 (,60) 9,7 ,000 
1 V 3 1 ,0 (,22) 1 , 9 (, 79) 1 0 , 5 , 000 
(e 
,15 ! 
,19 ! 
2 V 3 1 ,5 (,60) 1 ,9 (,79) 3,9 ,000 ,05! 
01=377: 02=]54: 03=97 
SUBJECTIVE NORM 
[1 (sd) g2 (sd) t p 6)2 
1 V 2 1,4 (,79) 2, 1 (,82) 8,7 ,000 ,12 
1 V 3 1 ,4 (,79) 2,5 (l,l) 9,5 ,000 , 16 
2 V 3 2, 1 (, 82) 2,5 (1,1) 3,4 ,001 ,00 
01 = 371; 02 = 151; 03 = 97 
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01=376: 02=155: 03=97 
PERSONAL ATTITUDE 
[] ~~g~ lQ ~~d~ ~ 12 a2 
1 V 2 1 , 1 ( ,38) 1 ,7 (,90) 8,3 ,000 ,11 
1 V 3 1 , 1 ( ,38) 2 , 2 (, 92) 1 1 , 3 , 000 , 21 
2 V 3 1 ,7 (,90) 2,2 (,92) 3,8 ,000 ,01 
01=377: 02=]55: 03=97 
PERSONAL NORM 
[] (sg) lQ (sg) t 12 6)2 
1 V 2 1 , 1 ( ,42) 1,9 (,74) 12,9 ,000 ,24 
1 V 3 1 , 1 ( ,42) 2,2 (,64) 15,6 ,000 ,34 
2 V 3 1,9 (,74) 2,2 (,64) 2,7 ,008 ,00 
Streogth Evaluatioo ! Crossproguct 
K] (~d) K2 (~d~ t p K] ~~g) K2 ~~g~ ~ p ! K] ~~g~ K2(~g~ t p 
1 V 2 ,2(1, ]) 1,7(1,2) 4,1 , 000 ! 2 , 5 ( 1 , 1 ) 2,on ,4) 4,0 ,000!5,8(3,9) 3,8(3,8) 5,2 ,000 
1 V 3 ,2(1,1) 1,6(1,4) 3,6 , 000 ! 2 , 5 ( 1 , 1 ) 1,9(1,3) 3,9 ,000!5,8(3,9) 3,5(4,0) 4,9 ,000 
2 V 3 1,7(1,2) 1,6<1,4) 0,7 ,506!2,0(1,4) 1 ,9 ( 1,3) 0,4 ,650! 3 , 8 (3,8) 3,5(4,0) 0,5 ,611 
1 - ')7')' o - oJ_il. n2 = 151: n3 = 97 
Strength 
xl (sd) x2 (sd) t 
1 V 2 2,8(0,7) 2,7(0,6) 1,5 
1 V 3 2,8(0,7) 2,5(1,1) 2,5 
2 V 3 2,7(0,6) 2,5<1,1) 1,5 
nl = 368: n2 =150: n3 =97 
Strength 
xl (sd) x2 (sd) t 
1 V 2 2,7(0,7) 2,5(0,9) 2,6 
1 V 3 2,7(0,7) 2,4(1,1) 2,9 
2 V 3 2,5(0,9) 2,4(1,1) 0,8 
01 = 373: n2 = 151; n3 = 97 
Strength 
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WANT TO BE TOLD 'STRAIGHT' 
! Eyalyation Cross~roduct 
! 
-
P ! xl (sd) 
,131 !2,7(O,9) 
,O16!2,7(O,9) 
,125!2,3<1,1 ) 
- I 
x2 (sd) t ~ ! xl (sd) x2(sd) t ~ 
2,3(1,1) 3,3 ,001 !7,5(3,3) 6,4(3,4) 3,4 ,001 
2 , 2 (1 ,2) 3, 1 ,002 ! 7 , 5 ( 3 , 3 ) 6 , 3 (3, 5) 3, 2 ,002 
2,2(1,2) 0,5 ,591 !6,4(3,4) 6,3(3,5) 0,3 ,787 
GEl eEACE DE ~I~Q 6Y T~E "ALL CLEAB" 
I Eyaluation Cross~roduct I 
! ! 
~ I xl (sd) x2 (sd) t ~ ! xl (sd) x2(sd) t ~ , 
,O10!2,8(O,5) 2,6(0,7) 2,7 ,007!7,9(2,3) 6,9(3,2) 3,3 ,001 
,O05!2,8(O,5) 2,5(0,9) 3,1 ,002!7,9(2,3) 6,6(3,3) 3,6 ,000 
,406!2,6(O,7> 2,5(0,9) 1 , 1 ,264!6,9(3,2) 6,6(3,3) 0,9 ,388 
COULD lAKE eBECAUlIONS 
Evalyation Cross~roduct 
! 
xl (sd) x2 (sd) t ~ ! xl (sd) x2 (sd) t p ! xl (sd) x2(sd) t ~ 
1 V 2 2,7(0,7) 2,4(0,9) 2,9 ,004!2,7(0,6) 2,5(0,6) 3,9 ,OOO!7,7(2,3) 6,4(3,1) 4,6 ,000 
1 V 3 2,7(0,7) 2,2(1,3) 3,8 ,OOO!2,7(0,6) 2,3(0,9) 4,5 ,000!7,7(2,3) 5,8(3,5) 5,0 ,000 
2 V 3 2,4(0,9) 2,2(1,3) 1,7 ,085!2,5(O,6) 2,3(0,9) 1,6 ,102!6,4(3,1) 5,8<:3,5) 1,5 ,144 
nl =371; n2 = 151: n3 = 97 
BE TOLD BEST PRECAUTIONS 
Strength Evaluation CrossprQduct 
I 
. - -
xl (sd) ;2 (sd) t p ! xl (sd) x2 (sd) t ~ xl (sd) x2(sd) t ~ 
1 V 2 2,7(0,7) 2,4(0,9) 3,4 ,001 !2,8(0,4) 2,5(0,7) 4,8 ,OOO!7,5(2,5) 6,2(3,0) 5,0 ,000 
I V 3 2,7(0,7) 2,2(1,2) 3,6 ,001 !2,8(0,4 2,4(0,8) 4,7 ,000!7,5(2,5) 5,8(3,2) 4,9 ,000 
2 V 3 2,4(0,9) 2,2(1,2) 1,3 ,195!2,5(O,7) 2,4(0,8) 0,9 ,345!6,2(3,O) 5,8(3,2) 0,8 ,413 
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nl =373: n2 = 151: n3 =97 
STAY FIT LONGER 
Strength ! Evaluation ! Cross~roduct 
I 
. - ! 
xl (sd) x2 (sd) t p ! xl (sd) x2 (sd) t P ! xl (sd) x2(sd) t ~ 
1 V 2 2.6(0.7) 2.2(1.0) 5.7 .00012.7(0.6) 2.5(0.7) 4.0 
.00017.5(2.4) 5.7(3.4) 5.6 .000 
1 V 3 2.6(0.7) 2.0(1.2) 5.4 .00012.7(0.6) 2.3(0.9) 4.4 .00017.5(2.4) 5.2(3.0) 6.6 .000 
2 V 3 2.2(1.0) 2.0(1.2) 1.5 .124!2.5(0.7) 2.3(0.9) 1.7 .096!5.7(3.4) 5.2(3.0) 1.2 .226 
nl = 370: n2 = 151: n3 =97 
LESSEN CHANCES OF LATER INFIRMITY 
Strength ! Eyalyation Cross~rodyct 
xl (sd) x2 (sd) t R ! xl (sd) x2 (sd) t p ! xl (sd) x2(sd) t P 
1 V 2 2.2(1.1) 1.8(1.3) 3.6 .000!2.6(0.8) 2.2(1.0) 3.8 .000!6.3(3.3) 4.9(3.7) 4.2 .000 
1 V 3 2.2 ( 1 • 1 ) 1.5 (J .2) 5.4 .OOO! 2 • 6 (0.8) 2 , ]( 1 • 1) 4. 1 .000 ! 6 . 3 (3.3) 4.0 (3.4) 5.7 .000 
2 V 3 1.8<1.3) 1.5(1.2) 1.8 .08012.2(1.0) 2.1(1.1) 1.0 .336!4.9(3.7) 4.0(3.4) 1.7 .084 
nl = 363: n2 = 149: n3 = 97 
GET LECTURE FROM DOCTOR 
Strength Eyaluation Crossproduct 
I 
- - '- - --
xl (sd) x2 (sd) t p 1 xl (sd) x2 (sd) t P xl (sd) x2(sd) t P 
1 V 2 0.8 (2. 1) 0 . 3 (2.0) 2. 1 .0371 1.4 ( 1.6) 1.0 (] .6) 2.2 .02813.0 (4.4) 1.9 (3.9) 2.4 ,016 
1 V 3 0 , 8 ( 2, J) 0 , 4 ( 1 , 9) 1, 7 • 080 ! 1 ,4 ( 1 ,6) 0 , 5 ( 1 ,8) 4, 9 ,OOO! 3 , 0 ( 4 ,4 ) 1,3 ( 4 ,0) 3, 2 ,001 
2 V 3 0,3(2,0) 0,4(1,9) 0,1 ,964!l,0(1,6) 0,5(1.8) 2,7 ,007!1.9(3,9) 1,3(4,0) 1.1,254 
nl = 369: n2 = 150: n3 = 97 
BE S~UBEO 1Q ~EA~1~IEB ~I~I~G 
Strength I Evaluation I Crossproduct , , 
! 
-
-
-
- ~2~;d~ i 
xl (sd) x2 (sd) t P I xl (sd) x2 (sd) t p I ~l ~;d~ p , . 
,O07!5,2(3,6) 4,1<3,8) 3,1 ' ' , 1 V 2 1,9(1,4) 1,6(1,6) 2,8 ,O06!2,O(l,3) 1,7(1.4) 2.7 ,VV .. 
1 V 3 1,9(1,A) 1,3(1,6) 3,7 ,00012,0 (] ,3) 1,5(1,3) 3,8 ,OOO!5,2(3,6) 3,0(3,5) 5,1 ,000 
2 V 3 1,6(1,6) 1,3(1,6) 1,0 , 293 ! 1 , 7 ( 1 ,4) I,S(J,3) 1.2 ,23014,1(3,8) 3,0(3,5) 2,1 ,036 
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The following variables,relating to lifestyle changes, are reported twice. 
Firstly, for all respondents, including those who indicated that the items 
were irrelevant to them. Secondly, for only those respondents to whom the 
items were relevant. Both sets of anaylses were performed to establish: 
(A) any differences in groups because of differences in smokers/non-
smokers etc. (large means are found in these analysis because the 
scoring code for 'not applicable' was 8, whereas all other scores 
range from -3 to +3 
B) any differences in groups because of beliefs held by respondents for 
whom the items were relevant ( scoring codes here ranges from -3 to 
+3 only. 
nl = 364: n2 = 150: n3 = 94 
SHQ~I~6 ~~mQker; & DQD-~mQker;~ 
Strength Evalua hon I CrQssprQduct . 
l!:] (sd} ~2 (sd~ ~ ~ l!:] ~;d) l!:2 (~d~ ~ p ~] ~;d~ ~2~~d~ 1 ~ 
1 V 2 5,7(2,1) 5,6(2,1 ) ,55 ,581 !5,4(2,6) 5,2(3,0) ,96 ,339!36,O(21) 34,5(21) 0,7 ,468 
1 V 3 5,7(2,1> 5,2(2,3) 1 ,9 ,057!5,4(2,6) 4,8(3,0) 2,1 ,037!36,O(21) 31,4(23) 1,9 ,059 
2 V 3 5,6(2,1) 5,2(2,3) 1,3 ,211 !5,2(3,O) 4,8(3,0) 1 ,0 ,306!34,5(21) 31,4(23) 1 , 1 ,279 
oJ = lQ2: 02 = 46: n~ = 3£ 
SHQKIN6~5moker~ Qnl¥~ 
Strength Evaluation CrQ;;~rQd~~l 
-
- ~2~;d~ t ~] ~sd~ x2 ~sd~ t p ~l ~~d~ ~2 ~sd~ t p ~l ~id~ p 
1 V 2 2,5(1,1) 2,6(0,8) ,36 ,717!1,7<1,7) 1,0(2,1> 2,3 ,025!4,6(5,2) 3,0(5,9) 1,6 ,111 
1 V 3 2,5(1,1) 2,6(0,8) ,35 ,724! 1 ,7(1 ,7) 1,1<1,5) 2,1 ,041 !4,6(5,2) 3,0(4,3) 1,7 ,093 
2 V 3 2,6(0,8) 2,6(0,8) ,01 , 986 ! 1 ,0 ( 2, 1 ) 1,1<1,5) ,28 ,781!3,O(5,9) 3,0(4,3) ,00 1,00 
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DRINKING (drinkers & non-drinkers) 
strength ! Evaluat ion Crossproduc t 
- ! 
-xl (sd) x2 (sd) t P ! xl (sd) x2 (sd) t p ! xl (sd) x2(sd) t P 
1 V 2 4,7(3,2) 5,0(3,1) ,82 ,410!5.0(2,9) 5,2(2,9) ,74 ,461 !31 ,3(23) 33,O(23) ,72 ,473 
1 V 3 4,7{3,2) 3,9(3,6) 2,3 ,024!5,O(2,9) 3,9(3,5) 2,6 ,O10!31,3(23) 26,9(24) 1,7 ,098 
2 V 3 5,0(3,1) 3,9(3,6) 2,6 ,OI0!S,2(2,9) 3,9(3.5) 2,9 ,005!33,O(23) 26,9(24) 2,0 ,048 
nl = 123: n2 = 46: n3 = 43 
DRINKING (Drinkers only) 
Strength Evalyation Crossproduct 
xl (sd) x2 (sd) t P xl (sd) x2 (sd) t p xl (sd) x2(sd) t P 
1 V 2 0,9 (2, 1 ) I, 1 ( 1,9) ,36 .717! I. 1 ( 1 ,5) 
1 V 3 0,9(2.1) 0,5(2,1) 1,2 ,213!1,1(1,5) 
1 ,0{1 ,5) ,59 ,S57!2,2(4,4) 1,6(4,3) ,85 ,396 
° , 3 ( 1 , 6) 2, 9 ,004! 2 , 2 ( 4 , 4) 1, 2 ( 3 , 7) 1, 3 , 1 96 
2 V 3 1,1<1,9) 0,5(2,1) 1,4 ,166!1,0(1.5) 0,3(1,6) 2,0 ,047!I,6(4,3) 1,2(3,7> ,39 ,699 
DIET ('healthy eaters' & others) 
Strength ! Evaluation Crossprodyct 
- - -!-
xl (sd) x2 (sd) t P ! xl (sd) x2 (sd) t p ! xl (sd) x2(sd) t p 
1 V 2 3,2(2,8) 3,1(2,9) ,S2 ,603!3,3(2,7) 2,9{2,9) I,S .069!16.8(21) 15,6(21) .58 .563 
1 V 3 3,2(2.S) 1,4(2,3) 5,S ,OOO!3.3(2.7> 1 ,7{2.]) 6.3 .000!16,S{21> 5.5(13) 6,4 .000 
2 V 3 3.1(2,9) 1,4(2.3) 5,0 ,OOO!2,9(2.9) 1 .7{2. 1) 3,6 ,OOO!15,6(21) 5.5(13) 4,6 ,000 
n1 = 247: n2 = 107: n3 = S6 
DIET ( non 'healthy eaters' only) 
Strength Eyalyation ! Crossproduct 
xl (sd) 
! - - ! - -
;2 (sd) t p ! xl (sd) x2 (sd) t p ! xl (sd) x2(sd) t P 
1 V 2 1.6(l,S) 1 ,5 ( 1 ,7) ,50 ,617! 1 ,7 ( 1,3) 1,2 ( 1,6) 2,6 ,009! 3 , 6 (4 • 0) 3,0 (4 ,2) 1,3 .202 
1 V 3 1.6{l,S) 1,0(1,7> 2,9 ,004!1,7{l,3) 1,2{1,4) 3.0 ,003!3.6{4,0) 2,3(3,5) 2,7,008 
2 V 3 1 2 (I 6) 1 2 (1 4) 19,848! 3.094,2) 2,3 (3,5) 1,2 ,219 1.S(1,7) 1,O{l,7) 1,9 .054!,. ", 
Strength 
xl (sd) x2 (sd) t 
1 V 2 3,3(2,6) 3,0(2,8) 1 , 1 
1 V 3 3,3(2,6) 2,7(2,8) 2,1 
2 V 3 3,O(2,S) 2,7(2,S) ,95 
nl = 252: n2 = 106: n3 = 70 
Strength 
-
xl (sd) x2 (sd) t 
1 V 2 l,8(J,3) l,A(] ,5) 2,2 
1 V 3 l,S(],3) l,A(J ,5) 2,3 
2 V 3 l,A(],5) l,A91,5) ,20 
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EXERCISE (regylar exercisers & others') 
I Evalyation I Crossproduct , , 
I ! 
P I xl (sd) x2 (sd) t P I xl (sd) x2(sd) t p , , 
,287!3,3(2,6) 3,0(2,6) 1 , 1 ,291 ! 16,5 (20) 15,6(20) ,46 ,648 
,039!3,3(2,6) 2,8(2,7) 1,7 ,098! 16,5(20) 13,6(21 ) 1,2 ,211 
,3Al !3,O(2,6) 2,8(2,7) ,67 ,503!15,6(20) 13,6(21) ,76 ,448 
EXERCISE (non-regylar exercisers only) 
! Evaluation ! Crossproduct 
! 
P ! xl (sd) x2 (sd) t p ! xl (sd) x2(sd) t p 
,031 ! 1 ,S (1 ,2) l, 5 ( 1 ,3) 1,7 ,089! A, 1 (3,5) 3,2 (3,4) 2,3 ,020 
, 02A ! 1 ,S (J ,2) 1,3 (J ,2) 2 I 5 ,013! 4 , J( 3,5) 2,.4 (3,2) 3,6,000 
,839! 1,5 (1,3) 1,3 (J ,2) ,88 ,383! 3,2 (3,4) 2,.4 (3,2) 1,4, 159 
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APPENDIX 19 
T-TESTS FOR 'OTHER' PILLS 
The following tables correspond to tables 31 to 33, for 'new pills' shown 
on pages 152 & 153 in the main text. 
Group 1 = respondents who marked any of the 3 'Yes' categories in 
answer to Q8 - intention to take part in pill testing of 'other pills' if 
asked. 
Group 2 = respondents who marked any of the 3 'No' categories in answer 
to this question. 
Together these respondents comprised 79% of responses to this question. 
'Don't Know's were excluded from analysis 
TABLE 3 Summary of T-Tests on Behavioural Belief Variables (Belief Strength Measures) 
Between Intending Participants and Non-Participants in Clinical Trials 
VARIABLE BELIEF STRENGTH 
GP _1 GP _2 
! n x (sd) n x (sd) t g I 6)2 . 
! 
Getting info, re the study 328 1,90 ( 1 ,50) 207 1,05 (2,02) 5,21 ! ,000 <,10! 
Get info, re the pills 327 1,77 ( 1 ,53) 207 1,06 ( 1 ,97) 4,41 ! ,000 <,10! 
! 
Could ask for any info, 327 2,30 (1,19 ) 207 1,64 ( 1,78) 4,70 ! ,000 <,10! 
Worry if felt 'off colour' 326 1,48 ( 1 , 72) 206 1,78 (1,76) -1,89 ! NS - I 
I 
Worry re side effects 326 0,93 (1,50) 207 2,07 (1,25) -9,49 ! ,000 ,14 ! 
Contributing to knowledge ( 1 ,67) 6,85 ,000 <,10 which might benefit self 326 2,07 ( 1,03) 207 1,18 
Contributing to knowledge 
which might benefit others 328 2,28 (0,85) 207 1.52 ( 1 ,62) 6,22 ,000 <,10 
Serving as a 'Guinea Pig' 327 1,93 ( 1 ,37) 207 2,43 (1,18) -4,49 ! ,000 <,10 
Worry re long-term effects 327 1,39 ( 1,38) 207 2,19 (1,17) -7,16 ! ,000 <,10 
Worry-acquired resistance 327 0,29 ( 1,67) 207 0,70 (1,70) -2.76 I .006 <.10. 
Worry re 'being taken off (2.05) 202 0,15 (2,04) -0,49 NS - I good pi 111 I 366 0,06 
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TABLE 4 Summary of T-Tests on Behavioural Belief Variables (Outcome Evaluation Measures) 
Between Intending Participants and Non-Participants in Clinical Trials 
VARIABLE OUTCOME EVALUATION 
SP _1 SP .J 
D ~ ~~d2 n ~ ~~dl ~ ~ ! ,2 
Getting info I re the study 328 2,76 (0,60) 207 2,62 (0,79) 2,12 ! ,035! <,10 
! 
Getting info, re the pills 327 2,78 (0,56) 207 2,63 (0,86) 2,20 ! ,029! <,10 
! ! 
Could ask for any info, 327 2,81 (0,59) 207 2,77 (0,60) 0,76 ! NS! -
! 
Worry if felt loff colour' 326 -0,53 (1,82) 206 -1,19 ( 1 ,82) 4,06 ! ,OOO! <,10 
Worry re side effects 326 -1 01 , (1 ,68) 207 -1,87 ( 1 ,66) 5,78 ! ,000 I < , 1 0 ! 
Contributing to knowledge 
which might benefit self 326 2,10 (0,98) 207 1,29 (1,34 ) 7,52 ! ,000 , 10! 
Contributing to knowledge 
which might benefit others 328 2,23 (0,97) 207 1.43 ( 1.26) 7.73 ,000 ,10 ! 
Serving as a 'Guinea Pig' 327 0,04 (1 ,68) 207 -1 ,67 ( 1 ,58) ! 11 ,82 ,000 .20! 
Worry re long-term effects 327 -1 18 , ( 1 ,63) 207 -2,01 ( 1 ,54) 5,79 ,000 <,10! 
Worry-acquired resistance 327 -0,76 (l ,57) 207 -1 ,49 ( 1 .46) 5,51 ,000 <,10! I 
Worry re Ibeing taken off ! 
good pi lIs I 326 -0 88 (1 ,56) 202 -1,48 (1.54 ) 4.28 ! . 000 ! < , 1 0 ! , 
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TABLE 5 Summary of T-Tests on Behavioural Belief Variables (Strength/Evaluation Cross-
Products) Between Intending Participants and Non-Participants in Clinical Trials 
VARIABLE OUTCOME STRENGTH/EVALUATION CROSSPRODUCT 
GP _1 GP _2 
n ~ ~Sdl D ~ ~5gl ! t I 12 ! 61 2 Getting info, re the study 328 5,32 (4,51) 207 2,96 ( 5 , 68 )! 5, 04 ! ,OOO! <,10 
I 
Getting info, re the pills 327 5,01 (4,53) 207 2,82 (5,63)! 4,72 ,000 <,10 
Could ask for any info, 327 6,54 (3,73) 207 4,57 (5,26)! 4,69 ,000 <,10 
I 
Worry if felt 'off colour ' I 326 -0,88 (4,67) 206 -2,33 (5,52) 3,13 ,002 <,10 
Worry re side effects 326 -1, 18 (3,72) 207 -4,07 (4,96) 7,18 ,000 <,10 
Contributing to knowledge 
which might benefit self 326 4,82 (3,30) 207 2,50 (3,65) 7,56 ,000 ,10 
Contributing to knowledge 
which might benefit others 328 5,47 (3,24) 207 3,15 (3,79) 7,26 ,OOO! <,10! 
Serving as a 'Guinea Pigl 327 0,35 (5,39) 207 -3,93 (5,18) 9,85 ,000 ,15! 
Worry re long-term effects 327 -2,03 (3,74) 207 -4,67 (4,67> 6,80 ,000 <,10! 
Worry-acquired resistance 327 -0,03 (3,16) 207 -1, 12 (4,23) 3,18 ! ,002 <,10! 
Worry re Ibeing taken off 
good pi lIs I 326 0,37 (3,99) 202 0,14 (4,96) ! 0,54 NS - I 
2~,7!2 O,Q2 ~=,QQQQ 
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APPENDIX 20 
DISCRIMINANT FUNCTION ANALYSIS 
SCREENING 
Table 6 below is a more detailed summary of the DFA shown in table 34 on 
page 155 in the main text. 
TABLE 6 DFA with Strongest Vs Weaker Positive Intention to Participate in Screening as the 
as Discriminant Groups; and Attitudes, Subjective Norms, Personal Norms 
and Behavioural Beliefs (Crossproduct values) as DiscriMinating Variables 
Actual Group Predicted Group 
Group 1 
Group 1(n=316) 81 ,8~ 
Grou~ 2(n=225) 21,8% 
Groyp 2 
8,2~ 
78,2% 
Percent of "grouped" cases correctly 
classified = 86, 14~ 
Wilks Standardised Pooled 
Lambda Canonical D,F, Within Group 
Correlations Correlations 
Personal Norm ,698 ,868 
,509 Personal AU, ,376 ,600 
XFFIT ,179 ,362 
XFDEF ,138 ,301 
Subj, Norm ,130 ,465 
XFEAT ,117 , 119 
XFDRINK -,009 ,004 
XFINFRM -,097 ,274 
XFPREVMS ,05S ,315 
XFSTRGHT -,049 ,196 
XFPEACE -,044 ,220 
XFLECT ,030 ,154 
XFTLDPMS ,029 ,298 
XFSMOKE ,016 ,053 
FXECERC ,011 ,046 
FXSPUR ,004 ,240 
Variables commencing XF represent crossproduct values for behavioural 
beliefs detailed in items 7 to 19 P 3 of the questionnaire (appendix 14). 
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CLINICAL TRIALS - • NEW PILLS' 
The following 2 tables are more detailed summaries of tables 36 & 38 on 
page 156 of the main text. 
NEWYES 1 = respondents who indicated some degree of positive intention to 
participate in clinical trials of 'new pills' 
NEWYES 2 = respondents who indicated some degree of negative intetion to 
participate 
NEWYESB 1 & 2 correspond to NEWYES but refer to participation in clinical 
trials of 'other pills' 
'Don't Know's were excluded from anlayis 
TABLE 7 Summary of DFA with NEWVES as Discriminant Groups and Attitudes, Subjective 
Norms, Personal Norms and Behavioural Beliefs (Crossproduct values) as 
Discriminating Variables 
Wi lks Standardised Pooled 
AI: tual Group Predicted Group Lambda Canonical D,F, Within Group 
Correlations Correlations 
grQ!'!~ 1 GrQ!'!~ , 
Group l(n=274) 91 ,6~ 8,4~ ,404 Personal Norm ,625 .866 
GrQY~ 2~D=2]A~ 16,S~ S~,2~ Att i tude ,342 ,730 
Percent of "grouped" cases cor rec tl y XFSEFFS .231 ,273 
classified = 76,27~ Subj, Norm ,199 ,588 
XFGPIG ,142 ,402 
XFCONTO -,125 ,286 
XFOFFCOL - 118 • ,123 
XFOFFGPS -.116 ,036 
XFCONTME .076 .308 
XFNOTWRK -,066 ,104 
XFASKINF ,027 ,186 
XFSTINFO ,020 ,192 
XFPINFO ,012 ,204 
XFLEFFS -.009 ,259 
t crossproduct values for behavioufdl 
N8 Variables commencing XF represen of the questionnaire {appendix 14). 
beliefs detailed in items 14 to 24 P 9 
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TABLE 8 Summary of DFA with NEWYES as Discriminant Groups and Behavioural Beliefs 
(Crossproduct values) as Discriminating Variables 
Wilks Standardised Pooled 
Actual Group Predicted Group Lambda Canonical D,F, Within Sroup 
Group 1 Group 2 
Group 1(n=276) 82,2~ 17,8i 
Groyp 2(n=217) 3] ,3i 68,7% 
Percent of "grouped" cases correctly 
classified = 76,27i 
,716 
Correlations Correlations 
XFGPIG ,624 
XFSEFFS ,387 
XFCONTME ,376 
XFOFFCOL - , 196 
XFOFFGPS-, 167 
XFPINFO ,150 
XFNTWRK -, 100 
XFCONTO ,097 
XFASKINF ,083 
XFLEFFS ,039 
XFSTINFO ,026 
,774 
,528 
,5S3 
,237 
,058 
,378 
,199 
,547 
,360 
,496 
,355 
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CLINICAL TRIALS - IOTHER PILLS I 
The following 3 tables relate to 'other pi lIs' and correspond to 'new 
pills' tables 36 to 38 shown on page 156 of the main text. 
TABLE 9 DFA with NEWVESB as Discriminant Groups and Attitudes, Subjective NorMs, Personal 
Normsand Behavioural Beliefs (Crossproduct values) as Discriminating Variables 
Wilks Standardised Pooled 
Actual Group Predicted Group Lambda Canonical D,F, Within Group 
Correlations Correlations 
grQ!.!j;1 ] GrQu~ 2 
Group 1(n=306) 93,S~ 6,2~ ,433 Personal Norm ,642 ,875 
grQUj;1 2~D=1~4~ ]9, U aQ,~1 Attitude ,367 ,742 
Percent of "grouped" cases correctly XFSEFFS ,270 ,296 
classified = SS,SO~ Subj, Norm ,137 ,579 
XFSTINFO ,132 ,223 
XFOFFCOL -,125 ,130 
XFCONTO - 105 , ,292 
XFOFFGPS -,097 ,044 
XFPINFO - 091 , ,218 
XFASKINF ,086 ,222 
XFGPIGS ,085 ,384 
XFLEFFS - 043 , ,273 
XFCONTI'IE ,034 ,291 
XFNTWRK -,0]2 ,123 
-89-
TABLE 10 Summary of DFA with NEWYESB as Discriminant Groups and Attitude, Subjective 
& Personal Norms as the IVs 
Actual Group 
Group 1(n=329) 
Group 2(n=210) 
Predicted Group 
Groyp 1 
92,71. 
21,0% 
Groyp 2 
7,3% 
79,0% 
Percent of "grouped" cases correctly 
classified = 87,38% 
Wilks 
Lambda 
,451 
Shndardi sed 
CaMnical D,F, 
Correlations 
Personal Norm ,664 
Attitude ,429 
Subjective Norm,130 
Pooled 
Within Group 
Correlations 
,903 
,762 
,568 
TABLE 11 DFA with NEWYESB as Discriminant Groups and Attitudes, Subjective Norms, Personal 
Normsand Behavioural Beliefs (Crossproduct values) as Discriminating Variables 
Wilks 
Predicted Group Lambda 
Groyp 1 Groyp 2 
Group 1(n=308) 85,7% 14,3% ,741 
Groyp 2(n=197) 38.1% 61,9% 
Percent of "grouped" cases correctly 
classified = 76,44% 
Standardised Pooled 
Canonical D,F, Within Group 
Correlations Correlations 
XFGPIG ,537 ,742 
XFSEFFS ,454 ,574 
XFCONTME ,266 ,553 
XFOFFCOL-,211 ,252 
XFCONTO ,182 ,559 
XFASKINF ,172 ,430 
XFOFFGPS-, 155 ,072 
XFSTI NFO ,153 ,417 
XFNTWRK -,060 ,237 
XFLEFFS ,044 ,527 
XFPINFO ,022 ,406 
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APPENDIX 21 
SAMPLING SOURCE T-TESTS 
Tab I es 12 and 13 give summar i es of samp ling source d if f erences re 1 a t i ng 
to participation in clinical trials of 'other' pills. The values given 
correspond to those relating to 'new' pills shown in tables 47 and 49 on 
pages 162 and 163 of the main text. 
Group 1 = respondents sampled from the electoral roll; Group 2 = respondents sampled from 
medical sources 
TABLE 12 Summary of T-Tests on Normative Beliefs and Perceived Likelihood of Trial 
Invitation Between Groups 1 and 2 as Detailed Above 
T-TEST VALUES 
VARIABLE 
GP _1 GP .J 
D ~ ~~d~ D ~ ~~d~ t ~ 
Personal Norm 314 -0,17 (2,11) 365 0,31 (2,02) -3,01 ! ,O03! 
Likel ihood of invitation 314 -1,91 ( 1,42) 365 -1,23 (1,81 ) -5,46! ,OOO! 
a2 
<,01 ! 
,04! 
TABLE 13 Summary of T-Tests Showing Significant Differences Between Groups 1 & 2 (above) 
Regarding Behavioural Belief Strength 
VARIABLE 
Getting info, re the study 
Getting info, re the pills 
Risk acquired resistance 
Might be taken off good pills 
BELIEF STRENGTH 
GP _1 
D x (sd) 
!318 1,40 (1,82) 
!318 1,34 (1,85 ) 
!318 0,72 (1,68) 
!316 0,46 (1,99) 
GP _2 
D x (sd) t 12 4)2 
!367 1,84 (1,59) -3,36! ,001 ! ,OIl 
!366 1 .74 (1,58) -3,09! ,O02! <,01 ! 
!366 0,32 (1,66) -3,13! ,O02! ,01 ! 
!358 -0,12 (2,01) 3,83! ,OOO! ,01 1 
